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Colorectal	anastomotic	healing:	why	the	biological	processes	that	lead	to	
anastomotic	leakage	should	be	revealed	prior	to	conducting	intervention	studies.	
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Background	
Colorectal	 cancer	 (CRC)	 is	 the	 fourth	 most	 common	 cause	 of	 cancer	 death	
worldwide,	estimated	to	be	responsible	for	694,000	deaths	in	20121.	The	number	of	
CRC	 patients	 is	 concomitantly	 increasing	 in	 the	 Netherlands	 due	 to	 a	 higher	
incidence,	 population	 growth,	 aging	 of	 the	 population	 and	 due	 to	 the	 recently	
established	nationwide	screening2.		
Surgery	 is	 the	 predominant	 curative	 treatment	 type	 for	 CRC,	 but	 has	 a	major	
impact	 on	 the	 patient’s	 wellbeing	 by	 demanding	 large	 amounts	 of	 metabolic	
reserves.	 Subsequently,	 surgery	 may	 lead	 to	 the	 development	 of	 frequently	
observed	and	severe	postoperative	complications.	Anastomotic	leakage	(AL)	is	the	
most	 important	 complication	 after	 colorectal	 surgery	 and	 has	 an	 incidence	 of	 8‐
15%	 in	 the	Netherlands3.	AL	 is	 associated	with	 a	 high	 short‐term	mortality,	with	
death	rates	of	up	to	40%4,5.	Although	many	attempts	have	been	made	to	prevent	AL,	
thus	 far	none	of	 the	proposed	 interventions	have	been	successful.	Despite	proper	
patient	 selection,	 reduction	 of	 known	 preoperative	 risk	 factors	 and	 improved	
surgical	techniques	as	well	as	introduction	of	‘fast	track’	protocols,	incidence	of	AL	
has	not	decreased	over	the	past	decade(s).		
Furthermore,	 AL	 is	 associated	 with	 a	 decreased	 disease‐specific	 survival	 in	
patients	 with	 CRC	 and	 an	 increased	 recurrence	 rate	 of	 CRC	 disease4,6‐8.	 The	
necessity	 to	 answer	 the	 question	 why	 some	 patients	 develop	 AL	 still	 remains,	
especially	with	the	current	incidence	of	CRC.		Previous	work	on	this	topic	together	
with	 findings	 from	 this	 thesis	 have	 led	 to	 a	 large	 observational	 study	 in	 patients	
(REVEAL)	which	aims	to	establish	and	validate	a	diagnostic	algorithm	for	the	pre‐
operative	 prediction	 of	 the	 development	 of	 AL	 using	 a	 combination	 of	
inflammatory,	immune‐related	and	genetic	parameters.	
Research	on	anastomotic	leakage	
Research	 on	 anastomotic	 leakage	 can	 be	 divided	 into	 clinical	 research	 and	 basic	
(translational)	 research,	 often	 performed	 in	 animal	 models.	 Basic	 (and	
translational)	 studies	 on	 AL	 have,	 for	 the	 largest	 part,	 been	 focusing	 on	
interventions	reducing	AL,	either	by	using	preventive	measures	that	mechanically	
supported	 the	 anastomosis	 or	 by	 accelerating	 the	 healing	 process	 of	 the	
anastomosis.	These	interventions	have	shown	to	reduce	the	effects	of	AL	in	animal	
models,	but	no	interventions	have	proven	their	value	in	the	clinical	setting.	Clinical	
research	 has	 predominantly	 focused	 on	 identifying	 risk	 factors	 of	 AL	 and	
accordingly	 aimed	 to	 eliminating	 or	 treat	 these	 risk	 factors.	 An	 overview	 of	 the	
pillars	of	research	on	anastomotic	leakage	can	be	found	in	Figure	1.1.	
Chapter	1	
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Figure	1.1				Research	themes	regarding	anastomotic	leakage.	
	
Animal	research	on	bowel	anastomoses		
In	an	ideal	world,	the	mechanisms	of	anastomotic	healing	are	investigated	in	a	true	
clinical	 model,	 the	 patient.	 In	 practice	 however,	 this	 is	 rather	 difficult	 except	 by	
retrospective	analysis.	Therefore	considerable	information	comes	from	knowledge	
obtained	from	animal	models,	despite	the	known	limitations	of	these	models.	
Animal	 research	 is	 regulated	 by	 international	 legislation	 regarding	 the	 use	 of	
animals	in	scientific	procedures	to	ensure	humane	treatment	of	the	animals.	There	
is	a	great	emphasis	 in	 the	scientific	community	on	minimising	use	of	animals	and	
improving	animal	welfare.	The	principles	of	the	3Rs	–	Replacement,	Reduction	and	
Refinement	–	are	a	useful	framework	for	humane	animal	research	and	the	ARRIVE	
guidelines	 aim	 to	 improve	 transparency	 in	 animal	 research	 together	 with	 more	
comparability	between	studies9.	
Replacement	can	be	achieved	by	using	alternative	methods,	for	example	in	vitro	
cells	or	even	complete	mini‐organs,	yet	this	latter	technique	uses	stem	cells	and	is	
still	 relatively	new	and	 therefore	not	used	on	a	 large	scale.	Also	reduction	can	be	
accomplished	using	new	techniques.	High	resolution‐imaging	mass	spectrometry	is	
such	a	new	technique	by	which	it	is	possible	to	visualize	the	spatial	distributions	of	
chemical	compositions,	such	as	proteins	or	metabolites.	Since	more	information	is	
obtained	 at	 once	 with	 this	 technique,	 less	 tissue	 and	 thus	 fewer	 animals	 are	
required	to	answer	specific	research	questions.		
	 General	introduction	
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The	use	of	animals	for	studies	into	(patho)‐physiology	of	bowel	anastomoses	is	
highly	 valuable	 since	 numerous	 study	 results	 can	 be	 translated	 to	 the	 human	
setting.	 Clinical	 observations	 can	 be	 investigated	 in	 depth	 and	 standardized	 in	
animal	models	and	solutions	can	be	designed	to	aid	patients	in	the	future.	However,	
the	 quality	 of	 animal	 studies	 can	 be	 significantly	 improved	 when	 researchers	
become	more	 transparent	 about	 their	 methods,	 provide	 detailed	 information	 on	
their	models	and	share	their	negative	results.		
If	researchers	could	come	to	consensus	on	what	is	acceptable	in	animal	research	
and	 more	 importantly,	 what	 are	 the	 best	 suited	 animal	 models,	 how	 should	
randomization	happen	and	what	are	the	minimum	requirements	to	provide	enough	
information	regarding	animal	experiments,	this	would	lead	to	more	reproducibility	
and	comparability	between	studies.	This	can	also	lead	to	more	refined	experimental	
studies,	 since	 methods	 become	 clear	 down	 to	 the	 last	 detail.	 Unfortunately,	
publication	bias	still	exists	resulting	in	a	discrepancy	between	the	amount	of	animal	
experiments	 performed	 and	 the	 amount	 actually	 reported.	 This	 results	 in	 re‐
performing	 studies	 by	different	 research	 groups	 and	unnecessary	use	 of	 animals.	
Despite	 the	 fact	 that	 specific	 journals	 have	 been	 established	 with	 a	 focus	 on	
negative	results,	 the	scientific	community	does	not	yet	endorse	the	 importance	of	
publishing	these	results10.	
Preventive	measures	for	colorectal	anastomotic	
leakage	
Considerable	 attempts	 have	 been	 made	 to	 prevent	 AL	 after	 colorectal	 surgery,	
either	 by	 enhancing	 the	 healing	 process	 through	 different	 pharmaceutical	
approaches,	 mechanically	 strengthen	 the	 anastomosis	 or	 by	 preventing	 the	
sequelae	of	 leakage	with	 specific	 intraluminal	devices.	Especially	 the	 last	 two	are	
currently	under	extensive	investigation.	
In	2011,	Morks	and	colleagues	provided	an	overview	on	strategies	that	prevent	
or	 reduce	 the	 	 anastomotic	 leakage	 rate	by	means	of	a	device.	Morks	divided	 the	
devices	 found	 in	 the	 literature	 into	 transanal	 decompression,	 intraluminal,	 and	
biodegradable	 protective	 devices11.	 Generally	 these	 devices	 showed	 promising	
results	 in	animals	 studies,	but	 failed	 to	do	so	 in	 the	clinical	 setting.	Some	devices	
such	as	the	Coloshield	seemed	to	have	great	potential,	but	have	never	been	widely	
accepted11.		
In	 the	 last	 5	 years,	 several	 new	 devices	 have	 been	 developed	 to	 reduce	 AL.	
Nevertheless,	 in	current	practice	not	a	single	of	these	devices	are	standardly	used	
during	colorectal	surgery.	Many	of	these	devices	work	as	faecal	diverting	methods,	
such	as	tube	ileostomy	or	transanal	tube	placement	and	were	successfully	tested	in	
several	patients12‐14.	A	disadvantage	of	the	aforementioned	devices	is	that	the	tubes	
Chapter	1	
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have	 to	 be	 removed	again	 at	 some	point.	 Recently,	 a	promising	degradable	 drain	
was	tested	in	a	clinical	trial	(C‐Seal)	but	this	study	was	stopped	preliminary	after	an	
interim	 analysis	 because	 there	 were	 no	 significant	 differences	 between	 the	
intervention	group	and	the	control	group15.		
Besides	 reducing	 the	 clinical	 burden	 of	 AL,	 research	 has	 also	 focused	 on	
mechanically	supporting	anastomoses.	One	of	the	most	promising	tools	to	enhance	
colorectal	 anastomoses	 seems	 to	 be	 tissue	 adhesives.	 Several	 sorts	 of	 tissue	
adhesives	have	been	tested	(see	also	Chapter	7)	and	this	has	led	to	the	conclusion	
that	 fibrin‐based	 glues	 do	 not	 have	 a	 positive	 influence	 on	 the	 healing	 of	
gastrointestinal	 anastomoses16.	 Cyanoacrylate‐based	 adhesives	 however,	 seem	 to	
have	a	beneficial	effect	on	the	mechanical	strength	ex	vivo	and	a	positive	influence	
on	anastomotic	healing,	even	in	an	inflamed	animal	model17‐18.	These	types	of	tissue	
adhesives	are	currently	under	investigation	for	gastric	varices19,	but	no	results	have	
been	reported	coming	from	human	studies	regarding	cyanoacrylate	and	colorectal	
anastomoses.	Furthermore,	new	compounds	were	developed	–	 for	example	based	
on	polyethylene	glycol	‐	and	have	made	it	through	feasibility	studies	 in	humans20.	
This	specific	area	within	the	field	of	research	on	colorectal	anastomosis	is	emerging	
and	time	will	tell	if	these	promising	results	will	lead	to	a	significant	change	in	daily	
practice.	
There	are	 several	 risks	 related	to	 the	use	of	 tissue	adhesives.	 It	 is	known	that	
tissue	 adhesives	 can	worsen	morbidity	 and	mortality	 caused	 by	 a	 severe	 foreign	
body	 reaction	 and	 increased	 fibrosis	 at	 the	 anastomotic	 site21.	 This	 reaction	 can	
interfere	 with	 the	 balance	 between	 collagen	 synthesis	 and	 lysis,	 the	 so‐called	
collagenous	equilibrium	that	is	critical	to	anastomotic	repair22.	A	simplified	model	
of	 this	 balance	 between	 collagen	 synthesis	 and	 lysis	 is	 depicted	 in	 Figure	 1.2.	 In	
addition,	 tissue	 adhesives	 can	 cause	 adhesions	 to	 the	 anastomotic	 site	 from	
surrounding	 fat	 tissue	 or	 intestines,	 which	 in	 turn	 can	 lead	 to	 mechanical	
obstruction	and	subsequent	ileus.	Complications	related	to	postoperative	adhesion	
formation	 are	 frequent,	 have	 a	 large	 negative	 effect	 on	 patients'	 health,	 and	
increase	workload	 in	 clinical	 practice23.	Therefore,	 several	prophylactic	measures	
have	been	developed	 to	prevent	 adhesion	 formation24.	 Again,	 these	 anti‐adhesive	
agents	 have	 not	 entered	 widespread	 clinical	 use	 because	 of	 concerns	 regarding	
possible	 interference	with	anastomotic	healing25.	Hence,	 the	effect	of	prophylactic	
measures	for	adhesion	prevention	on	anastomotic	healing	should	always	be	tested.	
Discussion	points	in	anastomotic	healing		
While	 there	 is	 an	 on‐going	 increase	 in	 experimental	 studies	 being	 published	
regarding	AL,	the	majority	of	these	articles	lack	in	providing	details	on	anastomotic	
healing.	 Moreover,	 the	 study	 endpoints	 mainly	 provide	 information	 on	 1)	 a	
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reduction	 in	 AL	 rate	 or	 2)	 an	 increase	 in	 bursting	 pressure.	 Although	 these	
endpoints	 are	 generally	 accepted	 in	 the	 literature,	 we	 wonder	 if	 these	 outcome	
measures	 truly	 are	 surrogate	 markers	 for	 anastomotic	 healing.	 Furthermore,	
numerous	 researchers	 draw	 direct	 parallels	 between	 anastomotic	 healing	 and	
cutaneous	 wound	 healing,	 but	 are	 these	 processes	 indeed	 comparable	 or	 should	
they	be	considered	as	two	separate	physiological	processes?		
Additionally,	 it	 is	 difficult	 to	 come	 up	 with	 new	 treatment	 strategies	 or	
preventive	 measures	 in	 order	 to	 decrease	 AL	 when	 the	 pathophysiology	 of	
anastomotic	 healing	 is	 largely	 unknown.	 The	 focus	 of	 research	 on	 bowel	
anastomoses	should	therefore	be	redirected	from	prophylactic	interventions	tested	
on	 animals	 towards	 studies	 that	 unravel	 the	 processes	 of	 normal	 anastomotic	
healing.	 This	 should	 include	 identification	 of	 essential	 factors	 and	 possible	
deficiencies	 in	 these	 factors	 that	 cause	 disruption	 of	 the	 anastomotic	 healing	
process,	and	consequently	AL.			
To	date,	no	consensus	has	been	reached	among	researchers	on	1)	which	layer	of	
the	 bowel	 wall	 is	 most	 important	 in	 anastomotic	 healing,	 2)	 if	 gastrointestinal	
healing	 can	 be	 compared	 to	 cutaneous	 healing,	 3)	 if	 bacteria	 play	 a	 role	 in	 the	
pathogenesis	 of	 anastomotic	 leakage,	 and	 4)	 if	 surrogate	 markers	 truly	 provide	
information	regarding	anastomotic	healing,	probably	due	to	a	lack	of	knowledge	on	
these	subjects.	The	majority	of	experienced	surgeons	and	scientists	believe	that	the	
most	common	cause	of	AL	is	still	unknown26;	resulting	in	on‐going	research	using	
several	 animal	 models.	 In	 our	 view	 this	 is	 not	 appropriate	 since	 an	 insightful	
understanding	 of	 the	 molecular	 and	 biochemical	 pathways	 of	 intestinal	
anastomotic	 healing	 is	 crucial	 before	 animal	 studies	 with	 evidence‐based	
interventions	to	prevent	AL	can	be	initiated.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.2		Collagenous	equilibrium	that	is	critical	for	anastomotic	healing.	
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The	role	of	different	tissue	layers	in	anastomotic	
healing		
The	bowel	wall	of	the	colon	consists	of	four	layers:	mucosa,	submucosa,	muscularis	
propria	and	serosa.	Whenever	a	colorectal	resection	is	performed,	all	 these	layers	
are	 transsected	and	an	anastomosis	can	be	constructed.	Although	surgeons	 in	the	
past	opted	for	suturing	either	the	serosa	(Lembert	1826),	the	serosa	together	with	
the	 mucosal	 surface	 (Czerny	 1881)	 or	 the	 submucosa	 (Halstead	 1887),	 modern	
techniques	for	creating	an	anastomosis	such	as	stapler	devices	make	no	distinction	
and	involve	all	these	layers27.	
Evidence	demonstrating	any	superiority	of	stapled	over	hand‐sewn	techniques	
in	 colorectal	 anastomosis	 surgery	 is	 lacking,	 regardless	 of	 the	 level	 of	
anastomosis28.	Besides	suture	methods,	the	configuration	of	the	suture	bite	may	be	
of	interest.	Both	full‐thickness	and	sero‐submucosal	sutures	seem	to	be	sufficient	to	
anatomically	 apposition	 both	 sides	 of	 the	 bowel,	 thereby	 promoting	 wound	
healing29.	 However,	 studies	 reporting	 on	 suture	 bites	 are	 rare	 and	 could	 be	 of	
particular	 interest.	 It	 can	 be	 hypothesized	 that	 the	 submucosa	 of	 the	 bowel	 is	 of	
great	importance	in	anastomotic	healing	since	it	is	a	though	fibrous	layer	consisting	
mainly	of	collagen	and	elastin	fibers	and	has	the	greatest	tensile	strength	of	the	four	
layers30.	Indeed,	the	submucosal	layer	is	the	source	of	fibroblasts	that	are	activated	
after	 gastrointestinal	 surgery	 and	 start	 to	 deposit	 collagen.	 In	 an	 experimental	
model	 Daams	 and	 colleagues	 showed	 that	 healing	 of	 an	 everting	 anastomosis	
occurred	by	formation	of	a	fibrotic	cap	at	the	serosal	side,	functioning	as	a	matrix	
for	fibroblasts31.	This	is	in	accordance	with	the	first	stage	of	classic	wound	repair:	
inflammation.	Here,	a	fibrin	matrix	is	formed	as	part	of	haemostasis,	which	serves	
as	a	scaffold	 for	 infiltrating	cells32.	However,	 the	role	of	 the	mucosa	 is	completely	
neglected	 in	 anastomotic	 healing	 when	 the	 submucosa	 is	 considered	 the	 most	
important	layer.		
In	 the	early	90s,	 it	has	been	demonstrated	 that	 an	anastomosis	 causes	a	deep	
and	long	lasting	reduction	in	energy	metabolism,	especially	in	the	mucosa	and	the	
muscle	 layers33.	 The	 function	 of	 the	 mucosa	 in	 anastomotic	 healing	 and	 leakage	
should	not	be	disregarded	and	may	even	play	a	more	important	role	than	currently	
recognized.	 Partly	 because	 bacteria	 house	 in	 the	 mucus	 of	 the	 colon	 and	 these	
bacteria	 are	 proposed	 as	 one	 of	 the	 causal	 factors	 in	 AL,	which	 occurs	when	 the	
healing	process	is	disrupted34,35.	In	addition,	our	data	showed	that	Muc2	knockout	
mice	are	more	prone	to	the	development	of	AL	than	control	mice,	indicating	that	a	
normal	 functioning	 mucus	 layer	 is	 essential	 for	 anastomotic	 healing	 (see	 also	
Chapter	 5).	 Furthermore,	 macrophages	 in	 the	 gastrointestinal	 mucosa	 represent	
the	largest	pool	of	tissue	macrophages	in	the	body	and	a	long‐lasting	macrophage	
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absence	 or	 dysfunction	 impairs	 anastomotic	 healing36,37.	Macrophages	 are	 one	 of	
the	main	factors	in	the	inflammatory	response,	and	based	on	their	behaviour,	this	
response	 is	 either	 pro‐inflammatory	 (M1)	 impairing	 wound	 healing	 or	 anti‐
inflammatory	 (M2)	 promoting	 wound	 healing;	 a	 shift	 in	 the	 M2/M1	 index	 can	
influence	 the	 outcome	 of	 anastomotic	 healing38.	 The	 interaction	 between	
intraluminal	content	and	 the	distinct	 layers	of	 the	bowel	wall	with	 their	 separate	
cell	types	and	function,	may	be	key	in	unravelling	the	healing	process.		
In	 summary,	 all	 layers	 of	 the	 bowel	 wall	 seem	 to	 have	 a	 role	 in	 anastomotic	
healing.	The	 submucosa	consists	of	 connective	 tissue	and	has	 the	greatest	 tensile	
strength	 of	 the	 four	 layers.	 Moreover,	 the	 serosa	 seems	 to	 be	 important	 in	
providing	 a	matrix	 for	 fibroblasts,	while	 the	 interaction	 between	 bacteria,	mucus	
and	 the	 mucosal	 layer	 also	 seem	 important	 to	 maintain	 homeostasis	 in	 which	
anastomotic	 healing	 can	 occur.	 The	 focus	 of	 research	 into	 anastomotic	 healing	
should	lie	on	transmural	evaluation	of	the	healing	process	and	interaction	between	
layers	of	the	bowel	wall,	which	was	the	aim	of	Chapter	3	of	this	thesis.	
Gastrointestinal	healing	versus	cutaneous	healing	
Although	it	is	often	believed	that	all	tissue	types	heal	in	a	similar	fashion,	this	is	not	
entirely	 true.	 Already	 in	 1997,	 it	 was	 stated	 by	 Thornton	 that	 unlike	 cutaneous	
healing,	 healing	 of	 the	 gastrointestinal	 tract	 ‐	 more	 specifically	 the	 intestinal	
anastomosis	 ‐	 is	 anatomically	 obscured	 from	 inspection,	 allowing	 the	 surgeon	 to	
judge	 the	 success	 of	 the	 operation	 only	 on	 the	 patient’s	 parameters	 of	 general	
wellbeing39.	Not	only	is	this	bothersome	in	daily	practice,	it	may	also	be	part	of	the	
explanation	that	knowledge	of	gastrointestinal	healing	is	lagging	behind	compared	
to	skin	wound	healing.		
The	 classic	 phases	 of	 wound	 healing	 (inflammation,	 proliferation	 and	
remodelling)	 have	 been	 studied	 extensively	 in	 skin40	 and	 many	 researchers	
describe	gastrointestinal	healing	in	terms	of	these	phases29,41.	It	is	true	that	these	3	
phases	 exist	 in	 all	 types	 of	 tissue,	 however,	 there	 are	 significant	 differences	
between	skin	and	gastrointestinal	healing42.	These	differences	relate	to	factors	such	
as	collagen	type,	collagenase	activity,	wound	strength	and	wound	environment.		
First	of	all,	collagen	subtypes	in	the	gastrointestinal	tract	(I,	III,	V)	are	produced	
by	 fibroblasts	 and	 smooth	muscle	 cells	 compared	 to	 the	 skin	where	 solely	 type	 I	
and	III	are	produced	by	fibroblasts.	Collagenase	activity	plays	an	important	role	in	
the	healing	of	anastomoses,	where	a	high	activity	causes	collagen	lysis	that	results	
in	low	anastomotic	strength	early	after	the	formation	of	an	anastomosis43.	Wound	
healing	 is	 far	more	 rapid	 in	 the	gastrointestinal	 tract	 than	 in	 the	skin	despite	 the	
potential	risks	such	as	shear	stress,	bacteria	possibly	affecting	anastomotic	healing	
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and	 changes	 in	 vascular	 perfusion	 that	 are	 more	 abundant	 in	 the	 intestinal	
environment39,43.	
The	 serosal	 layer	 plays	 an	 important	 role	 in	 terms	 of	 strength	 of	 the	 wound	
while	 there	 is	 no	 equivalent	 component	 in	 cutaneous	 healing.	 Not	 only	 are	 the	
components	 not	 similar,	 the	 reaction	 of	 both	 tissues	 also	 differs.	 For	 example,	
Törkvist	 and	 colleagues	 tried	 to	 block	 CD18‐dependent	 neutrophil	 infiltration	 to	
improve	wound	healing	and	concluded	that	neutrophils	may	 influence	the	wound	
healing	process	differently	in	specific	organs,	based	on	diverse	results	 in	skin	and	
intestinal	 tract44.	 One	 of	 the	 explanations	 for	 their	 different	 results	 may	 lie	 in	
differences	 between	 cutaneous	 and	 intestinal	 collagen	 synthesis45,	 however,	 also	
the	skin	flora	and	gut	microbiota	vary	completely,	which	can	play	an	important	role	
in	differences	in	wound	healing46,47.	
In	 conclusion,	 gastrointestinal	 –	 and	 more	 specifically	 anastomotic	 –	 healing	
differs	 significantly	 from	 cutaneous	 healing.	 Although	 there	 are	 similarities,	
especially	 in	the	phases	of	wound	healing,	one	cannot	directly	compare	these	two	
processes	and	therefore,	gastrointestinal	anastomotic	healing	should	be	considered	
a	separate	entity	that	needs	to	be	investigated	in	more	detail.		
The	involvement	of	bacteria	in	the	pathogenesis	of	
anastomotic	leakage	
From	experimental	studies,	evidence	suggests	a	positive	effect	of	antibiotics	on	the	
strength	of	colonic	anastomosis48,49.	This	implicates	that	when	certain	bacteria	are	
being	inhibited,	this	actually	enhances	anastomotic	healing.	Alverdy	and	colleagues	
have	been	 investigating	 this	hypothesis	 for	 some	 time	and	proposed	a	 significant	
role	 for	bacteria	 in	 the	pathophysiology	of	AL	 in	201350.	Over	 the	past	 few	years,	
they	 have	 shown	 that	 virulent	 bacteria	 with	 high	 collagenase	 activity	 may	
contribute	 to	 the	 development	 of	 AL34.	 The	 interaction	 between	 intraluminal	
content	and	 the	 several	 layers	of	 the	bowel	wall	may	be	key	 in	 the	physiology	of	
anastomotic	healing.	Since	bacteria	reside	in	the	colonic	mucus	layer,	they	could	be	
the	reason	why	mice	without	normal	mucus	composition	suffered	more	from	AL,	as	
stated	previously.	 In	addition,	 it	has	been	shown	that	butyrate,	a	short‐chain	fatty	
acid	(SCFA)	produced	by	microbiota	can	strengthen	colonic	anastomoses	in	rats51.	
Already	 in	 1973,	 it	 was	 demonstrated	 by	 Levison	 that	 SCFAs	 inhibited	 in	 vitro	
growth	of	P.	Aeruginosa52	 exactly	 the	pathogen	 that	was	 later	 identified	 as	 being	
able	to	transform	into	tissue	destroying	phenotype	with	high	collagenase	activity35.	
It	 seems	undeniable	 that	bacteria	play	a	role	 in	 the	pathogenesis	of	AL.	However,	
clinical	 implications	 for	 these	 findings	 are	 lacking.	 It	 remains	 to	 be	 elucidated	
whether	eliminating	bacteria	by	perioperative	antibiotics	or	promoting	the	growth	
of	 certain	 species	 with	 probiotics	 can	 improve	 anastomotic	 healing.	 Eliminating	
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bacteria	 and	 faeces	 from	 the	 colon	 prior	 to	 surgery	 can	 be	 achieved	 with	
mechanical	bowel	preparation.	Nevertheless,	mechanical	bowel	preparation	–	that	
was	traditionally	used	together	with	oral	antibiotics	–	did	not	show	any	beneficial	
effect	 according	 to	 several	 randomized	 trials	 and	 was	 therefore	 abandoned.	
Nonetheless,	 a	 recent	 study	 attempted	 to	 clarify	 the	 effect	 of	 mechanical	 bowel	
preparation	with	or	without	antibiotics53,	using	a	large	retrospective	cohort.	Since	
the	use	of	oral	antibiotics	alone	has	not	been	investigated	in	the	majority	of	these	
studies,	 there	 is	 not	 enough	 evidence	 to	 conclude	 anything	 regarding	 oral	
antibiotics	independently	of	mechanical	bowel	preparation.		
In	summary,	given	the	available	data,	there	seems	to	be	a	role	for	bacteria	in	the	
pathogenesis	 of	 anastomotic	 leakage.	 More	 research	 is	 needed	 to	 completely	
elucidate	 this	 role	 and	 the	 interaction	 of	 microbiota	 with	 specific	 cells	 and	
components	at	the	anastomotic	site.			
Surrogate	markers	of	anastomotic	healing	
The	 most	 frequently	 used	 surrogate	 marker	 for	 anastomotic	 healing	 in	 animal	
models	is	bursting	pressure	(BP).	Although	there	are	many	methods	to	test	BP,	it	all	
comes	down	to	inflating	or	filling	the	bowel	segment	including	the	anastomotic	site	
and	 measuring	 the	 intraluminal	 pressure	 at	 which	 either	 air	 or	 fluid	 leakage	 is	
observed	 at	 the	 site	 of	 the	 anastomosis.	 While	 this	 outcome	 measure	 has	 been	
debated	 for	 possibly	 disrupting	 tissue	 samples,	 making	 histological	 evaluation	
difficult	and	 though	critics	have	stated	 that	BP	 is	not	a	 relevant	 indicator	 since	 it	
can	not	be	applied	for	a	anastomosis	that	has	already	leaked54;	it	is	still	considered	
appropriate	by	researchers	in	the	field	since	it	offers	an	actual	surrogate	outcome:	
anastomotic	 strength	 (see	 also	 Chapter	 2).	 Quantitative	 comparison	 of	 BP	 is	 not	
valid	 between	 studies,	 since	 the	 protocols	 and	 instruments	 vary	 tremendously;	
therefore,	only	BP	values	can	be	directly	compared	between	experimental	groups	in	
the	same	study55.	Other	mechanical	 tests	such	as	measurement	breaking	strength	
or	tensile	strength	are	extensively	criticized	for	either	being	not	sensitive	enough	to	
measure	 in	 the	 early	 healing	 phase	 and	 because	 of	 the	 technical	 difficult	
implementation57.			
Histological	 healing	 parameters	 are	 often	 reported	 in	 experimental	 studies	
investigating	 gastrointestinal	 anastomoses,	 mostly	 by	 grading	 scales	 including	
factors	such	as	inflammatory	cell	infiltration,	fibroblast	activity,	collagen	deposition	
and	 vascularity	 or	 neoangiogenesis,	 factors	 that	 are	 mainly	 based	 on	 cutaneous	
wound	 healing29,56‐58.	 These	 parameters	 are	 considered	 helpful	 in	 evaluating	 the	
general	wound	healing	process	at	the	anastomotic	site.	However,	a	limitation	may	
be	that	to	 investigate	the	true	 leak	 in	the	anastomotic	 line,	histological	evaluation	
has	to	be	performed	right	at	the	spot	of	the	leak.		
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In	wound	healing,	fibroblasts	replace	the	provisional	matrix	that	is	established	
during	 inflammation	 with	 collagen‐rich	 granulation	 tissue	 making	 collagen	 an	
interesting	marker	 for	anastomotic	healing30.	Therefore,	other	potential	surrogate	
markers	are	analyses	 that	measure	collagen	content,	synthesis	and	degradation59.	
Quantification	of	collagen	is	often	performed	by	measuring	hydroxyproline	content,	
since	 this	 amino	 acid	 is	 found	 in	 few	 proteins	 other	 than	 collagen22.	 Although	
hydroxyproline	content	is	considered	informative	about	the	amount	of	collagen,	 it	
does	not	provide	information	on	collagen	subtypes,	the	maturity	of	the	collagen	and	
therefore	not	necessarily	 the	 tissue	 strength,	 since	 this	 lies	more	 in	 the	 type	 and	
quality	of	collagen	present	 in	the	anastomotic	tissue60‐62.	Picro	Sirius	Red	staining	
combined	with	digital	 imaging	to	analyse	the	percentage	of	collagen	type	I	and	III	
can	demonstrate	the	ratio	between	young	and	mature	collagen51,63.	A	disadvantage	
of	 this	 technique	 ‐	 and	 all	 immunohistochemistry	 analyses	 ‐	 is	 that	 it	 is	 a	 non‐
quantitative	method,	nevertheless	it	does	locate	the	specific	site	in	the	tissue	where	
the	deposition	of	collagen	occurs	and	current	computer	imaging	techniques	can	aid	
in	the	quantification	of	different	subtypes	of	collagen64.	Collagen	degradation	can	be	
mediated	 through	Matrix	Metalloproteinases	 (MMP)	 resulting	 in	 loosening	 of	 the	
matrix	that	may	result	in	AL65.	This	collagenase	activity	of	MMPs	–	especially	MMP9	
is	 associated	 with	 AL	 –	 can	 be	 measured	 by	 quantitative	 gelatin	
zymography34,51,66,67.	 Again	 the	 statement	 of	 the	 spatial	 and	 regional	 context	 of	
measuring	 bacteria	 and	 inflammatory	 mediators	 applies	 here;	 in	 grinding	 up	
tissues	 you	 are	 getting	 the	 average	 of	 the	 entire	 tissue	 sample,	 while	 the	 most	
important	measure	is	likely	to	be	right	at	the	site	of	the	necrosis	and	leak.	However,	
it	has	been	demonstrated	that	it	 is	possible	to	distinguish	between	changes	in	the	
composition	 of	 the	 intestinal	 microbiota	 associated	 with	 anastomotic	 tissue	 and	
microbiota	associated	with	luminal	contents68.		
In	 summary,	 frequently	 used	 surrogate	 markers	 for	 anastomotic	 healing	 in	
animal	 models	 are	 bursting	 pressure,	 tensile	 strength	 and	 a	 generic	 histological	
examination.	 Other	 additional	 analyses	 are	 used	 to	 answer	 specific	 research	
question,	 but	 new	 techniques	 are	 necessary	 to	 obtain	 more	 insight	 in	 the	
anastomotic	healing	process.		
Aim	and	outline	of	this	thesis	
Although	this	thesis	does	not	provide	indisputable	answers	to	the	discussion	points	
described	 above,	 it	 does	 provides	 new	 insights	 into	 research	 on	 anastomotic	
leakage.	 This	 thesis	 is	 divided	 into	 four	parts	 and	describes	discernments	 gained	
from	 animal	 studies	 regarding	 bowel	 anastomoses	 in	 the	 lower	 gastrointestinal	
tract.	
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In	 Part	 I,	 the	 use	 of	 animal	 models	 for	 anastomotic	 healing	 in	 the	 lower	
gastrointestinal	tract	is	investigated.	A	systematic	review	of	the	literature	is	given	
providing	an	overview	of	recent	literature	combined	with	recommendations	from	a	
recent	 Delphi	 analysis	 (Chapter	 2).	 These	 recommendations	 enable	 future	
researchers	to	perform	their	research	in	such	a	way	that	it	is	more	comparable	with	
other	animal	studies	and	more	translatable	to	the	human	setting.	Furthermore,	new	
imaging	 techniques	 make	 it	 possible	 to	 focus	 more	 in	 depth	 on	 the	 process	 of	
anastomotic	 healing	 using	 mass‐spectrometry‐imaging	 (Chapter	 3)	 reducing	 the	
amount	of	animals	needed	to	obtain	a	broad	range	of	information.		
	
Part	II	focuses	on	the	identification	of	risk	factors	for	anastomotic	leakage.	It	is	
known	 from	 clinical	 practice	 that	 the	 perioperative	 use	 of	 non‐steroidal	 anti‐
inflammatory	drugs	increases	the	risk	of	developing	anastomotic	leakage,	possibly	
due	to	the	inhibition	of	Cyclooxygenase‐2		(COX‐2).	The	role	of	COX‐2	in	colorectal	
anastomotic	 healing	 (Chapter	 4)	 as	 well	 as	 the	 necessity	 of	 normal	 mucus	
composition	(Chapter	5)	is	investigated	using	knockout	mice	model.		
	
The	aim	of	Part	III	is	to	reduce	anastomotic	leakage	rate	in	animal	models	using	
several	 different	 interventions.	 The	 positive	 effect	 of	 butyrate	 on	 the	 strength	 of	
colorectal	 anastomosis	 was	 already	 known,	 so	 new	 approaches	 –	 which	 are	
described	 in	Chapter	6	 –	 are	 necessary	 to	make	 the	 translation	 into	 the	 human	
setting.	In	Chapter	7,	the	use	of	glues	to	reduce	anastomotic	leakage	in	a	rat	model	
was	investigated	in	collaboration	with	colleagues	from	the	Erasmus	Medical	Center	
in	Rotterdam.	
	
In	Part	IV	the	balance	between	anastomotic	healing	and	adhesion	formation	is	
investigated.	With	new	approaches	to	prevent	adhesions	after	abdominal	surgery,	
there	may	be	a	potential	risk	of	disrupting	the	normal	anastomotic	healing	process.	
Therefore,	it	is	important	to	investigate	the	effect	of	such	anti‐adhesion	barriers	on	
colorectal	 anastomoses	 in	animals	 (Chapter	8).	Also	 the	use	of	new	biomaterials	
can	 have	 a	 negative	 effect	 on	 the	 abdominal	 environment	 that	 may	 cause	 a	
disruption	in	normal	healing	processes	(Chapter	9).		
Chapter	10	summarizes	the	main	results	and	contributions	as	presented	in	this	
thesis;	 it	 depicts	 future	 perspectives	 and	 implications	 for	 further	 experimental	
research	and	clinical	applications.		
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Abstract	
Purpose	
This	project	aimed	to	reach	consensus	on	the	most	appropriate	animal	models	and	outcome	
measures	 in	 research	 on	 anastomoses	 in	 the	 lower	 gastrointestinal	 tract	 (GIT).	 The	
physiology	of	 anastomotic	 healing	 remains	 an	 important	 research	 topic	 in	 gastrointestinal	
surgery.	Recent	results	 from	experimental	studies	are	 limited	with	regard	to	comparability	
and	clinical	translation.		
	
Methods	
PubMed	 and	 EMBASE	 were	 searched	 for	 experimental	 studies	 investigating	 anastomotic	
healing	in	the	lower	GIT	published	between	January	1,	2000	‐	December	31,	2014	to	assess	
currently	used	models.	All	 corresponding	authors	were	 invited	 for	a	Delphi‐based	analysis	
that	consisted	of	2	online	survey	rounds	followed	by	a	final	online	recommendation	survey	
to	reach	consensus	on	the	discussed	topics.	
	
Results		
277	original	articles	were	retrieved	and	167	articles	were	included	in	the	systematic	review.	
Mice,	 rats,	 rabbits,	 pigs	 and	 dogs	 are	 currently	 being	 used	 as	 animal	models,	with	 a	 large	
variety	in	surgical	techniques	and	outcome	measures.		
Forty‐four	 corresponding	 authors	participated	 in	 the	Delphi	 analysis.	 In	 the	 first	2	 rounds	
39/44	and	35/39	participants	completed	the	survey.	In	the	final	meeting	35	experts	reached	
consensus	on	76/122	 items	 in	6	categories.	Mouse,	rat	and	pig	are	considered	appropriate	
animal	 models;	 rabbit	 and	 dog	 should	 be	 abandoned	 in	 research	 regarding	 bowel	
anastomoses.	ARRIVE	guidelines	should	be	followed	more	strictly.	
	
Conclusions	
Consensus	 was	 reached	 on	 several	 recommendations	 for	 the	 use	 of	 animal	 models	 and	
outcome	 measurements	 in	 research	 on	 anastomoses	 of	 the	 lower	 GIT.	 Future	 research	
should	take	these	suggestions	into	account	to	facilitate	comparison	and	clinical		
translation	of	results.	
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Introduction	
Anastomotic	leakage	(AL)	is	one	of	the	most	dreaded	complications	after	colorectal	
surgery	 and	 leads	 to	 high	 morbidity	 and	 mortality1,2.	 Despite	 accumulated	
knowledge,	improvement	of	surgical	techniques	and	ongoing	research	on	this	topic,	
the	incidence	of	colorectal	AL	remains	approximately	11%	worldwide3.		
	
Animal	models	are	used	on	a	regular	basis	 to	 investigate	normal	healing	of	an	
intestinal	anastomosis	as	well	as	leakage	of	the	anastomosis.	These	animal	models	
are	 vital	 for	 our	 understanding	 of	 anastomotic	 healing	 and	 introduction	 of	 new	
therapies	 for	reduction	of	AL.	However,	over	 the	past	decades	a	variety	of	animal	
models	 have	 been	 used	 which	 leads	 to	 heterogeneity,	 accompanied	 by	 differing	
anatomy	and	physiology	between	species.	Recently,	a	systematic	review	concluded	
that	 animal	 research	on	AL	 is	 of	 poor	quality	 and	 improvement	 is	needed	before	
results	can	be	translated	into	the	human	setting4.		
	
In	 addition	 to	 the	 variety	 of	 animal	models,	 a	 wide	 range	 of	 study	 endpoints	
and/or	 goals	 is	 used.	 The	 majority	 of	 studies	 examined	 the	 effect	 of	 a	 certain	
intervention	on	anastomotic	healing,	for	example	aiming	at	improving	anastomotic	
strength	 or	 reducing	 leakage	 rate	 in	 models	 of	 insufficient	 anastomoses.	 Several	
studies	 have	 focused	 on	 different	 techniques	 to	 perform	 the	 anastomosis,	 for	
example	 evaluating	 or	 enforcing	 suturing	 techniques	 or	 various	 types	 of	
staplers5‐10.	Glues	and	patches	have	also	been	used	to	cover	the	anastomosis	in	an	
attempt	to	decrease	leakage	rate11‐19.	Other	methods	include	stenting	the	lumen	of	
the	 intestine	or	providing	specific	medication	 to	 improve	wound	healing20‐28.	The	
influence	of	specific	drugs	that	may	attenuate	the	anastomotic	healing	process	was	
also	investigated29‐32.	Due	to	the	large	variance	in	study	design,	outcome	measures	
and	 analyses	 for	 surrogate	 markers	 of	 anastomotic	 healing,	 the	 question	 arises	
whether	there	is	one	specific	animal	model	suitable	to	investigate	all	these	different	
research	 topics.	 Furthermore,	 the	 role	 of	 limitations	 such	 as	 availability,	 costs,	
handling	and	housing	requirements	 in	choosing	an	animal	model	remains	unclear	
and	may	also	influence	why	certain	animal	models	are	currently	being	used.		
	
To	date,	a	single	recommendation	on	the	use	of	animal	models	for	clinical	colon	
AL	 has	 been	 proposed	 by	 Pommergaard	 et	 al	 in	 201133.	 Based	 on	 a	 systematic	
review	the	authors	first	listed	pros	and	cons	for	different	experimental	animals	and	
subsequently	 opted	 for	 the	 mouse	 as	 best	 suited	 to	 mimic	 clinical	 colon	 AL.	
However,	 despite	 this	 recommendation,	 the	 use	 of	 mice	 to	 study	 bowel	
anastomoses	has	 not	 been	 universally	 adopted.	 This	 suggests	 that	 there	 is	 either	
insufficient	knowledge	or	limited	support	from	researchers	in	the	field.	This	lack	of	
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consensus,	 and	 the	 resulting	 inconsistencies	 and	 differences	 between	 reported	
research	limit	transparency	and	opportunities	to	compare	results	between	studies4.	
	
Ideally,	the	most	suited	model	can	be	selected	based	on	clear	evidence	regarding	
reproducibility	 and	 validity	 of	 a	 model.	 However,	 in	 animal	 research	 regarding	
bowel	 anastomoses	 there	 is	 no	 single	 animal	 model	 that	 is	 evidently	 the	 most	
appropriate	regarding	practical	ease,	costs,	reproducibility	and	clinical	translation.	
Therefore,	 expert	 consensus	 is	 a	 suitable	method	 to	 achieve	 homogeneity	 in	 the	
selection	of	animal	models.	If	consensus	can	be	reached,	there	will	be	more	support	
from	 fellow	 researchers	 leading	 to	 more	 frequent	 use	 of	 similar	 models.	 As	 a	
consequence,	 future	 research	 about	 anastomotic	 healing	 will	 become	 more	
comparable.	
	
The	 aim	 of	 this	 study	 is	 to	 review	 different	 experimental	 studies	 in	which	 an	
animal	 model	 was	 used	 to	 investigate	 either	 intestinal	 anastomotic	 healing	 or	
leakage	 and	 obtain	 information	 on	 the	 used	 animal	 models;	 location	 &	 type	 of	
surgery;	macroscopic	outcome;	histological	assessment;	mechanical	&	biochemical	
outcome	 measures	 and	 animal	 testing	 &	 welfare.	 Further,	 we	 aim	 to	 reach	
consensus	on	these	subjects	by	performing	a	Delphi‐based	analysis	using	an	online	
survey	 to	 collect	 judgements	 of	 animal	 surgeons	 who	 performed	 the	 studies	
reviewed	here.	
Methods	
Literature	search	and	study	selection		
In	December	2014,	an	extensive	literature	search	was	conducted	using	the	PubMed	
(MEDLINE)	 and	 OvidSP	 (EMBASE)	 databases	 for	 all	 papers	 related	 to	 animal	
models	 which	 were	 used	 in	 an	 experimental	 setting	 to	 either	 investigate	
anastomotic	 healing	 or	 anastomotic	 leakage	 in	 the	 lower	 gastrointestinal	 tract.	
Search	 terms	 included:	 “anastomosis/anastomotic”,	 “leak/leakage",	 “bowel/	
intestine/colon/colorectal”	 and	 “animal/animals/rat/mouse/mice/pig/dog/goat/	
rabbit/animal	model”.	 English	 and	Dutch	were	 used	 as	 language	 restrictions	 and	
the	 search	 was	 limited	 to	 articles	 published	 between	 January	 1,	 2000	 and	
December	1,	 2014.	The	 following	 inclusion	 criteria	were	 applied	 to	 the	 titles	 and	
abstracts	of	the	search	results:	experimental	setting,	use	of	an	animal	model	and	an	
anastomosis	 made	 in	 the	 lower	 gastrointestinal	 tract	 (GIT)	 (gastroduodenal/	
gastrojejunal	 were	 considered	 upper	 GIT	 and	 therefore	 excluded).	 We	 excluded	
commentary	reports,	 review	articles	and	articles	containing	results	 that	had	been	
previously	 reported	 in	 another	 included	 article.	 All	 articles	 were	 combined	 in	 a	
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single	 list	 of	 which	 JWAMB	 and	 LvB	 identified	 eligible	 reports;	 in	 case	 of	
discrepancy,	agreement	on	inclusion	was	reached	through	discussion	with	MA‐T	as	
a	 third	reviewer.	 	For	an	overview	of	 the	study	selection,	performed	according	 to	
the	Preferred	Reporting	Items	for	Systematic	Reviews	and	Meta‐Analyses	(PRISMA)	
guideline,	see	Figure	2.1.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.1			Prisma	flow	chart	of	the	review	process.	
	
Study	outcomes	
Our	 primary	 outcomes	were	 1)	 type	 of	 animal	 used	 and	 2)	 location	 and	 type	 of	
anastomosis.	 As	 secondary	 outcomes,	 we	 evaluated	 scoring	 models	 used	 for	
macroscopic	 findings	 reporting	on	AL,	 i.e.	 adhesions,	 bursting	 pressure,	 histology	
and	 other	 examinations	 performed.	 Further,	 we	 assessed	 the	 country	 of	 origin	
where	the	study	was	performed	and	the	year	in	which	the	study	was	published	and	
how	animal	welfare	was	reported.	
Online	survey	–	Adaptation	from	the	Delphi	technique	
The	qualitative	review	of	the	literature	served	as	our	starting	point	for	the	Delphi	
technique.	The	main	goal	was	to	achieve	consensus	on	the	use	of	animal	models	for	
research	on	anastomoses	 in	 the	 lower	gastrointestinal	 tract,	 specifically	on	which	
animal,	 location	&	type	of	surgery;	macroscopic	outcome;	histological	assessment;	
mechanical	 &	 biochemical	 outcome	measures	 and	 animal	 testing	 &	 welfare.	 The	
Delphi	 technique	 is	 a	widely	 used	 and	 accepted	 consensus	method	 for	 gathering	
data	 from	 respondents	 within	 their	 domain	 of	 expertise	 in	 order	 to	 formulate	
recommendations	or	guidelines	that	can	be	used	in	the	future.	For	this	report,	we	
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contacted	all	principal	investigators	from	included	articles	by	email,	explained	our	
study	and	invited	them	to	participate	in	this	international	Delphi	project.		
	
Questionnaires	 were	 developed	 and	 distributed	 using	 SurveyMonkey	
(SurveyMonkey	 Inc,	 Palo	 Alto,	 CA;	www.survey‐monkey.com).	 This	 online	 survey	
contained	 several	 questions	 on	 three	 main	 subtopics	 of	 intestinal	 anastomotic	
research:	 the	 first	 part	 consisted	 of	 questions	 regarding	 animal	 model	 used	 and	
reasoning	for	the	choice	of	this	model;	the	second	part	focused	on	macroscopically	
scoring	and	measurements	performed	on	the	anastomosis	(leakage	rate,	adhesion	
evaluation)	 and	 the	 last	 part	 inquired	 about	 histological	 analysis	 and	 additional	
tests	 (e.g.	bursting	pressure,	ELISA,	qPCR)	 that	were	used	 to	gain	more	 insight	 in	
the	healing	process	(inflammation,	proliferation).	There	were	no	open	questions	in	
the	survey,	but	participants	were	encouraged	to	provide	arguments	for	their	choice,	
suggestions	or	additional	remarks	in	free	text	fields	below	each	question.	
	
After	receiving	participants’	responses,	the	collected	information	was	converted	
into	a	second	questionnaire.	This	round	included	the	items	and	ratings	summarized	
from	the	previous	round.	Here	we	asked	all	participants	to	revise	their	judgments	
or	specify	reasons	why	they	were	not	convinced	of	the	most	commonly	used	animal	
model.	All	items	achieving	consensus,	remaining	items	and	their	ratings	as	well	as	
minority	 opinions	 were	 reported	 during	 the	 questionnaires.	 The	 RAND/UCLA	
Appropriate	Method	(RAM)34	was	used	to	assess	consensus	 in	an	expert	panel	on	
the	use	of	animal	models,	macroscopic	scoring	of	leakage	and	adhesion,	mechanical	
and	biochemical	parameters	and	histological	outcome.	For	reporting	our	study,	we	
used	the	recommendations	of	Sinha	et	al	regarding	the	Delphi	technique35.		
Statistical	analysis		
Results	of	 the	survey	were	exported	to	MS	Excel	2011	(Microsoft	Corp,	Redmond	
WA).	 Consensus	was	 reached	 if	 the	 panel	 rated	 the	 subject	 inappropriate	 (panel	
median	 1‐3)	 or	 appropriate	 (panel	 median	 7‐9)	 on	 a	 9‐points	 scale	 without	
disagreement,	according	to	the	method	used	by	Moossdorff	et	al.	36.	Disagreement	
was	tested	using	the	interpercentile	range	adjusted	for	symmetry	in	accordance	to	
the	RAND/UCLA	Appropriateness	Method	Manual34	
Results	
Literature	findings	
In	 total	 277	 articles	were	 retrieved	 from	 the	 search.	 After	 screening	 167	 articles	
were	 included	 in	 the	 systematic	 review	 (Figure	 2.1).	 An	 on‐going	 increase	 in	
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publication	frequency	on	anastomotic	healing	and	leakage	was	found,	from	only	3	
in	2000	to	18	in	2014	(Figure	2.2a).	Animal	models	used	in	these	experiments	were	
rat	(65%),	pig	(15%),	rabbit	(10%),	mouse	(5%)	and	dog	(5%)	(Figure	2.2b).	From	
all	 167	 studies,	 only	 4	 reported	 laparoscopic	 surgery	 in	 animals,	 3	 in	 pig	
models10,37,38	and	one	in	a	rat	model39.	One	study	performed	transanal	endoscopy40,	
while	all	other	studies	used	laparotomy.	Research	was	mainly	performed	in	Europe,	
with	several	research	groups	responsible	 for	a	relatively	 large	contribution	to	the	
total	number	of	articles	(Figure	2.2c).		
	
Outcome	measures	reported	in	the	included	studies	were:	anastomotic	healing,	
anastomotic	 leakage,	 bursting	 pressure,	 tensile	 strength,	 adhesion	 scores	 and	
histological	parameters	such	as	influx	of	granulocytes	and	collagen	deposition.	We	
summarized	 the	 characteristics	 of	 the	 used	 interventions	 and	 outcome	measures	
that	 were	 used	 in	 these	 studies.	 This	 summary	 was	 sent	 to	 panel	 members	 as	
background	 information	 when	 completing	 the	 questionnaires	 (see	 supplemental	
data	online:	doi:10.1007/s00384‐016‐2550‐5).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.2	 Incidence	 of	 articles	 published	 over	 the	 past	 14	 years	 (A).	 Animal	 models	 used	 in	 the	
studies	(B)	and	origin	of	published	articles	(C).	
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Participation	
In	total,	44	authors	were	willing	to	participate	in	the	Delphi	analysis,	together	being	
responsible	 for	 77	 of	 the	 included	 articles	 from	 the	 major	 research	 groups	
worldwide	 (Figure	 2.3).	 The	 first	 questionnaire	 was	 completed	 by	 39/44	
responders	(89%	response	rate).	After	non‐responders	were	excluded,	the	second	
round	was	 completed	 by	 35/39	 panel	members,	 all	 of	whom	 also	 completed	 the	
final	round	(Table	2.1).	No	additional	people	were	invited	as	the	Delphi	progressed.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	2.3	 Participants	 in	 this	 Delphi	 analysis	 were	 from	 the	 main	 research	 groups	 that	 have	
published	work	on	 the	 subject	 of	 bowel	 anastomoses	 in	 animals,	 results	obtained	during	
the	first	survey	(adapted	from	amcharts.com).	
Characteristics	of	panel	members	
The	occupation	of	the	panel	members	is	summarized	in	Table	2.2.	Researchers	had	
operated	on	approximately	200	animals	and	have	published	a	median	of	4	articles	
regarding	this	topic.	All	panel	members	were	affiliated	with	a	university	and	have	
experience	 performing	 animal	 research	 on	 this	 topic.	 The	 institutions	 listed	 in	
Table	2.1	were	not	involved	in	this	project	and	do	not	necessarily	subscribe	to	the	
consensus.	
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Table	2.1	 Panel	members	that	completed	the	entire	Delphi	analysis.	
Panel	members		 Institute	 	 	 	
Magnus	Ågren	 University	of	Copenhagen,	Denmark	
John	Alverdy		 University	of	Chicago	Medical	Center,	Chicago,	IL,	USA	
Marcel	Binnebösel		 University	Hospital	of	the	RWTH,	Aachen,	Germany	
Wim	Ceelen	 Ghent	University	Hospital,	Belgium	
Kadir	Cetinkaya	 Ankara	Oncology	Education	and	Research	Hospital,	Turkey	
Jorge	Cueto	 Anahuac	University,	Mexico	 	
Freek	Daams	 VU	University	Medical	Center,	The	Netherlands	
Alyssa	Fajardo	 Washington	University,	St.	Louis,	MO,	USA	
Laura	Fresno	 Autonomous	University	of	Barcelona,	Spain	
Wolfgang	Gaertner	 University	of	Minnesota,	Minneapolis,	MN,	USA	
Torben	Glatz	 University	Hospital	Freiburg,	Germany	
Jens	Höppner		 University	Hospital	Freiburg,	Germany	
Niels	Komen	 University	Hospital	Leuven,	Belgium	
Guy	Maddern		 University	of	Adelaide,	Australia	 	
Antonio	Morandeira‐Rivas	 "La	Mancha	Centro"	General	Hospital,	Spain	
Tyge	Nordentoft	 University	of	Copenhagen,	Denmark	
Adrian	Park	 Johns	Hopkins	University	School	of	
Medicine,	Maryland,	MD,	USA	
	
Pablo	Parra	Membrives	 Valme	University	Hospital,	Seville,	Spain	
Rogério	Parra	 University	of	São	Paulo,	Brazil	 	
Troy	Perry	 University	Medical	Center	Alberta,	Canada	
Hans‐Christian	Pommergaard	 University	of	Copenhagen,	Denmark	
Manousos‐Georgios	Pramateftakis	 Aristotle	University	of	Thessaloniki,	Greece	
Dimitrios	Raptis	 Aristotle	University	of	Thessaloniki,	Greece	&	
Friedrich‐Alexander	University	of	Erlangen,	Germany	
Francisco	Sánchez‐De	Pedro	 "La	Mancha	Centro"	General	Hospital,	Spain	
Marc	Schreinemacher	 Maastricht	University	Medical	Center,	The	Netherlands	
Baddr	Shakhsheer	 University	of	Chicago	Medical	Center,	Chicago,	IL,	USA	
Juliette	Slieker	 CHUV	University	Hospital	Lausanne,	Switzerland	
Lisette	te	Velde	 VU	University	Medical	Center,	The	Netherlands	
Hideo	Terashima	 University	of	Tsukuba,	Japan	 	
Bobby	Tingstedt	 Lund	University,	Sweden	 	
Go	van	Dam	 University	Medical	Center	Groningen,	The	Netherlands	
Harry	van	Goor	 Radboud	University	Medical	Center,	The	Netherlands	
Zhouqiao	Wu	 Erasmus	University	Medical	Center,	The	Netherlands	
Simon	Yauw	 Radboud	University	Medical	Center,	The	Netherlands	
Oded	Zmora	 Sheba	Medical	Center,	Tel	Aviv,	Israel	
		
	
Table	2.2	 Current	functions	of	the	panel	members,	results	obtained	during	the	first	survey.	
Function	 (N)	
PhD	Candidate	 		5	
MD/resident/surgeon	 		9	
Postdoctoral	researcher	 		4	
Assistant	Professor	 11	
Professor	 10	
All	 panel	members	 have	 conducted	 hands‐on	 animal	 experiments,	mostly	 during	 their	 PhD‐trajectory	
(17/35).		
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First	questionnaire		
The	first	questionnaire	consisted	of	95	items	in	6	categories,	namely	the	choice	of	
animal	model;	 location	 and	 technique	 of	 the	 anastomosis;	macroscopic	 outcome;	
histological	 assessment;	 mechanical	 and	 biochemical	 outcome	 measures;	 and	
reporting	specifics	on	animal	research.	
	
After	 the	 first	 round,	 consensus	 existed	 on	 58	 of	 the	 items	 (61%)	 and	
disagreement	 or	 uncertainty	 on	 37	 items.	 Based	 on	 additional	 remarks,	 7	 items	
were	 added	and	2	were	 rephrased.	The	7	newly	 introduced	 items	 for	 the	 second	
round	 consisted	 of	 additional	 techniques	 in	 the	 category	 mechanical	 and	
biochemical	outcome	measures	and	a	suggestion	by	one	of	the	panel	members	for	a	
new	macroscopic	scoring	system.	
Second	questionnaire		
The	 second	 questionnaire	 was	 based	 on	 the	 first	 and	 consisted	 of	 37	 items	 on	
which	 consensus	 did	 not	 exist	 in	 the	 first	 round	 and	 7	 items	 added	 based	 on	
additional	comments	(total	of	44	items).	The	most	important	item	that	was	added	
in	 round	 2	 and	 on	 which	 immediate	 consensus	 was	 reached	 was	 the	 newly	
introduced	 Anastomotic	 Complication	 Score	 (ACS,	 see	 Table	 2.3),	 which	 was	
proposed	 during	 the	 first	 round	 by	 one	 of	 the	 panel	members.	 After	 the	 second	
round,	 consensus	 existed	 only	 on	 3	 items,	 in	 addition	 to	 the	 58	 items	 on	 which	
consensus	was	reached	in	the	first	round.	
	
Table	2.3	 Anastomotic	 Complication	 Score	 for	 macroscopic	 outcome	 in	 animal	 research	 regarding	
bowel	anastomoses.	
Anastomotic	Complication	Score	
No	adhesions	or	abnormalities	
Adhesion	to	fatpad,	clean	anastomosis	underneath	
Adhesion	to	intestinal	loop,	abdominal	wall	or	other	organ	
Anastomotic	defect	found	underneath	adhesion,	no	other	abnormalities	
Signs	of	possible	contamination	(e.g.	small	abscesses)	
Clear	anastomotic	complication;	spread	of	pus,	obstruction	at	anastomosis,	sign	of	peritonitis	
Faecal	peritonitis/Death	due	to	peritonitis	
Final	round		
Feedback	was	provided	 to	 the	participants	 after	 each	 round.	 In	 the	 final	 round	 a	
clear	 distinction	 was	 made	 between	 positive	 and	 negative	 arguments	 from	 the	
second	 round	 to	 simulate	 a	 discussion	 between	 panel	 members.	 The	 topics	 for	
debate	 remained	why	certain	animal	models	 should	or	 should	not	be	used.	 Some	
panel	members	argued	that	small	animal	models	are	not	able	to	reflect	the	clinical	
setting	while	others	are	certain	that	with	the	right	scoring	systems	one	can	obtain	
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sufficient	 information	 to	 make	 the	 model	 more	 translational.	 Based	 on	 all	
arguments	 given	 by	 the	 panel	 members	 and	 the	 first	 two	 rounds,	 20	
recommendations	 were	 proposed.	 Consensus	 was	 reached	 on	 17	 of	 those	
recommendations	(Tabel	2.4).		
	
Table	2.4	 Summary	of	the	consensus	on	the	use	of	animal	models	for	bowel	anastomoses	in	the	lower	
gastrointestinal	tract.		
Category		 Consensus	 	 	 	
Selection	of	
animal	model	
‐	Mouse,	rat	and	pig	models	are	considered	appropriate	models.	
‐	Choice	of	animal	model	depends	on	research	question.	
	 ‐	A	rat	model	is	preferred	to	a	mouse	model	(mostly	because	of	size)	however	
knockout	mice	are	helpful	in	answering	specific	research	questions.	
	 ‐	Rabbit	and	dog	models	are	not	validated	and	are	considered	inappropriate	to	use.	
Location	&	type	
of	surgery	
‐	All	locations	in	the	colon	(proximal,	ascending,	transverse,	descending,	sigmoid	and	
rectum)	are	considered	appropriate.		
‐	The	small	intestine	should	not	be	used	for	research	purposes	regarding	anastomotic	
healing	in	the	lower	GIT.	
‐	A	resection	is	considered	appropriate	for	constructing	an	anastomosis;	no	
consensus	was	reached	on	using	transection.	
	 ‐	Depending	on	the	animal	model,	both	open	and	laparoscopic	surgery	are	considered	
appropriate.	
‐	Interrupted	sutures,	running	sutures	(in	all	animals)	or	staplers	(in	the	pig	model)	
are	considered	appropriate	to	construct	an	anastomosis.	
Macroscopic	
outcome	
‐	Anastomotic	leakage	should	always	be	an	outcome,	preferably	with	different	grades	
of	leakage	(small/large	abscesses,	faecal	peritonitis,	complete	dehiscence).	
‐	The	available	scoring	systems	for	grades	of	leakage	were	all	considered	
inappropriate	by	the	panel.	The	Anastomotic	Complication	Score	may	provide	an	
appropriate	scoring	method	for	macroscopic	outcome,	but	needs	to	be	evaluated	
first.	
‐	Adhesions	to	the	anastomotic	site	are	relevant	as	they	might	cover	signs	of	leakage.	
Adhesions	in	the	abdominal	cavity	are	less	relevant	and	should	only	be	taken	into	
account	in	(anti)adhesion	studies.	
Histological	
assessment	
‐	Histological	assessment	is	very	valuable	and	considered	as	an	appropriate	outcome	
measure,	especially	in	healing	studies.	
‐	Hematoxylin‐Eosine	staining,	Masson’s	trichrome	staining	and	Pico	Sirius	Red	
staining	are	all	considered	appropriate	for	histological	assessment.	
‐	No	specific	histological	score	is	considered	appropriate	for	microscopic	evaluation	
of	the	anastomosis;	most	important	is	the	comparison	with	a	control	group.	
Mechanical	and	
biochemical	
outcome	
measures	
‐	Both	bursting	pressure	and	tensile	strength	are	considered	appropriate	
measurements	for	anastomotic	strength.	These	measurements	can	be	compared	
within	one	experiment,	but	due	to	heterogeneity	not	between	different	
experiments.	
	 ‐	Additional	outcome	measures	such	as	hydroxyproline	content,	amount	of	collagen,	
specific	(immunohistochemistry)	stainings,	ELISA,	qPCR	are	not	considered	
appropriate	for	specific	anastomotic	measurements	but	can	provide	information	to	
answer	specific	research	questions.	
Animal	testing	&	
Welfare	
‐	Blinding	and	randomisation	should	be	used	and	reported	in	animal	studies	
‐	Detailed	information	on	analgesia,	anaesthesia,	antibiotics,	antiseptic	measures,	
intestinal	segment	involved,	surgical	technique,	anastomotic	complications	as	well	
as	animal	welfare	is	considered	appropriate	to	report	in	studies.	Many	panel	
members	suggested	providing	this	as	supplementary	(online)	data	to	the	
manuscript.	
‐	ARRIVE	guidelines	are	appropriate	to	follow	and	contribute	to	standardisation40		
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‐	An	online	registration	of	study	protocols	is	considered	appropriate	for	animal	
research.	
Summary	of	items	on	which	consensus	was	reached	
In	 this	 study	 consensus	 was	 reached	 amongst	 researchers	 studying	 intestinal	
anastomoses	 in	animals.	The	main	 result	 is	 that	 the	selection	of	an	animal	model	
depends	on	the	research	question	and	there	is	no	‘one	size	fits	all’.	Consensus	was	
reached	that	mouse,	rat	and	pig	models	are	considered	appropriate	models	but	dog	
and	rabbit	models	should	no	longer	be	used	for	research	on	bowel	anastomoses	in	
the	lower	GIT.		
	
The	main	outcome	of	the	study	(anastomotic	healing/leakage)	should	always	be	
evaluated	 macroscopically,	 where	 currently	 used	 scores	 were	 not	 considered	
appropriate	enough.	The	Anastomotic	Complication	Score	as	proposed	by	a	panel	
member	 may	 provide	 an	 objective	 scoring	 measure.	 Obviously,	 this	 new	 score	
needs	 to	 be	 evaluated	 in	 the	 experimental	 setting	 to	 obtain	 information	 about	
veracity	and/or	 inter‐observer	variation,	but	 it	does	seem	to	be	a	promising	 tool.	
Bursting	 pressure	 (or	 tensile	 strength)	 together	 with	 histological	 evaluation	
provides	 further	 information	 about	 the	 anastomosis.	 Additional	 analyses	 can	 be	
helpful	 to	 answer	 specific	 research	 questions	 but	 are	 not	 (yet)	 considered	
appropriate	 as	 surrogate	 markers	 for	 anastomotic	 healing.	 Reporting	 on	 animal	
testing	 and	welfare	 is	 still	 not	 detailed	 enough	 in	 current	 literature	 and	 ARRIVE	
guidelines	should	be	followed	as	much	as	possible.	
	
A	summary	of	items	on	which	consensus	was	reached	can	be	found	in	Table	2.4.		
Discussion	points	–	items	lacking	consensus	
The	first	topic	of	debate	was	the	use	of	small	animals.	Many	panel	members	felt	that	
they	 were	 appropriate	 to	 use	 when	 systemic	 interventions	 are	 tested,	 but	 when	
interested	 in	a	 local	device	a	 larger	animal	 is	preferred.	Although	 it	 is	obvious	 to	
prefer	 to	 test	devices	 intended	 for	human	use	 in	 an	 animal	model	 of	 comparable	
size,	testing	a	local	device	in	a	rat	model	is	also	considered	acceptable.	Mice	should	
not	be	used	to	answer	research	questions	on	local	devices.		Another	topic	of	debate	
was	the	use	of	mice	and	rats	as	models	for	healing	or	leakage.	Many	panel	members	
felt	 that	 rats	 cannot	 be	 used	 as	 a	model	 for	 AL	 since	 they	 are	more	 resistant	 to	
infections	and	show	hardly	any	clinical	signs	while	other	panel	members	have	been	
using	rats	for	this	purpose	for	many	years	with	very	good	results.	Even	though	the	
rat	 is	 a	 validated	model	 for	 both	 anastomotic	 healing	 and	 leakage,	 there	 are	 still	
opponents	 that	 claim	 that	 a	 rat	 is	 not	 suitable	 for	 this	 purpose,	mostly	 based	 on	
own	 experiences.	 There	was	 also	 disagreement	 on	 the	 consideration	 of	 practical	
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ease	 in	 large	 animal	 models.	 Some	 believe	 that	 they	 are	 difficult	 in	 terms	 of	
anesthesia	and	housing,	while	others	 find	 them	rather	easy	 to	handle	and	do	not	
see	any	practical	disadvantages.		
	
For	clinical	translation	to	the	human	setting,	all	panel	members	agreed	that	the	
pig	was	the	best‐suited	model	in	the	pre‐clinical	setting.	However,	the	use	of	mice	
as	a	clinically	relevant	model	was	also	suggested,	because	it	might	mimic	clinical	AL	
better	 than	 the	 rat	model.	 Despite	 solid	 arguments	 and	 a	 clinical	 scoring	 system	
proposed	by	one	of	the	panel	members,	there	was	no	consensus	on	the	use	of	small	
animal	models	for	clinical	translation.	The	proposition	to	first	test	a	hypothesis	in	a	
small	animal	model	(mouse,	rat,	rabbit)	and	then	use	a	large	animal	model	(pig	or	
dog)	to	make	it	more	clinically	transferable	was	not	agreed	upon	and	is	therefore	
not	recommended.	
Discussion	
The	frequency	of	studies	that	have	used	an	animal	model	to	investigate	anastomotic	
leakage/healing	in	the	lower	gastrointestinal	tract	has	increased	considerably	over	
the	 past	 decade,	 despite	 implementation	 of	 the	 3R	 principle	 of	 Replacement,	
Reduction	 and	 Refinement.	 As	 shown	 in	 a	 recent	 systematic	 review,	 reporting	
quality	 of	 these	 studies	 is	 poor	 and	 frequently	 insufficient4.	 Furthermore,	 a	wide	
variability	of	animal	models	and	measurement	outcomes	is	used.	This	study	aimed	
to	reach	consensus	on	the	most	appropriate	animal	models,	outcome	measures	and	
animal	welfare	in	research	on	anastomoses	in	the	lower	gastrointestinal	tract.	
	
This	project	used	 the	RAND/UCLA	Appropriateness	method	 (RAM)	 to	develop	
consensus‐based	 recommendation	 for	 the	 use	 of	 animal	 model	 in	 research	 on	
anastomoses	in	the	lower	gastrointestinal	tract.	While	other	methods	can	be	used,	
the	RAM	is	often	used	in	biomedical	research	and	considered	as	a	solid	method	to	
use	as	it	has	strict	parameters	to	what	is	defined	as	consensus.		
	
All	principal	investigators	of	the	studies	included	in	the	literature	review	were	
contacted,	and	 the	35	panel	members	were	 responsible	 for	46%	of	 these	studies.	
The	authors	that	became	panel	members	in	this	project	were	enthusiastic	about	the	
subject	 and	working	 in	 one	 of	 the	major	 research	 groups	worldwide	 involved	 in	
experimental	research	regarding	bowel	anastomoses.	Although	this	could	have	lead	
to	 selection	 bias,	 our	 approach	 is	 more	 objective	 than	 the	 ‘snowball	 method’	 in	
which	experts	are	asked	to	provide	email	addresses	of	other	experts.	This	method	
is	also	being	used	to	form	an	expert	panel	in	consensus	studies41.	Even	though	the	
number	 of	 panel	members	 is	 an	 intrinsic	 limitation	of	 any	 consensus	 project,	we	
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consider	the	panel	to	be	a	valid	representation	for	researchers	that	perform	animal	
research	on	bowel	anastomoses	in	the	lower	gastrointestinal	tract.		
	
We	invited	authors	from	studies	of	the	last	decade,	who	are	still	publishing	on	
this	topic.	It	became	clear	that	they	sought	to	persuade	other	panel	members	with	
their	 arguments,	 especially	 at	 the	 beginning	 of	 the	 project.	 During	 the	 second	
round,	all	panel	members	were	given	their	own	answers	in	respect	to	the	answers	
of	the	panel	as	well	as	arguments	provided	by	other	panel	members.	Obviously,	all	
researchers	are	 convinced	of	 their	 own	methods,	 believing	 that	 their	models	 and	
techniques	are	best	suited.	However,	during	the	project	panel	members	opened	up	
for	 discussion,	 making	 it	 possible	 to	 indeed	 reach	 consensus	 and	 come	 up	 with	
suggestions	 and	 recommendations	 that	 can	 be	 a	 useful	 tool	 for	 directing	 future	
research.	
	
In	2010	the	NC3Rs	Reporting	Guidelines	Working	Group	published	the	ARRIVE	
guidelines	 for	 reporting	 in	 vivo	 experiments	 in	 animals42.	 While	 considered	
appropriate	to	follow	by	the	panel	members	in	this	study,	few	studies	have	actually	
used	 them	 to	 report	 animal	 research43.	 Panel	 members	 suggested	 that	 although	
these	guidelines	can	contribute	to	an	increase	in	standardization,	and	thus	can	be	
useful,	they	are	also	very	detailed	and	complete.	Most	of	the	information	required	
by	 the	 guidelines	 should	 be	 available	 in	 an	 online	 supplementary	 data	 section	
instead	of	 in	 the	manuscript.	The	panel	also	 felt	 that	 it	was	appropriate	to	use	an	
online	 registration	 for	 study	protocols	 regarding	animal	 research,	 (comparable	 to	
clinicaltrial.gov	in	humans)	which	creates	complete	transparency.	 	Moreover,	they	
suggested	standardised	protocol	online,	per	animal	model,	with	guidelines	to	follow	
when	performing	animal	research.	More	transparency	in	the	methods	would	lead	to	
refinement	 and	 reduction	 in	 animal	 experiments	 due	 to	 knowledge	 on	 teething	
problems	 experienced	 by	 others,	 leading	 to	 a	 decrease	 in	 learning	 time	 of	 each	
model.		Also,	innovative	methods	such	as	intestinal	organoids	or	the	use	of	human	
tissue	that	can	replace	animal	models	should	be	further	investigated	to	reduce	the	
use	of	animals,	according	to	the	3R‐principle44.	
	
We	 recommend	 that	 future	 animal	 research	 that	 focuses	 on	 intestinal	
anastomosis	should	be	conducted	in	either	a	mouse,	rat	or	pig	model	and	provide	
detailed	 information	 on	 analgesia,	 anesthesia,	 antibiotics,	 antiseptic	 measures,	
intestinal	segment	involved,	surgical	technique,	anastomotic	complications	as	well	
as	animal	welfare.	The	ARRIVE	guidelines	should	be	 followed	more	stringently	 to	
increase	 transparency	 in	 animal	 research.	 A	 publicly	 available	 online	 registry	
together	with	standardized	protocols	per	animal	model	are	can	aid	in	advancing	the	
field	of	animal	research	on	bowel	anastomoses.	
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Introduction	
Colorectal	 anastomotic	 leakage	 is	 the	most	 dreaded	 complication	 after	 colorectal	
surgery	because	of	 its	high	morbidity	and	even	–	despite	 improved	postoperative	
care	–	mortality1.	The	 incidence	of	anastomotic	 leakage	has	 remained	stable	over	
the	 last	 decades	 despite	 very	 extensive	 research	 into	 risk	 factors,	 perioperative	
strategies	and	 intra‐operative	 interventions2.	The	pathophysiology	of	anastomotic	
leakage	 is	 largely	 unknown3	 and	 we	 strongly	 advocate	 that	 this	 should	 be	
elucidated	 prior	 to	 conducting	 intervention	 studies4.	 Despite	 some	 evidence	
regarding	 risk	 factors	 and	 some	 insight	 in	 the	 anastomotic	 healing	 process	 that	
involves	the	influx	of	inflammatory	cells,	interaction	with	intestinal	microbiota	and	
matrix	 metalloproteinases,	 it	 remains	 a	 challenge	 to	 study	 such	 complex	
mechanistic	pathways	within	biochemical	and	biological	organisms.		
	
Fortunately,	 rapid	 technological	 advances	 have	 been	made	 in	 recent	 years	 to	
address	these	kinds	of	challenges.		Among	these,	Mass	Spectrometry	Imaging	(MSI)	
has	emerged	as	an	enabling	technique	to	provide	insight	into	the	molecular	entities	
within	 cells,	 tissues,	 and	 whole‐body	 samples	 and	 to	 understand	 inherent	
complexities	 within	 biological	 metabolomes5.	 Mass	 spectrometry	 detects	
molecules,	 following	 ionisation,	 by	 virtue	 of	 the	 different	 mass‐to‐charge	 (m/z)	
rations.	Matrix‐assisted	 laser	desorption/ionization	 (MALDI)	 is	 the	most	common	
approach	 used	 for	MSI	 and	 involves	 the	 use	 of	 UV‐laser	 desorption	 of	 a	matrix‐
coated	tissue	section	to	acquire	mass	spectra	at	various	locations	across	a	sample	
(typically	 every	 50‐100	 µm).	 With	 this	 method,	 it	 is	 possible	 to	 assess	 a	 tissue‐
specific	spatial	molecular	distribution	without	the	need	for	labelling	–	in	contrast	to	
classical	histology	‐	allowing	the	discovery	of	prognostic	markers	and	enabling	the	
determination	 of	 effective	 (and	 personalized)	 therapies6.	 In	 addition,	 MALDI‐
imaging	is	unique	as	an	imaging	technique	since	it	can	determine	the	distribution	of	
hundreds	of	unknown	compounds	in	a	single	measurement7.	With	MALDI	imaging,	
recent	 breakthroughs	 were	 achieved	 as	 it	 became	 possible	 to	 reveal	 disease‐
specific	molecular	features.	This	process	is	known	as	disease	phenotyping	and	has	
already	 been	 done	 in	 atherosclerosis8,	 renal	 cell	 carcinoma9	 and	 metastatic	
endometrial	cancer10.		
	
In	this	short	communication	we	will	show	a	new	method	on	imaging	the	colonic	
anastomosis	 after	 in	 vivo	 experiments,	 indicating	 this	 tool	 as	 promising	 in	
providing	new	insights	that	eventually	can	 lead	to	therapeutic	or	even	preventive	
measures	for	anastomotic	leakage.	
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Methods	
Animals	
A	 total	 of	 28	Wistar	 rats	 with	 an	 average	 body	 weight	 of	 250	 gram	 were	 used.	
Animals	were	housed	at	the	Central	Animal	Facilities	of	the	Maastricht	University.	
All	animals	were	provided	ad	libitum	access	to	food	and	water,	and	were	cared	for	
according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	was	performed	
twice	daily	using	a	standardized	method	and	animals	were	given	pain	medication	in	
case	 of	 discomfort.	 The	 experimental	 protocol	 complied	 with	 the	 Dutch	 Animal	
Experimental	 Act	 and	 was	 approved	 by	 the	 Animal	 Experimental	 Committee	 of	
Maastricht	University	Medical	Center	(DEC2014‐120).	
Study	design	
The	primary	objective	of	this	study	was	to	investigate	if	the	processes	involved	in	
anastomotic	 healing	 can	 be	 detected	 by	 means	 of	 MALDI	 MSI	 over	 time.	
Additionally,	we	explored	if	the	components	of	this	healing	process	change	in	case	
of	 anastomotic	 leakage,	 in	 order	 to	 identify	 factors	 that	 are	 essential	 for	 both	
anastomotic	 healing	 and	 anastomotic	 leakage.	 Anastomotic	 healing	 was	
investigated	in	a	rat	model	with	a	sufficient	anastomosis.	The	colon	was	transected	
2	 cm	 distal	 from	 the	 cecum	 and	 an	 end‐to‐end	 anastomosis	 was	 created	 using	
12	interrupted	 polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	 Johnson,	
Somerville,	NJ).	Time	points	of	sacrifice:	6,	12	and	24	hours,	2,	3,	5,	and	7	days	after	
creation	of	the	anastomosis,	n=2	per	time	point.	
Sample	preparation	
Tissue	samples	(the	anastomosis	with	a	5mm	margin	on	both	sides	and	a	control	
sample	 2	 cm	 distal	 from	 the	 anastomosis)	 were	 embedded	 in	 a	 10%	 glycerol	
solution,	snap	frozen	in	liquid	nitrogen	and	stored	at	‐80°C.	The	samples	were	then	
cut	 into	10	μm	 sections	 for	MS	 analysis,	 and	 into	4	 μm	 sections	 for	 conventional	
staining	using	a	cryomicrotome	(CM	1860	UV,	Leica	Microsystems	GmbH,	Wetzlar,	
Germany)	 set	 at	 ‐20°C.	 10	 μm	 serial	 sections	 for	 MALDI	 imaging	 were	 thaw	
mounted	on	Indium‐Tin‐Oxide	(ITO)	coated	slides	(Delta	Electronics	(Loveland,	CO,	
USA,	4–8	Ω	sq−1),	whilst	 the	4	μm	slides	were	 thaw	mounted	on	non‐conducting	
tissue	slides.	The	ITO	slides	coated	with	10	μm	tissue	sections	for	MS	analyses	were	
then	 placed	 in	 a	 desiccator	 for	 15	 minutes.	 Tissue	 sections	 were	 sprayed	 with	
norharmane	 matrix	 (7	 mg/ml	 in	 1	 2	 methanol	 chloroform)	 using	 an	 automated	
sprayer	 (TM‐Sprayer,	 HTX	 Technologies,	 Carrboro,	 NC,	 USA).	 The	 samples	 were	
dried	and	stored	in	the	desiccator	until	MS	analysis.		
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Mass	spectrometry	acquisition	
Biomolecules	present	in	the	anastomotic	and	control	tissue	were	desorbed,	ionised	
and	 separated	 according	 to	 their	 mass‐to‐charge	 (m/z)	 ratios	 using	 a	 Waters	
Synapt	G2‐Si	mass	spectrometer	(Waters,	Manchester,	UK)	in	positive	ion	mode	at	a	
raster	 size	of	100	µm,	and	an	m/z	range	of	100‐2000.	Calibration	was	performed	
prior	to	each	measurement	with	red	phosphorous.	Regions	of	 interest	(ROI)	were	
created	 by	 using	 the	 HDI	 v1.4	 software	 (Waters).	 ROI	 were	 based	 on	 the	
histological	 layers	of	 the	gut	and	 in	 specific	 the	mucosal	 layer	 in	 interaction	with	
gut	microbiota,	both	 in	 control	 and	anastomotic	 tissue.	Commensal	microbes	and	
pathogenic	 bacteria	 colonizing	 the	 intestine	 have	 the	 potential	 to	 acquire	 an	
aggressive	 and	 virulent	 tissue	 degrading	 phenotype,	 resulting	 in	 anastomotic	
breakdown	as	was	shown	by	both	animal	and	human	research11.	
	
Each	m/z	value	present	in	this	spectral	collection	was	converted	to	an	image	by	
using	dedicated	 imaging	software	(see	also	data	analysis).	The	chemical	structure	
of	 each	 ion	detected	 from	 the	 tissue	 surface	was	 identified	 after	 its	 isolation	 and	
fragmentation	inside	the	mass	spectrometer	(tandem	mass	spectrometry,	MS/MS).	
Data	analysis	
Comparisons	between	the	different	time	points	and	between	the	anastomotic	and	
control	 tissue	 of	 the	 same	 animals	were	 conducted	 using	 Biomap	 (Novartis)	 and	
principal	 component	 analysis	 (PCA).	 Total	 ion	 count	 (TIC)	was	 used	 for	 spectral	
normalization	in	all	cases.	In	short,	PCA	is	an	unsupervised	statistical	method	that	
aims	 at	 pooling	 a	 maximum	 amount	 of	 variance	 in	 a	 minimum	 number	 of	
independent	variables.	Data	pre‐treatment	and	PCA	were	performed	using	our	in‐
house	built	ChemomeTricks	toolbox	for	MATLAB	version	2014a	(The	MathWorks,	
Natick,	 MA,	 USA).	 The	 peak	 assignments	 were	 performed	 according	 to	 the	
bibliography	 and	 LIPID	 MAPS	 software	 (http://www.lipidmaps.org/tools/	
index.html).	
Hematoxylin‐Eosin	staining	
After	analyses,	the	MSI	slides	were	rinsed	in	70%	Ethanol	for	10	minutes	to	remove	
residual	 matrix.	 Tissue	 specimens	 were	 then	 rehydrated	 with	 graded	 alcohol	 to	
H2O.	The	slides	were	submerged	into	haematoxylin	for	3	minutes	and	rinsed	with	
running	 tap	water	 for	3	minutes.	Subsequently,	 the	slides	were	 counterstained	 in	
eosin	for	30	seconds	and	rinsed	with	running	tap	water	for	one	minute.	Finally,	the	
slides	were	washed	 in	100%	Ethanol	 for	2	minutes	and	dehydrated	 in	xylene	 for	
30	seconds.	 Optical	 images	 were	 acquired	 using	 a	 MIRAX	 Desk	 Scanner	 (Zeiss,	
Gottingen,	Germany).	
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Results	
We	 focused	 on	 differences	 in	 lipid	 profiles	 (lipidomics)	 between	 colonic	 tissues.	
Changes	 in	 the	 distribution	 and	 density	 of	 cellular	 constituents	were	 visible	 as	 a	
result	 of	 changed	distribution	of	membrane	 lipids	 (Figure	3.1),	 possibly	 resulting	
from	altered	metabolism	or	cell‐response	in	the	process	of	anastomotic	healing.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.1	 Distribution	 of	 lipids	 in	 anastomotic	 and	 control	 tissue	 after	 3	 and	 7	 days	 following	 the	
construction	of	an	anastomosis	in	proximal	colon	of	the	rat.	Intensity	scales	are	set	to	50%	
maximum	and	all	images	were	set	on	the	same	scale	from	0‐15.		
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Clear	 differences	 were	 observed	 between	 different	 time	 points	 and	 between	
control	and	anastomotic	tissue	(Figures	3.2,	3.3	and	3.4).	The	signal	of	m/z	824.50	
(most	likely	a	phosphatidylcholine	(16:0/20:212)	showed	high	correlation	with	the	
mucosa	and	showed	an	increased	expression	and	signal	spreading	over	time	after	
construction	 of	 an	 anastomosis.	 The	 signal	 of	m/z	 725.40,	 which	 is	 likely	 to	 be	
sphingomyelin	 (d18:1/16:013)	 shows	 exclusive	 presence	 in	 damaged	 tissue,	 i.e.	
after	construction	of	the	anastomosis	and	an	increased	expression	over	time.	 	The	
control	 tissue	 on	 day	 7	 shows	 an	 expression	 profile	 that	 is	 more	 similar	 to	 the	
anastomotic	tissue	compared	to	the	control	tissue	on	day	3,	which	shows	relatively	
low	 expression	 of	 most	 mass	 signals.	 Control	 tissue	 that	 has	 been	 exposed	 to	 a	
longer	 follow‐up	 (7	days),	 shows	expression	profiles	 that	are	more	similar	 to	 the	
anastomotic	tissue	when	compared	to	control	tissue	after	3	days.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	3.2	 Discriminant	 analysis	 of	 cells	 in	 control	 and	 anastomotic	 tissue,	 which	 displays	 a	 clear	
separation	of	both	conditions	as	well	as	in	time.	
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Figure	3.3	 Representative	 combined	mass	 spectrum	 (DF	 1	 spectrum)	 detected	 by	MALDI‐MSI	 from	
both	control	and	anastomotic	tissue	at	day	3	(negative)	and	day	7	(positive).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
Figure	3.4	 Representative	 combined	mass	 spectrum	 (DF	 2	 spectrum)	 detected	 by	MALDI‐MSI	 from	
both	control	(positive)	and	anastomotic	tissue	(negative)	at	day	3	and	day	7.	
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Discussion	and	conclusion	
This	 is	 a	 pilot	 report	 of	 a	 discovery	 based	 longitudinal	 experiment	 of	 lipidomic	
molecular	 activities	 in	 healing	 and	 leaking	 intestinal	 anastomoses	 in	 a	 rat	model.	
For	 the	 first	 time,	 localised	 lipid	 differences	 between	 control	 and	 anastomotic	
tissue	has	been	detected	 through	MALDI‐MSI.	These	differences	will	be	expanded	
on	in	the	future.	The	fact	that	control	tissue	after	7	days	showed	similar	expression	
profiles	 to	 the	 anastomotic	 tissue	 suggests	 that	 the	processes	 involved	 in	healing	
are	not	 limited	 to	 the	damaged	 tissue	 at	 the	 anastomotic	 site,	 but	 instead	 spread	
over	 a	 larger	 segment	 over	 time.	 Some	mass	 signals	 show	 specific	 expression	 in	
damaged	tissue,	such	as	m/z	725.40,	sphingomyelin13.	Sphingomyelins	have	several	
structural	and	functional	roles	in	the	cell;	they	are	found	in	the	cell	membrane	and	
play	 a	 role	 in	 apoptosis.	 Recent	 studies	 have	 linked	 marked	 alterations	 in	
sphingolipid	biology	to	several	diseases14,15.	Particularly	detected	lipid	profiles	are	
specific	 for	 pathophysiological	 processes	 and	 can	 aid	 in	 finding	 new	 targets	 for	
therapy13.	This	has	already	led	to	the	identification	of	a	mitochondrial	key	factors	in	
ischemia/reperfusion16,17.	
	
This	short	communication	shows	that	mass	spectrometry	imaging	is	a	valuable	
tool	 to	 identify	 molecules	 that	 are	 involved	 in	 the	 normal	 healing	 process	 or	 in	
anastomotic	 leakage.	 When	 combined	 with	 other	 modalities	 (IHC,	 conventional	
staining,	 proteomics,	 peptidomics,	 metabolomics),	 this	 technique	 can	 be	 used	 to	
map	the	molecular	pathways	 involved	 in	the	normal	anastomotic	healing	process,	
as	 well	 pathways	 involved	 in	 leaking	 which	 are	 currently	 still	 largely	 unknown.	
Current	 studies	 from	 our	 research	 group	 are	 focusing	 on	 unravelling	 the	
biochemical	 processes	 involved	 in	 healing	 and	 leaking.	 Subsequent,	 specific	
analyses	can	be	run	on	the	same	tissues	in	order	to	discover	biomarkers	for	leakage	
and	possibly	to	develop	novel	preventive	techniques.	
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Abstract	
Background	
Cyclooxygenase‐2	(COX‐2)	is	a	key	enzyme	in	gastrointestinal	homeostasis.	COX‐2	inhibitors	
have	been	associated	with	colonic	anastomotic	leakage.	
	
Methods	
Wildtype,	 COX‐2	 knockout	 and	 COX‐2	 heterozygous	 mice	 were	 subjected	 to	 a	 model	 of	
colonic	anastomotic	leakage,	and	were	treated	with	vehicle,	diclofenac,	or	prostaglandin	E2	
(PGE2),	 the	 most	 important	 COX‐2	 product	 in	 the	 intestine.	 We	 assessed	 anastomotic	
leakage,	 mortality,	 angiogenesis,	 and	 inflammation.	 Furthermore,	 we	 investigated	 the	
association	 between	 anastomotic	 leakage	 and	 a	 human	 polymorphism	 of	 the	 COX‐2	 gene	
resulting	in	low	COX‐2	levels.	
	
Results		
Diclofenac,	 a	 nonsteroidal	 anti‐inflammatory	drug	 inhibiting	COX‐2,	 increased	 anastomotic	
leakage	 compared	 to	 vehicle‐treated	mice	 (100%	 vs	 25%,	 respectively).	 Similarly,	 92%	of	
COX‐2‐deficient	 mice	 developed	 anastomotic	 leakage	 (P=0.003)	 compared	 to	 WT.	 PGE2	
partly	 rescued	 this	 severe	 phenotype	 because	 only	 46%	 of	 PGE2‐administered	 COX‐2	
knockout	mice	developed	 anastomotic	 leakage	 (P=0.02).	This	may	be	 related	 to	decreased	
neovascularization,	 because	 decreased	 CD31	 staining,	 indicating	 less	 blood	 vessels,	 was	
observed	 in	 COX‐2‐/‐	 mice	 (2	 vessels/mm2	 vs.	 6	 vessels/mm2	 in	 controls	 (P=0.03)).	 This	
effect	 could	 partly	 be	 reversed	 by	 administration	 of	 PGE2	 to	 COX‐2‐/‐	mice.	 No	 significant	
differences	 in	 inflammation	 were	 found.	 PTGS2‐765G>C	 polymorphism	 in	 humans,	
associated	with	reduced	COX‐2	expression,	was	associated	with	higher	anastomotic	leakage	
rates.	
	
Conclusions	
COX‐2‐induced	 PGE2	 production	 is	 essential	 for	 intestinal	 wound	 healing	 after	 colonic	
surgery,	possibly	via	its	effects	on	angiogenesis.	These	data	emphasize	that	COX‐2	inhibitors	
should	be	avoided	after	colonic	surgery,	and	administration	of	PGE2	might	be	favorable	for	a	
selection	of	patients.	
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Introduction	
The	enzyme	cyclooxygenase‐2	(COX‐2),	also	known	as	prostaglandin‐endoperoxide	
synthase	 2	 (Ptgs2),	 plays	 an	 important	 role	 in	 gut	 homeostasis.	 In	 general,	
cyclooxygenase	regulates	the	conversion	of	arachidonic	acid	into	prostaglandins,	of	
which	 prostaglandin	 E2	 (PGE2)	 is	 reported	 to	 restore	 intestinal	 integrity	 in	
experimental	 models	 of	 intestinal	 inflammation	 and	 damage1‐5.	 COX‐2‐induced	
production	 of	 prostaglandins	 in	 mesenchymal	 stem	 cells	 in	 the	 colon	 have	 an	
immunomodulatory	 role2,	 and	 these	mesenchymal	 stem	 cells	may	 thereby	 act	 as	
monitors	 of	 the	 colonic	 environment.	 In	 addition,	 they	 might	 have	 important	
functions	in	colonic	wound	healing5.	Furthermore,	COX‐2	expression	is	 induced	in	
macrophages	and	myofibroblasts	upon	exposure	to	proinflammatory	cytokines	and	
bacterial	 products,	 leading	 to	 proliferation	 and	 protection	 against	 apoptosis2,3,6.	
Lastly,	 COX‐2	 and	 PGE2	 production	 by	 endothelial	 cells	 are	 critically	 involved	 in	
vascular	 endothelial	 growth	 factor	 (VEGF)‐induced	 angiogenesis7,8.	 Data	 from	
human	studies	underline	the	importance	of	COX‐2	in	colonic	wound	healing	as	the	
use	of	nonsteroidal	anti‐inflammatory	drugs	(NSAIDs),	especially	those	with	strong	
COX‐2‐inhibiting	 properties,	 is	 correlated	 with	 the	 development	 of	 anastomotic	
leakage	after	colorectal	surgery9‐12.	The	incidence	of	anastomotic	leakage	requiring	
re‐intervention	 is	 around	 7%13,	 making	 anastomotic	 leakage	 the	 primary	
complication	requiring	 re‐intervention	after	 colonic	 surgery.	Anastomotic	 leakage	
carries	 a	 high	 mortality	 of	 15%14.	 The	 pathophysiology	 of	 anastomotic	 leakage	
remains	 largely	 unknown	 and	 is	 supposedly	 multifactorial.	 Studies	 showing	
increased	 anastomotic	 leakage	 due	 to	 NSAID	 use	 are,	 however,	 retrospective	 in	
nature	 and	 a	 recent	 meta‐analysis	 could	 not	 prove	 an	 unambiguous	 detrimental	
effect	of	NSAIDs15.	Although	these	studies	suggest	to	restrict	NSAID	use	in	patients	
with	 intestinal	 anastomoses,	 omission	 of	 NSAIDs	 from	 postsurgical	 care	 in	 these	
patients	 is	 not	 yet	 standard	 clinical	 practice16,17.	 Because	 anastomotic	 healing	
requires	adequate	perfusion	of	the	anastomosis	and	anastomotic	healing	seems	to	
be	affected	by	the	use	of	NSAIDS,	we	set	out	to	investigate	the	role	of	COX‐2	in	the	
development	of	anastomotic	leakage	post	colonic	surgery.		
	
We	 provide	 evidence	 that	 COX‐2	 is	 essential	 for	 neovascularization	 of	 the	
colonic	anastomosis	and	thereby	plays	a	crucial	role	in	colonic	anastomotic	wound	
healing.	Both	pharmacological	and	genetic	disruption	of	COX‐2	function,	by	use	of	
NSAIDs	 or	 COX‐2‐/‐	 mice	 respectively,	 increased	 colonic	 anastomotic	 leakage	
significantly	 after	 colonic	 surgery	 in	 mice,	 which	 was	 associated	 with	 severely	
decreased	survival.		
	
Importantly,	 we	 additionally	 show	 that	 humans	 with	 decreased	 COX‐2	
expression	due	to	a	COX‐2	gene	polymorphism	show	increased	risk	for	developing	
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anastomotic	 leakage.	 These	 results	 indicate	 that	 COX‐2	 is	 essential	 in	 colonic	
anastomotic	healing.	
Methods	
Mice	
All	 animal	 experiments	 were	 approved	 by	 the	 Maastricht	 University	 Animal	
Experiments	Committee.	Mice	heterozygous	for	COX‐2	were	ordered	from	Jackson	
Laboratory	 (Bar	 Harbor,	ME)	 to	 obtain	 littermate	wildtype	 (WT,	 n=32),	 COX‐2+/‐	
(n=17)	 and	 COX‐2‐/‐	 (n=25)	 mice.	 For	 all	 experiments,	 COX‐2‐/‐	 	 mice	 were	 used	
simultaneously	with	their	wildtype	and/or	heterozygous	littermates.	
Model	
A	previously	described	murine	model	of	colonic	anastomotic	leakage	was	used	and	
adapted	 to	 reach	 an	 anastomotic	 leakage	 rate	 of	 25%	 to	 33%18.	 Briefly,	 10‐	 to	
12‐week‐old	 mice	 were	 anesthetized	 using	 isoflurane	 and	 were	 given	
buprenorphine	 as	 analgesic.	 After	 a	 1	 cm	 midline	 laparotomy,	 the	 cecum	 was	
exteriorized	and	the	right	colon	was	microscopically	transected,	without	damaging	
blood	 supply.	 An	 end‐to‐end	 anastomosis	 was	 performed	 with	 7	 interrupted	
sutures	(Prolene	8–0,	Ethicon,	Somerville,	NJ).	The	colon	was	repositioned	and	the	
abdomen	was	 closed	 in	 2	 layers	 of	 interrupted	 sutures	 (Vicryl	 4–0,	 Ethicon,	 and	
Ethilon	 4–0,	 Ethicon,	 respectively).	 The	 colon	 was	 kept	 moist	 with	 sterile	 saline	
during	 the	procedure.	Two	medically	 trained	researchers	 that	had	equal	skill	and	
experience	with	 the	 surgical	 procedure	 performed	 the	 surgical	 procedure.	 There	
was	no	difference	in	the	rate	of	anastomotic	leakage	between	the	2	surgeons.	The	
researchers	were	blinded	for	the	genotypes	at	the	time	of	surgery.	
Study	design	
WT,	COX‐2+/‐	 and	COX‐2‐/‐	mice	underwent	 laparotomy	with	 colonic	 anastomosis,	
and	 received	 vehicle	 Phosphate‐buffered	 saline	 (PBS),	 16,16‐dimethyl	 PGE2	
(dmPGE2,	 Cayman	 Chemical,	 Ann	 Arbor,	 MI),	 a	 stable	 analogue	 of	 PGE2,	 or	
diclofenac	 sodium	 (Cayman	 Chemical)	 by	 intraperitoneal	 injection.	 Dosage	 of	
dmPGE2	 was	 100mg/kg	 bodyweight,	 twice	 daily,	 and	 dosage	 of	 diclofenac	 was	
10	mg/kg	 bodyweight,	 twice	 daily5,19.	 This	 diclofenac	 dosage	 was	 comparable	 to	
dosages	 used	 in	 humans	 when	 using	 the	 dose	 translation	 formula	 published	 by	
Reagan‐Shaw	et	al20.	Vehicle,	dmPGE2	and	diclofenac	treatment	was	started	1	day	
prior	 to	 laparotomy	and	 continued	until	 the	 end	of	 the	 experiments	 (Figure	4.1).	
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Mice	 were	 killed	 at	 5	days	 postoperatively	 to	 ensure	 detection	 of	 anastomotic	
leakage,	or	when	humane	endpoints	were	reached.		
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	4.1	 Study	 design:	mice	 received	 intraperitoneal	 injections	 twice	 daily	 from	 one	 day	 prior	 to	
surgery	until	sacrifice.	
	
Endpoints	
Anastomotic	 leakage	was	 defined	 as	 either	 fecal	 peritonitis	 or	 abscess	 formation	
around	 the	 anastomosis.	 Two	 independent	 investigators	 who	 were	 blinded	 for	
genotype	at	the	time	of	evaluation	diagnosed	anastomotic	leakage.		
Tissue	preparation	
A	 1	 cm	 segment	 of	 colonic	 tissue	 surrounding	 the	 anastomosis	 was	 dissected	 in	
longitudinal	 direction,	 thereby	 dividing	 it	 into	 equal	 parts.	 One	 part	 was	 fixed	
overnight	 in	 10%	 formalin	 and	 embedded	 in	 paraffin	 using	 standard	 techniques.	
The	second	part	was	snap	frozen	in	liquid	nitrogen	and	used	for	mRNA	isolation.	
Immunohistochemistry	
For	immunohistochemistry,	sections	were	deparaffinized	in	xylene	and	rehydrated	
in	graded	ethanol	 to	distilled	water.	Endogenous	peroxidase	activity	was	blocked	
using	 0.6%	hydrogen	peroxide	 in	methanol	 for	 30	minutes.	Nonspecific	 antibody	
binding	 was	 blocked	 using	 5%	 bovine	 serum	 albumin	 in	 PBS	 [myeloperoxidase	
(MPO)	and	CD31	staining]	or	10%	normal	rabbit	serum	(MAC‐3	staining).	Antigen	
retrieval	was	required	for	CD31	immunohistochemistry	(IHC)	[0.1%	trypsin	(Difco	
Laboratories,	 Detroit,	 MI)	 in	 0.1%	 CaCl2	 solution	 for	 20	 minutes	 at	 37°C]	 and	
MAC‐3	IHC	(10mM	sodium	citrate,	pH	6.0).	Sections	were	incubated	with	primary	
antibodies	 rabbit	 antihuman	 MPO	 antibody	 (MPO,	 Dako‐Cytomation,	 Glostrup,	
Denmark),	which	cross‐reacts	with	mouse,	rat	anti‐mouse	CD31	(BD	Pharmingen,	
Breda,	 The	 Netherlands),	 or	 rat	 anti	 mouse	 MAC‐3	 (BD).	 After	 washing,	 biotin‐
conjugated	swine	anti‐rabbit	IgG	(DakoCytomation),	biotinylated	rabbit	anti‐rat	IgG	
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(DakoCytomation),	 or	 biotin‐conjugated	 rabbit	 anti‐rat	 IgG	 (Jackson	 Immuno‐
Research,	West‐Grove,	PA)	was	used	for	MPO,	CD31,	and	MAC‐3	IHC,	respectively,	
followed	by	incubation	with	the	streptavidin‐biotin‐HRP	system		
(DakoCytomation),	Brightvision	poly	HRP	anti‐rabbit	IgG	(Immunologic,	Duiven,	
The	 Netherlands),	 or	 streptavidin‐biotin‐HRP	 system	 (Vector	 Laboratories,	
Burlingame,	 CA),	 respectively.	 Binding	 of	 primary	 antibody	 was	 visualized	 with	
3,30‐diaminobenzidine‐tetrahydrochloride‐dihydrate	 (Sigma,	 St	 Louis,	 MO)	 and	
counterstained	 with	 hematoxylin.	 No	 staining	 was	 detected	 in	 slides	 incubated	
without	primary	antibody.	Stained	sections	were	photographed	by	a	Nikon	eclipse	
E800	microscope	with	a	Nikon	digital	camera	DXM1200F.	The	CD31	staining	was	
quantified	in	a	blinded	way	by	2	observers	by	counting	all	CD31	positive	vessels	at	
200x	magnification	and	expressed	as	 the	number	of	 vessels	per	 total	 area	 (mm2)	
using	 ImageJ	 (NIH	 Software,	 Bethesda,	 MD).	 Staining	 of	 MPO	 was	 quantified	 by	
ImageJ	 as	 well	 and	 staining	 of	 MAC‐3	 was	 quantified	 by	 2	 independent	 blinded	
observers	using	computerized	morphometry	(Leica	QWin	V3,	Cambridge,	UK).	The	
results	 were	 presented	 as	 neutrophils	 per	 field	 of	 view	 (MPO)	 or	 percentage	 of	
positive	cells	per	total	tissue	area	(MAC‐3).	
Real‐time	Quantitative	Polymerase	Chain	Reaction	
RNA	 was	 isolated	 from	 snap‐frozen	 anastomotic	 tissue	 samples	 with	 AllPrep	
DNA/RNA/Protein	kit	 (Qiagen,	Hilden,	Germany)	according	 to	 the	manufacturer’s	
protocol.	 In	 short,	 samples	 were	 crushed	 with	 a	 pestle	 and	 mortar	 in	 liquid	
nitrogen.	 Disruption	 and	 homogenization	 of	 the	 tissue	 was	 performed	 using	 an	
Ultra	 Turrax	 Homogeniser	 (IKA	 Labortechnik,	 Staufen,	 Germany)	 in	 lysis	 buffer	
containing	b‐mercaptoethanol	(Promega,	Madison,	WI).	RNeasy	spin	columns	were	
used	to	bind	RNA.	Samples	were	treated	with	DNAse	(Promega)	to	ensure	complete	
removal	of	genomic	DNA.	Columns	were	washed	and	RNAwas	eluted	in	RNase‐free	
water.	 RNA	 quantity	 was	 measured	 using	 the	 NanoDrop	 spectrophotometer	
(Thermo	Scientific,	Wilmington,DE).	OnlyRNAsamples	with	a	clearly	visible	S28	and	
S18	on	agarose	gel	were	considered	as	intact	RNA	and	were	used.	Total	cDNA	was	
synthesized	 using	 the	 iScriptcDNAsynthesis	 kit	 (Bio‐Rad,	 Hercules,	 CA).	 qPCR	
reactions	were	performed	on	10ng	cDNA	with	300nM	of	gene‐specific	forward	and	
reverse	 primers	 and	 1X	 Absolute	 qPCR	 SYBR	 Green	 Fluorescein	 Mix	 (Bioline,	
London,	United	Kingdom)	using	 the	MyIQ	system	(Bio‐Rad).	 Sequence	of	primers	
for	 VegfA	 were:	 forward	 TATTCAGCGGACTCACCAGC,	 reverse	
CCTCCTCAAACCGTTGGCA).	 Gene	 expression	 levels	 were	 calculated	 with	 IQ5	
software	 using	 a	 ΔCt	 relative	 quantification	 model.	 The	 geometric	 mean	 of	 2	
internal	 control	 genes	 (b2‐microglobulin	 and	 cyclophilin	 A)	 was	 calculated	 and	
used	as	a	normalization	factor.	
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Human	tissue	collection	
From	 148	 consecutive	 patients	 who	 underwent	 oncologic	 colorectal	 surgery,	
paraffin‐embedded	 colonic	 or	 rectal	 tissue	 sections	 were	 collected	 from	 the	
pathology	 department’s	 database	 for	 DNA	 extraction.	 In	 all	 cases,	 surgery	 with	
primary	 anastomosis	 was	 performed	 in	 a	 single	 non‐academic	 centre	 with	 a	
dedicated	team	of	colorectal	surgeons	from	January	2010	until	August	2011.	Data	
on	 clinical	 outcome,	 including	 development	 of	 anastomotic	 leakage,	 had	 been	
electronically	and	prospectively	registered	in	detail	for	nationwide	audit	purposes.	
DNA	isolation	from	human	tissue	
Genomic	 DNA	 was	 obtained	 from	 formalin‐fixed	 paraffin‐embedded	 tissue	 using	
either	a	QIAamp	DNA	FFPE	Tissue	Kit	(Qiagen)	or	an	in‐house	protocol.	In	short,	4	
tissue	 sections	 of	 8mm	per	 sample	were	 deparaffinized,	 and	 samples	were	 lysed	
under	 denaturing	 conditions	 with	 proteinase	 K	 (at	 least	 3	 h	 at	 55°C).	 After	
centrifuging	 multiple	 times,	 pure	 genomic	 DNA	 was	 obtained	 and	 concentration	
was	determined	using	Nanodrop.	To	obtain	more	purified	DNA,	 all	 samples	were	
twice	 precipitated	 with	 sodium	 acetate,	 both	 after	 the	 amplification	 and	 the	
restriction	step.		
PTGS2‐765G>C	Genotyping	
A	common	promoter	variant	in	the	COX‐2	gene,	‐765G>C,	leads	to	lower	expression	
of	 COX‐2	 as	 the	 ‐765C	 allele,	 compared	with	 the	 ‐765G	 allele,	 reduces	 promoter	
activity21.	 In	 this	 study,	 it	was	 also	demonstrated	 that	 the	 ‐765C	 allele	 correlates	
with	lower	C	reactive	protein	levels.	Therefore,	the	presence	of	‐765G>C	may	have	
significant	 clinical	 implications.	 We	 hypothesized	 that	 the	 PTGS2‐765G>C	
polymorphism	would	be	associated	with	an	 increased	risk	of	anastomotic	 leakage	
through	lower	promoter	activity	of	the	COX‐2	gene.	Amplification	of	this	region	was	
performed	using	specific	forward	and	reverse	primers	(CCGCTTCCTTTGTCCATCAG	
and	 GGCTGTATATCTGCTCTATATGC,	 respectively).	 Subsequently,	 AciI	 restriction	
enzyme	(New	England	Biolabs,	Ipswich,	MA)	was	applicated	(60	min	incubation	at	
37°C,	20	min	inactivation	at	65°C)	resulting	in	both	a	188	base	pair	product	and	a	
118	base	pair	product	in	case	of	a	‐765G	allele,	or	an	uncut	306	base	pair	product	in	
case	 a	 ‐765C	 allele.	 The	 presence	 of	 homozygous	 PTGS2‐765G>C	 polymorphism	
(‐765CC)	was	then	correlated	to	anastomotic	leakage.	
Statistics	
Statistical	 analysis	 was	 performed	 using	 Prism	 5.0	 for	 Windows	 (Graphpad	
software,	 Inc,	 San	Diego,	 CA)	 and	 SPSS	20.0	 for	Windows	 (SPSS	 Inc,	 Chicago,	 IL).	
Normality	 was	 tested	 using	 Kolmogorov‐Smirnov.	 All	 continuous	 variables	 are	
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presented	as	mean	and	standard	error	of	the	mean	and	compared	using	student	t	
test.	 Dichotomous	 variables	 were	 compared	 using	 chi‐square	 test.	 Survival	 was	
analyzed	by	logrank	test.	
Results	
Diclofenac	increases	colonic	anastomotic	leakage	in	an	experimental	colonic	
surgery	model	
To	 study	 whether	 the	 observed	 retrospective	 human	 data	 on	 colonic	 anastomic	
leakage	 in	 patients	 receiving	 COX‐2	 inhibitors	 were	 also	 observed	 in	 mice,	
anastomotic	 leakage	 rates	 in	 mice	 receiving	 either	 vehicle	 or	 NSAIDs	 were	
determined.	Three	of	11	mice	in	the	wildtype	group	developed	anastomotic	leakage	
(27%),	 which	 is	 consistent	with	 previous	 studies	 using	 this	 experimental	model.	
Intriguingly,	 all	 mice	 in	 the	 diclofenac	 group	 (n=9,	 100%),	 however,	 developed	
anastomotic	leakage,	P=0.001	(Figure	4.2A).	As	expected,	survival	was	significantly	
reduced	 in	 the	 group	 receiving	 diclofenac	 compared	 with	 the	 group	 receiving	
vehicle	[hazard	ratio	(HR)	17.9	(95%	confidence	 interval	(CI),	3.7–87.4),	P<0.001,	
Figure	 4.2B].	 These	 data	 confirm	 that	 NSAIDs	 in	 this	 experimental	mouse	model	
also	have	detrimental	effects	on	anastomotic	healing,	making	 it	a	useful	model	 to	
study	the	deleterious	effects	of	NSAIDs	in	more	detail.	
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Figure	4.2	 Effect	 of	 diclofenac	 on	 experimental	 anastomotic	 healing.	 A.	 Incidence	 of	 anastomotic	
leakage	 in	 mice	 treated	 with	 vehicle	 (n=11)	 and	 mice	 treated	 with	 diclofenac	 (n=9).	
B.	Survival	of	mice	treated	with	vehicle	and	mice	treated	with	diclofenac.	Mice	treated	with	
diclofenac	showed	higher	anastomotic	leakage	incidence	and	mortality	rates.	
	
Cyclooxygenase	2	is	critically	involved	in	colonic	anastomotic	healing	
Because	 we	 hypothesized	 that	 the	 adverse	 effects	 of	 NSAIDs	were	 particularly	 a	
consequence	 of	 COX‐2	 inhibition,	 we	 further	 investigated	 the	 selective	 effects	 of	
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COX‐2	in	anastomotic	healing	using	COX‐2‐/‐	mice.	Eleven	of	12	COX‐2‐/‐	mice	(92%)	
had	macroscopic	 leakage	 compared	with	 only	 27%	 of	WT	mice	 (P=0.003,	 Figure	
4.3A).	 Survival	 was	 significantly	 reduced	 in	 COX‐2‐/‐	 mice	 compared	 to	WT	mice	
[HR,	3.5	(95%CI,	1.2–10.3],	P=0.02,	Figure	4.3B].	Because	COX‐2	is	essential	for	the	
production	 of	 PGE2,	 which	 is	 an	 important	 mediator	 in	 gut	 homeostasis,	 we	
investigated	whether	PGE2	administration	could	rescue	COX‐2‐/‐	from	anastomotic	
leakage.	 Indeed,	 supplementation	 with	 dmPGE2	 halved	 the	 anastomotic	 leakage	
rate	 in	 COX‐2‐/‐	 mice	 from	 92%	 (11	 of	 12	 mice)	 to	 46%	 (6	 of	 13	 mice),	 P=0.02	
(Figure	4.4).		
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Figure	4.3	 Effect	 of	 genotype	 on	 experimental	 anastomotic	 healing.	 A.	 Incidence	 of	 anastomotic	
leakage	 in	 wildtype	 (n=11),	 COX‐2+/‐	 (n=17),	 and	 COX‐2‐/‐	 (n=12)	 mice.	 B.	 Survival	 of	
wildtype	and	COX‐2‐/‐	mice.	COX‐2‐/‐	mice	showed	higher	anastomotic	leakage	and	mortality	
rates	compared	to	wildtype	mice.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	4.4	 Effect	of	PGE2	administration	on	anastomotic	leakage	rates	in	wildtype	(n=12)	and	COX‐2‐/‐	
(n=13)	mice.	PGE2	administration	decreased	anastomotic	leakage	rates	in	COX‐2‐/‐	mice.	
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Lack	of	COX‐2	does	not	lead	to	inflammatory	changes	in	anastomotic	tissue	
Having	determined	a	clear	role	for	COX‐2	in	anastomotic	healing,	we	set	out	to	dig	
further	 into	 the	mechanisms	 involved	 in	 COX‐2‐dependent	 impaired	 anastomotic	
healing.	One	of	the	obvious	mechanisms	that	could	be	disturbed	by	blocking	COX‐2	
function	is	the	inflammatory	response,	which	is	critical	in	the	first	phases	of	wound	
healing.	In	the	early	phase	of	wound	healing,	neutrophils	are	the	predominant	cell	
type;	however,	no	significant	differences	were	observed	 in	 influx	of	MPO‐positive	
cells	 between	WT	 and	 COX‐2‐/‐	 mice	 (Figure	 4.5A).	 On	 average	 148	 cells/field	 of	
view	were	found	vs.	188	cells/field	of	view	at	100x	magnification,	WT	vs.	COX‐2‐/‐,	
respectively	 (Figure	 4.5B).	 Apart	 from	 neutrophils,	 macrophages	 are	 important	
COX‐2	expressing	inflammatory	cells	that	also	play	a	major	role	in	wound	healing.	
We	observed	no	 significant	differences	 in	 the	presence	of	MAC‐3‐positive	 cells	 in	
colonic	anastomotic	tissue	of	WT	vs.	COX‐2‐/‐	mice.	(Figure	4.5A).		
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Figure	4.5	 Immunohistochemical	 staining	 of	MPO.	 A.	 Sections	 of	 colonic	 anastomotic	 tissue	 stained	
with	MPO.	Upper	panel:	wildtype;	 lower	panel:	COX‐2‐/‐.	Magnification	40x,	 inlay	100x.	B.	
Quantification	of	MPO	staining	of	wildtype	and	COX‐2‐/‐	mice.	Data	are	presented	as	mean	
with	SEM	(number	of	positive	cells	per	field	of	view	at	100x	magnification).	We	observed	
no	differences	in	MPO	staining	between	wildtype	and	COX‐2‐/‐	mice.	
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On	 average	 a	 25%	 vs.	 23%	 ratio	 of	 positive	 staining/total	 tissue	 area,	 WT	 vs.	
COX‐2‐/‐,	 respectively	 (Figure	 4.6B).	 These	 data	 indicate	 that	 local	 cellular	
inflammatory	 responses	 after	 colonic	 surgery	 are	 not	 affected	 in	 COX‐2‐/‐	 mice,	
which	 may	 point	 toward	 a	 different	 underlying	 factor	 involved	 in	 the	 impaired	
anastomotic	healing	in	COX‐2‐/‐	mice.	
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Figure	4.6	 Immunohistochemical	staining	of	MAC‐3.	A.	Sections	of	colonic	anastomotic	tissue	stained	
with	MAC‐3.	 Upper	panel:	wildtype;	 lower	panel:	 COX‐2‐/‐.	Magnification	40x,	 inlay	100x.	
B.	Quantification	of	MPO	staining	of	wildtype	and	COX‐2‐/‐	mice.	Data	are	presented	as	mean	
with	SEM	(percentage	of	positive	cells	per	total	tissue	area).	We	observed	no	differences	in	
MAC‐3	staining	between	wildtype	and	COX‐2‐/‐	mice.	
	
Angiogenesis	is	impaired	in	anastomotic	tissue	of	COX‐2	knockout	mice	
Ischemia	of	the	anastomosis	is	an	important	factor	associated	with	the	occurrence	
of	anastomotic	leakage,	and	(neo)vascularization	of	the	wound	region	is	critical	for	
adequate	 wound	 healing22.	 Because	 COX‐2	 is	 well	 known	 to	 be	 involved	 in	
angiogenesis,	we	next	assessed	whether	vascularization	of	 the	wound	region	was	
impaired	 in	COX‐2‐/‐	mice.	Staining	of	CD31,	an	endothelial	marker,	was	markedly	
reduced	in	anastomotic	tissue	of	COX‐2‐/‐	mice	compared	to	control.	Quantification	
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of	 the	 amount	 of	 blood	 vessels	 showed	 that	 only	 2	 vessels/mm2	were	 stained	 in	
anastomotic	tissue	of	COX‐2‐/‐	mice	compared	to	6	vessels/mm2	 in	wildtype	mice,	
5	days	 after	 surgery	 (P=0.03,	 Figures	 4.7A,	 4.7B).	 This	 effect	 could	 partly	 be	
reversed	 by	 administration	 of	 dmPGE2	 to	 COX‐2‐/‐	 mice,	 because	 significantly	
higher	numbers	of	blood	vessels	were	observed	in	COX‐2‐/‐	mice	receiving	dmPGE2	
compared	to	COX‐2‐/‐	receiving	vehicle	(4	vs.	2	vessels/mm2,	respectively,	P=0.03,	
Figure	 4.7B).	 Similarly,	 anastomotic	 tissue	 mRNA	 levels	 of	 VEGF	 were	 higher	 in	
wildtype	mice	compared	to	COX‐2‐/‐	mice	(P=0.02),	and	 in	COX‐2‐/‐	mice	receiving	
dmPGE2	compared	to	COX‐2‐/‐	mice	receiving	vehicle	(P=0.03).		
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Figure	4.7	 COX‐2‐/‐	 mice	 exhibit	 less	 vascularization	 in	 colonic	 anastomotic	 tissue.	 A.	
Immunohistochemical	 staining	 of	 CD31	 on	 sections	 of	 colonic	 anastomotic	 tissue.	 Upper	
panel:	wildtype;	 lower	panel:	 COX‐2‐/‐.	Magnification	40x,	 inlay	100x.	B.	Quantification	of	
MPO	 staining	 of	 wildtype	 and	 COX‐2‐/‐	 mice,	 and	 COX‐2‐/‐	 mice	 receiving	 PGE2.	 Data	 are	
presented	 as	 mean	 with	 SEM.	 CD31	 expression	 was	 significantly	 lower	 in	 COX‐2‐/‐	 mice	
compared	 to	 wildtype	 mice	 and	 compared	 to	 COX‐2‐/‐	 mice	 receiving	 PGE2.	 C.	 Relative	
expression	of	VEGF	mRNA	in	colonic	anastomotic	tissue	of	wildtype	and	COX‐2‐/‐	mice,	and	
COX‐2‐/‐	mice	receiving	PGE2.	Data	are	presented	as	mean	with	SEM.	Relative	VEGF	mRNA	
expression	 was	 significantly	 lower	 in	 COX‐2‐/‐	 mice	 compared	 to	 wildtype	 mice	 and	
compared	to	COX‐2‐/‐	mice	receiving	PGE2.	
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Humans	with	genetically	impaired	COX‐2	expression	show	high	anastomotic	
leakage	incidence	
Of	 148	 patients	 undergoing	 colorectal	 resection	 for	 malignancy,	 7	 were	
homozygous	 for	 the	 PTGS2–765G>C	 polymorphism.	 Three	 of	 7	 (43%)	 developed	
anastomotic	leakage	compared	with	16	of	141	(11%)	patients	with	the	‐765GC	or	‐
765GG	genotype	(P=0.02,	Figure	4.8).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	4.8	 Effect	of	human	genotype	(a	common	promoter	variant	in	
the	 COX‐2	 gene,	 −765G>C)	 on	 anastomotic	 leakage	
incidence.	‐765CC	(n=7)	and	‐765GC	pooled	with	‐765GG	
(n=157)	are	depicted.	
Discussion	
This	 study	 shows	 that	 COX‐2	 is	 of	 critical	 importance	 in	 preventing	 anastomotic	
leakage	after	colonic	surgery	 in	a	mouse	experimental	colonic	anastomosis	model	
using	both	a	pharmacological	and	a	genetic	approach.	Mice	lacking	COX‐2	showed	
increased	 rates	 of	 anastomotic	 leakage	 and	 mortality,	 which	 could	 be	 partly	
counteracted	by	administration	of	PGE2,	supposedly	the	most	important	product	of	
COX‐2	 in	 preserving	 gut	 homeostasis.	 Intriguingly,	 PTGS2‐765G>C	 polymorphism	
in	humans,	associated	with	reduced	COX‐2	expression,	was	associated	with	higher	
anastomotic	 leakage	rates.	 Impaired	angiogenesis	 in	mice	 lacking	COX‐2	seems	 to	
be	 at	 least	 part	 of	 the	 explanation	 for	 increased	 anastomotic	 leakage	 rates	 and	
mortality.		
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A	 correlation	 between	 the	 use	 of	 COX‐2	 blocking	 NSAIDs	 and	 impaired	
anastomotic	 healing	 after	 colorectal	 surgery	 has	 already	 been	 established	 in	
patients9,11,12.	However,	 these	data	are	of	 retrospective	nature	and	a	 fundamental	
role	 of	 COX‐2	 in	 gut	 healing	 after	 colorectal	 surgery	 has	 never	 been	 established.	
Manieri	 et	 al	 showed	 that	 COX‐2	 is	 critically	 involved	 in	 mucosal	 repair	 after	
intestinal	 biopsies5.	 Furthermore,	 abundant	 evidence	 exists	 showing	 that	 COX‐2	
and	 its	 derived	 prostaglandins	 stimulate	 intestinal	 cancer	 progression	 through	
enhanced	angiogenesis	and	proliferation	and	by	decreasing	apoptosis23‐25.	Although	
these	mechanisms	should	be	counteracted	 to	reduce	cancer	progression,	 they	are	
indispensable	 in	 adequate	 wound	 healing.	 As	 shown	 by	 Binion	 et	 al,	 COX‐2	 and	
PGE2	 stimulate	 angiogenesis	 through	 VEGF	 production	 (by	 endothelial	 cells)8.	
Indeed,	 our	 study	 showed	 that	 mice	 lacking	 COX‐2	 have	 significantly	 lower	
amounts	 of	 CD31+	 vessels	 in	 anastomotic	 tissue	 that	was	 accompanied	 by	 lower	
levels	 of	 VEGF	 mRNA	 levels	 and	 was	 at	 least	 partly	 restored	 by	 PGE2	
administration.	
	
The	 current	 study	has	 several	 important	 implications.	As	 suggested	earlier	by	
retrospective	 human	 data,	 the	 perioperative	 use	 of	 NSAIDs	 should	 be	 avoided	 in	
patients	undergoing	surgery	with	a	bowel	anastomosis.	Furthermore,	patients	with	
mutations	in	the	COX‐2	gene	may	be	particularly	vulnerable	to	impaired	intestinal	
wound	healing	and	the	subsequent	risk	of	complications	after	colorectal	surgery	or	
other	 therapeutic	 hits	 impairing	 gut	 homeostasis.	 This	 was	 underlined	 in	 the	
current	 study	 by	 the	 increased	 anastomotic	 leakage	 risk	 in	 patients	 carrying	
2	alleles	 of	 the	 PTGS2‐765G>C	 polymorphism.	 Although	 the	 prevalence	 of	 the	
homozygous	‐765C	gene	is	reported	to	be	around	3%26,	selection	and	personalized	
treatment	of	these	patients	should	be	investigated,	for	example,	the	administration	
of	 prostaglandins	 such	 as	 PGE2	 in	 phases	 when	 adequate	 intestinal	 healing	 is	
crucial.		
	
A	 number	 of	 methodologic	 remarks	 must	 be	 made	 when	 interpreting	 these	
observations.	As	with	nearly	all	animal	anastomotic	leakage	models,	in	the	current	
model	a	mechanically	insufficient	anastomosis	was	created.	However,	these	models	
provide	an	excellent	and	unique	opportunity	to	study	the	mechanisms	of	intestinal	
wound	healing,	while	also	providing	clinical	readouts,	such	as	anastomotic	leakage	
and	mortality.	 Another	 limitation	 was	 the	 lack	 of	 a	 random	 computer‐generated	
multiple‐area	 analysis	 of	 our	 IHC	 data,	which	may	 have	 biased	 our	 observations.	
Furthermore,	 there	 could	 be	 differences	 between	 inflammatory	 mediators	 that	
were	missed.	Future	studies	should	address	this.	
	
A	discrepancy	between	previous	human	reports	and	our	used	model	is	that	all	
mice	 receiving	 diclofenac	 developed	 anastomotic	 leakage.	 Although	 this	
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underscores	 the	 importance	 of	 this	 pathway	 in	 anastomotic	 healing,	 such	 high	
anastomotic	 leakage	 rates	 were	 not	 observed	 in	 previous	 animal	 studies27,28.	
Blockage	of	both	COX‐2	and	COX‐1	by	diclofenac,	which	is	constitutively	expressed	
in	colonic	tissue29,	may	be	the	reason	for	this	effect.		
	
The	 survival	 of	 mice	 with	 anastomotic	 leakage	 in	 the	 current	 study	 was	
remarkably	 low,	 with	most	 mice	 dying	 within	 several	 days.	 For	 example,	 higher	
survival	rates	are	reported	for	most	cecal	puncture	and	ligation	protocols,	although	
cecal	 puncture	 and	 ligation	 protocols	 inducing	 high‐grade	 sepsis	 are	 reported	 to	
have	 similar	 survival	 rates30.	 This	 might	 indicate	 a	 high	 degree	 of	 necrosis;	
however,	we	did	not	find	this	on	tissue	sections.		
	
PGE2	administration	did	not	fully	reverse	the	incidence	of	anastomotic	leakage	
in	COX‐2	knockout	mice	to	wildtype	levels.	This	could	be	explained	by	the	fact	that	
we	 only	 used	 PGE2	 to	 counteract	 the	 effects	 of	 genetic	 lack	 of	 COX‐2.	 However,	
other	 prostaglandins	 are	 converted	 from	 arachidonic	 acid	 by	 COX‐2,	 as	 well.	 In	
particular,	prostacyclin	(PGI2)	is	expressed	in	colonic	tissue	and	may	therefore	play	
a	 role	 in	 anastomotic	 healing5.	 Another	 explanation	 could	 be	 that	 the	 dose	 or	
frequency	of	PGE2	administration	should	be	increased	for	optimal	effects.	
	
In	 conclusion,	 we	 show	 that	 COX‐2	 inhibition	 is	 deleterious	 for	 anastomotic	
healing	after	colonic	surgery,	which	is	mediated	at	least	in	part	by	PGE2	production.	
Mice	 lacking	 COX‐2	 show	 higher	 rates	 of	 anastomotic	 leakage	 and	 increased	
mortality.	 In	 addition,	 angiogenesis	 is	 significantly	 impaired	 in	 the	 absence	 of	
COX‐2	 and	 PGE2,	 providing	 clues	 for	 the	mechanism	 by	 which	 COX‐2	 influences	
anastomotic	healing.	Importantly,	we	show	that	patients	with	a	polymorphism	that	
is	associated	with	decreased	COX‐2	levels	were	more	likely	to	develop	anastomotic	
leakage,	 which	 further	 supports	 our	 conclusions.	 We	 suggest	 that	 until	 proven	
otherwise,	 the	perioperative	use	of	COX‐2	 inhibitors	 in	 colonic	 surgery	 should	be	
replaced	by	alternative	analgesics,	and	future	studies	should	assess	the	potential	of	
PGE2	administration	prior	to	colonic	surgery	to	reduce	anastomotic	 leakage	rates	
in	a	selection	of	patients.	
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Abstract	
Background	
Anastomotic	leakage	(AL)	is	the	most	dreaded	complication	after	colorectal	surgery	causing	
high	morbidity	and	mortality	without	its	pathophysiology	being	completely	elucidated.	Since	
mucus	 is	 a	 first	 line	of	defence	 against	 external	 factors	 in	 the	 gastrointestinal	 tract,	 it	was	
investigated	 if	depletion	of	 the	structural	mucus	protein	Muc2	 is	associated	with	 impaired	
colon	anastomotic	healing.	
	
Methods	
Mice	of	different	Muc2	genotypes	were	subjected	to	a	model	of	proximal	colonic	AL.	Tissues	
were	histologically	scored	for	inflammation,	bacterial	translocation	was	determined	by	qPCR	
of	bacterial	16S	rDNA,	and	epithelial	cell	damage	was	determined	by	assessing	serum	levels	
of	intestinal	fatty	acid	binding	protein.	
	
Results		
Of	22	Muc2	deficient	(Muc2‐/‐)	mice,	20	developed	AL,	compared	with	7	of	22	control	animals	
(P<0.001).	Control	mice	showed	normal	healing	whereas	Muc2‐/‐	showed	more	inflammation	
with	 less	 collagen	 deposition	 and	 neoangiogenesis.	 A	 tendency	 towards	 higher	 bacterial	
translocation	was	 seen	 in	Muc2‐/‐	mesenteric	 lymph	 node	 and	 spleen.	 Intestinal	 fatty	 acid	
binding	 protein	 levels	 were	 significantly	 higher	 in	 Muc2‐/‐	 mice	 compared	 to	 controls	
(P=0.011).	
	
Conclusions	
A	functional	mucous	layer	facilitates	the	healing	of	colonic	anastomoses.	
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Introduction	
Anastomotic	 leakage	 (AL)	 is	 one	 of	 the	most	 dreaded	 complications	 of	 colorectal	
surgery,	 and	 leads	 to	 high	morbidity	 and	mortality1,2.	 AL	 rates	 remain	 high,	with	
reported	 rates	 ranging	 from	1	 to	 almost	 20	 per	 cent,	 despite	 extensive	 research,	
improvement	 of	 surgical	 techniques	 and	 the	 development	 of	 fast‐track	
programmes3,4.	Identified	risk	factors	for	AL	development,	such	as	male	sex,	steroid	
use	and	location	of	the	tumour,	as	well	as	concurrent	disease	and	malnutrition,	can	
help	clinicians	to	determine	which	patients	are	at	risk5,6.	However,	the	underlying	
pathophysiological	mechanisms	 for	 AL	 remain	 unclear7.	 A	 better	 insight	 to	 these	
mechanisms,	 and	 the	 factors	promoting	 anastomotic	healing,	 is	 needed	 to	 reduce	
rates	of	AL8.	
	
The	 colon	 is	 protected	 by	 a	 two‐phase	 mucous	 layer	 built	 around	 the	 gel‐
forming	MUC2	mucin	and	a	limited	number	of	other	components	secreted	from	the	
goblet	 cells9,10.	MUC2	mucin	polymers	 form	net‐like	 sheets	 that,	when	 layered	on	
top	 of	 one	 another,	 form	 an	 inner	 colonic	 mucous	 layer	 that	 is	 impenetrable	 to	
bacteria11.	This	 layer	 is	about	50	µm	thick	 in	mice	and	200	µm	 in	humans,	and	 is	
quickly	renewed12.	The	 inner	 layer	 is	converted	to	an	non‐attached	outer	mucous	
layer,	which	is	penetrable	for	colonic	bacteria	that	use	this	layer	as	their	habitat9,10.	
Muc2	 gene‐deficient	 mice	 lack	 a	 functional	 mucous	 layer,	 and	 have	 bacteria	 in	
direct	contact	with	the	epithelial	cells	in	the	intestine9.	These	mice	develop	colonic	
inflammation	 with	 a	 severity	 that	 depends	 on	 the	 bacterial	 flora	 in	 the	 animal	
housing	facility.	
	
Among	 the	 numerous	 factors	 contributing	 to	 healing	 of	 surgical	 anastomoses,	
the	 intestinal	mucus	 system	has	 been	 largely	 overlooked.	 This	 is	 despite	 the	 fact	
that	 numerous	 studies	 have	 shown	 that	 mucus	 is	 essential	 for	 protection	 of	 the	
epithelium	from	luminal	challenge.	For	example,	it	was	recently	demonstrated	that	
colonic	ischaemia	resulted	in	detachment	of	mucus,	which	allowed	bacteria	to	come	
into	contact	with	the	epithelium13.	When	blood	flow	was	restored,	crypt	goblet	cells	
secreted	stored	mucus,	which	cleared	the	bacteria	 in	contact	with	the	epithelium,	
and	re‐established	homeostasis.	Thus,	goblet	cell	mucous	secretion	plays	a	central	
role	in	regenerating	a	functional	mucous	layer	that	protects	the	host	epithelium14.	
	
Mucin	secretion	influences	the	capacity	of	the	mucous	layer	to	protect	the	colon,	
and	altered	secretion	may	result	in	different	physiological	consequences15.	Barcelo	
and	colleagues16	demonstrated	that	mucin	secretion	can	be	modulated	by	 luminal	
factors	 such	 as	 certain	 algal	 polysaccharides,	 uronic	 acids	 and	 short‐chain	 fatty	
acids	 (SCFAs).	Other	 factors	 influencing	mucous	 secretion	are	prostaglandins	and	
certain	bacteria,	such	as	Listeria	monocytogenes	and	Akkermansia	muciniphila17,18.	
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In	 addition,	 prostaglandin	 (PG)	 E2,	 produced	 by	 the	 two	 isoforms	 of	 cyclo‐
oxygenase	 (COX)	1	and	2,	 can	 stimulate	mucous	 secretion	 in	both	 small	 intestine	
and	 proximal	 colon	 ex	 vivo19.	 Non‐steroidal	 anti‐inflammatory	 drugs	 (NSAIDs)	
inhibit	 COX	 enzymes,	 leading	 to	 a	 decrease	 in	 prostaglandin	 synthesis20.	 An	
association	 between	 the	 use	 of	 NSAIDs	 and	 AL	 has	 been	 described	 in	 both	
experimental	 and	 observational	 studies21–23,	 suggesting	 an	 interaction	 between	
prostaglandins	and	anastomotic	healing.	PGE2	could	thus	have	a	positive	influence	
on	anastomotic	healing,	mediated	by	its	effect	on	mucous	secretion.	
	
In	the	present	study,	the	protective	role	of	a	functional	mucous	layer	on	AL	rates	
after	 colonic	 surgery	 in	 mice,	 and	 the	 influence	 of	 PGE2	 administration	 on	
anastomotic	wound	healing,	was	investigated.	
Methods	
Animals	
All	 animal	 experiments	 were	 approved	 by	 the	 Gothenburg	 Animal	 Experiments	
Ethics	 Committee	 (permit	 63‐2014),	 and	 all	 experiments	 were	 performed	 in	
compliance	 with	 the	 directive	 on	 the	 protection	 of	 animals	 used	 for	 scientific	
purposes	(2010/63/EU).	This	study	followed	the	ARRIVE	guidelines24;	Appendix	S1	
(supporting	information)	provides	more	detailed	information.	
	
Forty‐four	mice	(mean(s.d.)	weight	22.3(3.8)	g)	of	different	genotypes	(Muc2−/−,	
Muc2+/−	and	Muc2+/+)	were	matched	for	age	(8–20	weeks)	and	sex	when	possible,	in	
order	 to	obtain	equal	distribution	within	experimental	groups	(2	groups:	Muc2−/−	
versus	 control	 (Muc2+/−	 and	 Muc2+/+);	 22	 mice	 per	 group).	 Additionally,	 eight	
Muc2−/−	mice	served	as	control	animals	in	the	quantitative	PCR	(qPCR)	experiment	
for	bacterial	 translocation,	 to	distinguish	between	effects	 induced	by	 surgery	and	
the	genotype.	The	mice	had	unlimited	access	 to	standard	mouse	chow	and	water.	
Welfare	of	the	animals	was	assessed	twice	daily	using	extensive	scoring	according	
to	 Pommergaard	 and	 colleagues25.	 Postoperative	 pain	 relief	 treatment	 with	
buprenorphine	 0.1	 mg/kg	 subcutaneously	 (Buprecare®;	 AST	 Farma,	 Oudewater,	
The	Netherlands)	was	administered	when	needed.		
Study	design	
Muc2−/−,	 Muc2+/−	 and	 wild‐type	 (WT;	 Muc2+/+)	 mice	 underwent	 laparotomy	with	
colonic	 anastomosis	 and	 were	 killed	 on	 at	 day	 3	 after	 the	 operation.	 The	
heterozygous	 and	WT	mice	were	 considered	 control	 animals	 (Muc2+),	 as	 both	 of	
these	genotypes	determine	a	normal	mucous	layer.	The	primary	outcome	was	AL,	
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defined	 by	 either	 faecal	 peritonitis	 or	 abscess	 formation	 at	 the	 anastomotic	 site.	
Macroscopic	AL	was	diagnosed	by	two	 independent	observers,	who	were	blinded	
for	the	genotypes	at	the	time	of	death.	
Model	
The	model	of	AL	used	was	 that	described	previously	by	Komen	and	co‐workers26	
and	 subsequently	 adapted	 by	 Reisinger	 et	 al.27	 to	 obtain	 a	model	 that	 resembles	
clinical	 practice.	 In	 this	 model,	 mice	 undergo	 anaesthesia	 with	 isoflurane	 and	
receive	 pain	 treatment	 with	 buprenorphine	 (0.1	 mg/kg	 subcutaneously)	 before	
surgery	 in	 which	 a	 proximal	 colonic	 anastomosis	 is	 performed	 with	 seven	
interrupted	 extramucosal	 sutures	 (Prolene®	 8‐0;	 Ethicon,	 Johnson	 &	 Johnson,	
Somerville,	 New	 Jersey,	 USA),	 providing	 a	 leakage	 rate	 of	 33.3	 per	 cent.	 During	
surgery,	 the	 colon	 and	 caecum	 are	 kept	 moist	 with	 sterile	 saline.	 The	 body	
temperature	 of	 the	mice	 is	 held	 constantly	 at	 37°C	 using	 a	 heat	 pad.	 The	muscle	
layer	 and	 skin	 are	 closed	using	 interrupted	 sutures	 (Vicryl®	4‐0	 and	Monocryl®	
Plus	 4‐0	 respectively,	 both	 from	 Ethicon).	 After	 surgery,	 the	mice	 receive	 0.5	ml	
saline	subcutaneously	as	fluid	therapy.	All	surgical	procedures	were	performed	by	a	
single	investigator	who	was	blinded	for	genotype	at	the	time	of	surgery.	
	
The	 main	 outcome	 after	 surgery	 was	 macroscopic	 evaluation	 of	 the	
anastomosis,	 evaluated	 as	 follows:	 no	 AL;	 small	 abscess,	 less	 than	 0.5	 cm3;	 large	
abscess,	0.5	cm3	or	more;	or	faecal	peritonitis.	
Tissue	and	blood	sampling	
Histological	 assessment	 was	 performed	 on	 anastomotic	 tissue.	 To	 conserve	 the	
mucous	layer,	the	anastomosis	was	dissected	en	bloc,	leaving	the	sutures	intact,	and	
fixed	in	Carnoy	solution	(60	per	cent	methanol,	30	per	cent	chloroform,	10	per	cent	
glacial	acetic	acid).	Unaffected	proximal	and	distal	colonic	tissues	were	obtained	in	
the	 same	manner,	 serving	 as	 control	 tissue.	Mesenteric	 lymph	nodes	 (MLNs)	and	
spleen	were	snap‐frozen	in	liquid	nitrogen	for	further	analysis.	Blood	samples	were	
taken	by	intracardial	puncture	at	time	of	animal	killing,	collected	in	EDTA	vacuum	
tubes	 (BD	Vacutainer®;	 BD,	 Stockholm,	 Sweden)	 and	 kept	 on	 ice.	 Blood	 samples	
were	centrifuged	at	4000	r.p.m.,	at	4°C	for	15	min.	Plasma	was	stored	immediately	
in	aliquots	at	−80°C	until	analysis.	
Mucus	thickness	measurements	
To	evaluate	whether	mucus	was	present	at	the	anastomotic	site	of	control	animals,	
measurements	 of	 mucus	 were	 performed	 as	 described	 previously28,	 with	 some	
modifications.	 Briefly,	 unflushed	 proximal	 colon	 was	 opened	 longitudinally	 after	
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removal	of	the	mesenteric	border.	The	tissue	was	pinned	down	on	a	silica	gel	plate	
with	the	luminal	side	facing	upwards.	Pellet	material	was	gently	removed	and	the	
mucus	 was	 visualized	 by	 adding	 charcoal	 particles	 on	 top	 of	 the	 mucus.	 The	
thickness	 of	 the	 mucous	 layer	 was	 then	 determined	 by	 measuring	 the	 distance	
between	 the	mucous	 surface	 and	 the	 epithelial	 surface	 by	 a	micropipette	 viewed	
through	 a	 stereomicroscope	 (Leica	 MZ12;	 Leica	 Microsystems,	 Heerbrugg,	
Switzerland).	 Mucus	 was	 measured	 directly	 at	 the	 anastomotic	 site.	 Unaffected	
tissue	 was	 used	 for	 control	 measurements.	 The	 tissue	 was	 submerged	 in	
oxygenated	Kreb’s	solution	at	all	 times.	As	Muc2−/−	mice	do	not	have	a	 functional	
mucous	layer,	this	could	not	be	measured	in	these	animals29.	
Histological	analysis		
Tissue	 samples	were	embedded	 in	paraffin	and	cut	 in	4‐μm	sections.	To	evaluate	
the	morphology	 of	 cells	 and	 glycoproteins	 in	 the	 colonic	mucous	 layer,	 standard	
haematoxylin	 and	 eosin,	 and	 periodic	 acid–Schiff–Alcian	 Blue	 (PAS‐AB)	 staining	
was	 performed.	 Specimens	 were	 scored	 based	 on	 inflammation,	 granulocyte	
infiltration,	 fibroblast	 activity	 and	 neoangiogenesis,	 according	 to	 the	 Ehrlich	 and	
Hunt	numerical	scale	(0–4)	as	modified	by	Phillips	et	al.30.	
	
Immunohistochemistry	 for	 Ki‐67	 (proliferation),	 cleaved	 caspase	 3	 (CC‐3)	
(apoptosis)	and	Muc2	(to	confirm	the	phenotype	of	the	animals)	was	performed.	In	
short,	 slides	 were	 deparaffinized	 in	 xylene	 and	 rehydrated	 in	 graded	 ethanol	 to	
distilled	 water.	 Antigen	 retrieval	 was	 performed	 using	 target	 retrieval	 solution	
(Dako,	Glostrup,	Denmark)	at	95°C	for	20	min.	Non‐specific	antibody	binding	was	
blocked	using	5	per	cent	fetal	calf	serum	in	phosphate‐buffered	saline	(PBS)	(Ki‐67)	
or	1	per	cent	bovine	serum	albumin	(Asp175).	Sections	were	then	incubated	with	
specific	 primary	 antibodies	 (Ki‐67	 clone	 Sp6;	 Thermo	 Fisher	 Scientific,	 Life	
Technologies,	Bleiswijk,	The	Netherlands;	CC‐3	Asp175,	Cell	Signalling	Technology,	
Leiden,	The	Netherlands;	or	anti‐MUC2C3	(provided	by	the	Mucin	biology	group)9).	
After	washing,	 swine	antirabbit	 IgG	biotin	 labelled	 (Dako,	Glostrup,	Denmark)	 for	
Ki‐67	and	CC‐3	stainings,	and	fluorophore‐conjugated	CY3	antirabbit	antibody	(Life	
Technologies)	 for	 Muc2	 staining	 were	 used	 as	 second	 antibodies.	 Nuclei	 were	
stained	 using	 (nickel)	 3,3'‐diaminobenzidine	 (DAB)	 or	 4',6‐diamidino‐2‐
phenylindole	 (DAPI).	 All	 staining	 was	 evaluated	 by	 two	 independent	 observers	
using	microscopy;	they	were	blinded	for	the	genotype	of	the	mice.	Ki‐67	expression	
was	 analysed	 using	 ImmunoRatio	 software31,	 which	 calculates	 the	 percentage	 of	
positively	 stained	nuclei	 (DAB)	 in	 relation	 to	 the	other	nuclei	 (haematoxylin).	All	
CC‐3	positive	cells	in	one	tissue	sample	were	counted	and	comparisons	were	made	
between	control	and	anastomotic	tissue.	
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ELISA	for	intestinal	fatty	acid	binding	protein	(I‐FABP)		
Intestinal	 fatty	 acid‐binding	 protein	 (I‐FABP)	 is	 a	 plasma	 marker	 for	 enterocyte	
damage,	as	these	small	cytosolic	proteins	are	present	in	mature	enterocytes	at	the	
tip	 of	 the	 villus	 and	 released	 into	 the	 circulation	 following	 loss	 of	 enterocyte	
membrane	 integrity32.	 Patients	 who	 developed	 AL	 after	 colorectal	 surgery	 were	
shown	 to	 have	 raised	 I‐FABP	 plasma	 levels	 before	 the	 operation33.	 I‐FABP	 was	
measured	 in	 plasma	 using	 a	 commercially	 available	 sandwich	 enzyme	
immunoassay	 (lower	 detection	 limit	 0.061	 ng/ml;	 Cloud‐Clone,	 Houston,	 Texas,	
USA)	according	to	manufacturer’s	protocol.	
Effect	of	PGE2	supplementation	
Inhibition	of	COX	has	been	shown	to	increase	the	risk	of	AL,	an	effect	suggested	to	
be	 PGE2‐mediated27.	 To	 investigate	 whether	 PGE2	 has	 a	 positive	 influence	 on	
anastomotic	healing,	mice	 received	 either	 vehicle	 (PBS)	or	 100	μg/bodyweight	of	
16,16‐dimethyl	 PGE2	 (dmPGE2),	 a	 stable	 PGE2	 analogue	 (Cayman	 Chemical,	 Ann	
Arbor,	Michigan,	USA),	by	twice‐daily	 intraperitoneal	 injection.	Both	interventions	
started	1	day	before	surgery	and	continued	until	postoperative	day	(POD)	3,	after	
which	all	mice	were	killed.	
qPCR	for	bacterial	translocation		
Total	 DNA	 was	 extracted	 from	 snap‐frozen	 MLN	 and	 spleen	 tissue	 using	 a	
combination	 of	 sodium	 dodecyl	 sulphate	 and	 proteolytic	 digestion	 with	 bead	
beating	and	phenol/chloroform	DNA	purification,	 as	previously	described34.	Bead	
beating	was	performed	using	Lysing	Matrix	E	tubes	in	a	FastPrep‐24™	instrument	
(MP	 Biomedicals,	 Thermo	 Fisher	 Scientific,	 Göteborg,	 Sweden).	 DNA	 was	
precipitated	using	0.2	mol/l	sodium	chloride	and	isopropanol,	then	resuspended	in	
100	µL	 Tris–EDTA	 buffer	 and	 quantified	 using	 a	 NanoDrop™	 ND‐1000	
spectrophotometer	(Thermo	Fisher	Scientific,	Göteborg,	Sweden).	DNA	extractions	
from	 tubes	 containing	 no	 tissue	 served	 as	 contamination	 controls.	 Purified	 and	
quantified	16S	DNA	from	Escherichia	coli	was	used	as	a	standard.	Initially,	bacterial	
ribosomal	 DNA	 (rDNA)	 was	 enriched	 from	 host	 DNA	 by	 limited‐cycle	 (LC)	 PCR	
amplification	 of	 16S	 rDNA	 using	 the	 universal	 16S	 rDNA	 primer	 pair	 27F	
(AGAGTTTGATCMTGGCTCAG)	and	1492r	(CGGTTACCTTGTTACGACTT).	Briefly,	50‐
µl	PCR	mixtures	 containing	480	ng	DNA,	0.2	µmol/l	primers	 and	HotStarTaq	Plus	
Mastermix	 (Qiagen,	 Sollentuna,	 Sweden)	were	 subjected	 to	 5	min	 at	 95°C	 and	 16	
cycles	of	94°C	for	1	min,	55°C	for	1	min	and	72°C	for	1.5	min,	followed	by	10	min	at	
72°C.	 Sample,	 standard	 and	 control	 LC‐PCRs	were	 then	 compared	by	 qPCR	using	
16S	 rDNA	 primer	 pair	 926F	 (AAACTCAAAKGAATTGACGG)	 and	 1062R	
(CTCACRRCACGAGCTGAC).	In	brief,	20‐µl	qPCR	mixtures	were	prepared	using	2	µl	
LC‐PCR	mixture,	0.3	µmol/l	primers	and	SSoFast™	EvaGreen®	Supermix	 (Bio‐Rad,	
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Sundbyberg,	Sweden)	and	subjected	 to	95°C	 for	5	min,	 then	30	cycles	of	95°C	 for	
15	s,	61.5°C	 for	15	s	and	72°C	 for	20	s,	with	EvaGreen®	 fluorescence	measured	at	
the	final	step	of	each	cycle.	qPCR	thermocycling	and	fluorescence	measurement	was	
performed	on	 a	 CFX96™	 instrument	 (Bio‐Rad).	 Sample	 amplification	 curves	were	
compared	with	 contamination	 control	 curves,	 and	 samples	were	 considered	16S‐
positive	 if	 they	 amplified	 before	 controls.	 Sample	 16S	 was	 quantified	 using	 a	
standard	curve	generated	from	standard	qPCR	reactions. 
Statistical	analyses	
Statistical	analysis	was	performed	using	GraphPad	Prism®	5.0	 for	Mac	(GraphPad	
Software,	San	Diego,	California,	USA).	Normality	was	tested	using	the	Kolmogorov–
Smirnov	 test.	All	 continuous	variables	are	presented	as	mean(s.d.)	and	compared	
using	Student’s	t	test,	the	Mann–Whitney	U	test,	ANOVA	or	the	Kruskal–Wallis	test	
as	appropriate.	Dichotomous	variables	were	compared	using	the	χ2	test.	
Results	
AL	rate	is	significantly	higher	in	Muc2	deficient	mice		
All	 mice	 (n=44)	 completed	 follow‐up	 of	 3	 days.	 After	 killing,	 the	 abdomen	 was	
reopened	and	the	anastomotic	site	evaluated.	Evaluation	showed	a	wide	range	from	
normal	 healing/no	 AL	 to	 small	 and	 large	 abscesses,	 and	 even	 faecal	 peritonitis	
(Figure	 5.1A–C).	 Muc2−/−	 mice	 had	 AL	 more	 frequently	 (score	 greater	 than	 2)	
compared	 with	 control	 animals	 (20	 of	 22	 versus	 7	 of	 22	 respectively;	 P<0.001)	
(Figure	5.2A).	Three	animals	in	the	Muc2−/−	group	suffered	from	faecal	peritonitis,	
whereas	none	of	the	control	animals	showed	any	sign	of	peritonitis.	Further,	both	
large	(8	versus	1	in	the	control	group)	and	small	(9	versus	6	respectively)	abscesses	
were	found	more	frequently	in	Muc2−/−	mice.	Bodyweight	was	similar	at	baseline	in	
the	 two	 experimental	 groups,	 and	 remained	 so	 over	 time	 (Figure	 5.2B).	 A	
significant	 decrease	 in	welfare	 score	was	 observed	 in	Muc2−/−	mice	 from	 POD	 1,	
with	maximum	effect	at	POD	3	(P<0.001)	(Figure	5.2C).	
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Figure	5.1	 Evaluation	 of	 the	 anastomosis:	 A)	 no	 anastomotic	 leakage,	 B)	 abscess	 (either	 small,	 less	
than	0.5	cm3,	or	large,	0.5	cm3	or	more),	C)	faecal	peritonitis	
	
	
	
	
	
	
	
	
	
	
Figure	5.2	 A)	Muc2−/−	mice	showed	more	frequent	anastomotic	leakage	(AL)	(score	greater	than	2;	20	
of	22	mice)	compared	with	control	animals	(7	of	22)	*P<0.001.	B)	Bodyweight	was	similar	
at	 baseline	 in	 the	 two	 experimental	 groups	 and	did	not	 differ	 over	 time.	 C)	A	 significant	
decrease	 in	 Pommergaard	 welfare	 score	 was	 seen	 in	 Muc2−/−	 mice	 on	 day	 3	 (8.8(1.93)	
versus	10.76(1.30)	in	control	mice;	*P<0.001,	2‐way	ANOVA	with	Bonferroni	post	hoc	test	
(time)).	
Mucus	is	present	at	the	anastomotic	site	of	control	animals		
The	mucous	layer	was	visualized	by	the	addition	of	charcoal	and	its	thickness	was	
measured	 by	 means	 of	 a	 glass	 capillary	 attached	 to	 micrometer,	 observed	 via	 a	
stereomicroscope	(Figure	5.3A).	A	mucous	layer	was	observed	in	Muc2+	animals,	at	
the	site	of	anastomosis	as	well	as	in	the	proximal	and	distal	colonic	tissues	(Figure	
5.3B).	 In	 the	 proximal	 colon,	 the	 mean	 mucous	 layer	 thickness	 was	 greatest	
between	 folds	 (238(17)μm)	 and	 lowest	 on	 top	 of	 the	 folds	 (71(25)μm).	 Mean	
thickness	 of	 the	 mucous	 layer	 at	 the	 anastomotic	 site	 was	 119(65)μm.	 In	 the	
control	 group,	 no	 significant	 difference	 was	 found	 in	 mucous	 layer	 thickness	
between	heterozygous	(Muc2+/−)	and	WT	(Muc2+/+)	mice,	or	between	mice	that	had	
AL	and	those	that	did	not.	As	Muc2‐deficient	mice	lack	the	structural	component	of	
intestinal	mucus	 and	 therefore	 lack	 a	 defined	mucous	 layer,	measurement	 of	 the	
mucous	layer	in	Muc2−/−	mice	was	not	feasible.	
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Figure	5.3	 Adding	charcoal	on	the	sample	enables	mucus	thickness	measurements.	Mucus	thickness	is	
defined	as	the	distance	between	the	charcoal	particles	and	the	tissue	and	was	measured	on	
top	of	colonic	 folds,	 in	between	 folds	and	at	 the	anastomotic	site	 (A).	A	mucus	 layer	was	
observed	in	Muc2+	animals,	at	the	site	of	anastomosis	as	well	as	in	the	proximal	and	distal	
colon	control	tissues	(B).	
Histological	analysis	showed	more	inflammation	in	Muc2	deficient	mice	
Muc2−/−	mice	showed	a	 tendency	 for	more	 leucocyte	 infiltration	and	 less	collagen	
deposition	and	neoangiogenesis	at	killing	on	POD	3	compared	with	Muc2+	animals	
(Figure	5.4B).	 In	addition,	 continuation	of	 the	 intestinal	 tissue	was	evident	 in	 the	
case	of	normal	 anastomotic	healing,	whereas	AL	 caused	disruption	or	dehiscence	
(Figure	 5.4B).	 There	 was	 no	 difference	 in	 proliferation	 determined	 by	 Ki‐67	
staining	between	Muc2−/−	and	control	mice	at	the	serosal	tissue	of	the	anastomosis	
or	 in	 the	 enterocytes	 (Figure	 5.4C,D).	 CC‐3	 staining	 showed	 no	 differences	 in	
apoptosis	between	Muc2−/−	and	control	mice	(Figure	5.4E,F).	
	
A	 normal	 inner	 mucous	 layer,	 as	 shown	 by	 PAS‐AB	 staining,	 was	 clearly	
observed	in	the	Muc2+	control	mice,	but	was	absent	in	Muc2−/−	mice	(Figure	5.5A).	
In	 addition,	 goblet	 cells	 in	 Muc2−/−	 mice	 showed	 only	 PAS‐positive	 staining,	
whereas	 those	 from	 control	 animals	 also	 had	 positive	 AB	 staining.	
Immunohistochemistry	 revealed	 the	 presence	 of	 Muc2‐positive	 goblet	 cells	 in	
control	animals,	but	in	Muc2−/−	mice	there	was	no	expression	of	Muc2,	indicating	no	
Muc2‐positive	goblet	cells	(Figure	5.5B).	
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Figure	5.4	 A)	 Inflammatory	 parameters	 (mean(s.d.)	 scored	 on	 day	 3	 after	 surgery	 did	 not	 differ	
significantly	between	experimental	groups.	B)	In	Muc2+	animals	with	normal	anastomotic	
healing	 there	 was	 continuation	 of	 the	 intestinal	 tissue,	 whereas	 anastomotic	 leakage	 in	
Muc2−/−	 mice	 caused	 disruption	 or	 dehiscence	 (arrows)	 (haematoxylin	 and	 eosin	 stain).	
C+D)	There	was	no	difference	in	proliferation	measured	by	Ki‐67	staining	between	Muc2−/−	
and	 control	mice.	 E+F)	 3,3'‐Diaminobenzidine	 (DAB)	 staining	 for	 cleaved	 caspase	 (CC)	 3	
indicated	no	difference	in	apoptosis	(arrows)	between	Muc2−/−	and	control	mice.	
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Figure	5.5	 A+B)	A	normal	inner	mucous	layer,	as	shown	by	periodic	acid–Schiff–Alcian	Blue	(PAS‐AB)	
staining,	 was	 clearly	 observed	 in	 the	 Muc2+	 control	 mice	 (arrows),	 but	 was	 absent	 in	
Muc2−/−	 animals.	 C+D)	 Immunohistochemistry	 revealed	 the	 presence	 of	 Muc2‐positive	
goblet	 cells	 in	 control	 animals,	 but	 in	 Muc2−/−	 mice	 there	 was	 no	 expression	 of	 Muc2,	
indicating	 no	 Muc2‐positive	 goblet	 cells.	 The	 minimal	 staining	 found	 in	 Muc2−/−	 is	
attributed	 to	 slight	 cross‐reactivity	of	 the	 anti‐MUC2C3	antiserum	with	 the	mouse	Fcgbp	
protein	(Fc	fragment	of	IgG‐binding	protein).	
Epithelial	cells	were	damaged	in	Muc2	deficient	mice		
When	 enterocytes	 are	 damaged	 they	 leak	 one	 of	 their	main	 cytosolic	 proteins,	 I‐
FABP.	 Hence,	 measurement	 of	 I‐FABP	 in	 plasma	 gives	 an	 estimate	 of	 intestinal	
tissue	damage.	Muc2−/−	mice	 showed	 significantly	 higher	plasma	 levels	 of	 I‐FABP	
compared	with	 control	 animals	 (3.88(2.63)	 versus	 1.82(1.83)ng/ml	 respectively;	
P=0.011)	(Figure	5.6A),	indicating	greater	enterocyte	damage	in	the	Muc2−/−	mice.	
PGE2	administration	did	not	reduce	anastomosis	leakage	in	this	model	
dmPGE2	was	 administered	1	day	before	 surgery	 and	on	 every	postoperative	day	
until	 the	 animals	 were	 killed	 (day	 3).	 With	 the	 protocol	 and	 doses	 used,	 no	
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reduction	in	the	rate	of	AL	was	observed	in	Muc2−/−	animals	(10	of	11	animals	for	
both	vehicle	and	PGE2).	The	same	was	true	for	control	animals	(AL	 in	5	of	11	for	
vehicle	versus	2	of	11	for	PGE2;	P=0.362)	(Figure	5.6B).	Within	the	control	group,	
no	 difference	 was	 found	 in	 AL	 rate	 between	 heterozygous	 (Muc2+/−)	 and	 WT	
(Muc2+/+)	mice.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.6	 A)	 The	 concentration	 of	 intestinal	 fatty	 acid‐binding	 protein	 (I‐FABP)	 was	 significantly	
increased	in	Muc2−/−	mice	compared	with	that	in	control	animals	(mean(s.d.)	 	3	 .88(2.63)	
versus	 1.82(1.83)ng/ml	 respectively),	 indicating	 more	 epithelial	 damage.	 *P=0.011	
(Student’s	 t	 test).	 B)	 Following	 prostaglandin	 (PG)	 E2	 supplementation	 ,	 there	 was	 no	
reduction	in	the	anastomotic	leakage	(AL)	rate	for	Muc2−/−	mice	(10	of	11	for		both	vehicle	
and	 PGE2	 ),	 and	 the	 reduction	 in	 the	 AL	 rate	 in	 control	 animals	 was	 not	 significant	
(P=0.362,	Student’s	t	test	per	experiment	as	well	as	2‐way	ANOVA	with	post	hoc	testing	).	
*P<0.001.	 C)	 Bacterial	 translocation	 to	 the	 mesenteric	 lymph	 node	 was	 present	 in	 both	
control	and	Muc2−/−	animals	that	underwent	surgery,	but	not	in	Muc2−/−	mice	that	had	no	
operation.	 *P<0.050	 (Kruskal–Wallis	 test).	 Box‐and‐whisker	 plots	 represent	 median	 and	
range.	 D)	 No	 differences	 were	 found	 between	 experimental	 groups	 in	 bacterial	
translocation	to	the	spleen.	Box‐and‐whisker	plots	represent	median	and	range.	
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Bacterial	translocation	in	control	and	Muc2	deficient	mice	that	underwent	
surgery	
Bacterial	16S	rDNA	was	quantified	 from	MLN	and	spleen	 tissue	 from	control	and	
Muc2−/−	mice	that	underwent	surgery,	and	from	Muc2−/−	mice	that	had	no	surgical	
intervention.	The	MLN	16S	load	in	both	groups	of	mice	having	surgery	was	higher	
than	that	in	the	group	that	did	not,	indicating	that	the	surgical	procedure	did	cause	
increased	 bacterial	 translocation	 to	 the	 intestinal	 lymphatics	 (Figure	 5.6C).	 No	
significant	difference	was	detected	between	control	and	Muc2−/−	mice,	although	the	
median	 16S	 load	 was	 4.4	 times	 lower	 in	 control	 mice	 compared	 with	 Muc2−/−	
mice.	 Spleen	 load	 was	 similar	 in	 the	 three	 groups,	 with	 approximately	 100	 16S	
rDNA	copies	per	mg	tissue	detected	in	most	animals	(Figure	5.6D).	However,	three	
of	 11	 mice	 in	 the	 Muc2−/−	 surgery	 group	 had	 more	 than	 104	 16S	 copies/mg,	
indicating	that	more	bacteria	had	penetrated	the	systemic	tissue	 in	a	subgroup	of	
these	 animals.	 Thus,	 the	 surgical	 procedure	 increased	 translocation	 of	 bacteria	
from	 the	 intestine,	 and	 Muc2	 deficiency	 resulted	 in	 a	 tendency	 towards	 higher	
systemic	bacterial	load.	
Discussion	
The	incidence	of	AL	has	remained	high	over	the	years,	despite	extensive	research,	
the	 introduction	 of	 new	 surgical	 techniques	 and	 the	 construction	 of	 a	 diverting	
stoma	in	high‐risk	patients35.	Many	risk	factors	are	being	investigated,	but	the	first	
line	 of	 defence	 in	 the	 gastrointestinal	 tract,	 the	 mucous	 layer,	 has	 been	 largely	
overlooked.	
	
Mice	deficient	in	the	Muc2	gene	(Muc2−/−	mice)	lack	a	functional	mucous	layer,	
and	were	more	prone	 to	develop	AL	 than	matched	Muc2+/−	and	Muc2+/+	controls.	
Control	animals	had	a	leakage	rate	of	32	per	cent	(7	of	22	animals),	in	line	with	the	
model	of	Reisinger	and	colleagues27.	 In	addition,	Muc2−/−	mice	had	 lower	welfare	
scores	than	control	animals	despite	co‐housing	and	matching	for	age	and	sex	where	
possible.	 It	 should	 be	 noted	 that	 Muc2−/−	 mice	 develop	 spontaneous	 colitis,	
although	 this	 often	 remains	 asymptomatic	 in	 the	 animal	 facility36.	 The	 effects	
observed	 in	Muc2−/−	mice	are	 therefore	ascribed	to	the	development	of	AL	rather	
than	 to	 the	 colitis	 phenotype.	 Weight	 loss	 did	 not	 differ	 significantly	 between	
Muc2−/−	and	control	mice.	However,	the	mice	were	killed	only	3	days	after	surgery,	
and	it	is	known	that	the	difference	in	weight	loss	between	animals	with	and	those	
without	leakage	does	not	become	evident	until	after	3	days25.	At	this	time	animals	
without	AL	 start	 to	 gain	weight,	whereas	mice	with	 AL	 start	 to	 gain	weight	 only	
after	POD	525.	Not	only	did	 the	Muc2−/−	mice	show	more	clinical	 symptoms	of	AL	
than	 control	 mice,	 they	 also	 had	 significantly	 higher	 I‐FABP	 levels,	 indicating	
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enterocyte	 damage	 and	more	 bacterial	 translocation.	 The	 damaged	 epithelia	 and	
increased	 translocation	 could	 indicate	 that	 the	 mucous	 layer	 is	 important	 for	
reducing	 the	 number	 of	 bacteria	 that	 reach	 the	 vulnerable	 anastomosis	 site,	 and	
hence	 is	 important	 in	 the	healing	process.	 In	 line	with	 this,	 there	 is	accumulating	
evidence37,38	that	bacteria	are	involved	in	the	pathogenesis	of	AL.	
	
It	was	hypothesized	 that	 supplementation	with	dmPGE2	would	 reduce	 the	AL	
rate	by	increasing	mucous	secretion.	However,	dmPGE2	did	not	reduce	the	AL	rate	
in	either	Muc2−/−	or	control	mice.	It	has	been	suggested	that	dmPGE2	can	prevent	
AL	 when	 COX‐2	 activity	 is	 decreased,	 induced	 either	 by	 drug	 treatment	 (COX	
inhibitors)	or	by	knocking	out	the	COX‐2	gene27.	In	the	present	study,	no	difference	
in	 AL	 rate	 was	 observed	 following	 PGE2	 administration,	 despite	 using	 a	 stable	
analogue	of	PGE2	in	the	same	dosage	that	had	an	effect	in	a	Cox2‐deficient	mouse	
model.	 Perhaps	PGE2	 is	 effective	only	when	 there	 is	 a	 severe	deficiency	of	PGE2,	
which	 is	not	 the	case	 in	Muc2−/−	mice.	A	higher	dose	of	dmPGE2	 induces	adverse	
reactions	in	mice,	with	dose‐	and	time‐dependent	PGE2‐induced	diarrhoea39.	In	the	
present	study,	no	diarrhoea	was	observed,	indicating	that	the	PGE2	dose	used	was	
safe.	
	
In	 the	present	study	only	anastomoses	 in	 the	proximal	colon,	and	not	 in	other	
parts	 of	 the	 gastrointestinal	 tract,	 were	 investigated.	 Interestingly,	 Yauw	 and	 co‐
workers40	recently	showed	that	diclofenac,	a	commonly	used	NSAID,	caused	AL	in	
the	 ileum	 and	 proximal	 colon,	 but	 not	 in	 the	 distal	 colon.	 Furthermore,	 more	
recently,	Rutegård	et	al.	41	found	no	increased	risk	of	AL	with	NSAID	use	in	patients	
undergoing	anterior	resection	for	rectal	cancer.	Previous	associations	between	AL	
and	NSAIDs	were	derived	from	pooled	data	of	colorectal	surgery,	not	solely	rectal	
resections.	Additionally,	it	has	been	shown	by	ex	vivo	analysis	of	the	mucous	layer	
that	PGE2	caused	a	significantly	increased	mucous	secretion	in	the	small	 intestine	
and	less	in	the	proximal	colon,	and	none	in	the	distal	colon19.	Moreover,	in	humans,	
membrane	 protein	 profiling	 has	 demonstrated	 distinctive	 regional	 differences	 in	
the	colon42.	These	different	observations	suggest	that	the	healing‐promoting	effect	
of	PGE2	might	differ	along	the	gastrointestinal	tract,	and	that	this	might	also	be	the	
case	 for	the	healing‐promoting	effect	of	a	 functional	mucous	 layer	suggested	here	
for	the	proximal	colon.	
	
Potentially	 interesting	 factors	 that	 can	 influence	 the	 colonic	mucous	 layer	 are	
certain	bacteria	or	SCFAs.	A	frequent	colonizer	of	the	human	colonic	mucous	layer	
is	 Akkermansia	 muciniphila,	 a	 mucin‐degrading	 bacterium	 that	 is	 suggested	 to	
increase	the	thickness	of	the	inner	mucous	layer18.	The	presence	of	A.	muciniphila	
correlated	with	increased	Muc2	gene	expression,	suggesting	that	A.	muciniphila	can	
enhance	 its	 own	 nutrient‐rich	 environment43.	 Therefore,	 it	 can	 be	 hypothesized	
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that	supplementation	with	A.	muciniphila	or	other	bacteria	before	gastrointestinal	
surgery	may	boost	mucous	secretion,	which	can	support	anastomotic	healing.	
	
SCFAs	 from	 bacteria	 in	 the	 distal	 colon	 are	 important	 as	 the	 primary	 energy	
source	for	colonic	epithelial	cells,	but	also	stimulate	mucous	secretion16.	One	of	the	
most	 abundant	 SCFAs	 in	 the	 colon,	 butyrate,	 can	 strengthen	 distal	 anastomoses	
when	 given	 in	 enema	 form44,	 perhaps	 through	 stimulated	 mucous	 secretion16.	
Thus,	commensal	bacteria	in	the	outer	mucous	layer	of	the	distal	colon	may	help	to	
prevent	AL	in	animal	models	by	producing	SCFAs.	Furthermore,	mucins	have	been	
suggested	 to	 have	 a	 trophic	 effect,	 as	 they	 are	 not	 readily	 digested	 and	 can	 be	
considered	 an	 important	 nutrient	 source	 for	 many	 intestinal	 organisms.	 Colonic	
mucus	 also	 contains	 trefoil	 factor	 (TFF)	 3,	 a	 molecule	 known	 to	 have	 a	 trophic	
effect	in	the	colon45.	Mucus	acts	as	a	diffusion	barrier,	thereby	hindering	molecules	
such	as	TFF‐3	 from	diffusing	out	quickly	 into	 the	 lumen,	 and	 increasing	 the	 local	
epithelial	concentration.	The	colonic	mucus	and	its	main	component	MUC2	can	thus	
be	envisaged	to	have	many	effects	that	might	be	important	for	anastomotic	healing.	
	
When	 inflammation	 and	 cell	 proliferation	 were	 studied	 with	 immuno‐
histochemistry,	 no	 differences	 were	 observed	 between	 the	 two	 experimental	
groups.	 This	might	 be	 explained	 by	 the	 fact	 that	mice	were	 killed	 on	 day	 3.	 It	 is	
known	 from	 other	 experiments26,27	 that	 day	 3	 is	 early	 in	 the	 intestinal	 healing	
process	 and	 that	 potential	 differences	 become	 evident	 in	 later	 phases	 of	 healing.	
However,	 POD	 3	was	 chosen	 for	 killing	 in	 the	 present	 study	 in	 order	 to	 prevent	
animal	suffering.	
	
Results	 from	 animal	 experiments	 cannot	 be	 translated	 directly	 to	 the	 human	
setting.	 Paradoxical	 to	 the	 observation	 that	 the	 thick	 mucous	 layer	 in	 the	 distal	
colon	may	be	protective	 is	 that	distal	 tumour	 location	 in	patients	 is	a	known	risk	
factor	 for	 the	 development	 of	 AL.	 For	 this	 reason,	 a	 diverting	 stoma	 is	 often	
constructed	in	clinical	practice3,46.	Although	animal	findings	should	be	interpreted	
with	caution,	they	can	lead	to	new	insights	and	provide	possible	 interventions	for	
the	human	setting.	One	important	lesson	is	that	the	controlled	ischaemia	necessary	
in	surgery	can	be	maintained	for	some	time	(up	to	1	h)	and	that	the	mucous	layer	
recovers	 quickly	 after	 this	 time13.	 Owing	 to	 the	 slow	 biosynthesis	 of	 mucins,	 a	
second	period	of	ischaemia	should	be	avoided47.	
	
The	mucous	 layer	 of	 the	 gastrointestinal	 tract	 has	 been	 largely	 overlooked	 in	
research	on	AL,	despite	its	function	as	a	primary	defence	mechanism.	In	this	study,	
mucus	has	been	shown	to	play	an	essential	role	in	normal	anastomotic	healing,	and	
is	probably	also	crucial	in	other	types	of	gastrointestinal	healing.	Further	research	
on	anastomotic	healing	should	focus	on	positively	influencing	the	mucous	layer,	to	
promote	better	postoperative	recovery.	
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Supplementary	information	according	to	ARRIVE	
guidelines	
 Muc2−/−	mice	backcrossed	on	C57BL/6	background	between	8–16	weeks	of	age	
were	used.	Muc2−/−	mice	on	the	C57BL/6	background	were	bred	as	Muc2+/−	×	
Muc2+/−	 at	 the	 Experimental	 Biomedicine	 animal	 facility	 at	 the	 University	 of	
Gothenburg	and	offspring	were	genotyped.		
 Mice	were	kept	under	 standard	 conditions	 and	were	provided	with	 food	and	
water	 ad	 libitum.	 Mice	 were	 housed	 together	 with	 their	 littermates,	 with	 a	
maximum	of	6	companions	per	cage.	The	general	health	of	mice	was	monitored	
several	 times	 per	week	 for	 signs	 of	 inflammation	 and	 animals	were	weighed	
once	per	week.	During	the	experiment	animals	were	weighed	daily	and	scored	
for	discomfort	twice	daily.	
 Scoring	was	performed	according	Pommergaard	et	al:		
Parameter	 Grading	 Score	
Activity	 Normal/medium/low	 2/1/0	
Fur	 Smooth/fluffy/erect	 2/1/0	
Eyes	 Clean	and	open/clean	and	closed/dirty	and	closed	 	
Able	to	stand	straight	 Yes/no	 1/0	
Posture	 Normal/modestly	curied/fully	curled	up	 2/1/0	
Position	on	feet	 Normal/high	 1/0	
Solitary	 Yes/no	 0/1	
Shivering	 Yes/no	 0/1		
Scoring	was	done	by	one	researcher	who	was	blinded	for	treatment	at	the	time	
of	 scoring,	while	 the	 other	 researcher	performed	preparation	of	 the	PGE2	or	
placebo	syringes	for	peritoneal	injection.	
 Protocols	 were	 approved	 by	 the	 government	 animal	 ethics	 committee	 and	
institutional	animal	use	and	care	guidelines	were	followed	(permit	63‐2014).		
 Mice	were	sacrificed	by	intracardial	puncture	after	isoflurane	anaesthesia	using	
an	airstream	of	2	l/min	and	3.5%	isoflurane.	
 A	sample	size	calculcation	was	conducted	prior	to	the	experiment	based	on	an	
expected	 reduction	 in	 anastomotic	 leakage	 of	 20%.	 To	 detect	 a	 relevant	
difference	in	leakage	reduction	of	20%	(δ)	between	the	different	experimental	
groups	with	a	variance	of	±16%	(σ),	the	number	of	animals	per	group	should	
be:	(poweranalysis	α:	0.05,	π:	0.8,	2	sided	testing):	
 n	=	2(zα/2	‐	zπ)2	*	(σ/δ)2		(Sachs)	
 n	=	2(1.96	+	0.84)²	*	(16/20)²	
 n	=	15.7	*	0.64	=	10.03	≈	11/group	
 In	 total	 there	were	52	mice	used	 in	 this	 study.	We	used	11	per	 experimental	
group,	 and	 4	 groups	 (knockout	 vs	 control	 mice,	 with	 and	 without	 dmPGE2	
supplementation).	 In	addition,	8	mice	were	sacrificed	 to	obtain	control	 tissue	
(MLN,	spleen)	for	bacterial	translocation	analysis.	
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 Animals	 were	 matched	 for	 age	 and	 gender	 where	 possible,	 making	 it	
impossible	to	use	randomisation	procedures.		
Chapter	5	
96	
	
97 
Part	III	
		
Reducing	anastomotic	leakage	rate:		
glues	and	enema	intervention	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
98 
  
 
CHAPTER	6	
		
Comparison	of	three	different	
	application	routes	of	butyrate	
to	improve	colonic	anastomotic	strength	in	rats	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
J.W.A.M.	Bosmans,	A.C.H.M.	Jongen,	
	B.T.C.	Boonen,	S.	van	Rijn,	F.	Scognamiglio,		
L.	Stucchi,	M.J.J.	Gijbels,	E.	Marsich,	N.D.	Bouvy	
Int	J	Colorectal	disease,	2016	
Chapter	6	
100	
Abstract	
Introduction	
Despite	 extensive	 research,	 anastomotic	 leakage	 (AL)	 remains	 one	 of	 the	 most	 dreaded	
complications	 after	 colorectal	 surgery.	 Since	 butyrate	 enemas	 are	 known	 to	 enhance	
anastomotic	healing,	several	administration	routes	have	been	explored	in	this	study.	
	
Methods	
Three	intraluminal	approaches	involving	butyrate	were	investigated:	1)	butyrin‐elucidating	
patch;	 2)	 a	 single	 injection	 of	 hyaluronan‐butyrate	 (HA‐But)	 prior	 to	 construction	 of	 the	
proximal	 anastomosis;	 and	 3)	 rectal	 hyaluronan‐butyrate	 (HA‐But)	 enemas	 designed	 for	
distal	 anastomoses.	 The	 main	 outcome	 was	 AL	 and	 secondary	 outcomes	 were	 bursting	
pressure,	 histological	 analysis	of	 the	 anastomosis,	 zymography	 to	detect	MMP	activity	 and	
qPCR	for	gene	expression	of	MMP2,	MMP9,	MUC2	and	TFF3.	
	
Results		
Neither	 the	 patches	 nor	 the	 injections	 led	 to	 a	 reduction	 of	 AL	 in	 experiment	 1	 and	 2.	 In	
experiment	 3,	 a	 significant	 reduction	 of	 AL	 was	 accomplished	 with	 the	 (HA‐But)	 enema	
compared	 to	 the	 control	 group	 together	 with	 a	 higher	 bursting	 pressure.	 Histological	
analysis	 detected	 only	 an	 increased	 inflammation	 in	 experiment	 2	 in	 the	 hyaluronan	
injection	group	compared	 to	 the	control	group.	No	other	differences	were	 found	regarding	
wound	healing.	Zymography	identified	a	decreased	pro‐enzyme	of	MMP9	when	HA‐But	was	
administered	 as	 a	 rectal	 enema.	 qPCR	 did	 not	 show	 any	 significant	 differences	 between	
groups	in	any	experiment.	
	
Conclusions	
Butyrate	 enemas	 are	 effective	 in	 the	 enhancement	 of	 colonic	 anastomosis.	 Enhanced	
butyrate‐based	approaches	designed	 to	reduce	AL	 in	animal	models	 for	both	proximal	and	
distal	 anastomoses	were	not	more	 effective	 than	butyrate	 enemas	 alone.	 Further	 research	
should	 focus	 on	 how	 exogenous	 butyrate	 can	 improve	 anastomotic	 healing	 after	
gastrointestinal	surgery.	
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Introduction	
Despite	 extensive	 research,	 anastomotic	 leakage	 (AL)	 remains	 one	 of	 the	 most	
dreaded	complications	after	colorectal	surgery.	It	still	results	in	high	morbidity	and	
mortality,	 and	 causes	prolonged	hospital	 stay	and	high	health	 care	 costs1‐3.	Many	
studies	have	been	performed	regarding	this	subject,	all	aiming	at	 improvement	of	
anastomotic	 healing,	 and	 thereby	 preventing	 leakage.	 Since	 the	 incidence	 of	
anastomotic	 leakage	 has	 not	 declined	 over	 the	 years,	 the	 need	 for	 a	 solution	
continues	to	exist4,5.	
	
Previous	animal	studies	have	shown	that	rectal	administration	of	butyrate	‐	one	
of	 the	predominant	 short	 chain	 fatty	 acids	 (SCFAs)	 ‐,	 results	 in	 a	higher	 bursting	
pressure	 in	 colonic	 anastomoses,	 thereby	 claiming	 an	 enhanced	 strength	 which	
may	prevent	anastomotic	leakage6‐8.		
	
These	positive	results	did	not	change	current	practice,	nor	have	human	studies	
been	 reported	 in	 which	 patients	 received	 postoperative	 butyrate	 enemas	 to	
enhance	 anastomotic	 strength.	 This	 is	 not	 surprising,	 when	 you	 consider	 that	
clinicians	are	not	keen	on	enemas	directly	after	surgery,	especially	when	a	 fragile	
rectal	 anastomosis	 is	 involved.	Water‐soluble	 contrast	 enemas	 are	 often	 used	 to	
determine	 the	presence	of	 colorectal	AL,	mostly	after	 rectum	resection.	However,	
these	 enemas	 are	 never	 given	 in	 the	 very	 early	 postoperative	 phase	
(<postoperative	 day	 5)	 due	 to	 the	 potential	 risk	 of	 complications5.	 Another	
disadvantage	 of	 the	 use	 of	 enemas	 is	 the	 low	 compliance	 rate	 and	 the	 short	 and	
discontinuous	exposure	of	butyrate	to	the	colonic	mucosa.		
	
A	 recent	 study	 however	 showed	 that	 butyrate	 has	 remarkable	 anti‐
inflammatory	and	regenerative	effects	improving	the	repair	of	intestinal	mucosa	in	
rats	with	colitis9.	Butyrate	stimulates	re‐epithelisation	and	may	influence	collagen	
lysis	by	reducing	matrix	metalloproteinase	(MMP)	release10.	Butyrate	is	a	product	
of	 the	 fermentation	 process	 by	 bacteria	 that	 occurs	 mainly	 in	 the	 distal	 colon.	
Because	 it	 serves	 as	 the	 most	 important	 energy	 source	 for	 colonocytes11,	 our	
hypothesis	is	that	increasing	the	concentration	of	butyrate	will	lead	to	an	enhanced	
anastomotic	healing	in	the	colon.	A	number	of	studies	indicate	that	butyrate	affects	
the	 composition	 and	 thickness	 of	 the	 colonic	 mucus	 layer	 through	 alteration	 of	
mucin	 gene	 expression12	 and	 nutritional	 deficiency	 of	 the	 colonic	 epithelium	 and	
that	 butyrate	 also	 can	 act	 as	 a	 signalling	 molecule	 through	 specific	 G‐protein	
coupled	 receptors	 that	 are	 involved	 in	 the	 immune	 surveillance	 of	 the	 colonic	
mucosa	 towards	microbial	 activity13.	More	 recently,	 it	 has	 been	 shown	 that	mice	
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with	 an	 insufficient	 mucus	 layer	 on	 the	 colonic	 mucosa	 (Muc2‐/‐)	 suffered	 more	
often	from	anastomotic	leakage	compared	to	control	mice14.	
	
Furthermore,	 animal	 studies	 showed	 that	 butyrate	 enemas	 have	 a	 significant	
positive	 effect	 on	 the	 left	 colonic	 anastomoses,	 but	 this	 effect	was	weaker	on	 the	
right	 side	 of	 the	 colon8.	 Obviously,	 not	 the	 same	 volume	will	 reach	 the	 proximal	
anastomotic	 site	 compared	 to	 the	 distal	 anastomosis,	 which	 may	 explain	 these	
findings.	Another	explanation	might	be	that	the	butyrate‐producing	bacteria	mainly	
reside	 in	 the	mucus	 layer	 at	 the	 distal	 part	 of	 the	 colon,	 that	 the	 proximal	 colon	
does	 not	 respond	 to	 a	 higher	 amount	 of	 butyrate,	 simply	 because	 the	 proximal	
enterocytes	are	not	familiar	to	having	that	energy	source	available	and	are	not	able	
to	use	it.	To	increase	the	beneficial	effect	of	butyrate,	we	added	hyaluronan	(HA),	a	
glycosaminoglycan	 that	 is	 known	 to	 promote	 neovascularization,	 to	 enhance	 the	
process	 of	 scarring,	 and	 has	 beneficial	 effects	 on	 cell	 proliferation	 in	 several	
tissues15,16.	Hyaluronan	also	plays	a	role	in	the	downregulation	of	the	inflammatory	
response.	 Its	 free‐radical	 scavenging	and	antioxidant	properties	 and	 its	 supposed	
inhibiting	 effect	 on	 proteinases	 such	 as	 MMPs,	 seem	 to	 be	 responsible	 for	 this	
downregulation,	stabilizing	the	granulation	tissue	during	the	healing	process16.	
	
In	 this	 study,	we	 investigated	 several	ways	 to	 improve	 the	proximal	 anastomotic	
strength	by	applying	butyrate	near	this	anastomosis:	using	a	patch;	injections;	and	
enemas.	 Our	 aim	was	 to	 develop	 a	method	 that	 resulted	 in	 a	 lower	 anastomotic	
leakage	 rate	 and	 more	 practical	 methods	 that	 can	 be	 applied	 in	 daily	 clinical	
practice.	
Methods	
Animals	
Eighty‐four	Wistar	 rats	with	 a	 body	weight	of	 250‐300	 gram	were	used.	Animals	
were	housed	and	cared	for	at	the	Central	Animal	Facility	of	Maastricht	University.	
All	animals	were	provided	ad	libitum	access	to	food	and	water,	and	were	cared	for	
according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	was	performed	
twice	daily	using	a	standardized	method	and	animals	were	given	pain	medication	in	
case	 of	 discomfort.	 The	 experimental	 protocol	 complied	 with	 the	 Dutch	 Animal	
Experimental	 Act	 and	 was	 approved	 by	 the	 Animal	 Experimental	 Committee	 of	
Maastricht	University	Medical	Center.	The	ARRIVE	guidelines	for	reporting	in	vivo	
experiments	were	followed17	(see	also	Supplementary	Data	S6.1).		
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Study	design	
Primary	 objective	 of	 the	 study	 was	 to	 investigate	 if	 anastomotic	 leakage	 can	 be	
reduced	in	a	leakage	model	by	application	of	either	an	intraluminal	butyrin‐eluting	
patch,	 a	 single‐time	 intraluminal	 administration	 of	 butyrate	 or	 a	 daily	 HA‐But	
enema.	For	the	proximal	anastomoses	we	used	both	an	intraluminal	butyrin‐eluting	
patch	that	covered	the	anastomosis	and	a	single‐time	 intraluminal	administration	
of	 hyaluronan‐butyrate	 (HA‐But).	 Since	most	 research	 is	 performed	 in	 the	 distal	
part	of	 the	colon,	we	also	used	a	 left‐colon	anastomosis	model	 to	 test	 the	HA‐But	
enemas.	This	resulted	in	the	following	3	experiments:	
	
Experiment	1:		 Butyrin	 eluting	 patches	 (20	 massa%	 tributyrin)	 versus	 placebo		
patches	(n=12/group).	
Experiment	2:		 HA‐But	 injection	 (5%	 HA,	 60mM	 butyrate)	 versus	 HA	 injection		
(5%	HA)	versus	Saline	injection	(0.9%	NaCl)	(n=8/group).	
Experiment	3:		 5mL	 of	 HA‐But	 enema	 (5%	 HA,	 60mM	 butyrate)	 versus	 5mL	
sodium	 Butyrate	 (60	 mM)	 enema	 versus	 a	 control	 group	 that	
received	no	enemas	(n=12/group).	
Patches	 were	 kindly	 provided	 by	 Polyganics	 (Groningen,	 the	 Netherlands)	 and	
enemas	and	injections	were	produced	by	Sigea	(Trieste,	 Italy).	 In	all	experiments,	
follow	up	was	7	days.	
Surgical	procedure	
All	 rats	 received	 0.05mg/kg	 buprenorphine	 as	 analgesic	 and	 were	 anesthetized	
using	 isoflurane.	 To	 acquire	 access	 to	 the	 abdominal	 cavity,	 a	 5	 cm	 craniocaudal	
midline	 incision	 of	 the	 skin	 and	 abdominal	 musculature	 was	 made	 in	 all	
experiments.	The	 cecum	was	 then	 identified	and	moved	outside	of	 the	peritoneal	
cavity	 and	 onto	 sterile	 gauzes	 that	 were	 hydrated	with	 sterile	 saline	 solution	 to	
prevent	 dehydration.	 For	 proximal	 anastomoses:	 the	 colon	 was	 transected	 two	
centimeters	 distal	 from	 the	 cecum	 and	 an	 end‐to‐end	 anastomosis	 was	 created	
using	 4	 interrupted	 polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	
Johnson)	 (Exp	 1	 &	 2,	 see	 Supplementary	 Data	 S6.1).	 In	 Experiment	 3,	 the	
anastomosis	was	 performed	 in	 similar	 fashion	 but	 at	 4	 centimeters	 ab	 ani.	 After	
performing	 the	 anastomosis,	 the	 intestines	 were	 repositioned	 and	 the	 abdomen	
was	closed	in	two	layers,	a	running	suture	for	the	muscle	layer	(Vicryl	4‐0,	Ethicon,	
Inc)	and	interrupted	sutures	for	the	skin	(Monocryl	4‐0,	Ethicon,	Inc).		
Macroscopic	endpoints	
Anastomotic	leakage	was	defined	as	1)	no	anastomotic	leakage,	2)	small	abscess	at	
the	anastomotic	site	<	1	cm3,	3)	large	(>1	cm3)	abscess	at	the	anastomotic	site	or	4)	
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complete	 dehiscence	with	 peritonitis/death	 due	 to	 fecal	 peritonitis.	 Adhesions	 to	
the	anastomotic	site	were	assessed	according	to	van	der	Ham	et	al.18.		
Bursting	pressure	
Bursting	 pressure	 was	 measured	 as	 previously	 described19.	 In	 short,	 a	 5‐cm	
segment	 of	 intestine	 including	 the	 anastomosis	 with	 and	 adherent	 organs	 was	
resected	en	bloc	and	the	part	distal	of	the	anastomosis	was	clamped.	A	plastic	tube	
was	inserted	in	the	proximal	end	and	ligated	with	a	single	polyglactine	4/0	suture	
(Vicryl,	Ethicon).	The	complete	anastomosis	was	 immersed	 in	phosphate	buffered	
saline,	while	air	was	infused	using	a	manometer	(IDEE,	Maastricht	University,	The	
Netherlands)	and	pressure	was	manually	increased	by	inflating	the	colon.	Bursting	
pressure	was	defined	as	the	intraluminal	pressure	at	which	air	leakage	was	initially	
observed	from	the	anastomosis	(mBar).		
Tissue	preparation	
In	anesthetized	rats,	 the	anastomotic	site	was	dissected	(after	measuring	bursting	
pressure)	 with	 a	 0.5	 cm	margin	 at	 each	 site	 of	 the	 anastomosis.	 Tissue	 samples	
were	divided	in	three	equal	pieces,	one	for	qPCR,	one	for	zymography	purposes	and	
one	 for	 immunohistochemistry	 purposes.	 This	 latter	 one	 was	 cut	 in	 longitudinal	
direction	and	tissue	was	stretched	and	pinned	onto	a	cork	layer	in	order	to	secure	a	
straight	 anastomotic	 line	 and	 improve	 quality	 of	 histological	 assessment	 prior	 to	
fixation	 in	 formalin.	 Sections	 were	 deparaffinized	 in	 xylene	 and	 rehydrated	 in	
graded	ethanol	to	distilled	water	prior	to	performing	histological	staining.	The	part	
dedicated	for	qPCR	analysis	was	snap	frozen	in	liquid	nitrogen	and	stored	at		‐80°C	
until	required	for	mRNA	isolation.	
Histology	and	immunohistochemistry	
Sections	were	stained	with	standard	hemotoxylin‐eosin	and	Picro	Sirius	Red	using	
Direct	Red	80	and	Picric	Acid	solution	(both	Sigma‐Aldrich,	the	Netherlands).		
An	independent,	experienced	animal	pathologist	performed	blinded	histological	
assessment	 on	 the	 obtained	 tissue,	 scoring	 (from	 0‐4)	 histological	 sections	 on	
inflammation,	 granulocyte	 influx,	 fibroblast	 activity	 and	 collagen	 deposition.	
Collagen	 ration	 was	 calculated	 using	 an	 in‐house	 software	 program	 on	 pictures	
obtained	with	 a	polarized	 light	microscope	 (Leica	DM5000B,	 Leica	Microsystems,	
Wetzlar,	Germany).	
MMP2,	pro‐MMP9	and	MMP9	activity	analysis	using	zymography	
MMP‐2	 and	 MMP‐9	 activity	 were	 assessed	 using	 gelatin	 zymography	 since	 it	
increased	MMP	activity	has	been	 implicated	 in	 the	pathogenesis	of	AL20.	 Samples	
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were	lysed	from	tissue	and	loaded	on	a	polyacrylamide	gel	containing	gelatin	(10%	
Ready	Zymogram	Gel,	Bio‐Rad,	the	Netherlands).	Gel	electrophoresis	took	place	at	
100V	during	30min.	After	that,	the	gel	was	incubated	with	2.5%	Triton	X‐100	in	MQ	
for	30	min	at	 room	temperature.	The	gel	was	 then	placed	 in	developing	buffer	at	
37°C	overnight.	Colouring	of	the	gel	took	place	the	following	night	with	PAGE‐Blue	
protein	staining	solution	(Thermo	Scientific,	the	Netherlands).	At	day	3,	the	staining	
was	 decoloured	 with	 MQ,	 revealing	 MMP‐2	 and	 MMP‐9	 activity.	 The	 gels	 were	
scanned	 using	 a	 Bio‐Rad	 GS‐800	 Densitometer	 and	 digitally	 quantification	 was	
done	 using	 ImageJ	 software	 (ImageJ	 Software,	 U.	 S.	 National	 Institutes	 of	Health,	
Bethesda,	Maryland,	USA).	
MMP2,	MMP9,	TFF3	and	Muc2	expression	analysis	using	qPCR	
The	expression	of	matrix	metalloproteinases	2	 (MMP2)	 and	9	 (MMP9)	 as	well	 as	
Mucin	2	 (MUC2)	and	 trefoil	 factor	3	 (TFF3)	was	determined	using	qPCR	 to	 see	 if	
exogenous	butyrate	had	an	effect	on	the	expression	of	 these	MMPs;	 the	abundant	
secretory	mucin	MUC2	as	well	as	its	associated	trefoil	factor.	All	qPCR‐experiments	
were	 carried	 out	 by	 a	 dedicated	 technician	 (BB)	 and	 are	 reported	 as	 detailed	 as	
possible	 according	 to	 the	 MIQE	 guidelines21.	 RNA	 was	 isolated	 from	 the	 tissue	
sample	 using	 TRI	 reagent	 (Sigma‐Aldrich,	 the	 Netherlands)	 and	 treated	 with	
RNase‐Free	 DNase	 Set	 (Qiagen).	 The	 purity	 of	 RNA	 was	 tested	 using	 Nanodrop	
Spectrophotometer	 (Thermo	 Scientific)	 by	 260/280	 absorbance	 (A260/A280)	
ratios,	 ranged	 from	 1.89	 to	 2.02.	 Therefore,	 the	 purity	 of	 the	 isolated	 RNA	 was	
satisfactory	for	further	studies.	RNA	of	750ng	was	converted	to	DNA	with	sensifast	
cDNA	Synthese	kit	(Bioline,	London,	UK).	qPCR	was	performed	on	10ng	cDNA	with	
0,3µM	primers	 	 in	Sensimix	SYBR	&	Fluorescein	Kit	 (Bioline,	London,	UK)	using	a	
white	 384	wells	 qPCR	 plate.	 Primer	 sequences	 are	 listed	 in	 Table	 6.1.	 Reference	
genes	included	were	glyceraldehyde‐3‐phosphate	dehydrogenase	(GAPDH)	and	B‐
actin.	Reactions	were	run	on	the	LightCycler480	(Roche).	PCR	conditions	used	were	
10	 min	 at	 95°C,	 followed	 by	 40	 amplification	 cycles	 of	 15s	 at	 95°‐60°C‐72°C	
followed	by	a	melting	curve	to	validate	the	amplifications.	The	cycle	threshold	(Ct)	
value	 of	 each	 reference	 gene	was	 obtained	 from	q‐PCR	 analysis.	 The	 obtained	 Ct	
values	were	applied	to	evaluate	the	expression	of	the	genes	of	interest.	The	mean	Ct	
value	of	the	reference	genes	ranged	from	16	to	23	cycles,	with	HA‐injection	having	
the	highest	transcript	levels	in	MMP9	and	butyrin	patch	was	associated	with	having	
the	 lowest	 transcript	 levels	 in	 TTF3.	 For	 analysis	 purposes,	 the	 level	 of	 MMP2	
expression	of	the	saline	group	was	set	at	1	and	used	as	a	control.			
	
Statistical	analyses	
Statistical	analysis	was	performed	using	Prism	5.0	for	Mac	(Graphpad	software,	San	
Diego,	 CA).	 Normality	 was	 tested	 using	 Kolmogorov‐Smirnov.	 All	 continuous	
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variables	 are	 presented	 as	 mean	 and	 standard	 error	 of	 the	 mean	 (SEM)	 and	
compared	 using	 students	 t‐test	 or	 Mann	 Whitney	 U	 when	 appropriate.	
Dichotomous	variables	were	compared	using	the	Chi‐square	test.	
	
Table	6.1	 Primer	sequences	used	for	qPCR	experiments.	
r‐MMP9‐F1	 AGCCGACGTCACTGTAACTG	
r‐MMP9‐R1	 AACAGGCTGTACCCTTGGTC	
r‐MMP2‐F1	 ACAACAGCTGTACCACCGAG	
r‐MMP2‐R1	 GGACATAGCAGTCTCTGGGC	
R‐MUC‐F1	 CGAAGTGAAGAGTGAGCACG	
R‐MUC‐R1	 GATCCGGGTGGTATTCAGCA	
R‐Tff‐F1	 GGCCTATCTCCAAGCCAATGT	
R‐Tff‐R1	 TGCAGAGGTTTGAAGCACCA	
GAPDH	FW	 GGAAGCTCACTGGCATGGC	
GAPDH	RV	 CCTGCTTCACCACCTTCTTG	
Beta‐actin	FW	 GACAGGATGCAGAAGGAGATTACTG	
Beta‐actin	RV	 CCACCGATCCACACAGAGTACTT	
	
Results	
Macroscopical	results	
In	 experiment	 1,	 two	 rats	 in	 the	 butyrin	 patch	 group	 died	 prior	 to	 completing	
follow‐up	due	to	faecal	peritonitis.	All	animals	in	experiment	2	completed	the	7‐day	
follow	up.	In	experiment	3,	three	rats	(1	in	the	HA‐But	group,	2	 in	the	But	group)	
were	 euthanized	 because	 they	 had	 reached	 humane	 endpoints,	 due	 to	 faecal	
peritonitis.	 An	 overview	 of	 the	 types	 of	 anastomotic	 leakage	 within	 each	
experimental	 group	 can	 be	 found	 in	 Figure	 6.1A.	 Adhesions	 occurred	 in	 every	
experiment	 and	 there	 were	 no	 significant	 differences	 between	 experiments	
(proximal	versus	distal	anastomoses)	nor	within	each	experiment	(Figure	6.1B).	It	
became	evident	 that	animals	receiving	a	patch	(either	butyrin	eluting	or	placebo)	
had	 lower	 welfare	 scores	 and	 significant	more	weight	 loss	 compared	 to	 animals	
receiving	enemas	(Figure	6.1C),	possibly	due	to	an	extended	bowel	proximal	to	the	
location	of	the	patch	upon	sacrifice.		
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Figure	6.1	 Butyrate‐enriched	 enemas	 reduced	 AL	 in	 Exp.	 3,	 no	 other	 butyrate‐based	 intervention	
caused	 a	 decrease	 in	 AL	 rates	 (A).	 Adhesion	 scores	 did	 not	 differ	 significantly	 between	
groups	in	Exp.	1,2	or	3	(B).	Weight	loss	was	most	prominent	in	Exp.	1	where	placement	of	
the	patches	caused	a	sudden	change	in	calibre	of	the	colon;	Animals	receiving	enemas	had	
the	 lowest	 percentage	 of	 weight	 loss	 but	 also	 received	 a	 different	 type	 of	 anastomosis	
compared	 to	 animals	 in	 Exp.	 1	 and	 2	 (distal	 vs	 proximal	 respectively)	 (C).	 The	
administration	 of	 butyrate	 enemas	 caused	 a	 significant	 higher	 bursting	 pressure	 of	 the	
anastomosis	in	Exp.	3	compared	to	the	control	group.	No	differences	were	found	in	Exp.	2	
and	in	Exp.	1	no	BP	was	measured	due	to	porous,	distended	intestines.				
	
Bursting	pressure	
Bursting	pressure	(BP)	was	not	measured	during	experiment	1	because	of	evident	
extended	intestines	in	the	majority	of	the	rats	at	the	place	where	the	patches	were	
placed.	This	abrupt	change	in	luminal	calibre	made	the	dilated	bowel	very	porous,	
disabling	 accurate	 BP	 measurements.	 In	 experiment	 2,	 BP	 was	 measured	 and	
compared	to	a	historical	control	group	since	the	control	group	from	experiment	3	
received	a	distal	anastomosis.	No	differences	were	found	in	experiment	2	between	
saline	injections,	HA	injections	and	HA‐But	injections.	In	experiment	3	however,	a	
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significant	difference	could	be	found	between	the	control	group	(104.1	±	40.8)	and	
HA‐But	(250.7	±	23.1)	and	But	enemas	(256.4	±	44.4,	P<0.05).		
Histology	and	collagen	ratio	
Inflammatory	 parameters	 were	 scored	 as	 a	 surrogate	 marker	 of	 anastomotic	
healing,	 as	 indicated	 appropriate	 by	 a	 recent	 Delphi	 consensus	 method22.	
Histological	 analysis	 (Figure	 6.2)	 only	 detected	 an	 increased	 inflammation	 in	
experiment	 2	 in	 the	 hyaluronan	 injection	 group	 (2.18±0.22)	 compared	 to	 the	
control	 group	 (3.27±0.27,	 P<0.05).	 No	 other	 differences	 were	 found	 regarding	
wound	 healing.	 Picro	 Sirius	 red	 staining,	 which	 depicts	 the	 level	 of	 collagen	
maturity,	of	the	anastomotic	region	showed	comparable	percentages	of	collagen	for	
all	groups	(Table	6.2).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.2	 Histological	 analysis	 detected	 only	 an	 increased	 inflammation	 in	 experiment	 2	 in	 the	
hyaluronan	 injection	 group	 (2.18±0.22)	 compared	 to	 the	 control	 group	 (3.27±0.27,	
P<0.05).	 No	 other	 differences	 were	 found	 regarding	 wound	 healing.	 Values	 are	 mean	
ranking	(S.E.M.).	
	
Pro‐MMP9,	MMP2	and	MMP9	activity	measured	by	zymography	
Zymography	 revealed	 no	 differences	 between	 MMP2	 and	 MMP9	 activity	 within	
each	experiment	between	control	and	intervention	groups	(Figure	6.3).	There	was	
relatively	large	variability	within	the	samples	of	each	group	as	can	be	seen	by	the	
error	 bars/whiskers	 in	 the	 different	 graphs.	 In	 experiment	 3,	 the	 addition	 of	
hyaluronan	 to	 the	butyrate	enema	did	decrease	 the	activity	of	pro‐MMP9	 (40.6	±	
8.2)	 compared	 to	 the	butyrate	enema	alone	 (102.6	±	26.9)	and	 the	control	group	
(114	±	20.9,	P=0.01).	
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Table	6.2	 Total	collagen	and	mature/immature	collagen	ratios.	
Experiment	1	 Butyrin	patch	 Placebo	patch	 	 P‐value	
Collagen	percentage	(%)	 32.25	(±2.69)	 28.64	(±2.00)	 		 0.239	
Red/green	ratio	 464.83	(±278.36)	 361.42	(±207.96)	 	 0.861	
Experiment	2	 Saline	injection	 HA‐But	injection	 HA	injection	 P‐value	
Collagen	percentage	(%)	 53.22	(±2.04)	 45.29	(±4.51)	 46.50	(±4.83)	 0.361	
Red/green	ratio	 66.89	(±16.76)	 39.66	(±7.88)	 95.64	(±44.43)	 0.340	
Experiment	3	 Control	 HA‐But	enema	 Butyrate	enema	 P‐value	
Collagen	percentage	(%)	 42.84	(±	4.75)	 35.57	(±	4.23)	 35.93	(±	2.12)	 0.343	
Red/green	ratio	 321.50	(±71.60)	 282.00(±154.85)	 176.54	(±46.35)	 0.355	
The	relative	collagen	area	was	quantified	as	the	percentage	of	total	tissue	surface.		Maturity	of	collagen	
was	estimated	by	calculating	the	red/green	ratio.	Red	indicates	thick,	mature	collagen.	Green	indicates	
thin,	immature	collagen.	In	terms	of	collagen	percentage	and	red/green	ratio,	no	significant	differences	
were	found	between	groups.	All	measurements	in	this	table	are	presented	as	mean	(±	SEM).	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6.3	 Zymography	 revealed	 no	 differences	 between	 MMP2	 and	 MMP9	 activity	 within	 each	
experiment	 between	 control	 and	 intervention	 groups.	 The	 addition	 of	 hyaluronan	 to	 the	
butyrate	enema	did	decrease	the	activity	of	pro‐MMP9	(40.6±8.2)	compared	to	the	butyrate	
enema	 alone	 (102.6±26.9)	 and	 the	 control	 group	 (114±20.9)	 in	 experiment	 3	 (P=0.01).	
Values	are	given	in	arbitrary	units	and	data	represent	mean	+	S.E.M.	
	
qPCR	showed	no	significant	differences	in	the	3	experiments	regarding	gene	
expression		
In	experiment	1,	a	trend	was	found	in	the	expression	of	MMP2	between	the	group	
that	 received	 a	 butyrin	 patch	 (0.35	 ±	 44.4)	 and	 the	 placebo	 patch	 group	 (1.14	 ±	
0.34,	 P<0.07,	 Figure	 6.4).	 The	 other	 tested	 matrix‐metalloproteinase	 MMP9	 also	
showed	 a	 trend	 between	 these	 two	 groups,	 0.39	 ±	 0.21	 versus	 1.14±0.34	
respectively,	P<0.08.	No	differences	were	found	regarding	MUC2	and	TFF3.		
In	 experiment	 2	 and	 3	 no	 significant	 differences	 were	 found	 in	 gene	 expression	
between	the	intervention	and	control	groups	regarding	all	genes	of	interest.	
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Figure	6.4	 Overview	 of	 relative	 gene	 expression	 where	 the	 level	 of	 MMP2	 expression	 of	 the	 saline	
group	was	 set	 at	1	 and	used	as	 a	 control.	 	No	 significant	differences	were	 found	 in	 gene	
expression	between	the	intervention	and	control	groups	regarding	all	genes	of	interest	in	
the	separate	experiments.	
	
Discussion	
This	 study	 is	 the	 first	 study	 as	 far	 as	 we	 know	 that	 aims	 to	 improve	 butyrate	
supplementation	 in	 animal	 models	 to	 overcome	 the	 reservation	 of	 surgeons	 to	
optimize	their	patients	with	butyrate	prior	or	during	gastrointestinal	surgery.	We	
investigated	 different	 administration	 routes	 besides	 enemas	 that	 could	 enable	
surgeons	to	incorporate	butyrate	in	the	surgical	procedure.	Unfortunately,	a	single	
dosage	 of	 butyrate	 or	 a	 butyrin‐eluting	 patch	 that	we	 used	 in	 this	 study	 did	 not	
seem	promising.	Addition	of	hyaluronan	to	butyrate	did	not	improve	the	effect	of	an	
enema	on	the	healing	of	distal	anastomoses.	Unfortunately,	this	study	did	not	lead	
to	promising	tools	to	transport	butyrate	to	the	proximal	anastomotic	site,	but	it	did	
confirmed	that	butyrate	can	lead	to	better	anastomotic	healing	and	this	should	be	
further	investigated	in	the	future.	
Butyrate	is	known	to	have	a	critical	mediating	role	in	the	colonic	inflammatory	
response,	for	example	it	can	induce	the	differentiation	of	colonic	regulatory	T	cells	
and	 thereby	 ameliorate	 the	development	 of	 colitis	 as	 shown	by	Furusawa	 et	 al23.	
More	 recently,	 it	 has	 been	 shown	 that	 exogenous	 butyrate	 restoration	 improved	
intestinal	 epithelial	 cell	 junctional	 integrity,	 decreased	 apoptosis	 and	 mitigated	
graft‐versus‐host‐disease	after	allogeneic	bone	marrow	transplant24.	Especially	the	
restorative	 effect	 of	 butyrate	 on	 the	 epithelial	 integrity	 and,	 consequently,	 a	
decreased	 translocation	 of	 luminal	 contents	 are	 of	 great	 interest	 in	 the	 field	 of	
anastomotic	 leakage.	 It	 was	 often	 assumed	 that	 butyrate	 increases	 collagen	
synthesis	and	maturation	and	that	this	reduced	the	risk	of	anastomotic	leakage6‐8,	
however	with	 these	new	 insights,	 it	can	be	hypothesized	 that	 increased	epithelial	
integrity	leads	to	a	lesser	amount	of	(clinically	relevant)	anastomotic	leakage.	
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As	stated	before,	enemas	seem	to	be	a	promising	tool	to	deliver	butyrate	in	the	
colon,	especially	in	more	distal	anastomoses,	however	it	remains	difficult	to	reach	
the	 same	 levels	 of	 butyrate	 in	 proximal	 anastomoses.	 In	 addition,	 butyrate	 is	
metabolized	 rapidly	 as	 soon	 as	 it	 enters	 the	 colonocyte	 via	 its	 active	 transport	
system.	This	could	be	the	reason	that	experiment	2	was	not	successful;	the	amount	
of	 available	 butyrate	 by	 a	 single	 injection	was	 simply	 not	 sufficient	 to	 cause	 any	
effect	on	the	anastomotic	site.		
	
It	was	suggested	that	a	pro‐drug	of	natural	butyrate,	tributyrin,	could	overcome	
the	pharmacokinetic	drawbacks	of	natural	butyrate	as	a	drug25.	 Since	 it	was	very	
difficult	 to	 incorporate	 butyrate	 in	 an	 eluting	 patch,	 butyrin	 was	 used	 instead,	
making	 sure	 that	 there	were	 high	 concentrations	 available	 at	 the	 site	 of	 release.	
Unfortunately	 the	 attachment	 of	 a	 patch	 into	 the	 colon	 caused	 extension	 of	 the	
bowel	proximal	to	the	location	of	the	patch,	indicating	colonic	stenosis.	This	effect	
of	 patches	 or	 fleeces	 has	 been	 previously	 described26,	 however	 in	 that	 study	 the	
authors	 used	 an	 external	 fleece	 and	 in	 experiment	 1	 the	 film‐like	 resorbable	
patches	were	attached	intraluminally.	This	stenosis	effect	–	clinically	translatable	to	
ileus	 –	 could	 be	 the	 explanation	 of	 why	 the	 animals	 in	 experiment	 1	 had	 lower	
welfare	scores	and	lower	weight	compared	to	the	other	groups.	
	
Hyaluronan	 is	generally	known	to	be	associated	with	 tissue	repair	and	wound	
healing	and	its	concentration	is	high	in	healing	tissues27.	Its	biological	functions	are	
the	 result	 of	 both	 its	 physicochemical	 properties	 and	 its	 biological	 interactions,	
depending	on	molecular	weight28.	Despite	 the	 logical	hypothesis	 that	the	addition	
of	 hyaluronan	 to	 butyrate	 would	 enhance	 anastomotic	 healing,	 this	 was	 not	
observed	in	this	study,	possibly	due	to	a	low	concentration	or	not	the	appropriate	
molecular	weight.		
	
One	of	the	limitations	of	this	study	–	even	if	the	newly	tested	approaches	were	
successful	 –	 is	 the	 translation	 to	 the	 human	 setting.	 While	 butyrate	 can	 be	
administered	as	a	rectal	enema,	this	is	rather	invasive	and	not	the	preferred	choice	
in	drug	administration.	The	risk	of	anastomotic	dehiscence	in	a	recent	constructed	
anastomosis	 remains,	 which	 could	 be	 an	 explanation	 of	 the	 fecal	 peritonitis	 that	
was	 found	 in	 the	 enema	 groups	 in	 experiment	 3.	 However,	 the	 very	 unpleasant	
odour	and	taste	of	butyrate	makes	oral	administration	extremely	difficult.	For	this	
reason,	Raso	et	al	have	studied	a	derivative	of	butyrate,	N‐(1‐carbamoyl‐2‐phenyl‐
ethyl)	butiramide	(FBA)	as	a	successful	therapeutic	alternative	to	butyrate,	sharing	
a	comparable	efficacy,	but	a	better	palatability	and	compliance,	unfortunately	so	far	
only	 in	 a	 rat	model29.	Other	 articles	 that	describe	oral	 administration	of	 butyrate	
were	also	designed	as	animal	studies30,31.	Nevertheless,	 there	are	a	 few	studies	 in	
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which	oral	butyrate	or	its	pro‐drug	was	given	in	humans	and	was	considered	safe	
and	 well	 tolerated32.	 The	 question	 remains	 if	 butyrate	 can	 be	 administered	 as	 a	
local	agent	at	the	site	of	the	anastomosis,	without	potential	harmful	effects	when	it	
enters	 the	 systemic	 circulation.	 Van	 Beek	 et	 al.	 have	 recently	 demonstrated	 that	
splanchnic	 butyrate	 release	 was	 prevented	 in	 patients	 after	 colonic	 butyrate	
administration,	 indicating	 that	 rectal	 enemas	 even	 with	 high	 therapeutic	 dosage	
(up	to	100mmol/l)	of	butyrate	can	be	given	safely33.		
	
Conceivably	new	approaches	may	become	available	as	nano‐based	drug	delivery	
systems	for	encapsulation	and	release	of	drugs	are	currently	being	investigated	in	
different	 fields	 of	medicine34,35.	 Imaginably	 in	 the	 future	 butyrate	 tablets	 become	
standard	 perioperative	 treatment	 and	 due	 to	 nanotechnology	 the	 release	 of	
butyrate	will	only	take	place	at	the	site	of	interest,	the	colonic	anastomosis.		
	
In	 conclusion,	 butyrate	 can	 enhance	 the	 colonic	 anastomosis,	 making	 it	 less	
prone	to	lead	to	leakage.	The	most	effective	method	thus	far	is	by	rectal	enemas	and	
the	addition	of	hyaluronan	did	not	ameliorate	the	effect	of	butyrate	on	the	AL	rate.	
Further	research	should	be	done	to	identify	the	optimal	way	of	butyrate	delivery	to	
the	anastomotic	site	where	it	can	enhance	anastomotic	healing.	
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Supplemental	Data	6.1	
Ethical	statement	
 The	experimental	protocol	complied	with	 the	Dutch	Animal	Experimental	Act	
and	 was	 approved	 by	 the	 Animal	 Experimental	 Committee	 of	 Maastricht	
University	 Medical	 Center.	 Protocols	 for	 institutional	 animal	 use	 and	 care	
guidelines	were	followed	(permit	DEC	2013‐101).	
Study	design	
 In	 total	 there	 were	 84	 rats	 used	 in	 this	 study.	 We	 used	 8	 or	 12	 rats	 per	
experimental	group,	 and	2‐3	groups	per	experiment,	 as	 is	 shown	 in	 the	 table	
below:	
	
Experiment	 Intervention	 Control	group	 Number	of	animals	 Proximal/Distal	colon	
1	 Butyrin‐eluting	
patch	
Placebo	patch	 12/group	
24	in	total	
Proximal	
2	 Hyaluronan‐
butyrate	injection	
Hyaluronan	 injection	
and	saline	injection	
8/group	
24	in	total	
Proximal	
3	 Hyaluronan‐
butyrate	enema	
Butyrate	 enema	 and	
no	enema	
12/group	
36	in	total	
Distal	
Experimental	procedures	
 For	surgical	procedure,	see	manuscript	and	figure	S6.1	below.	This	was	carried	
out	 in	 the	 rat	 operating	 room	 of	 the	 animal	 facility	 of	 Maastricht	 University	
under	semi‐sterile	conditions.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	S6.1	 Creating	 the	 proximal	 colonic	 anastomosis	 after	 transection	 (A),	 constructed	 using	 4	
interrupted	sutures	(B).	
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Experimental	animals	
 Male	Wistar	rats	(RccHan:WIST)	were	purchased	from	Harlan	laboratories,	the	
Netherlands	with	a	weight	of	275g.	Rats	had	an	average	weight	of	327g	on	the	
day	of	surgery	(SD	19.3).	
 We	 have	 chosen	 for	 male	 rats,	 since	 it	 is	 known	 that	 female	 estrogens	 and	
androgens	have	an	 important	 influence	on	wound‐healing	 (Ashcroft	GS,	 et	al.	
Estrogen	modulates	cutaneous	wound	healing	by	downregulating	macrophage	
migration	 inhibitory	 factor.	 The	 Journal	 of	 clinical	 investigation.	 2003,	
111:1309‐1318).	
Housing	and	husbandry		
 An	acclimatization	period	of	one	week	was	observed	prior	 to	 the	start	of	 the	
experiment.	
 Rats	were	 kept	 under	 standard	 conditions	 and	were	 provided	with	 food	 and	
water	ad	 libitum.	Rats	were	housed	2	animals	per	cage.	The	general	health	of	
rats	 was	 monitored	 several	 times	 per	 week	 for	 signs	 of	 inflammation	 and	
animals	 were	 weighed	 once	 per	 week.	 During	 the	 experiment	 animals	 were	
weighed	daily	and	scored	for	discomfort	twice	daily	(every	morning	and	every	
evening).	In	case	of	discomfort,	additional	pain	treatment	was	administered	by	
giving	buprenorphine	0.05mg/kg	s.c.	
 Discomfort	 was	 scored	 using	 a	 standard	 scheme	 (zie	 below).	 Humane	
endpoints	 were	 defined	 according	 to	 Roughan	 &	 Flecknell	 (Roughan,	 J.	 V.	&	
Flecknell,	 P.	 A.	 Behavioural	 effects	 of	 laparotomy	 and	 analgesic	 effects	 of	
ketoprofen	and	carprofen	in	rats.	Pain	90,	65–74	(2001).	
 Humane	endpoints	are	defined	as:	
o Significant	weight	loss	>20%		
o Fever	(temperature	is	only	measured	on	indication)	
o Tachypnoe		
o Significant	differences	in	behavior:	
 Lethargia	
 Twitching:	random	spasms	of	the	muscles,	can	be	seen	when	
animals	are	asleep	or	inactive	in	huddled	up	position.			
 Walking:	unable	to	stand	on	four	legs,	wobbly	walk	
 Huddled	up	posture:	showing	a	concave	abdominal	side.	Can	be	
seen	when	walking/sitting.	
o Signs	of	severe	dehydration	
o Severe	diarrhea		
o Severely	inflammed	surgical	wound	
o Cachexia	
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Allocating	animals	to	experimental	groups	
 Animals	 were	 randomized	 by	means	 of	 taking	 a	 card	 out	 of	 an	 envelope	 on	
which	either	1‐2‐3	was	printed.	For	each	animal	a	card	was	drawn	and	the	rat	
received	 the	 assigned	 treatment.	 We	 had	 3	 separate	 envelopes	 for	 each	
experiment	a	new	envelope	(with	either	2	or	3	types	of	card	in	there).	
Numbers	analysed		
 All	 analyses	 were	 performed	 according	 to	 an	 intention‐to‐treat	 analysis.	
However,	 since	 there	were	 adverse	 events	 and	 deaths	 prior	 to	 follow‐up,	 for	
ABP	and	histological	assessment	these	animals	were	not	taken	into	account.	
Welfare	scoring	rat	model	
Description	
	 0	 1	 2	 3	
Activity	 Normal	 Isolated,	less	active	 Inactive	 Somnulent,	stupor,	
coma,	lifeless	
Behavior		 Normal	 Back	arching,	
twitching,	shivering	
Once/10	min	
Back	arching,	twitching,	
shivering	
Stereotype	behavior,	
auto	mutilation,	
aggressive	behavior	
	Gait	 Normal	 Mildly	uncoordinated/	
Abnormality	
uncordinated	walking	on	
toes,		limping	
Paralysis,	limp,	
convulsions,	tremor.		
Posture	 Normal	 Huddled	up,	stretching	 Imbalance,	twitching		 Fall	over,	circle	
Physical	
condition	
Normal	 BC2=	condition	 BC5=	obese	 BC1=	emaciated	
BC6=extreme	obese	
Fur/skin	 Normal	 Dry,	rough,	not	shiny	
anymore		
Piloerection,	small	
wounds,	porfyrie,	dry	
white	skin		
Red/black	skin,	
inflammation,		wounds,		
loss	of	fur	
Hydratation	 Normal	 Loss	of	skin	elasticity		 Reduced	skin	turgor	 Severly	reduced	turgor	+	
sunken	eyes	
Breathing	 Normal	 Fast	and	superficial	 Fast	abdominal	breathing	
+	audible	breathing		
Respiratory	problems,	
cyanosis,	breathing	with	
open	mouth	
Faeces/urine	 Normal	 Moist	faeces,	polyurie		 Diarrhea,	abnormal	urine		 Uncontrolled	diarree,	
bloody	stool,	
obstipation,	hematuria	
Surgical	
wound	
Normal	
healing	
Sutures	intact,	slighty	
red/bloody	
Dehiscence	of	wound,	
sutures	open,	fluid	
secretion	
Severe	bleeding,	wound	
open,	severe	redness,	
necrosis		
Edema	 Normal	 Mild	abnormal	fluid	
collections,	swollen	
appearance	
Abnormal	large	abnormal	
fluid	collections,	ascites	
Severe	large	abnormal	
fluid	collections	
Necrosis	 Normal	 Dark	skin	colouring	 Small	dark/black	spots,	
burning	wounds,	blisters	
Big	black	spots,	crusts	
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Abstract	
Background	
Tissue	 adhesives	 (TA)	 may	 be	 useful	 to	 strengthen	 colorectal	 anastomoses,	 thereby	
preventing	 anastomotic	 leakage	 (AL).	 Previous	 studies	 have	 identified	 Cyanoacrylate	 (CA)	
TAs	as	possible	colonic	anastomotic	sealants.	This	study	investigates	the	protective	effects	of	
sealing	colonic	anastomoses	with	CA.	
	
Materials	and	methods	
55	Wistar	rats	underwent	laparotomy	and	transection	of	the	proximal	colon.	An	anastomosis	
was	created	with	4	interrupted	sutures	followed	by	either	application	of	Histoacryl	Flexible,	
Omnex,	Glubran	2,	or	no	TA	seal.	An	additional	control	group	was	included	with	12	sutures	
and	 no	 TA	 seal.	 After	 7	 days	 rats	 were	 sacrificed	 and	 scored	 for	 presence	 of	 AL	 as	main	
outcome.	 Secondary	 outcomes	 were	 occurrence	 of	 bowel	 obstruction	 or	 adhesions,	
anastomotic	bursting	pressure	and	histological	evaluation.	
	
Results		
The	 highest	 AL	 rate	was	 found	 in	 the	 Glubran	 2	 group	 (7/11),	 followed	 by	 the	 4‐sutures	
group	 without	 TA	 (5/11)	 and	 the	 Omnex	 group	 (5/11).	 Histoacryl	 Flexible	 showed	 the	
lowest	AL	rate	(2/11).	In	the	control	group	only	1	rat	showed	signs	of	AL.	Histologically,	the	
highest	 influx	 of	 inflammatory	 cells	 was	 found	 in	 the	 4‐suture	 group	 without	 TA	 and	 for	
Omnex	 and	 Glubran	 2.	 Histoacryl	 Flexible	 caused	more	mature	 collagen	 deposition	 when	
compared	to	the	other	TA	groups.	
	
Conclusions	
Histoacryl	Flexible	showed	the	lowest	leakage	rates	compared	to	the	other	TA	groups	and	to	
the	4	suture	control	group.	Glubran	2	showed	the	highest	AL	rate	and	a	high	inflammatory	
response.	 	 Histoacryl	 Flexible	 was	 associated	 with	 a	 higher	 and	 more	 mature	 collagen	
deposition,	and	seems	to	promote	anastomotic	healing.	
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Introduction	
Anastomotic	 leakage	(AL)	 in	colorectal	surgery	remains	a	major	problem.	Despite	
years	 of	 extensive	 research,	 AL	 is	 still	 commonplace,	 occurring	 in	 5‐15%	 of	
colorectal	anastomoses1.	
	
Over	the	years,	various	approaches	have	been	proposed	to	prevent	the	onset	of	
AL.	Mechanical	intraluminal	devices	creating	a	magnetic	anastomosis2,	intraluminal	
sheets	 of	 plastic	 covering	 the	 anastomosis3	 and	 exotic	 techniques	 such	 as	 tissue	
welding4	 have	 all	 been	 proposed,	 but	 most	 were	 quickly	 abandoned	 after	 their	
introduction	due	to	inefficacity	or	high	complication	rate.	
	
More	 recently,	 the	 idea	 of	 sealing	 an	 anastomosis	 externally	 with	 a	 tissue	
adhesive	has	been	in	the	spotlight,	and	has	been	linked	to	promising	results5.	The	
benefit	of	such	a	technique	is	that	a	surgeon	can	create	an	anastomosis	in	a	normal	
manner,	 using	 sutures	 or	 staples	 and	 performing	 an	 intra‐operative	 leak	 test	 or	
other	post‐	anastomotic	testing,	before	applying	an	extra	layer	of	protection	to	the	
serosal	surface	of	the	anastomosed	colon.	Of	the	various	available	tissue	adhesives	
(TAs),	a	special	interest	has	arisen	for	cyanoacrylate	(CA)	based	tissue	adhesives6.	
CA	is	a	type	of	chemical	polymer,	also	known	as	‘superglue’.	In	the	early	years	of	CA	
tissue	adhesives,	their	use	was	linked	to	the	impairment	of	anastomotic	healing	by	
exothermic	 polymerization	 and	 tissue	 toxicity7,8.	 Newer	 CA	 formulations	 have	
eliminated	 this	 highly	 exothermic	 curing	 process	 by	 shortening	 the	 length	 of	 the	
polymer‐chains	and	adding	various	additives,	 also	 increasing	 the	 flexibility	of	 the	
CA9.	Recent	studies	show	that	these	new	CAs	are	inert	when	used	on	the	colon,	not	
causing	toxic	reactions,	while	maintaining	enough	elasticity	to	cope	with	peristaltic	
movement	and	intraluminal	forces10.		
	
Several	 experimental	 studies	 have	 been	 performed	 using	 CAs	 to	 prevent	 AL,	
yielding	ambiguous	results5,6.	This	may	be	due	to	a	large	spectrum	of	experimental	
methodology	 in	 the	 various	 studies,	 in	 which	 large	 differences	 exist	 in	 the	 used	
animal	models,	TA	dosage	and	experimental	end‐points,	which	is	a	well‐recognized	
problem	in	the	field	of	experimental	research	on	colorectal	anastomoses11.	
Previous	 research	 regarding	TAs	and	colonic	healing	has	proposed	a	 stepwise	
approach	in	which	a	large	number	of	TAs	have	been	evaluated	following	a	similar	
experimental	protocol,	yielding	promising	results	for	CA	based	TAs12.		
	
In	the	current	study	we	use	a	rat	model	to	simulate	high	rates	of	AL,	based	on	
the	creation	of	a	mechanically	insufficient	colon	anastomosis,	which	we	seal	with	a	
protective	barrier	of	one	of	3	CA	formulations.	The	aim	of	this	study	is	to	 identify	
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promising	 CAs	 for	 the	 prevention	 of	 AL,	 by	 blocking	 the	 intra‐peritoneal	 leak	 of	
bowel	contents.	
Methods	
Study	design	
Three	clinically	available	CAs	were	included	in	this	study.	These	TAs	were	chosen	
based	 on	 their	 mechanical	 and	 rheological	 profiles	 as	 derived	 from	 previous	
research10.	TA	composition	and	manufacturer	details	are	listed	in	table	1.	A	positive	
control	group,	with	a	12‐suture	colonic	anastomosis	was	used,	as	well	as	a	negative	
4‐suture	control	group,	without	a	TA	seal.		The	included	study	groups	are	described	
in	Table	7.1.	Rat	allocation	was	performed	in	a	randomized	manner	using	a	lottery	
system.	 Data	 are	 reported	 according	 to	 the	 ARRIVE	 guidelines	 (see	 also	
supplemental	data)13.	A	power	analysis	was	calculated	based	on	a	reduction	of	20%	
(δ)	 in	 inflammation,	 as	 scored	 on	 histological	 data,	 between	 the	 different	
experimental	 groups	 with	 a	 variance	 of	 ±16%	 (σ).	 The	 number	 of	 animals	 per	
group	 was	 calculated	 as	 follows:	 (α:	 0.05,	 π:	 0.8,	 2‐sided	 testing):	 n	 =	 2(zα/2	 ‐	
zπ)2*(σ/δ)2	,	n	=	2(1.96	+	0.84)²*(16/20)²,	n	=	15.7*0.64	=	10.03	≈	11.	
	
Table	7.1	 Study	groups.	
Group	 Name	 Anastomotic	
technique	
Tissue	adhesive	(TA)	 Manufacturer	
1	 Control	 12	sutures	 ‐	 N/A	
2	 No	TA		
(negative	control)	
4	sutures	 ‐	 N/A	
3	 Histoacryl	Flex	 4	sutures	 n‐butyl‐2‐cyanoacrylate	 B.	Braun	(Tuttingen,	
GER)	
4	 Omnex	 4	sutures	 2‐octyl‐cyanoacrylate/	butyl	
lactoyl	cyanoacrylate	
Ethicon	(J&J,	
Sommerville,	NJ,	USA)	
5	 Glubran	2	 4	sutures	 n‐butyl‐2‐cyanoacrylate	and	
methacryloxy	sulfolane	
GEM	S.r.l.	(Viarregio,	
IT)	
	
Animals	
Male	 specific‐pathogen‐free	Wistar	 rats	 (250‐350	 g)	 were	 housed	 at	 the	 Central	
Animal	Facility	of	 the	Maastricht	University	Medical	Centre,	 the	Netherlands.	Rats	
were	 housed	 according	 to	 standard	 laboratory	 conditions,	 including	 individually	
ventilated	 cages	 with	 unrestricted	 access	 to	 standard	 rat	 chow	 and	 water.	 The	
experimental	 protocol	 complied	with	 the	 Dutch	 Animal	 Experimentation	 Act	 and	
was	approved	by	the	local	Animal	Experimental	Committee.		
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Surgical	procedure	
Experienced	 researchers,	 certified	 for	 animal	 research,	 performed	 all	 surgical	
procedures.	 Rats	 received	 buprenorphine	 0.1	mg/kg	 (Temgesic,	 Schering‐Plough,	
USA)	 pre‐operatively	 for	 analgesia	 which	 was	 repeated	 when	 necessary	
postoperatively.	 Anesthesia	 was	 induced	 by	 inhalation	 of	 isoflurane	 5.0	 vol%	
(Forene,	Abbott	 Laboratories,	USA),	 followed	by	 a	maintenance	dose	of	2.5	 vol%.	
The	 abdominal	 skin	 was	 shaved,	 disinfected	 with	 iodine	 1%	 and	 covered	 with	
sterile	 drapes.	 A	 5‐cm	midline	 incision	was	made	 through	which	 the	 cecum	was	
identified	and	exteriorized	onto	sterile	gauzes.	The	ascending	colon	was	transected	
2‐cm	 distally	 to	 the	 cecum,	 without	 damaging	 the	 mesenteric	 vessels.	 An	
insufficient	end‐to‐end	colonic	anastomosis	was	created	using	4	evenly	distributed	
polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	 Johnson,	 USA).	 After	
construction	 of	 the	 anastomosis,	 in	 the	 TA	 groups,	 0.025	 ml	 of	 TA	 was	 applied	
evenly	to	the	anastomotic	site	using	the	provided	applicators.		In	the	control	group,	
12	sutures	were	used	instead	of	4,	obtaining	a	sufficient	anastomosis.	Postoperative	
hydration	was	provided	by	injecting	a	bolus	of	5	mL	sterile	saline	solution	(37°C)	
into	 the	 abdominal	 cavity	 after	 repositioning	 of	 the	 abdominal	 contents.	 The	
abdominal	 wall	 was	 closed	 using	 a	 running	 suture	 of	 polyglactine	 4/0	 (Vicryl,	
Ethicon,	 Johnson	 &	 Johnson,	 USA).	 Skin	 closure	 was	 performed	 with	 an	
intracutaneous	running	suture	of	polyglecaprone	4/0	(Monocryl,	Ethicon,	Johnson	
&	Johnson,	USA).	Postoperatively,	a	daily	evaluation	of	all	animals	was	carried	out.	
Animal	weight	and	signs	of	distress	were	noted.	 In	case	of	 severe	distress/illness	
the	animals	were	sacrificed	prior	to	the	completion	of	the	follow‐up	time.		
Outcome	measures	
The	 main	 outcome	 of	 the	 study	 was	 anastomotic	 leakage	 (AL),	 including	
macroscopic	 anastomotic	 dehiscence,	 fecal	 peritonitis	 or	 large	 anastomotic	
abscesses.	 After	 7	 days	 or	 when	 humane	 endpoints	 were	 reached,	 rats	 were	
sacrificed	using	an	overdose	of	 carbon	dioxide.	The	abdomen	was	 re‐opened	and	
the	 abdomen	 was	 macroscopically	 inspected	 for	 signs	 of	 leakage	 or	 TA‐related	
complications,	 that	 is,	 the	presence	of	 intraperitoneal	abscess	or	 fecal	matter	and	
ileus	 formation.	 Abscess	 formation	 was	 scored	 using	 the	 following	 parameters:	
1)	one	 or	 several	 millimetric	 abscesses;	 2)	 abscess	 up	 to	 ¼	 of	 anastomotic	
circumference;	 3)	 Large	 abscess	 >1/4	 of	 anastomotic	 circumference;	 4)	 intra‐
abdominal	abscess	formation.	Based	on	our	previous	research,	 in	which	we	found	
that	an	abscess	score	of	1	was	not	associated	with	any	clinical	complications	and	
therefore	not	clinically	 significant,	we	defined	AL	 in	 this	 study	as	 the	presence	of	
fecal	peritonitis	or	an	abscess	score	of	>212,20.	The	Zühlke	score,	which	depicts	the	
tenacity	of	intra‐abdominal	adhesions	was	also	determined14.	
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Anastomotic	bursting	pressure	
To	measure	anastomotic	bursting	pressure	(ABP),	a	plastic	tube	was	inserted	into	
the	colon	proximally	to	the	anastomotic	site,	and	ligated	with	a	single	polyglactine	
4/0	 suture.	 The	 distal	 colonic	 segment	 was	 clamped	 to	 ensure	 an	 airtight	
compartment.	 Pressure	was	 gradually	 increased	 in	 the	 anastomotic	 compartment	
using	 an	 automatic	 pressure	 pump	 (IDEE,	Maastricht,	 the	Netherlands).	ABP	was	
monitored	 and	 recorded	 using	 a	 digital	 manometer	 until	 the	 colon	 bursted/air	
bubbles	appeared.	The	maximum	bursting	pressure	was	recorded	for	each	rat.	
Histological	evaluation	
After	 ABP	 testing,	 the	 anastomotic	 segment	 was	 subsequently	 resected	 and	
prepared	 for	 histological	 evaluation.	 Tissue	 samples	 were	 embedded	 in	 paraffin	
and	 cut	 in	 4μm	 sections.	 To	 evaluate	morphology	 of	 cells,	 standard	 hematoxylin‐
eosin	 (H&E)	 staining	 was	 performed.	 Specimens	 were	 scored	 based	 on	
inflammation,	 fibroblast	 activity,	 collagen	 deposition	 and	 neoangiogenesis	
according	to	the	Ehrlich	and	Hunt	numerical	scale	(0‐4)	as	modified	by	Phillips	et	
al:	 0	 =	 no	 evidence,	 1	 =	 occasional	 evidence,	 2	 =	 light	 scattering,	 3	 =	 abundant	
evidence,	4	=	confluent	cells	or	fibers15.	All	slides	were	evaluated	by	an	experienced	
pathologist	(MG)	who	was	blinded	for	the	experimental	groups.	
Evaluation	of	collagen	formation		
Tissue	 sections	 were	 stained	 for	 collagen	 using	 Picro	 Sirius	 red	 as	 previously	
described16.	The	results	between	experimental	groups	were	compared,	no	collagen	
staining	was	performed	in	de	12‐suture	control	groups,	as	these	findings	are	well‐
known	and	have	been	reported	 in	numerous	recent	studies17‐19.	 In	short,	sections	
were	exposed	to	a	0.1%	solution	of	Sirius	red	in	saturated	aqueous	picric	acid	for	
90	minutes,	followed	by	2	min	of	washing	in	0.01N	HCl,	dehydration	and	mounted	
with	Entellan.	 Images	of	 the	anastomotic	 region	were	 taken	 (200x	magnification)	
using	 cross	 polarization	 light	 microscopy	 (Leica	 DM5000B,	 Leica	 Microsystems,	
Switzerland).	Collagen	percentages	of	anastomotic	tissue	were	calculated.	Maturity	
level	 of	 collagen	 was	 estimated	 by	 calculating	 the	 red	 (mature	 fibers,	 collagen	
type	I)	versus	green	(immature	fibers,	collagen	type	III)	area	ratio	using	the	Qwin	
morphometry‐system	(Leica	QWin	V3.5.1,	Leica	Microsystems).		
Statistics	
One‐way	ANOVA	was	used	in	case	of	continuous	variables,	with	a	Bonferroni	post‐
hoc	 test.	 A	 χ2‐test	 or	 Fisher’s	 exact	 was	 used	 in	 case	 of	 categorical	 variables.	 A	
P‐value	≤0.05	was	considered	statistically	significant.	All	analyses	were	performed	
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using	IBM	SPSS	Statistics,	version	21.0	for	Mac	(IBM	SPSS,	USA),	while	graphs	were	
composed	using	GraphPad	Prism,	version	5.0a	for	Mac	(GraphPad	Software,	USA).	
Results	
Anastomotic	Leakage	
Both	in	the	4‐suture	non‐TA	and	Glubran	2	groups,	one	rat	died	prior	to	completion	
of		the	follow‐up	period	due	to	fecal	peritonitis	caused	by	AL.	Except	for	these	two	
rats,	AL	only	consisted	of	the	presence	of	anastomotic	abscesses.		In	the		12‐suture	
control	group	AL	occurred	in	one	rat,	associated	with	an	abscess	score	of	1.	In	the	
4‐suture	non‐TA	group	4	 rats	 showed	signs	of	AL,	with	an	abscess	score	of	2	 in3	
rats	and	an	abscess	score	of	4	in	1	rat.	In	the	TA	groups	there	was	a	large	difference	
in	 AL‐rate.	 Glubran	 2	 had	 the	 highest	 AL‐rate,	 consisting	 of	 1	 total	 anastomotic	
dehiscence	 and	 subsequent	 fecal	 peritonistis,	 and	 6	 cases	 of	 abscess	 formation.	
Abscess	scores	in	this	TA	group	ranged	from	1	to	4.	Five	rats	in	the	Omnex	group	
and	 two	rats	 in	 the	Histoacryl	Flexible	group	showed	signs	of	AL,	with	maximum	
abscess	scores	of	4	and	2,	respectively.	Statistical	analysis	shows	that	Glubran	2	had	
a	significantly	higher	amount	of	abscesses	when	compared	to	the	positive	control	
group	 (P=0.013)	 and	 Histoacryl	 Flexible	 (P=0.049).	 A	 synopsis	 of	 AL‐rates	 is	
provided	in	Figure	7.1A.	
Clinical	outcomes	
Discomfort	in	the	various	groups	is	reflected	by	changes	in	weight	loss	throughout	
the	follow‐up	period	(Figure	7.1B).	The	negative	control	group,	in	which	no	TA	was	
used,	showed	the	highest	rate	of	weight	 loss.	For	 the	TA	groups,	Glubran	2	group	
showed	the	most	weight	loss	at	7	days,	significantly	higher	than	the	control	group	
(P<0.01)	and	the	Histoacryl	Flexible	group	(P<0.01).	
Mechanical	ileus	rate	varied	significantly	between	the	TA	groups,	with	Glubran	
2	 showing	 the	highest	 ileus	 rate,	 significantly	 higher	 than	when	 compared	 to	 the	
negative	control	group	(P=0.01).	The	number	and	Zuhlke	score	of	adhesions	did	not	
differ	 significantly	 between	 experimental	 groups.	 A	 synopsis	 of	 the	 clinical	
outcomes	in	presented	in	Table	7.2.	
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Figure	7.1	 A)	Histoacryl	Flexible	had	the	 lowest	amount	of	anastomotic	 leakage	(2/11)	compared	to	
the	other	intervention	groups	Omnex	5/11	and	Glubran2	7/11	and	the	no	TA	group	5/11.	
The	 control	 group	 with	 12	 sutures	 only	 showed	 one	 case	 of	 AL	 (Χ2=9.43,	 P=0.05).	
B)	Weight	loss	was	monitored	as	a	measure	of	discomfort	and	the	percentage	weight	loss	
was	 highest	 in	 the	 no	TA	 group,	 followed	 by	 the	Glubran	 2	 group	with	was	 significantly	
higher	 than	 the	 Histoacryl	 Flexible	 group	 and	 the	 control	 group.	 C)	 No	 significant	
differences	were	 found	between	the	experimental	groups	regarding	anastomotic	bursting	
pressure.	 Control	 group	 (12	 sutures)	 and	 the	 group	 without	 TA	 showed	 significanly	
different	ABP	(P=0.004).	
	
Anastomotic	Bursting	Pressure	(ABP)	
The	highest	ABP,	as	depicted	 in	Fig.	1C,	was	found	in	the	12‐suture	control	group	
(272	mmHg	±70)	and	differed	significantly	from	the	4‐suture	no	TA	control	group	
(147	mmHg	±37,	P<0.01).	The	use	of	TA	resulted	in	an	increase	in	ABP	in	all	three	
TA	groups,	however	no	statistically	significant	differences	were	found.	The	highest	
increase	 in	 ABP	 was	 found	 in	 the	 Histoacryl	 Flexible	 group	 (217	 mmHg	 ±53),	
followed	by	the	Glubran	2	group	(205	mmHg	±	67).	Omnex	showed	the	lowest	ABP	
of	the	TA	groups	(173	mmHg	±	69).	
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Table	7.2	 Synopsis	of	clinical	outcomes.	
Group	
	
Number	
of	rats	
Fecal	
peritonitis*	
Mechanical	
Ileus*	
Adhesions,		
total	(mean)	
Median	
Zuhlke	score	
1)	12	sutures	 11	 0	 1	 4,4	 3	
2)	4	sutures	 11	 1	 0	 5	 3	
3)	Histoacryl	Flex	 11	 0	 1	 5,5	 3	
4)	Omnex	 11	 0	 1	 5,7	 3	
5)	Glubran	2	 11	 1	 5	 5,8	 3	
*Number	of	affected	rats.	
	
Histological	evaluation		
The	 use	 of	 a	 4‐suture	 anastomosis,	 with	 or	without	 the	 presence	 of	 a	 TA,	 led	 to	
more	inflammation	when	compared	to	the	12‐suture	control	group	(Figure	7.2A).	A	
significantly	 higher	 inflammation	 score	 was	 found	 in	 the	 Omnex	 and	 Glubran	 2	
groups	when	compared	to	the	control	group	(P<0.01).	Significantly	more	collagen	
deposition	 was	 found	 in	 the	 Histoacryl	 Flexible	 group	 and	 the	 Omnex	 group	 in	
comparison	with	 the	 control	 group	 (Figure	 7.2B,	P<0.01).	 Fibroblast	 activity	 and	
neoangiogenesis	 did	 not	 differ	 between	 the	 experimental	 groups	 (Figure	 7.2C	 &	
7.2D).	
	
Picro	 Sirius	 red	 staining,	 which	 depicts	 the	 level	 of	 collagen	 maturity,	 of	 the	
anastomotic	 region	 showed	 comparable	 percentages	 of	 collagen	 for	 all	 groups	
(Figure	7.3A,	P=0.214).	When	focusing	on	collagen	maturity,	a	significant	difference	
was	found	in	red/green	ratios	between	the	Histoacryl	Flexible	and	Glubran	2	group	
(Figure	7.3B,	P<0.05),	illustrating	a	higher	level	of	healing	in	the	Histoacryl	Flexible	
group.	
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Figure	7.2	 A)	significantly	more	inflammation	occurred	in	the	Omnex	and	Glubran	2	group	compared	
to	 the	 control	 group.	 B)	No	 differences	were	 found	 between	 groups	 regarding	 fibroblast	
acitivity.	 C)	More	 collagen	 deposition	was	 found	 in	 the	Histoacryl	 group	 and	 the	Omnex	
group	 compared	 to	 the	 control	 group.	 Neoangiogenesis	 (D)	 did	 not	 differ	 between	 the	
experimental	groups.	
 
	
	
	
	
	
	
	
	
	
	
	
Figure	7.3	 A)	No	differences	were	 found	between	groups	 in	 the	relative	collagen	area	(quantified	as	
the	percentage	of	total	tissue	surface).	B)	Maturity	of	collagen	was	estimated	by	calculating	
the	 red/green	 ratio,	 which	 was	 significantly	 higher	 in	 the	 Histoacryl	 Flexible	 group	
compared	to	the	Glubran	2	group,	indicating	more	mature	collagen.		
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Discussion	
The	sealing	of	colonic	anastomoses	with	tissue	adhesives	(TAs)	has	been	proposed	
as	 a	 promising	 method	 for	 the	 prevention	 of	 anastomotic	 leakage	 by	 forming	 a	
mechanical	barrier	that	can	protect	from	the	leakage	of	intraluminal	contents	into	
the	 peritoneum,	 giving	 the	 anastomosis	 time	 to	 heal20.	 Of	 the	 large	 amount	 of	
available	TAs,	recent	research	has	provided	evidence	that	cyanoacrylate	(CA)	TAs	
may	 be	 useful	 in	 the	 prevention	 of	 AL6.	 In	 the	 current	 study,	 we	 selected	 three	
clinically	available	CAs	to	seal	insufficient	colonic	anastomoses	in	a	rat	model,	also	
including	 a	 positive	 control	 group	 in	which	 a	 12	 suture	 colonic	 anastomosis	was	
used	as	well	as	a	negative,	4‐suture,	control	group.	We	evaluated	the	effectiveness	
of	 each	TA	 in	 the	 prevention	 of	 AL,	 also	 taking	 into	 account	mechanical	 strength	
and	histological	profile.		
	
Overall,	there	were	large	differences	between	AL	rates	of	the	various	groups..	In	
this	 study	 AL	 was	 mostly	 presented	 as	 peri‐anastomotic	 abscess	 formation.	 The	
described	abscess	 score	was	used	 to	 score	 the	 severity	and	amount	of	abscesses;	
generally	 an	 abscess	 score	 of	 <2	was	 not	 associated	with	 any	 clinical	 symptoms,	
and	therefore	not	considered	clinically	relevant.	Histoacryl	Flexible,	a	combination	
of	n‐butyl‐2‐cyanoacrylate	and	a	softener,	showed	the	lowest	rate	of	AL,	occurring	
in	 2	 rats.	 Furthermore,	 the	maximum	 abscess	 score	with	Histoacryl	 Flexible	was	
lower	than	with	the	other	TAs,	and	consisted	only	of	punctiform	abscesses	around	
the	 anastomosis,	 which	 did	 not	 have	 any	 clinical	 consequences.	 The	 histological	
evaluation	showed	that	this	TA	resulted	in	the	least	 inflammation	and	the	highest	
level	of	collagen	formation	and	healing	of	the	TA	groups.	Overall,	Histoacryl	Flexible	
showed	 promising	 results,	 	with	 an	AL	 rate	 comparable	 to	 the	 12‐suture	 control	
group,	with	positive	clinical	outcomes	and	improved	histological	assessment.	This	
TA	seems	to	be	a	safe	and	effective	colonic	sealant.		
	
Glubran	 2,	 based	 on	 an	 n‐butyl‐2‐cyanoacrylate	 and	 methacryloxy	 sulfolane	
mixture,	showed	the	poorest	results	in	our	study.	In	terms	of	AL,	the	use	of	this	TA	
resulted	 in	 one	 case	 of	 premature	 death	 due	 to	 fecal	 peritonitis	 as	 well	 as	 the	
highest	 rates	 of	 abscess	 formation	 and	 severity.	 Furthermore,	 its	 use	 was	
associated	 with	 higher	 incidence	 of	 mechanical	 ileus,	 occurring	 in	 five	 rats,	
significantly	higher	 than	 in	the	4‐suture	control	group.	Rats	 in	 this	group	showed	
the	most	weight	loss	of	all	study	groups.	Histological	analysis	associated	Glubran	2	
use	with	 the	highest	 degree	 of	 inflammation,	 and	 a	 significantly	more	 premature	
collagen	 ratio,	 indicating	 less	 healing	 capability.	 Glubran	 2	 induced	 an	 extended	
inflammatory	 response	 with	 mild	 local	 muscle	 lysis	 as	 deep	 as	 the	 submucusal	
colonic	 layer.	 This	 finding	 was	 also	 reported	 in	 a	 previous	 study	 by	 Kayaoglu21.	
Omnex,	 a	 2‐octyl‐cyanoacrylate	 /	 butyl‐lactoyl‐cyanoacrylate	 mixture,	 showed	
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similar	 results	 to	 the	 negative	 control	 group	 in	 terms	 of	 AL	 rate,	 clinical	 effects,	
mechanical	 strength	 and	 histological	 analysis.	 Presence	 of	 this	 TA	 thus	 did	 not	
improve	outcomes	nor	lead	to	any	complications	when	used	on	the	colon.		
	
Results	 of	 this	 study	 are	 in	 line	 with	 previous	 research	 on	 the	 use	 of	 CA	 in	
experimental	AL	models.	 In	a	previous	study	 from	our	group	the	same	set	of	CAs	
were	applied	on	rat	colon	without	the	presence	of	a	colonic	defect	and	followed	for	
1	 or	 4	 weeks12.	 That	 study	 showed	 that	 Histoacryl	 Flexible	 retained	 the	 lowest	
complication	rate	and	a	relatively	inert	histological	profile,	with	a	limited	local	host	
reaction	and	an	increase	in	inflammatory	markers	at	7	days,	a	finding	which	did	not	
persist	 at	 28	 days	 when	 no	 ongoing	 inflammation	 reaction	 was	 found.	 In	 the	
present	 study,	 Histoacryl	 Flexible	 was	 associated	 with	 a	 higher	 inflammatory	
reaction	 than	 the	12‐suture	controle	group	at	7	days,	 comparable	 to	 the	4‐suture	
no‐TA	 group.	 The	 longterm	 inflammatory	 reaction	 of	 this	 TA	 in	 an	 anastomosis	
model	may	be	an	interesting	subject	for	further	research.		
	
All	 three	 TAs	 included	 are	 modern	 CAs,	 clinically	 in	 use.	 When	 examing	 the	
chemical	 composition	 of	 each	 CA	 (as	 depicted	 in	 table	 1),	 one	may	 note	 that	 the	
main	ingredients	of	the	included	CAs	are	similar	to	one	another.	Glubran	2	(n‐butyl‐
2‐cyanoacrylate/methacryloxysulfolane)	 does	 not	 differ	 considerably	 from	 either	
Histoacryl	 Flexible	 (n‐butyl‐2‐cyanoacrylate)	 or	 Omnex	 (n‐octyl‐
cyanoacrylate/butyl/lactoyl	 acrylate),	 while	 differences	 exist	 in	 the	 various	
additives	 and	 softeners.	 As	 reported	 in	 previous	 research,	 Glubran	 2	 elicits	 a	
significantly	higher	 	 inflammatory	 response	 than	 the	other	 included	Cas,	 and	 this	
may	possibly	be	attributed	to	methacryloxysulfolane,	an	additive	in	Glubran	2	that	
increases	flexibility6.	This	finding	should	be	addressed	in	future	studies.		
	
Our	 study	 has	 several	 limitations.	 Firstly,	 we	 opted	 for	 a	 follow‐up	 time	 of	 7	
days	 to	 evaluate	 short‐term	 effectiveness	 after	 creation	 of	 an	 anastomosis.	
Therefore,	 we	 cannot	 comment	 on	 the	 long‐term	 safety	 of	 CA	 use	 on	 colonic	
anastomosis.	This	may	be	in	part	extrapolated	from	our	previous	studies,	however,	
a	future	objective	would	be	to	use	several	time‐points.	By	doing	this,	one	could	also	
evaluate	the	clinical	relevance	of	the	(sub)clinical	local	abscesses	we	encountered,	
which,	 in	 fact,	 may	 reflect	 perioperative	 spillage	 of	 bowel	 contents	 instead	 of	
postoperative	 anastomotic	 leakage.	 Secondly,	 as	 a	 large	 number	 of	 colorectal	
anastomoses	are	 stapled	nowadays,	 a	 study	on	 the	 interaction	between	CA	and	a	
stapled	anastomosis	may	an	interesting	step	for	further	research.		
	
In	conclusion,	this	study	shows	that	the	use	of	Glubran	2	was	directly	associated	
with	poor	outcomes	and	does	not	seem	to	be	a	suitable	TA	for	the	sealing	of	colonic	
anastomosis.	Furthermore,	we	 found	 limited	evidence	of	a	protective	effect	of	 the	
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use	of	Histoacryl	Flexible	as	an	anastomotic	sealant.	The	use	of	 this	CA	showed	a	
trend	for	the	decrease	of	AL,	an	increase	in	mechanical	strength	and	stimulation	of	
wound	healing	when	compared	to	the	other	CAs	and	to	a	negative	control	group.	It	
was	 associated	 with	 an	 incidence	 of	 AL	 comparable	 to	 a	 standard,	 12	 suture	
anastomosis	and	its	potential	should	be	further	evaluated	in	future	research.	
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S	7.1	Supplemental	information	according	to	ARRIVE	
guidelines	
Ethical	statement	
 The	experimental	protocol	complied	with	the	Dutch	Animal	Experimental	Act	
and	was	approved	by	the	Animal	Experimental	Committee	of	Maastricht	
University	Medical	Center.	Protocols	for	institutional	animal	use	and	care	
guidelines	were	followed	(permit	DEC	2012‐055)	
	
Study	design	
 In	total	there	were	55	rats	used	in	this	study.	We	used	11	rats	per	experimental	
group,	and	5	groups.			
	
Experimental	procedures	
 For	surgical	procedure,	see	manuscript.	This	was	carried	out	in	the	rat	
operating	room	of	the	animal	facility	of	Maastricht	University	under	semi‐
sterile	conditions.		
	
Experimental	animals	
 Male	Wistar	rats	(RccHan:WIST)	were	purchased	from	Harlan	laboratories,	the	
Netherlands.	Rats	had	an	average	weight	of	307g	on	the	day	of	surgery	(SD	
16.7).	
 We	have	chosen	for	male	rats,	since	it	is	known	that	female	estrogens	and	
androgens	have	an	important	influence	on	wound‐healing	(Ashcroft	GS,	et	al.	
Estrogen	modulates	cutaneous	wound	healing	by	downregulating	macrophage	
migration	inhibitory	factor.	The	Journal	of	clinical	investigation.	2003,	
111:1309‐1318.)	
	
Housing	and	husbandry		
 An	acclimatization	period	of	one	week	was	observed	prior	to	the	start	of	the	
experiment.	
 Rats	were	kept	under	standard	conditions	and	were	provided	with	food	and	
water	ad	libitum.	Rats	were	housed	2	animals	per	cage.	The	general	health	of	
rats	was	monitored	several	times	per	week	for	signs	of	inflammation	and	
animals	were	weighed	once	per	week.	During	the	experiment	animals	were	
weighed	daily	and	scored	for	discomfort	twice	daily	(every	morning	and	every	
evening).	In	case	of	discomfort,	additional	pain	treatment	was	administered	by	
giving	buprenorphine	0.05mg/kg	s.c.	
 Discomfort	was	scored	using	a	standard	scheme	(zie	below).	Humane	
endpoints	were	defined	according	to	Roughan	&	Flecknell	(Roughan,	J.	V.	&	
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Flecknell,	P.	A.	Behavioural	effects	of	laparotomy	and	analgesic	effects	of	
ketoprofen	and	carprofen	in	rats.	Pain	90,	65–74	(2001).	
 Humane	endpoints	are	defined	as:	
o Significant	weight	loss	>20%		
o Fever	(temperature	is	only	measured	on	indication)	
o Tachypnoe		
o Significant	differences	in	behavior:	
 Lethargia	
 Twitching:	random	spasms	of	the	muscles,	can	be	seen	when	animals	are	
asleep	or	inactive	in	huddled	up	position.			
 Walking:	unable	to	stand	on	four	legs,	wobbly	walk	
 Huddled	up	posture:	showing	a	concave	abdominal	side.	Can	be	seen	
when	walking/sitting.	
o Signs	of	severe	dehydration	
o Severe	diarrhea		
o Severely	inflammed	surgical	wound	
o Cachexia	
	
Allocating	animals	to	experimental	groups	
 Animals	were	randomized	by	means	of	throwing	a	dice.	Groups	were	divided	
into	1‐5	(see	table	1).	For	each	animal	the	dice	was	thrown	and	the	rat	received	
the	assigned	treatment.	Whenever	6	was	thrown,	the	dice	was	rolled	again.	
	
Numbers	analysed		
 All	analyses	were	performed	according	to	an	intention‐to‐treat	analysis.	
However,	since	there	were	adverse	events	and	deaths	prior	to	follow‐up,	for	
ABP	and	histological	assessment	these	animals	were	not	taken	into	account.	
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Welfare	scoring	rat	model	
Description	
	 0	 1	 2	 3	
Activity	 Normal	 Isolated,	less	active	 Inactive	 Somnulent,	stupor,	
coma,	lifeless	
Behavior		 Normal	 Back	arching,	
twitching,	shivering	
Once/10	min	
Back	arching,	twitching,	
shivering	
Stereotype	
behavior,	auto	
mutilation,	
aggressive	behavior	
	Gait	 Normal	 Mildly	
uncoordinated/	
Abnormality	
uncordinated	walking	on	
toes,		limping	
Paralysis,	limp,	
convulsions,	tremor.	
Posture	 Normal	 Huddled	up,	
stretching	
Imbalance,	twitching		 Fall	over,	circle	
Physical	
condition	
Normal	 BC2=	condition	 BC5=	obese	 BC1=	emaciated	
BC6=extreme	obese	
Fur/skin	 Normal	 Dry,	rough,	not	shiny	
anymore		
Piloerection,	small	wounds,	
porfyrie,	dry	white	skin		
Red/black	skin,	
inflammation,		
wounds,		loss	of	fur	
Hydratation	 Normal	 Loss	of	skin	elasticity		 Reduced	skin	turgor	 Severly	reduced	
turgor	+	sunken	
eyes	
Breathing	 Normal	 Fast	and	superficial	 Fast	abdominal	breathing	+	
audible	breathing		
Respiratory	
problems,	cyanosis,	
breathing	with	open	
mouth	
Faeces/urine	 Normal	 Moist	faeces,	polyurie	 Diarrhea,	abnormal	urine		 Uncontrolled	
diarree,	bloody	
stool,	obstipation,	
hematuria	
Surgical	wound	 Normal	
healing	
Sutures	intact,	slighty	
red/bloody	
Dehiscence	of	wound,	
sutures	open,	fluid	secretion	
Severe	bleeding,	
wound	open,	severe	
redness,	necrosis		
Edema	 Normal	 Mild	abnormal	fluid	
collections,	swollen	
appearance	
Abnormal	large	abnormal	
fluid	collections,	ascites	
Severe	large	
abnormal	fluid	
collections	
Necrosis	 Normal	 Dark	skin	colouring	 Small	dark/black	spots,	
burning	wounds,	blisters	
Big	black	spots,	
crusts	
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Part	IV	
		
Potential	disruption	of	the	balance		
between	anastomotic	healing		
and	adhesion	formation	
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Abstract	
Introduction	
Plasticizers	 are	 commonly	used	 to	 improve	 the	mechanical	 characteristics	 of	 biomaterials.	
We	 studied	 two	 biomaterials	 designed	 as	membranes	 able	 to	 reduce	 colonic	 anastomotic	
leakage	 (AL),	 which	 were	 plasticized	 with	 glycerol,	 a	 frequently	 used	 plasticizer.	 The	
pathophysiology	of	the	observed	extensive	patch‐host	interaction	was	investigated.	
	
Methods	
Animal	 experiments	 were	 performed	 in	 male	 Wistar	 rats,	 which	 received	 a	 colonic	
anastomosis	using	4	sutures	(leakage	model,	n=30)	or	12	sutures	(healing	model,	n=36).	In	
both	cases,	two	membranes,	either	containing	Hyaluronic	Acid‐Alginate‐Glycerol	or	Gelatin‐
Glycerol	were	used	to	cover	the	anastomosis.	A	chorioallantoic	membrane	(CAM)	assay	was	
performed	assessing	the	pro‐inflammatory	effects	of	the	materials	employed.	In	vitro	studies	
were	performed	evaluating	viability	of	human	multipotent	adipose	derived	stem	cells	in	the	
presence	of	increasing	concentrations	of	glycerol.	
	
Results		
Both	patches	 containing	glycerol	 induced	 large	abscess	 formation	and	severe	adhesions	 in	
the	 leakage	model	(n=20),	while	these	parameters	were	present	only	at	a	 limited	extent	 in	
control	 animals	 (n=10).	 In	 animals	 that	 did	 not	 show	 AL,	 encapsulation	 of	 the	 glycerol	
patches	 was	 evident.	 CAM	 assay	 identified	 glycerol	 as	 the	 cause	 of	 adverse	 patch‐host	
reactions.	 Cell	 culture	 revealed	 a	 decrease	 of	 adipocyte‐viability	 upon	 increase	 of	 glycerol	
concentration	beyond	2%.	
	
Conclusions	
Glycerol‐plasticized	 patches	 induced	 adverse	 events	 in	 a	 rat	 model.	 CAM	 assay	 data	
demonstrated	that	glycerol	compromises	the	biocompatibility	of	the	patch	while	in	vitro	data	
showed	that	adipocytes	are	less	viable	in	the	presence	of	glycerol	(>2%).	Caution	should	be	
taken	when	selecting	glycerol	as	plasticizer	in	biomaterials	designed	for	intra‐abdominal	use.	
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Introduction	
Anastomotic	 leakage	 (AL)	 is	 a	 complication	 occurring	 in	 up	 to	 10%	 of	 patients	
undergoing	colorectal	surgery,	a	type	of	surgery	that	is	commonly	used	to	remove	
the	 affected	 part	 of	 intestine	 in,	 e.g.	 colorectal	 cancer	 or	 inflammatory	 bowel	
disease.	AL	causes	higher	rates	of	morbidity	and	mortality	in	patients1,2,	making	AL	
a	 dreaded	 complication	 for	 the	 surgeon.	 It	 is	 commonly	 accepted	 that	 AL	 is	 a	
consequence	of	 improper	anastomotic	healing3.	A	conceivable	solution	 to	prevent	
or	limit	the	occurrence	of	AL	is	the	use	of	an	external	patch	composed	of	bioactive	
biopolymers,	which	 should	 stimulate	 a	 fast	 cicatrization	 of	 the	 anastomosis,	 thus	
preventing	 intestinal	content	along	with	bacteria	from	spilling	 into	the	abdominal	
cavity.		
	
In	 the	 EU	 AnastomoSEAL	 project4,	 two	 promising	 membranes	 consisting	 of	
natural‐based	 biopolymers	 were	 proposed	 for	 reinforcement	 of	 the	 anastomotic	
line,	 one	 based	 on	 hyaluronan	 and	 alginate5	 and	 one	 based	 on	 gelatin	 due	 to	 its	
hemostatic	characteristics6.	
	
The	choice	of	Hyaluronan	(HA)	as	a	bioactive	component	to	be	delivered	to	the	
anastomosis	originated	from	its	ability	to	promote	neovascularization,	 to	enhance	
the	process	of	scarring	and	from	its	beneficial	effects	on	cell	proliferation	in	several	
tissues7,8.	 Alginate	 is	 widely	 used	 in	 biomedical	 applications	 due	 to	 its	 excellent	
biocompatibility	 and	 low	 toxicity9,10.	 The	 combination	 of	 HA	 and	 alginate	 is	 of	
particular	 interest	 as	 it	 combines	 the	 gel‐forming	 ability	 of	 the	 biologically	 inert	
alginate	 with	 the	 biological	 activity	 of	 HA11,12.	 A	 recent	 study	 on	 a	 hyaluronan‐
alginate	(HA‐A)	membrane	demonstrated	that	the	HA	released	by	such	a	device	is	
able	to	simulate	both	proliferation	and	migration	of	fibroblasts	 in	vitro,	 leading	to	
the	promising	hypothesis	that	it	could	accelerate	anastomotic	healing5.	Moreover,	a	
similar	hyaluronan‐based	membrane	was	 recently	 shown	 in	vivo	 not	 to	exert	any	
adverse	reaction	in	direct	contact	with	intestinal	serosa13.		
	
Porcine‐derived	 gelatin	 is	widely	 used	 by	 surgeons	 as	 hemostatic	material	 to	
stop	 bleeding	 in	 wound	 surfaces6.	 It	 can	 be	 postulated	 that	 gelatin	 enhances	
anastomotic	 healing,	 mainly	 by	 achieving	 quick	 hemostasis	 assisting	 the	 wound	
healing	process14.	This	aim,	early	hemostasis,	is	also	the	rationale	behind	the	use	of	
fibrin	sealants,	which	are	designed	to	mimic	the	final	steps	of	the	blood	coagulation	
cascade,	 forming	 a	 stable	 physiological	 fibrin	 clot	 leading	 to	 early	 hemostasis15.	
While	 the	 theory	 behind	 it	 seems	 promising,	 fibrin	 sealants	 have	 not	 shown	 a	
convincing	positive	effect	on	 the	healing	of	gastrointestinal	anastomoses16,	 so	 the	
need	for	a	successful	alternative	still	exists.		
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The	 addition	 of	 a	 plasticizer	 agent	 to	 biodegradable	 blend	 films	 represents	 a	
feasible	 approach	 to	 enhance	 the	 pliability	 of	 biopolymer‐based	 membranes17.	
Glycerol	 is	 commonly	 recognized	as	one	of	 the	most	 suitable	plasticizers,	 since	 it	
has	low	molecular	weight	with	low	volatility,	causing	an	increase	in	free	volume	of	
the	polymer	matrices	as	well	as	enhancement	of	molecular	mobility	of	polymers	by	
disrupting	 the	 hydrogen	 bonding	 interaction	 between	 polymer	 chains18.	 Glycerol	
has	been	safely	used	 in	many	 industrial	and	pharmaceutical	applications	 for	over	
100	years	and	is	generally	recognized	for	its	low	risk	health	effects19‐22.	
	
Given	 these	 premises,	 we	 investigated	 the	 effects	 of	 two	 glycerol‐plasticized	
biomaterials	 (Alginate‐Glycerol	 (HA‐A‐G)	 and	 Gelatin‐Glycerol	 (Ge‐G)),	 on	 a	 rat	
model	of	colonic	anastomosis.	The	outcomes	were	further	studied	by	means	of	CAM	
assay	and	in	vitro	tests	on	the	different	components	of	the	biomaterials.	
Methods	
Materials	
Sodium	 alginate	 from	 Laminaria	 hyperborea	 (Alginate	 Pronova	 UP	 LVG,	 relative	
molecular	mass,	MW,	~120.000;	fraction	of	guluronic	G	residues,	FG=0.69;	fraction	
of	guluronic	diads,	FGG=0.59;	number	average	of	G	residues	in	G‐blocks,	NG>1=16.3)	
was	 kindly	 provided	 by	 Novamatrix/FMC	 Biopolymer	 (Sandvika,	 Norway).	 HA	
(MW∼240.000,	 Phylcare	 Sodium	 Hyaluronate	 extra	 LW)	 was	 kindly	 provided	 by	
Sigea	 S.r.l.	 (Trieste,	 Italy).	 Calcium	 carbonate	 (CaCO3),	 D‐Gluconic	 acid	 δ‐lactone	
(GDL),	glycerol,	were	purchased	from	Sigma	Aldrich.	The	gelatin‐based	membrane	
(Willospon®)	was	purchased	from	Will‐Pharma,	the	Netherlands.	
Membrane	preparation	
HA‐A‐G	membranes	were	prepared	according	to	the	procedure	described	by	some	
of	 the	 authors5.	 Briefly,	 alginate	 and	HA	were	dissolved	 in	 deionized	water	 (final	
concentration=15	 g/l	 of	 each	 polysaccharide)	 and	 glycerol	 was	 added	 as	 a	
plasticizer	 (final	 concentration=5%	 v/v).	 Then,	 CaCO3	 (final	 concentration	 of	
Ca2+=20	mM)	and	GDL	(final	concentration=40	mM)	were	added	to	the	mixture	to	
enable	 the	 in	 situ	 gelation	 of	 the	 solution.	 After	 gelation,	 the	 membranes	 were	
obtained	 by	 freeze‐drying.	Membranes	without	 the	 addition	 of	 glycerol	 (samples	
HA‐A	 and	 A)	 were	 also	 prepared.	 The	 resulting	 freeze‐dried	 materials	 were	
rehydrated	 with	 saline	 solution	 before	 application.	 The	 gelatin‐glycerol	 (Ge‐G)	
sample	 was	 prepared	 by	 soaking	 the	 gelatin‐based	 membrane	 in	 10	 ml	 of	 an	
aqueous	 solution	 of	 glycerol	 (5%	 v/v)	 for	 1	min,	 followed	 by	 freeze‐drying.	 The	
gelatin‐HA	(Ge‐HA)	material	was	prepared	by	soaking	the	membrane	in	10	ml	of	a	
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solution	 of	 HA	 (1.5%	w/v)	 for	 1	min,	 followed	 by	 freeze‐drying.	 All	 the	 samples	
were	sterilized	by	gamma	radiation	(25	kGy).	
Animals	
Sixty‐six	 male	Wistar	 rats	 with	 an	 average	 body	 weight	 of	 250‐300	 grams	 were	
used.	 Animals	 were	 housed	 at	 the	 Central	 Animal	 Facilities	 of	 the	 Maastricht	
University,	 where	 they	 were	 provided	 ad	 libitum	 access	 to	 food	 and	 water,	 and	
were	 cared	 for	 according	 to	 local	 standards.	 Postoperatively,	welfare	 assessment	
was	performed	 twice	daily	 using	 a	 standardized	method	 and	 animals	were	 given	
pain	 medication	 in	 case	 of	 discomfort.	 At	 7	 days	 follow‐up	 or	 when	 humane	
endpoints	 were	 reached,	 animals	 were	 sacrificed.	 The	 experimental	 protocol	
complied	with	the	Dutch	Animal	Experimental	Act	and	was	approved	by	the	Animal	
Experimental	 Committee	 of	 Maastricht	 University	 Medical	 Center.	 This	 article	
followed	 ARRIVE	 guidelines	 for	 reporting	 the	 experiments.	 Supplementary	
information	regarding	the	animal	experiments	can	be	found	online.	
Study	design	
Experiment	1	(“leaking	model”)	
HA‐A‐G	 patch	 versus	 Ge‐G	 versus	 control	 group	 in	 a	 rat	 model	 of	 colonic	
anastomotic	leakage	(4	interrupted	sutures)	to	obtain	an	anastomotic	leakage	rate	
of	60‐70%	(n=30).		
Experiment	2	(“healing	model”)	
HA‐A‐G	 patch	 versus	 Ge‐G	 versus	 control	 group	 in	 a	 rat	 model	 of	 colonic	
anastomosis	(12	interrupted	sutures,	non‐leaking	model,	n=36).	
Surgical	procedure	
All	rats	received	0.05mg/kg	buprenorphine	s.c.	as	analgesic	and	were	anesthetized	
using	 isoflurane	 (5%	 induction,	 2‐2.5%	 maintenance).	 To	 acquire	 access	 to	 the	
abdominal	cavity,	a	5	cm	craniocaudal	midline	 incision	of	the	skin	and	abdominal	
musculature	 was	 made	 in	 all	 experiments.	 The	 cecum	 was	 then	 identified	 and	
moved	outside	of	the	peritoneal	cavity	and	onto	sterile	gauzes	that	were	hydrated	
with	 sterile	 saline	 solution	 to	 prevent	 dehydration.	 Subsequently,	 the	 colon	 was	
transected	two	centimeters	distal	 from	the	cecum	and	an	end‐to‐end	anastomosis	
was	created	using	either	4	or	12	interrupted	poly(propylene)	6/0	sutures	(Prolene,	
Ethicon,	 Johnson	&	Johnson)	in	experiment	1	and	2,	respectively.	The	membranes	
were	fixated	around	the	anastomosis	using	sutures	(poly(propylene)	6/0).	In	both	
experiment	 1	 and	 2,	 rats	 assigned	 to	 control	 groups	 received	 no	 patch.	 After	
placement	 of	 the	 membrane,	 the	 intestines	 were	 repositioned	 and	 the	 abdomen	
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was	closed	in	two	layers,	a	running	suture	for	the	muscle	layer	(Vicryl	4‐0,	Ethicon,	
Inc)	and	interrupted	sutures	for	the	skin	(Monocryl	4‐0,	Ethicon,	Inc).		
Macroscopic	endpoints	
Anastomotic	 leakage	 was	 evaluated	 with	 the	 following	 scoring	 system:	 0=no	
anastomotic	 leakage,	 1=small	 abscess	 at	 the	 anastomotic	 site	 (<1	 cm3),	 2=large	
abscess	 at	 the	 anastomotic	 site	 (>1	 cm3),	 3=complete	 dehiscence	with	 peritonitis	
and	 4=death	 due	 to	 fecal	 peritonitis.	 Adhesions	 to	 the	 anastomotic	 site	 were	
assessed	according	to	van	der	Ham	et	al.23:	0=no	adhesions,	1=minimal	adhesions	
occurring	 mainly	 between	 the	 anastomosis	 and	 the	 omentum,	 2=moderate	
adhesions	occurring	between	the	omentum	and	the	anastomotic	site	and	between	
the	anastomosis	and	a	loop	of	small	bowel	and	3	=	severe	and	extensive	adhesions,	
including	abscess	formation.	
Tissue	and	plasma	preparation	
In	 anesthetized	 rats,	 the	 anastomotic	 site	was	 dissected	with	 a	 0.5	 cm	margin	 at	
each	site	of	the	anastomosis.	Tissue	samples	were	cut	in	longitudinal	direction	and	
tissue	 was	 stretched	 and	 pinned	 onto	 a	 cork	 layer	 in	 order	 to	 secure	 a	 straight	
anastomotic	line	and	improve	quality	of	histological	assessment	prior	to	fixation	in	
formalin.			
Histology	and	Immunohistochemistry	
Sections	 were	 deparaffinized	 in	 xylene	 and	 rehydrated	 in	 graded	 ethanol	 to	
distilled	water	and	subsequently	stained	with	standard	hematoxylin‐eosin	staining	
and	 Ki67	 immunohistochemistry.	 For	 the	 latter,	 endogenous	 peroxidase	 activity	
was	 blocked	 by	 incubating	 slides	 in	 0.6%	 hydrogen	 peroxide/methanol	 for	 15	
minutes.	 Antigen	 retrieval	 was	 performed	 using	 target	 retrieval	 solution	 (Dako,	
Denmark)	at	95C	for	20	min.	Non‐specific	antibody	binding	was	blocked	using	5%	
fetal	 calf	 serum	 in	 PBS.	 Antibodies	 were	 Ki67	 Clone	 Sp6	 (Thermo	 Scientific,	 the	
Netherlands)	 and	 rabbit	 IgG	 biotine	 labelled	 (Dako,	 Denmark)	 as	 primary	 and	
secondary	 antibodies,	 respectively.	 Binding	 of	 primary	 antibody	 was	 visualized	
with	 3,3′‐diaminobenzidine‐tetrahydrochloride‐dihydrate	 (Sigma,	 St	 Louis,	 MO)	
and	counterstained	with	hematoxylin.	No	staining	was	detected	in	slides	incubated	
without	 primary	 antibody.	 An	 independent,	 experienced	 animal	 pathologist	 (MG)	
performed	blinded	histological	assessment	on	the	obtained	tissue,	scoring	sections	
on	 inflammation,	 granulocyte	 influx	 and	collagen	deposition.	 Serosa	 thickness	 (in	
μm)	was	measured	using	the	free	hand	line	selection	tool	in	ImageJ	(Rasband,	NIH,	
Maryland,	USA).		
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Chorioallantoic	membrane	(CAM)	Assay		
The	 biocompatibility	 of	 each	 patch	 component	 (alginate,	 hyaluronan,	 gelatin	 and	
glycerol)	was	tested	by	performing	the	chicken	embryo	chorioallantoic	membrane	
(CAM)	assay	on	patches	with	different	 compositions	 (Table	8.1).	 Samples	HA‐A‐G	
and	Ge‐G	are	the	original	patches	tested	in	vivo.	Samples	HA‐A	and	Ge	are	controls	
introduced	 to	verify	 the	effect	of	 the	 removal	of	glycerol;	patch	A	 is	 composed	of	
only	alginate,	and	was	used	to	test	its	specific	effect	on	CAM;	patch	Ge‐HA,	obtained	
by	 adding	 hyaluronan	 (at	 the	 same	 concentration	 of	 the	 HA‐A‐G	 patch)	 to	 the	
gelatin	 matrix,	 was	 studied	 to	 verify	 the	 effect	 of	 HA	 released	 from	 a	 different	
substrate.	 Pure	 sterile	 glycerol	 was	 also	 tested	 (sample	 G).	 For	 the	 assay,	 the	
fertilized	 eggs	 were	 disinfected	 (ethanol	 70%	 v/v)	 and	 placed	 in	 an	 incubator	
(38°C,	 60%	 relative	 humidity).	 At	 day	 3	 of	 incubation,	 a	 window	 opening	 was	
performed	at	the	blunt	end	of	the	egg,	to	select	the	living	embryos.	The	window	was	
covered	 with	 a	 polyethylene	 film	 glued	 with	 albumen,	 to	 avoid	 water	 loss	 and	
microbial	 contamination.	 At	 day	 6	 of	 incubation,	 the	 samples	 (round	 pieces	 of	
patches,	 diameter	 of	 6	 mm,	 or	 30	 μl	 of	 glycerol)	 were	 applied	 directly	 on	 the	
CAM24,25.	 Samples	HA‐A	and	A	were	hydrated	with	30	μl	of	 saline	solution	before	
application.	
	
Table	8.1	 Components	tested	in	the	CAM	assay.	
Number	 Sample	 Composition	
1	 HA‐A‐G	 Patch	of	alginate	with	hyaluronan	and	glycerol	
2	 Ge‐G	 Patch	of	gelatin	with	glycerol	
3	 HA‐A	 Patch	of	alginate	with	hyaluronan	
4	 Ge	 Patch	of	gelatin	
5	 A	 Patch	of	alginate	
6	 Ge‐HA	 Patch	of	gelatin	with	hyaluronan	
7	 Ge‐A	 Patch	of	gelatin	with	alginate	
8	 G	 Pure	glycerol	
	
	
A	 system	 composed	 of	 a	 Leica	WILD	M32	 stereomicroscope,	 equipped	with	 a	
WILD	PLAN	1X	lens,	and	connected	to	a	Leica	DFC	320	camera,	was	used	to	follow	
the	 effects	 of	 the	 samples	 on	 the	 CAM	 (at	 time	 points	 t=24	 h,	 48	 h).	 A	 blinded	
evaluation	was	carried	out	by	 two	 independent	experts,	by	considering	 the	tissue	
damage	and	the	inflammatory	response,	in	particular	vascular	changes	in	the	CAM	
such	 as	 hemorrhages,	 neoangiogenesis,	 and	 the	 occurrence	 of	 vessels	 devoid	 of	
blood	flow	(ghost	vessels).	Each	sample	has	been	assayed	at	least	in	6	replicates.	
Cell	culture	
To	test	 the	hypothesis	 that	glycerol	 in	 the	patch	was	harmful	 to	or	could	activate	
the	 omentum	 leading	 to	 encapsulation	 of	 the	 patch,	 the	 effect	 of	 glycerol	 in	 four	
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different	concentrations	(1%	v/v,	2%	v/v,	4%	v/v	and	8%	v/v)	on	cell	viability	was	
tested	on	two	sets	of	primary	cells	called	human	multipotent	adipose	derived	stem	
cells	 (hMADS)	 isolated	 from	human	visceral	adipose	 tissue.	 	One	obtained	 from	a	
male	lean	donor	(BMI	25.1)	and	the	other	from	a	male	obese	donor	(BMI	39.6).	Rats	
have	 a	 relatively	 large	 amount	 of	 fat	 tissue,	 especially	 scrotal	 fat,	 which	 is	 the	
reason	 why	 two	 different	 donorsets	 of	 hMADS	 were	 chosen.	 As	 a	 control,	 cells	
cultured	in	plain	medium	were	considered.	Cells	were	plated	at	a	density	of	2x103	
cells/cm2	 and	 kept	 in	 proliferation	medium	 (DMEM‐HAM’s	 F12	 (Gibco,	 Blijswijk,	
the	 Netherlands)/10%FBS	 (Bodinco	 BV,	 the	 Netherlands)/1xAnti‐Anti	 (Gibco,	
Bleiswijk,	the	Netherlands)).	Both	cell	lines	were	maintained	at	37°C,	5%	CO2	in	a	
humidified	 incubator	 as	 described	 previously26.	 After	 24h,	 proliferation	 medium	
was	 replaced	by	proliferation	medium	supplemented	with	 sterile	 glycerol	 (Sigma	
Alderich,	 the	Netherlands)	 in	 increasing	 concentrations.	 Cells	were	 trypsinized	at	
day	3	and	day	10	and	the	obtained	cell	suspensions	were	counted	using	trypan	blue	
and	a	Bürker	Türk	counting	chamber.		
Statistical	analyses	
One‐way	 ANOVA	 was	 used	 in	 case	 of	 continuous	 variables,	 with	 a	 Dunnett's	
Multiple	 Comparison	 Test	 as	 post‐hoc	 analysis	 to	 compare	 groups	 versus	 the	
control	 group.	A	Kruskal‐Wallis	one‐way	analysis	of	 variance	was	used	 in	 case	of	
dichotomous	variables.	A	P‐value	≤0.05	was	considered	statistically	significant.	All	
analyses	were	performed	using	IBM	SPSS	Statistics,	version	21.0	for	Mac	(IBM	SPSS,	
USA),	 while	 graphs	 were	 composed	 using	 GraphPad	 Prism,	 version	 5.0a	 for	Mac	
(GraphPad	Software,	USA).	
Results	
Macroscopic	examination	
Both	in	Experiment	1	and	2,	the	addition	of	the	plasticized	membranes	around	the	
anastomotic	 site	 caused	 adverse	 tissue	 reactions	 –	 which	 lead	 to	 higher	
anastomotic	 leakage	 rates	 compared	 to	 the	 control	 groups	 (Figure	 8.1A).	 In	
Experiment	 1	 (leaking	 model),	 four	 rats	 of	 the	 experimental	 groups	 reached	
humane	endpoints	and	were	 sacrificed	before	 the	 end	of	 follow‐up.	 Inspection	of	
the	 abdominal	 cavity	 following	 sacrifice	 confirmed	 that	 the	 4	 rats	 suffered	 from	
extensive	fecal	pollution;	therefore	the	cause	of	death	was	stated	to	be	sepsis	as	a	
result	 of	 fecal	 peritonitis.	 Remaining	 animals	were	 sacrificed	 at	 follow‐up	 day	 7.	
Control	animals	recovered	readily	from	surgery	and	additional	pain	treatment	was	
hardly	necessary	while	membrane‐receiving	rats	showed	clear	signs	of	discomfort,	
which	 resulted	 in	 a	 non‐significant	 higher	 percentage	 weight	 loss	 (Figure	 8.1B).	
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Animals	who	had	received	a	membrane	showed	formation	of	 large	abscesses	and	
extensive	 adhesions,	 whilst	 control	 animals	 had	 significantly	 less	 signs	 of	 AL	
(Figure	8.2).	In	Experiment	2	(healing	model),	no	animals	died	and	the	anastomosis	
healed	 properly	 in	 both	 the	 intervention	 and	 the	 control	 group.	 All	 membranes	
were	 evidently	 encapsulated;	 some	 cavities	 were	 filled	 with	 purulent	 or	
serosanguineous	fluid.	All	encapsulation	sites	were	next	to	the	anastomotic	site	and	
did	not	involve	the	anastomosis.	Adhesions	were	significantly	more	present	in	the	
membrane	groups	as	compared	with	the	control	group,	both	in	the	leakage	model	
and	in	the	healing	model	(Figure	8.1C).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	8.1	 Anastomotic	 leakage	rate	were	approximately	70%	 in	 the	control	group	with	a	4‐sutures	
anastomosis	 (A).	 Patches	 did	 not	 reduce	 anastomotic	 leakage	 rates,	 not	 in	 the	 healing	
model	 nor	 in	 the	 leakage	model,	 but	 showed	 an	 increase	 in	 the	 amount	 of	 animals	 that	
suffered	from	anastomotic	leakage.	Weight	loss	was	more	severe	in	the	leakage	model	(B),	
but	 also	 increased	 by	 adding	 a	 patch	 (HA‐A‐G	 vs	 control,	 P<0.05).	 In	 the	 sufficient	
anastomosis	model,	 weight	 loss	was	 significantly	 higher	 in	 the	 HA‐A‐G	 compared	 to	 the	
control	group	(P<0.05).	Severe	adhesions	with	abscess	formation	were	mostly	found	in	the	
leakage	group,	but	also	in	the	sufficient	anastomosis	group	in	animals	that	received	patches	
(C).	No	significant	differences	were	 found	 in	 terms	of	 inflammation	when	obtained	tissue	
was	histologically	evaluated	(D).	
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Figure	8.2	 Macroscopic	evaluation	revealed	encapsulation	with	large	abscess	formation	in	the	leakage	
model,	 In	 the	healing	model,	 similar	 results	were	 found,	 but	 here	 there	were	no	 evident	
abscesses,	 the	 cavities	 were	 not	 filled	 with	 purulent	 but	 serosanguineous	 fluid.	 In	 both	
experiments,	adverse	events	were	more	severe	in	the	HA‐A‐G	group	than	in	the	Ge‐G	group.	
Control	animals	showed	filmy	adhesions	to	the	anastomotic	site.	
Histological	assessment		
A	 trend	 in	 increase	 in	 inflammatory	 cells,	 such	as	granulocytes	and	macrophages	
was	 observed	 in	 all	 interventions	 groups	 compared	 to	 control	 animals	 with	 a	
significant	 difference	 in	 inflammation	 between	 control	 and	 Ge‐G	 patches	 (Figure	
8.1D,	 P=0.03	 in	 the	 4	 sutures	 group	 and	 P=0.05	 in	 the	 12	 sutures	 group).	
Furthermore,	 a	 large	 increase	 in	 serosa	 thickness	 was	 observed	 in	 the	 healing	
model	(Figure	8.4)	in	the	presence	of	the	patches	(101±10.3	μm	and	92±7.8	μm	vs.	
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23±3.4	μm,	P<0.0001,	Figure	8.3A).	In	the	leakage	model	this	could	not	be	analysed	
due	to	insufficient	quality	of	the	tissue.			
	
	
	
	
	
	
	
	
	
	
Figure	8.3	 Serosal	thickness	was	significantly	increased	in	the	presence	of	a	patch	(A).	No	significant	
differences	were	found	in	proliferation	measured	by	Ki67	expression	at	the	serosa	(B)	nor	
at	the	anastomotic	site	(C).	
Immunohistochemistry	
To	assess	cell	proliferation,	 the	amount	of	Ki67	positive	cells	was	counted.	At	 the	
anastomotic	 site,	 no	 differences	 could	 be	 found	 in	 the	 percentage	 of	 Ki67+	 cells	
between	membrane	 (%)	and	 control	 groups	 (%)	 (P=0.12,	 Figure	8.3B).	However,	
when	 the	 focus	 was	 transferred	 to	 the	 serosal	 tissue,	 a	 trend	 towards	 a	 higher	
proliferation	 rate	 was	 observed	 in	 the	 presence	 of	 the	 HA‐A‐G	 membrane	
(7.3±1.6%)	compared	with	control	tissue	(3.2±0.8%)	(P=0.056,	Figure	8.3C).	
	
	
Figure	8.4	 Overview	of	the	different	histological	layers	in	the	intestinal	wall.	The	presence	of	a	patch	
(B+C)	caused	an	increase	in	serosa	thickness	compared	to	control	tissue	(A).	
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Glycerol	showed	reduced	biocompatibility	in	CAM	Assay		
Since	the	in	vivo	studies,	unexpectedly,	pointed	out	adverse‐tissue	reactions	in	the	
presence	of	 the	plasticized	membranes,	a	 further	biological	 insight	was	tackled	to	
elucidate	 the	cause	of	 such	behaviour.	To	 this	end,	 the	chorioallantoic	membrane	
(CAM)	assay	was	employed	to	evaluate	the	biological	response	to	the	materials.	The	
CAM	assay	is	a	test	that	has	shown	a	renewed	interest	in	the	biomaterial	field25,27,28	
since	 it	 can	 be	 used	 to	 easily	 investigate	 and	 evaluate	 tissue	 reaction	 and	
biocompatibility	of	materials,	both	in	solid	and	liquid	form.			
	
The	CAM	photographs	obtained	at	time	points	t	=	24	h,	48	h	after	the	deposition	
of	the	samples	are	reported	in	Figure	8.5.	For	the	samples	HA‐A‐G	and	Ge‐G	(Figure	
8.5,	rows	a	and	b)	tissue	injury,	characterized	by	vessel	damage	and	bleeding,	was	
observed.	 This	 reaction	 corresponds,	 generally,	 to	 toxicity	 and/or	 inflammatory	
responses	 in	 vivo	 and,	 in	 the	 case	 of	 biomaterials,	 it	 is	 associated	 to	 low	
biocompatibility.	When	pure	glycerol	was	tested	on	the	CAM,	it	also	induced	a	clear	
adverse	reaction:	tissue	damage	‐	with	hemorrhagic	events	after	sample	placement	
on	the	CAM	‐	was	observed,	combined	with	an	increased	mortality.	After	24	h	from	
the	 treatment,	 changes	 in	 the	structure	of	 the	CAM	(thickening	of	 the	membrane,	
formation	of	 a	white	 callus,	 and	presence	of	 red	blood	 cells)	were	observed,	 as	 a	
consequence	 of	 the	 chemical	 insult	 (Figure	 8.5,	 row	 c).	 On	 the	 contrary,	 all	 the	
patches	without	glycerol	(Figure	8.5,	rows	d‐g)	resulted	completely	biocompatible.	
Indeed,	changes	over	time	were	associated	to	the	normal	membrane	development	
and	growth	of	blood	vessels,	without	any	significant	adverse	reaction.	
Cell	culture	revealed	a	dose‐response	effect	of	glycerol	on	pre‐adipocytes	
Next,	 hMADS	were	 treated	with	 increasing	 glycerol	 concentration	 (1‐8%	 v/v)	 to	
investigate	 cell	 viability.	 All	 cells	 were	 affected	 by	 the	 introduction	 of	 glycerol,	
however,	hMADS	derived	 from	lean	patients	showed	better	recovering	properties	
compared	with	obese	hMADS	(Figure	8.6).	Overall,	cells	seemed	to	recover	quicker	
and	when	only	1%	glycerol	was	added,	cells	reached	the	same	level	of	confluence	as	
the	 control	 group.	 In	 both	 experimental	 setups,	 8%	 v/v	 glycerol	 was	 toxic	 and	
caused	cell	death,	 shortly	after	adding	glycerol	 to	 the	plate.	Both	 the	2%	v/v	and	
4%	 v/v	 groups	 showed	 debris	 and	 dead	 cells	 in	 the	 supernatant,	 but	 to	 a	 lesser	
extent	than	the	8%	v/v.		
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Figure	8.5			CAM	images	at	12x	
magnification	taken	from	the	top	
of	the	egg	after	deposition	of	the	
samples.	Effect	of	the	patches	on	
chicken	embryos	after	0,	24	and	
48	h	from	deposition	of	samples	
HA‐A‐G	(a),	Ge‐G	(b),	HA‐A	(c),	
Ge	(d),	A	(e),	Ge‐HA	(f).	Effect	of	
pure	glycerol	on	chicken	embryo	
after	0	and	20	min	from	
deposition	(g)	
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Figure	8.6	 hMADS	were	 exposed	 to	 glycerol	 and	 cell	 viability	was	measured	by	 counting	 cells/well.	
Both	 adipose‐derived	 stem	 cells	 from	 an	 obese	 person	 (A)	 and	 from	 a	 lean	 person	 (B)	
showed	complete	cell‐death	after	8%	v/v	glycerol	in	the	medium	and	severe	damage	from	
both	2%	v/v	and	4%	v/v.	
Discussion	
Several	 attempts	 have	 been	 made	 to	 seal	 off	 the	 anastomotic	 site	 in	 order	 to	
prevent	 anastomotic	 leakage	 in	 patients	 undergoing	 colorectal	 surgery.	 Previous	
studies	have	shown	that	the	use	of	membranes	around	the	anastomosis	can	cause	
stenosis	or	bowel	obstruction29,30	making	it	crucial	that	the	patches	be	flexible	and	
do	not	 interfere	with	 intestinal	motility.	 For	 that	 reason,	 glycerol	was	added	as	a	
plasticizer.	 Glycerol	 is	 a	 commonly	 used	 plasticizer,	 even	 in	 medical	 and	
pharmaceutical	 applications	 and	 is	used	 to	 increase	 the	process‐ability,	 flexibility	
and	 durability	 of	 biomaterials17.	 The	 addition	 of	 glycerol	 improves	 the	
characteristics	of	the	material,	making	it	easy	to	use	and	suitable	for	a	broad	range	
of	applications31.		
	
In	 this	 study,	 two	 membranes	 based	 on	 hyaluronan/alginate	 and	 porcine‐
derived	 gelatin	 plasticized	with	 glycerol	were	 tested	 in	 animal	models	 of	 colonic	
anastomoses	 to	 promote	 anastomotic	 healing.	 In	 both	 experiments	 (leaking	 and	
healing	model),	 the	plasticized	membranes	did	not	reduce	AL	rates,	however,	rats	
receiving	 membranes	 experienced	 more	 discomfort,	 showed	 encapsulation/	
induration	 of	 patch	 tissue	 and	 had	 a	 decreased	 survival	 compared	 to	 the	 control	
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groups.	Additional	CAM	assay	and	cell‐culture	analysis	revealed	glycerol	being	the	
cause	of	 the	side	effects,	possibly	due	to	 its	pro‐inflammatory	effect	and	cytotoxic	
effect.	
	
Morphologically,	 a	 clear	 encapsulation	 of	 the	 patch	with	 indurated	 tissue	was	
observed	 in	 both	models.	 This	 tissue	 remodeling	 has	 been	 described	 by	Wilkosz	
and	 colleagues	 during	 adhesion	 formation32.	 In	 their	 experiment,	 collagen	
deposition	and	 fibrotic	 foci	were	predominantly	present	 at	day	7,	 an	observation	
that	 could	 also	 be	 found	 in	 this	 study.	 A	 possible	 explanation	 for	 the	 observed	
morphological	changes	is	that	glycerol	in	the	patch	can	activate	the	omentum	which	
lead	to	rapid	extension	and	expansion,	resulting	in	encapsulation	of	the	patch	as	if	
to	 protect	 the	 adjacent	 internal	 organs	 from	 contact	 with	 it.	 This	 biological	
response	can	prevent	the	potential	beneficial	effects	from	the	patch	on	the	healing	
process33.	This	was	evident	 in	 the	healing	model,	where	no	 leakage	occurred,	but	
even	 the	 construction	 of	 a	 sufficient	 anastomosis	 causes	 serosal	 damage	 due	 to	
suture	 placement.	 Serosal	 healing	 involves	 implantation,	 proliferation	 and	
incorporation	of	free‐floating	mesothelial	cells	into	the	regenerating	mesothelium34	
which	may	explain	the	increase	of	serosa	thickness	in	histological	transections.	It	is	
known	that	adhesions	can	occur	postoperatively	due	to	injury	of	the	mesothelium	
which	 lines	 the	peritoneal	 cavity32,35.	 If	 encapsulation	occurs	 simultaneously	with	
AL,	 an	 abscess	 can	develop	with	 extensive	 adhesions,	which	was	observed	 in	 the	
leakage	 model	 of	 this	 study.	 To	 evaluate	 if	 the	 omentum	 reacts	 to	 glycerol,	 we	
performed	 cell‐culture	 with	 hMADS	 from	 human	 omentum	 in	 the	 presence	 of	
different	concentrations	of	glycerol	and	noticed	a	severe	decrease	in	the	amount	of	
viable	cells	when	adding	>2%	v/v	glycerol	to	the	medium.	
	
The	 latter	 observation	 suggests	 a	 dose‐dependent	 effect	 of	 glycerol.	
Interestingly,	 it	 has	 been	 demonstrated	 that	 high	 concentrations	 of	 glycerol	 can	
cause	 damage	 to	 cell	 membranes36.	 Garcia	 and	 colleagues	 suggested	 that	 this	
damage	could	be	related	to	an	osmotic	effect36.	Indeed,	glycerol	is	often	used	in	the	
clinical	 setting	 to	 treat	 diarrhea	 since	 it	works	 as	 an	 osmotic	 diuretic.	 Therefore,	
extracellular	hyperosmolarity	might	also	be	a	potential	reason	for	the	unexpected	
results.	 It	has	been	described	that	 inflammation	occurs	when	cells	are	exposed	to	
high	 osmolarities	 (>300	 mOsm)37.	 Epithelial	 cells,	 such	 as	 normal	 colorectal	
epithelial	 cells	 can	 induce	 proinflammatory	 cytokine	 secretion	 through	
hyperosmolarity37.		
	
The	 glycerol‐containing	membranes	 caused	 adverse	 reactions	 in	 rats	 and	 the	
CAM	assay	showed	clear	negative	effects	of	glycerol.	This	was	also	found	in	the	cell	
culture	 experiment,	 in	 which	 the	 percentage	 of	 glycerol	 had	 an	 obvious	 harmful	
effect	 on	 adipose‐derived	 stem	 cells.	 Concerns	 that	 glycerol	 may	 have	 harmful	
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effects	on	different	cell	 types	and	species	were	already	raised	 in	the	80s	by	some	
research	groups38,39.	Nevertheless,	glycerol	has	been	a	frequently	used	plasticizer	in	
several	commercial	biomaterials31.	For	example,	it	has	been	demonstrated	that	high	
concentrations	 of	 glycerol	 (>75%)	 in	 a	 commercially	 available	 bone	matrix	 could	
lead	 to	 myonecrosis	 and	 rhabdomyolysis	 which	 resulted	 acute	 renal	 failure	 in	
experimental	 animals40.	 Despite	 the	 obvious	 differences	 between	 animal	 models	
and	 the	 clinical	 setting,	 the	 combination	 of	 detrimental	 effects	 observed	 both	 in	
vitro	 (on	 human	 cells)	 and	 in	 vivo,	 together	 with	 some	 evidence	 from	 literature,	
makes	us	advocate	taking	caution	when	selecting	glycerol	as	a	plasticizer.	
	
Overall,	this	paper	pointed	out	that,	despite	preliminary	indications	of	materials’	
biocompatibility	 in	 vitro5,	 unexpected	 adverse	 reactions	 could	 take	 place	 in	 real	
surgical	models:	 the	 CAM	 assay	might	 provide	 a	 useful	mean	 to	 predict	 possible	
adverse	effects	of	single	components	of	the	biomaterials.		
	
From	 this	 study,	 we	 can	 conclude	 that	 glycerol	 can	 have	 a	 pro‐inflammatory	
effect	 in	 vivo	 and	 that	 it	 reduces	 viability	 of	 human	multipotent	 adipose‐derived	
stem	 cells	 (hMADS).	 The	 widespread	 use	 of	 glycerol	 as	 a	 plasticizer	 should	 be	
limited	to	only	cases	in	which	it	 is	100%	certain	that	its	use	is	safe	and	causes	no	
potential	 risks.	 In	 the	 future,	 caution	 should	 be	 taken	when	 selecting	 glycerol	 as	
plasticizer	in	biomaterials	designed	for	intra‐abdominal	use.	
 
	 Effects	of	glycerol	as	a	plasticizer	in	biomaterials	designed	for	intra‐abdominal	use		
155	
References	
1.	 McArdle	CS,	McMillan	DC,	Hole	DJ.	Impact	of	anastomotic	leakage	on	long‐term	survival	of	patients	
undergoing	curative	resection	for	colorectal	cancer.	Br	J	Surg.	2005;92(9):1150–1154.		
2.	 Khan	AA,	Wheeler	JMD,	Cunningham	C,	George	B,	Kettlewell	M,	Mortensen	NJM.	The	management	
and	outcome	of	anastomotic	leaks	in	colorectal	surgery.	Colorectal	Dis.	2008;10(6):587–592.		
3.	 Bosmans	 JWAM,	 Jongen	ACHM,	 Bouvy	ND,	 Derikx	 JPM.	 Colorectal	 anastomotic	 healing:	why	 the	
biological	 processes	 that	 lead	 to	 anastomotic	 leakage	 should	 be	 revealed	 prior	 to	 conducting	
intervention	studies.	BMC	Gastroenterol.	2015;15(1):180.		
4.	 Dornish	M,	Donati	I,	Bouvy	N.	Anastomoseal‐Biopolymeric	Patches	for	the	Treatment	of	Colorectal	
Anastomosis.	Tissue	Engineering	Part	A,	2014;2:S78.	
5.	 Travan	A,	Scognamiglio	F,	Borgogna	M,	Marsich	E,	Donati	I,	Tarusha	L,	et	al.	Hyaluronan	delivery	
by	 polymer	 demixing	 in	 polysaccharide–based	 hydrogels	 and	 membranes	 for	 biomedical	
applications.	Carbohydr	Polym.	2016	Oct	5;150:408‐418	
6.	 Sundaram	 CP,	 Keenan	 AC.	 Evolution	 of	 hemostatic	 agents	 in	 surgical	 practice.	 Indian	 J	 Urol.	
2010;26(3):374–378.		
7.	 Aya	KL,	Stern	R.	Hyaluronan	in	wound	healing:	rediscovering	a	major	player.	Wound	Repair	Regen.	
2014;22(5):579–93.		
8.	 Price	 RD,	 Berry	 MG,	 Navsaria	 HA.	 Hyaluronic	 acid:	 the	 scientific	 and	 clinical	 evidence.	 JPRAS.	
2007;60(10):1110–1119.		
9.	 Wiegand	C,	Heinze	T,	Hipler	UC.	Comparative	in	vitro	study	on	cytotoxicity,	antimicrobial	activity,	
and	 binding	 capacity	 for	 pathophysiological	 factors	 in	 chronic	 wounds	 of	 alginate	 and	
silver‐containing	alginate.	Wound	Repair	Regen.	2009;17(4):511–521.		
10.	 Augst	 AD,	 Kong	 HJ,	 Mooney	 DJ.	 Alginate	 Hydrogels	 as	 Biomaterials.	 Macromol	 Biosci.	
2006;6(8):623–33.	
11.	 Travan	 A,	 Fiorentino	 S,	 Grassi	 M,	 Borgogna	 M,	 Marsich	 E,	 Paoletti	 S,	 et	 al.	 Rheology	 of	 mixed	
alginate‐hyaluronan	aqueous	solutions.	Int	J	Biol	Macromol.	2015;78:363–369.		
12.	 Geremia	I,	Borgogna	M,	Travan	A,	Marsich	E,	Paoletti	S,	Donati	I.	Determination	of	the	composition	
for	 binary	 mixtures	 of	 polyanions:	 the	 case	 of	 mixed	 solutions	 of	 alginate	 and	 hyaluronan.	
Biomacromolecules.	2014;15(3):1069–1073.		
13.	 Scognamiglio	 F,	 Travan	 A,	 Borgogna	 M,	 Donati	 I,	 Marsich	 E,	 Bosmans	 J,	 et	 al.	 Enhanced	
bioadhesivity	 of	 dopamine‐functionalized	 polysaccharidic	 membranes	 for	 general	 surgery	
applications.	Acta	Biomater.	2016:1–20.		
14.	 Rullan	 PP,	 Vallbona	 C,	 Rullan	 JM,	 Mansbridge	 JN,	 Morhenn	 VB.	 Use	 of	 gelatin	 sponges	 in	 Mohs	
micrographic	 surgery	 defects	 and	 staged	 melanoma	 excisions:	 a	 novel	 approach	 to	 secondary	
wound	healing.	J	Drugs	Dermatol.	2011;10(1):68–73.		
15.	 Pantelis	 D,	 Beissel	 A,	 Kahl	 P,	 Wehner	 S,	 Vilz	 TO,	 Kalff	 JC.	 The	 effect	 of	 sealing	 with	 a	 fixed	
combination	of	collagen	matrix‐bound	coagulation	factors	on	the	healing	of	colonic	anastomoses	in	
experimental	high‐risk	mice	models.	Langenbecks	Arch	Surg.	2010;395(8):1039–1048.		
16.	 Nordentoft	T,	Pommergaard	HC,	Rosenberg	J,	Achiam	MP.	Fibrin	Glue	Does	Not	Improve	Healing	of	
Gastrointestinal	Anastomoses:	A	Systematic	Review.	Eur	Surg	Res.	2015;54(1‐2):1–13.		
17.	 Vieira	MGA,	 da	 Silva	MA,	 Santos	 dos	 LO,	 Beppu	MM.	Natural‐based	 plasticizers	 and	 biopolymer	
films:	A	review.	Eur	Polym	J.	2011;47(3):254–263.		
18.	 Cervera	 MF,	 Karjalainen	 M,	 Airaksinen	 S,	 Rantanen	 J,	 Krogars	 K,	 Heinämäki	 J,	 et	 al.	 Physical	
stability	and	moisture	sorption	of	aqueous	chitosan–amylose	starch	films	plasticized	with	polyols.	
Eur	J	Pharm	Biopharm.	2004;58(1):69–76.				
19.	 Migneco	F,	Huang	Y‐C,	Birla	RK,	Hollister	SJ.	Poly(glycerol‐dodecanoate),	a	biodegradable	polyester	
for	medical	devices	and	tissue	engineering	scaffolds.	Biomaterials.	2009;30(33):6479–6484.		
20.	 Morrison	 LR.	 'Glycerol'	 in	 Kirk‐Othmer	 Encyclopedia	 of	 Chemical	 Technology.	 2000.	 DOI:	
10.1002/0471238961.0712250313151818.a01.	
21.	 Sundback	 CA,	 McFadden	 J,	 Hart	 A,	 Kulig	 KM,	 Wieland	 AM,	 Pereira	 MJN,	 et	 al.	 Behavior	 of	
poly(glycerol	 sebacate)	 plugs	 in	 chronic	 tympanic	membrane	 perforations.	 J	 Biomed	Mater	 Res	
Part	B	Appl	Biomater.	2012;100(7):1943–1954.		
Chapter	8	
156	
22.	 Sundback	CA,	Shyu	JY,	Wang	Y,	Faquin	WC,	Langer	RS,	Vacanti	JP,	et	al.	Biocompatibility	analysis	of	
poly(glycerol	sebacate)	as	a	nerve	guide	material.	Biomaterials.	2005;26(27):5454–5464.		
23.	 van	 der	Ham	AC,	 Kort	WJ,	Weijma	 IM,	 van	 den	 Ingh	HF,	 Jeekel	 J.	 Effect	 of	 fibrin	 sealant	 on	 the	
healing	colonic	anastomosis	in	the	rat.	Br	J	Surg.	1991;78(1):49–53.		
24.	 Ribatti	D,	Vacca	A,	Roncali	L,	Dammacco	F.	The	chick	embryo	chorioallantoic	membrane	as	a	model	
for	in	vivo	research	on	angiogenesis.	Int	J	Dev	Biol.	1996;40(6):1189–1197.		
25.	 Schoubben	 A,	 Blasi	 P,	 Marenzoni	 ML,	 Barberini	 L,	 Giovagnoli	 S,	 Cirotto	 C,	 et	 al.	 Capreomycin	
supergenerics	 for	 pulmonary	 tuberculosis	 treatment:	 Preparation,	 in	 vitro,	 and	 in	 vivo	
characterization.	Eur	J	Pharm	Biopharm.	2013;83(3):388–395.		
26.	 Jocken	 JWE,	 Goossens	 GH,	 Popeijus	 H,	 Essers	 Y,	 Hoebers	 N,	 Blaak	 EE.	 Contribution	 of	 lipase	
deficiency	 to	mitochondrial	 dysfunction	 and	 insulin	 resistance	 in	 hMADS	 adipocytes.	 Int	 J	 Obes	
(Lond).	2015	Oct	16.	DOI:	10.1038/ijo.2015.211201524.	
27.	 Saw	CLL,	Heng	PWS,	Liew	CV.	Chick	chorioallantoic	membrane	as	an	in	situ	biological	membrane	
for	 pharmaceutical	 formulation	 development:	 a	 review.	 Drug	 Dev	 Ind	 Pharm.	 2008;34(11):	
1168‐1177.		
28.	 Vargas	A,	Zeisser‐Labouèbe	M,	Lange	N,	Gurny	R,	Delie	F.	The	chick	embryo	and	its	chorioallantoic	
membrane	 (CAM)	 for	 the	 in	 vivo	 evaluation	 of	 drug	 delivery	 systems.	 Adv	 Drug	 Deliv	 Rev.	
2007;59(11):1162–1176.			
29.	 Schreinemacher	MH,	Bloemen	JG,	Heijden	SJ,	Gijbels	MJ,	Dejong	CH,	Bouvy	ND.	Collagen	fleeces	do	
not	improve	colonic	anastomotic	strength	but	increase	bowel	obstructions	in	an	experimental	rat	
model.	Int	J	Colorectal	Dis.	2011;26(6):729–735	
30.	 Bae	 K‐B,	 Kim	 S‐H,	 Jung	 S‐J,	 Hong	 K‐H.	 Cyanoacrylate	 for	 colonic	 anastomosis;	 is	 it	 safe?	 Int	 J	
Colorectal	Dis	2010;25(5):601–606.	
31.	 Snejdrova	 E,	 Dittrich	M.	 Pharmaceutically	 Used	 Plasticizers.	 In:	 Recent	 Advances	 in	 Plasticizers.	
InTech;	2012.	DOI:	10.5772/2228	
32.	 Wilkosz	S,	Epstein	J,	de	Giorgio	Miller	A,	McLean	W,	Ireland	G,	Herrick	S.	Remodelling	of	adipose	
tissue	during	experimental	omental	adhesion	formation.	Br	J	Surg.	2008;95(3):387–396.	
33.	 Litbarg	 NO,	 Gudehithlu	 KP,	 Sethupathi	 P,	 Arruda	 JAL,	 Dunea	 G,	 Singh	 AK.	 Activated	 omentum	
becomes	 rich	 in	 factors	 that	 promote	 healing	 and	 tissue	 regeneration.	 Cell	 Tissue	 Res.	
2007;328(3):487–497.		
34.	 Foley‐Comer	 AJ,	 Herrick	 SE,	 Al‐Mishlab	 T,	 Prêle	 CM,	 Laurent	 GJ,	 Mutsaers	 SE.	 Evidence	 for	
incorporation	 of	 free‐floating	 mesothelial	 cells	 as	 a	 mechanism	 of	 serosal	 healing.	 J	 Cell	 Sci.	
2002;115:1383–1389.			
35.	 Beyene	 RT,	 Kavalukas	 SL,	 Barbul	 A.	 Intra‐abdominal	 adhesions:	 Anatomy,	 physiology,	
pathophysiology,	and	treatment.	Curr	Probl	Surg.	2015;52(7):271–319.		
36.	 Macías	 García	 B,	 Ortega	 Ferrusola	 C,	 Aparicio	 IM,	 Miró‐Morán	 A,	 Morillo	 Rodriguez	 A,	 Gallardo	
Bolaños	JM,	et	al.	Toxicity	of	glycerol	for	the	stallion	spermatozoa:	Effects	on	membrane	integrity	
and	 cytoskeleton,	 lipid	 peroxidation	 and	 mitochondrial	 membrane	 potential.	 Theriogenology.	
2012;77(7):1280–1289.		
37.	 Schwartz	L,	Guais	A,	Pooya	M.	 Is	 inflammation	a	consequence	of	extracellular	hyperosmolarity.	 J	
Inflamm	(Lond).	2009;23(6):21.	.		
38.	 Armitage	WJ,	Mazur	P.	Toxic	and	osmotic	effects	of	glycerol	on	human	granulocytes.	Am	J	Physiol.	
1984;247:C382–389.		
39.	 Rengachary	 SS,	 Watanabe	 IS,	 Singer	 P,	 Bopp	 WJ.	 Effect	 of	 Glycerol	 on	 Peripheral	 Nerve:	 An	
Experimental	Study.	Neurosurgery.	1983;13(6):681.		
40.	 Wang	JC,	Kanim	LE,	Nagakawa	IS,	Yamane	BH,	Vinters	HV,	Dawson	EG.	Dose‐dependent	toxicity	of	
a	commercially	available	demineralized	bone	matrix	material.	Spine.	2001;26(13):1429–1436.		
	
	
	 Effects	of	glycerol	as	a	plasticizer	in	biomaterials	designed	for	intra‐abdominal	use		
157	
S	8.1	Supplemental	information	according	to	ARRIVE	
guidelines	
Ethical	statement	
 The	experimental	protocol	complied	with	the	Dutch	Animal	Experimental	Act	
and	was	approved	by	the	Animal	Experimental	Committee	of	Maastricht	
University	Medical	Center.	Protocols	for	institutional	animal	use	and	care	
guidelines	were	followed	(permit	DEC	2012‐055).	
	
Study	design	
 In	total	there	were	55	rats	used	in	this	study.	We	used	11	rats	per	experimental	
group,	and	5	groups.			
	
Experimental	procedures	
 For	surgical	procedure,	see	manuscript.	This	was	carried	out	in	the	rat	
operating	room	of	the	animal	facility	of	Maastricht	University	under	semi‐
sterile	conditions.		
	
Experimental	animals	
 Male	Wistar	rats	(RccHan:WIST)	were	purchased	from	Harlan	laboratories,	the	
Netherlands.	Rats	had	an	average	weight	of	307g	on	the	day	of	surgery	(SD	
16.7).	
 We	have	chosen	for	male	rats,	since	it	is	known	that	female	estrogens	and	
androgens	have	an	important	influence	on	wound‐healing	(Ashcroft	GS,	et	al.	
Estrogen	modulates	cutaneous	wound	healing	by	downregulating	macrophage	
migration	inhibitory	factor.	The	Journal	of	clinical	investigation.	2003,	
111:1309‐1318).	
	
Housing	and	husbandry		
 An	acclimatization	period	of	one	week	was	observed	prior	to	the	start	of	the	
experiment.	
 Rats	were	kept	under	standard	conditions	and	were	provided	with	food	and	
water	ad	libitum.	Rats	were	housed	2	animals	per	cage.	The	general	health	of	
rats	was	monitored	several	times	per	week	for	signs	of	inflammation	and	
animals	were	weighed	once	per	week.	During	the	experiment	animals	were	
weighed	daily	and	scored	for	discomfort	twice	daily	(every	morning	and	every	
evening).	In	case	of	discomfort,	additional	pain	treatment	was	administered	by	
giving	buprenorphine	0.05mg/kg	s.c.	
 Discomfort	was	scored	using	a	standard	scheme	(zie	below).	Humane	
endpoints	were	defined	according	to	Roughan	&	Flecknell	(Roughan,	J.	V.	&	
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Flecknell,	P.	A.	Behavioural	effects	of	laparotomy	and	analgesic	effects	of	
ketoprofen	and	carprofen	in	rats.	Pain	90,	65–74	(2001).	
 Humane	endpoints	are	defined	as:	
o Significant	weight	loss	>20%		
o Fever	(temperature	is	only	measured	on	indication)	
o Tachypnoe		
o Significant	differences	in	behavior:	
 Lethargia	
 Twitching:	random	spasms	of	the	muscles,	can	be	seen	when	animals	are	
asleep	or	inactive	in	huddled	up	position.			
 Walking:	unable	to	stand	on	four	legs,	wobbly	walk	
 Huddled	up	posture:	showing	a	concave	abdominal	side.	Can	be	seen	
when	walking/sitting.	
o Signs	of	severe	dehydration	
o Severe	diarrhea		
o Severely	inflammed	surgical	wound	
o Cachexia	
	
Allocating	animals	to	experimental	groups	
 Animals	were	randomized	by	means	of	throwing	a	dice.	Groups	were	divided	
into	1‐5	(see	table	1).	For	each	animal	the	dice	was	thrown	and	the	rat	received	
the	assigned	treatment.	Whenever	6	was	thrown,	the	dice	was	rolled	again.	
	
Numbers	analysed		
 All	analyses	were	performed	according	to	an	intention‐to‐treat	analysis.	
However,	since	there	were	adverse	events	and	deaths	prior	to	follow‐up,	for	
ABP	and	histological	assessment	these	animals	were	not	taken	into	account.	
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Welfare	scoring	rat	model	
Description	
	 0	 1	 2	 3	
Activity	 Normal	 Isolated,	less	active	 Inactive	 Somnulent,	stupor,	
coma,	lifeless	
Behavior		 Normal	 Back	arching,	
twitching,	shivering	
Once/10	min	
Back	arching,	twitching,	
shivering	
Stereotype	
behavior,	auto	
mutilation,	
aggressive	behavior	
	Gait	 Normal	 Mildly	
uncoordinated/	
Abnormality	
uncordinated	walking	on	
toes,		limping	
Paralysis,	limp,	
convulsions,	tremor.	
Posture	 Normal	 Huddled	up,	
stretching	
Imbalance,	twitching		 Fall	over,	circle	
Physical	
condition	
Normal	 BC2=	condition	 BC5=	obese	 BC1=	emaciated	
BC6=extreme	obese	
Fur/skin	 Normal	 Dry,	rough,	not	shiny	
anymore		
Piloerection,	small	wounds,	
porfyrie,	dry	white	skin		
Red/black	skin,	
inflammation,		
wounds,		loss	of	fur	
Hydratation	 Normal	 Loss	of	skin	elasticity		 Reduced	skin	turgor	 Severly	reduced	
turgor	+	sunken	
eyes	
Breathing	 Normal	 Fast	and	superficial	 Fast	abdominal	breathing	+	
audible	breathing		
Respiratory	
problems,	cyanosis,	
breathing	with	open	
mouth	
Faeces/urine	 Normal	 Moist	faeces,	polyurie	 Diarrhea,	abnormal	urine		 Uncontrolled	
diarree,	bloody	
stool,	obstipation,	
hematuria	
Surgical	wound	 Normal	
healing	
Sutures	intact,	slighty	
red/bloody	
Dehiscence	of	wound,	
sutures	open,	fluid	secretion	
Severe	bleeding,	
wound	open,	severe	
redness,	necrosis		
Edema	 Normal	 Mild	abnormal	fluid	
collections,	swollen	
appearance	
Abnormal	large	abnormal	
fluid	collections,	ascites	
Severe	large	
abnormal	fluid	
collections	
Necrosis	 Normal	 Dark	skin	colouring	 Small	dark/black	spots,	
burning	wounds,	blisters	
Big	black	spots,	
crusts	
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A	new	slow‐resorbable	Poly(1,3‐trimethylene	
carbonate)	film	provides	safe	and	effective	
adhesion	reduction	after	major	abdominal	
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Abstract	
Introduction	
Postoperative	adhesions	remain	a	major	clinical	problem	following	abdominal	surgery.	We	
evaluated	 the	 efficacy	 of	 a	 new	 Poly(trimethylene	 Carbonate)	 (PTMC)	 film	 as	 an	 anti‐
adhesive	 material.	 In	 many	 abdominal	 operations	 there	 is	 an	 increased	 risk	 of	 faecal	
contamination;	therefore	the	safety	of	this	film	was	studied	in	two	additional	animal	models.	
	
Methods	
A	validated	rat	adhesion	model	with	peritoneal	 ischemic	buttons	was	used	 to	compare	 the	
new	 PTMC	 film	 with	 a	 Hyaluronate	 Carboxymethylcellulose	 (HA‐CMC)	 sheet,	 Icodextrin	
solution,	and	a	control	group.	Primary	endpoint	was	occurrence	of	adhesions	at	the	ischemic	
buttons	 after	 14	 days	 in	 44	 rats	 (n=11	per	 group).	 To	 evaluate	 safety	 of	 the	 film,	 both	 an	
anastomotic	 leakage	 model	 and	 a	 cecal	 ligation	 and	 puncture	 model	 were	 used.	 Kruskal‐
Wallis	 tests	with	subsequent	Mann‐Whitney	tests	were	used	 to	detect	differences	between	
groups.	P‐values	<0.008	were	considered	statistically	significant.	
	
Results		
PTMC	film	showed	a	significant	reduction	in	the	amount	of	adhesions	(median:	0.5	buttons),	
when	 compared	 to	 control	 group	 (median:	 4	 buttons,	 P<0.001)	 and	 Icodextrin	 group	
(median:	4.5,	P<0.001).	The	amount	of	adhesions	was	similar	to	the	HA‐CMC	group	(median:	
2,	 P=0.04).	 The	 presence	 of	 the	 film	 did	 not	 increase	 the	 risk	 of	 anastomotic	 leakage	 or	
bacterial	growth	in	a	contaminated	environment.	
	
Conclusions	
The	presence	of	a	PTMC	film	leads	to	a	significant	reduction	in	the	amount	of	adhesions	after	
14	days	in	an	ischemic	button	rat	model.	Furthermore,	this	film	can	be	safely	used,	even	in	
complex	abdominal	operations	with	an	increased	risk	of	fecal	contamination.	
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Introduction	
Adhesion	 formation	 after	 abdominal	 surgery	 is	 a	major	 clinical	 problem,	with	 an	
incidence	 of	 over	 93%	 of	 all	 patients	 undergoing	 a	 laparotomy1‐3.	 These	
postoperative	 adhesions	 are	 associated	 with	 many	 short‐	 and	 long‐term	
postoperative	complications	and	lead	to	readmission	of	one	in	three	patients	within	
the	first	ten	years2‐4.		
	
Unfortunately,	 the	 appearance	 of	 adhesion	 formation	 still	 is	 an	 underestimated	
clinical	 problem5‐7.	 Many	 different	 materials	 have	 been	 developed	 for	 the	
prevention	 of	 postoperative	 adhesions8‐10.	 Of	 these	materials	mainly	 the	 “barrier	
type”	materials,	 like	 Hyaluronate	 Carboxymethylcellulose	 (HA‐CMC)	 (Seprafilm®)	
have	been	 found	 to	be	effective	 in	 reducing	 the	amount	of	 severe	adhesions8,11,12.	
Results	 on	 “liquid‐based”	 adhesion	 prevention,	 such	 as	 intraperitoneal	
administration	of	Icodextrin	(Adept®),	are	still	inconclusive10,12,13.		
	
Aforementioned	barrier	materials	are	believed	 to	work	by	providing	an	 inert	and	
inactive	 barrier	 between	 tissues	 to	 reduce	 adhesion	 formation	without	 providing	
bioactive	 properties,	 allowing	 the	 peritoneum	 to	 heal,	 while	 inducing	 minimal	
foreign	 body	 reaction14,15.	 Although	 these	materials	 show	 significant	 reduction	 in	
amount	 of	 adhesions,	we	 believe	 these	 results	 can	 be	 improved	 by	 using	 a	more	
stable	 barrier	 material.	 This	 could	 be	 achieved	 by	 using	 poly(trimethylene	
carbonate)	 (PTMC),	 an	 inert,	 slow	 degrading	 polymer	 with	 excellent	
biocompatibility16.	 In	 addition,	 it	was	 shown	 that	 the	polymer	 is	phagocytised	by	
macrophages	 and	 that	 at	 12	weeks	 PTMC	 is	 degraded	while	 only	 a	 small	 area	 of	
inflammatory	cells	could	be	observed	at	 the	site	of	 implantation16‐17.	Unlike	other	
materials	 that	 can	 be	 used	 to	 produce	membrane,	 such	 as	 collagen,	 this	 polymer	
degrades	 through	 surface	 degradation,	 allowing	 it	 to	 retain	 its	 mechanical	
characteristics	 throughout	 the	 degradation	 process16‐18.	 Furthermore,	 in	 bone	
regeneration	 studies	 PTMC	 promoted	 bone	 healing,	 without	 leading	 to	 osseous	
depositions	 inside	 the	 film	 due	 to	 solid	 composition,	 in	 contrast	 to	 collagenous	
membranes17.	 This	 lead	 to	 the	 hypothesis	 that	 PTMC	 could	 provide	 an	 adequate	
barrier	against	postoperative	adhesions	when	placed	intraperitoneally.		
	
To	evaluate	 the	efficacy	of	PTMC	 film	(Flexisurge	Adhesion	Barrier®,	Medisse	BV,	
Ede,	The	Netherlands)	as	an	anti‐adhesive	material,	we	compared	this	material	to	
two	commercially	available	anti‐adhesive	therapies	(Seprafilm®	and	Adept®)	and	a	
control	group	in	a	rat	adhesion	model.	We	hypothesize	that	the	PTMC	film	provides	
adequate	 adhesion	 prevention,	 at	 least	 comparable	 to	 that	 of	 commercially	
available	therapies.		
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Since	abdominal	surgery	is	often	performed	to	resect	parts	of	the	bowel,	it	should	
be	 investigated	 if	 the	 use	 of	 the	 PTMC	 film	 is	 safe	 in	 the	 presence	 of	 bowel	
anastomoses.	 The	 concept	 that	 an	 equilibrium	 exists	 between	 collagen	 synthesis	
and	lysis,	which	can	result	 in	either	adhesion	formation	or	anastomotic	 leakage	is	
widely	accepted19.	Furthermore,	the	presence	of	a	foreign	body,	persistent	infection	
or	trauma	can	cause	adhesions20.	Therefore,	it	is	crucial	to	examine	if	the	PTMC	film	
will	still	be	effective	in	an	infected	milieu,	without	aggravating	the	infection.	In	this	
study,	 we	 additionally	 investigated	 safety	 of	 use	 of	 the	 PTMC	 film	 both	 in	 the	
presence	 of	 a	 colonic	 anastomosis	 and	 in	 the	 case	 of	 polymicrobial	 sepsis	 in	 an	
experimental	rat	model.	
Materials	and	methods	
Materials	
Poly(1,3‐trimethylene	 carbonate)	 (PTMC)	 was	 polymerized	 at	 150°C	 by	 ring	
opening	 polymerization	 of	 1,3‐trimethylene	 carbonate	 (For	 You	 Medical,	 P.R.	
China).	Ring	opening	polymerization	was	performed	under	a	nitrogen	blanket	using	
stannous	 octoate	 (Sigma	 Aldrich,	 U.S.A.)	 as	 a	 catalyst.	 Subsequently,	 the	 PTMC	
polymer	was	compression	molded	 into	 films,	without	additional	purification.	This	
was	 done	 at	 160°C	 using	 a	 LabEcon	 600	 press	 (Fontijne	 Grotness,	 The	
Netherlands).	 Films	 produced	 had	 an	 average	 thickness	 of	 150	 μm.	 Sterilization	
with	 simultaneous	 cross‐linking	 was	 performed	 under	 inert	 atmosphere	 using	
gamma‐radiation	from	a	60Co	source	with	a	dose	of	25kGy.		An	A‐B‐A	PTMC‐PEG‐
PTMC	 tri‐block	 co‐polymer	 was	 synthesized	 at	 140°C	 by	 ring	 opening	
polymerization	 of	 1,3‐trimethylene	 carbonate	 using	 poly(ethylene	 glycol)	 (PEG)	
(Sigma	Aldrich,	U.S.A)	as	initiator.		
	
Commercially	 available	 products	 of	 Hyaluronate	 Carboxymethylcellulose	
(Seprafilm®,	 Genzyme	 Biosurgery,	 Sanofi,	 The	 Netherlands)	 and	 Icodextrin	 4%	
(Adept®	Adhesion	Reduction	 Solution,	Baxter,	 The	Netherlands)	were	purchased	
and	 used	 according	 to	 the	 manufacturer’s	 instructions.	 Prior	 to	 surgery,	
Hyaluronate	 Carboxymethylcellulose	 sheets	 were	 cut	 to	 5x7	 cm	 patches	 under	
sterile	 conditions.	 The	 experimental	 PTMC	 sheets	 were	 provided	 as	 individually	
packed	 sterile	 films	measuring	 9x6	 cm	 and	were	 cut	 to	 a	 size	 of	 5x7	 cm	 before	
operation.			
Animals	
Ninety	adult	male	Wistar	rats	(Harlan,	Horst,	The	Netherlands)	with	a	body	weight	
of	 200‐250g	 were	 housed	 at	 the	 Central	 Animal	 Facilities	 of	 the	 Maastricht	
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University.	Male	rats	were	chosen	because	of	their	anatomy	that	allows	scrotal	fat	
to	 form	 adhesions	 quite	 easily.	 Furthermore,	 studies	 have	 showed	 that	 female	
hormones	can	affect	adhesion	 formation21,22.	Animals	were	cared	 for	according	to	
local	 standards	 and	 were	 provided	 with	 free	 access	 to	 food	 and	 water.	 The	
experimental	protocol	complied	with	the	Dutch	Animal	Experimental	Act	and	was	
approved	by	the	Ethical	Committee	of	Animal	Experiments.	
Study	design	
The	 experiment	was	divided	 into	 three	parts.	 In	 the	 first	 part,	 the	 efficacy	 of	 the	
PTMC	film	was	compared	to	commercially	available	anti‐adhesion	products	(n=44,	
n=11/group)	with	a	follow‐up	of	14	days:	
•	 Group	1	was	implanted	with	the	PTMC	film.	This	film	was	fixed	intraperitoneally	
with	the	tacky	copolymer	layer	directed	towards	the	visceral	organs.	To	prevent	
migration	 of	 the	 film,	 additional	 fixation	 of	 the	 corners	 to	 the	 abdominal	wall	
using	4	polyglactin	4‐0	(Vicryl®)	sutures	was	applied.		
•	 Group	 2	 had	 the	 HA‐CMC	 film	 implanted	 intraperitoneally.	 Application	 of	 the	
film	was	done	according	to	manufacturer’s	instructions.		
•	 Group	 3	 received	 an	 intraperitoneal	 dose	 of	 5	 ml	 Icodextrin	 4%,	 which	
corresponds	to	1,5l	in	an	adult	male	subject	of	75	kg.		
•	 Group	4	had	no	material	implanted	and	was	considered	the	control	group.	
	
In	 the	 second	 part,	 the	 effect	 of	 the	 PTMC	 film	 on	 a	 colonic	 anastomosis	was	
investigated	(n=26,	n=13/group),	and	in	the	third	part	a	cecal	ligation	and	puncture	
model	was	used	to	compare	infection	rate	between	the	PTMC	group	and	a	control	
group	(n=20,	n=10/group).	Follow	up	was	7	days	in	the	safety	studies.		
Surgical	procedure	efficacy	study	
Prior	 to	 surgery,	 all	 animals	 received	 a	 subcutaneous	 injection	 of	 0,05	 mg/kg	
Buprenorphine.	Anaesthesia	was	induced	with	Isoflurane	5%	and	maintained	with	
Isoflurane	2.5%.	The	abdomen	was	shaved	and	disinfected,	and	the	animals	were	
placed	 in	 the	 supine	 position.	 A	 5‐6	 cm	midline	 incision	was	performed,	 through	
which	the	abdomen	was	accessed.	Ischemic	buttons	were	created	according	to	the	
technique	described	by	Rajab	et	al.23.	In	short,	musculoperitoneal	tissue	was	lifted	
using	surgical	forceps	after	which	a	suture	was	run	through	the	base	of	the	button.	
A	ligature	was	made	on	one	side	of	the	button,	followed	by	a	similar	ligature	around	
the	complete	base	of	the	button.	Using	this	technique,	six	buttons	were	created	in	
each	 animal,	 three	 on	 each	 side	 of	 the	 midline.	 The	 buttons	 had	 a	 diameter	 of	
approximately	0.5	cm,	and	were	spaced	1	cm	apart	(Figure	9.1)23,24.		
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Subsequently,	 a	 1x1	 cm	 portion	 of	 the	 tip	 of	 the	 cecum	was	 abraded	 using	 a	
sterile	 cotton	 swab	 until	 petechial	 lesions	 occurred25,26.	 After	 euthanasia	with	 an	
inhalation	 overdose	 of	 carbon	 dioxide,	 the	 abdomen	 was	 opened	 through	 an	 H‐
shaped	 incision	along	 the	old	midline	 incision,	and	 towards	 the	 flanks	caudal	and	
cranial	 of	 the	 ischemic	 buttons.	 Care	 was	 taken	 to	 avoid	 dissection	 through	 the	
ischemic	 buttons	 or	 through	 existing	 adhesions.	 The	 amount	 of	 adhesions	 to	 the	
ischemic	buttons,	midline,	cecum,	or	sutures	was	scored	macroscopically.		
Surgical	procedure	safety	study	
A	rat	model	 for	colonic	anastomosis	was	used	 in	which	the	abdominal	cavity	was	
accessed	 through	a	5	cm	craniocaudal	midline	 incision	of	 the	skin	and	abdominal	
musculature.	The	cecum	was	identified	and	placed	on	sterile	gauzes	hydrated	with	
sterile	saline	solution	to	prevent	dehydration.	The	colon	was	transected	2	cm	distal	
from	the	cecum	and	an	end‐to‐end	anastomosis	was	created	using	12	 interrupted	
polypropylene	 6/0	 sutures	 (Prolene,	 Ethicon,	 Johnson	 &	 Johnson)	 (Figure	 9.2a),	
after	which	the	intestines	were	repositioned	into	the	abdominal	cavity.		
	
To	 induce	a	controlled	 infection	cecal	 ligation	and	puncture	was	performed	as	
previously	 described27,28.	 In	 this	 model,	 the	 cecum	 was	 carefully	 manipulated	
outside	 the	 abdominal	 cavity	 and	 ligated	 just	 distal	 to	 the	 ileocecal	 valve	with	 a	
monofilament	 non‐absorbable	 suture	 (4/0	 Ethilon®;	 Ethicon,	 Johnson	&	 Johnson,	
Somerville,	New	Jersey,	USA,	Figure	9.2b),	maintaining	the	continuity	of	the	bowel.	
The	caecum	was	punctured	distally	to	the	ligation	with	an	18‐G	needle.		
	
Both	 intervention	 groups	 received	 the	 PTMC	 film,	 which	 was	 fixed	
intraperitoneally	 covering	 the	 visceral	 organs.	 For	means	 of	 hydration	 a	 bolus	 of	
2	ml	sterile	saline	solution	was	injected	s.c..	In	all	experiments,	the	abdominal	wall	
was	closed	using	an	absorbable	running	suture	of	polyglactin	4‐0	(Vicryl®;	Ethicon,	
Johnson	&	Johnson).	The	skin	was	closed	intracutaneously	with	a	running	suture	of	
polyglecaprone	4‐0	(Monocryl®;	Ethicon,	Johnson	&	Johnson).		
Adhesion	scoring	
Adhesions	 to	buttons	were	 scored	by	 two	 independent	observers.	The	amount	of	
buttons	 with	 adhesions	 present	 was	 recorded.	 Data	 were	 presented	 as	 mean	
number	 of	 buttons	with	 adhesions.	Adhesions	 to	 the	 abraded	 cecum	and	midline	
were	recorded	in	a	similar	fashion.			
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Figure	9.1	 Three	ischemic	buttons	were	created	on	each	side	of	the	abdominal	wall.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
Figure	9.2	 Safety	 of	 PTMC	 in	 the	 abdominal	 cavity	 was	 investigated	 using	 an	 anastomotic		
leakage	model	(a)	and	a	cecal	ligation	and	puncture	model	(b).		
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Examination	of	anastomotic	leakage	
Anastomotic	leakage	was	defined	as	0	=	no	anastomotic	leakage,	1=small	abscess	at	
the	 anastomotic	 site	 <	 1	 cm3,	 2=large	 (>1	 cm3)	 abscess	 at	 the	 anastomotic	 site,	
3=faecal	 pollution	 of	 the	 abdomen,	 4=complete	 dehiscence	 with	 peritonitis.	
Adhesions	at	the	anastomotic	site	were	evaluated	in	a	blinded	fashion	according	to	
the	 scoring	 scale	 of	 van	 der	Ham29.	 After	 sacrifice,	 the	 anastomotic	 segment	was	
resected	 and	 paraffin‐embedded	 sections	 were	 prepared.	 Sections	 were	 stained	
with	 haematoxylin	 and	 eosin	 using	 standard	 histological	 techniques.	 Specimens	
were	 randomly	 scored	 according	 to	 the	 0–4	Ehrlich	 and	Hunt	 numerical	 scale	 as	
modified	by	Phillips	et	al.30.		
Bursting	pressure	
A	5‐cm	segment	of	 intestine	 including	 the	anastomosis	with	and	adherent	organs	
was	resected	en	bloc.	The	colon	distally	of	the	anastomosis	was	clamped,	a	plastic	
tube	was	 inserted	 in	 the	proximal	 end	 and	 ligated	with	 a	 single	 polyglactine	4/0	
suture	(Vicryl,	Ethicon).	Each	anastomosis	was	immersed	in	1x	phosphate	buffered	
saline,	 air	 was	 infused	 using	 a	 manometer	 (IDEE,	 Maastricht	 University,	 the	
Netherlands)	and	pressure	was	manually	increased	by	inflating	the	colon	with	air.	
The	bursting	pressure	of	the	anastomosis	was	defined	as	the	intraluminal	pressure	
at	which	air	leakage	was	initially	observed	from	the	anastomosis	(mBar).		
Infection	rate		
The	day	after	the	cecal	ligation	and	puncture,	the	abdomen	was	re‐opened	through	
the	midline	 incision,	 and	a	 culture	 swab	of	 the	 abdominal	 cavity	was	obtained	 to	
conﬁrm	fecal	peritonitis.	At	sacrifice,	this	action	was	repeated	to	measure	infection	
at	day	7.	Swabs	were	analyzed	using	broad‐range	16S	ribosomal	RNA	(rRNA)	gene	
polymerase	 chain	 reaction	 (PCR)	 for	 detection	 and	 identification	 of	 bacterial	
pathogens.	 Furthermore,	 plasma	 was	 collected	 with	 an	 intracardial	 puncture	 to	
perform	a	blood	culture	to	check	for	sepsis.		
Statistical	analysis	
All	data	concerning	adhesions	are	expressed	as	median	with	range.	Normality	tests	
using	 the	 Kolmogoroc‐Smirnov	 test	 were	 performed.	 Non‐parametric	 data	 was	
analysed	using	the	Kruskal‐Wallis	test.	For	categorical	data	a	Fisher’s	exact	test	was	
performed.	 In	 case	 of	 significance,	 the	 difference	 was	 confirmed	 by	 the	 Mann‐
Whitney	 test,	 followed	 by	 a	 Bonferroni	 post‐hoc	 test.	 A	 P‐value	 <0.008	 was	
considered	statistically	significant.	Statistical	analyses	were	performed	using	Prism	
5.0	for	Mac	(Graphad	software,	Inc,	San	Diego,	CA)	and	SPSS	20.0	for	Mac	(SPSS	Inc,	
Chicago,	IL).	
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Results	
Two	animals	died	during	follow‐up	in	the	efficacy	study.	One	animal	from	group	3	
died	 preoperatively,	 possibly	 due	 to	 an	 overdose	 of	 anaesthetic.	 Another	 animal	
from	 group	 1	 died	 five	 days	 after	 the	 initial	 operation;	 this	 was	 due	 to	 a	 severe	
sepsis	 caused	 by	 leakage	 of	 bowel	 content	 through	 a	 cecal	 perforation.	 All	 other	
animals	showed	a	normal	postoperative	recovery.	In	the	safety	studies,	all	animals	
completed	the	7‐day	 follow‐up.	Welfare	of	animals	 in	both	the	efficacy	and	safety	
studies	 was	 assessed	 using	 extensive	 scoring,	 but	 no	 humane	 end	 points	 were	
reached	 and	 no	 significant	 differences	 were	 found	 between	 intervention	 and	
control	groups.	
Macroscopic	evaluation		
The	PTMC	films	showed	no	significant	signs	of	degradation	after	14	days	and	could	
be	 explanted	at	 sacrifice.	The	 film	was	 still	 in	 situ	 in	all	 of	 the	 surviving	 animals.	
Contrary	 to	 PTMC,	 the	 Icodextrin	 and	 HA‐CMC	 were	 completely	 resorbed	 after	
14	days.	None	of	 the	 surviving	 animals	 in	 the	 efficacy	 study	 showed	macroscopic	
signs	 of	 infection	 or	 severe	 inflammatory	 reaction.	 In	 the	 safety	 studies,	 signs	 of	
inflammation	and	discomfort	were	found,	but	were	equal	in	both	PTMC	and	control	
groups.	
The	use	of	a	PTMC	film	reduces	adhesion	formation	
PTMC	films	had	the	lowest	amount	of	adhesions	to	ischemic	buttons	of	all	studied	
groups	with	a	median	of	0.5	 (range:	0‐3)	buttons	per	animal.	This	difference	was	
statistically	 significant	 to	 both	 the	 control	 group	 (median:	 4	 range:	 2‐6)	 and	
Icodextrin	 group	 (median:	 4.5,	 range:	 0‐6)	 (P<0,001)	 but	 not	 to	 the	 HA‐CMC	
implant	group	(median	2,	range:	0‐5,	P=0.04).	Results	of	adhesion	formation	to	the	
ischemic	buttons	are	presented	in	Figure	9.3	and	Figure	9.4	
	
	
Figure	9.3	
	
Number	 of	 buttons	 with	 adhesions	 per	 group.	
Data	 are	 presented	with	median	 ±	 interquartile	
range.	*	P<0.008	
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Figure	9.4	 PTMC	film	remains	intact	and	in	situ	after	14	days	retaining	its	mechanical	characteristics.	
Sutures	fixing	the	film	are	prone	to	adhesion	formation	(a+b).	Pictures	c	and	d	show	absent	
to	minor	 adhesion	 formation,	with	 involvement	 of	 omental	 or	 scrotal	 fat	 only	 as	 seen	 in	
most	PTMC	and	HA‐CMC	animals.	Pictures	e	and	f	show	severe	adhesions	with	involvement	
of	visceral	organs	as	seen	in	some	of	the	animals	in	the	control	group	or	in	the	Icodextrin	
group.	
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Adhesions	in	the	PTMC	and	HA‐CMC	groups	appeared	to	be	mostly	filmy	and	of	
omental	 and	 scrotal	 fat	 origin.	 None	 of	 these	 adhesions	 required	 aggressive	 or	
sharp	 dissection.	 No	 adhesions	 of	 visceral	 organs	 to	 the	 buttons	 were	 found	 in	
these	 groups.	 In	 contrast,	 the	 control	 and	 Icodextrin	 groups	 showed	 more	
pronounced	dense	adhesions.	These	adhesions	required	more	aggressive	blunt	and	
sharp	 dissection.	 Adhesions	 of	 liver,	 cecum	 and	 small	 intestine	 to	 the	 ischemic	
buttons	were	recorded	besides	the	usual	fatty	adhesions	in	these	groups.	The	use	of	
sutures	to	fix	the	PTMC	to	the	abdominal	wall,	however,	seems	to	increase	the	risk	
of	undesirable	adhesions	 to	 these	sutures.	Although	the	 film	seems	 to	protect	 the	
ischemic	 buttons	 from	 adhesions	 forming	 to	 these	 buttons,	 the	 sutures	 are	 not	
protected.	 All	 of	 the	 eleven	 animals	 in	 the	 PTMC	 group	 had	 adhesions	 present	
attached	to	sutures	fixing	the	film.	These	adhesions	were	denser	and	more	difficult	
to	 dissect	 than	 those	 to	 the	 ischemic	 buttons	 in	 the	 same	 animals.	 Furthermore,	
most	adhesions	 to	 ischemic	buttons	 in	 this	group	seemed	 to	be	closely	 related	 to	
adhesions	 formed	 to	 these	 sutures.	 No	 differences	 were	 found	 in	 the	 amount	 of	
adhesions	adhered	 to	 the	abraded	cecum.	 In	all	but	 the	PTMC	group,	4	out	of	 the	
total	 11	 animals	 have	 some	 sort	 of	 adhesion	 towards	 the	 abraded	 cecum.	 In	 the	
PTMC	group	only	2	animals	 showed	adhesions	 towards	 the	cecum.	No	significant	
results	were	found	between	the	groups	using	the	Fisher’s	exact	test	(Figure	9.5A).	
Equal	anastomotic	leakage	in	both	PTMC	and	control	group	
The	 anastomoses	 in	 the	 PTMC	 group	needed	 higher	 pressure	 to	 burst	 (249±14.2	
mBar	 versus	 195±22.0	mBar),	 however	 this	was	 not	 significant	 (P=0.067,	 Figure	
9.5B).	We	found	no	higher	anastomotic	leakage	rate	in	the	PTMC	group	compared	
to	 the	 control	 group	 (P=1.00,	 Figure	 9.5C)	 and	 also	 the	 severity	 of	 anastomotic	
leakage	did	not	differ	between	groups	(P=0.695,	Figure	9.5D).	Microscopically,	no	
differences	were	found	between	experimental	groups.		
No	differences	in	infection	rate	between	experimental	groups	
Bacterial	load	at	day	7	did	not	differ	between	PTMC	(3.1*108	copies/μl)	and	control	
groups	(8.1*108	copies/μl,	P=0.35,	Figure	9.5E).	There	were	no	differences	 in	 the	
frequency	 of	 positive	 versus	 negative	 blood	 cultures	 between	 groups	 (P=0.637,	
Figure	9.5F).	
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Figure	9.5	 Results	 of	 safety	 study.	 No	 differences	 were	 detected	 between	 groups	 in	 percentage	 of	
animals	 per	 group	 with	 adhesions	 present	 from	 the	 abraded	 cecum	 to	 other	 structures	
within	the	peritoneal	cavity	(Figure	A).	Bursting	pressure	was	slightly	greater	in	the	PTMC	
group	 (249	 ±	 14	 mBar)	 compared	 with	 the	 control	 group	 (195	 ±	 22	 mBar;	 P=0.067,	
Figure	B),	 There	 was	 no	 difference	 in	 anastomotic	 leakage	 rate	 between	 the	
poly(trimethylene	carbonate)	(PTMC)	and	control	group	(Figure	C	+D).	When	the	severity	
of	 anastomotic	 leakage	 was	 studied	 into	 more	 detail,	 a	 complete	 dehiscence	 of	 the	
anastomosis	could	only	be	found	in	the	PTMC	group	(P=0.695).	Bacterial	load	at	day	7	did	
not	differ	between	PTMC	(3.1*108	copies/μl;	 interquartile	 range	 [IQR],	0.58)	and	control	
groups	(8.1*108	copies/μl;	 IQR,	2.49;	P=0.35,	Figure	E).	No	differences	were	found	in	the	
frequency	of	positive	versus	negative	blood	cultures	between	groups	(P=0.637,	Figure	E).		
	
Discussion	
In	 this	 study	 we	 investigated	 a	 new	 anti‐adhesive	 barrier	 composed	 of	 PTMC	
(co)polymers	 and	 compared	 it	 to	 commercially	 available	 anti‐adhesive	 therapies.	
Prevention	of	 intraperitoneal	 adhesions	 remains	an	 integral	part	of	daily	 surgical	
practice6.	 Postoperative	 adhesions	 are	 known	 to	 have	 a	 devastating	 impact	 on	
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quality	 of	 life	 and	 increases	 the	 risk	 for	 reoperations31.	 Even	 though	 the	 use	 of	
minimally	invasive	techniques	seems	to	reduce	the	risk	of	adhesion	formation,	this	
is	not	sufficient	to	adequately	prevent	all	postoperative	adhesions,	indicating	there	
is	 still	 need	 for	 additional	 adhesion	 prevention1,15,32,33.	 PTMC	 is	 a	 highly	
biocompatible	 and	 versatile	 material	 with	 highly	 favourable	 characteristics34,35.	
Contrary	 to	 currently	 available	 materials,	 the	 PTMC	 film	 degrades	 by	 surface	
degradation,	 not	 by	 bulk	 degradation.	 This	 allows	 the	 material	 to	 retain	 its	
mechanical	 characteristics	 and	give	prolonged	 separation	of	 adhering	 tissues34‐36.	
Furthermore,	 degradation	 of	 PTMC	 induces	 only	 mild	 inflammatory	 reaction	
leading	 to	 the	 hypothesis	 that	 intraperitoneal	 placement	 of	 PTMC	 film	 gives	 a	
reduction	 of	 postoperative	 adhesions	 comparable	 to	 or	 even	 better	 than	
commercially	available	materials34.		
	
The	 results	 of	 this	 experiment	 indicate	 PTMC	 film	 (FlexiSurge	 Adhesion	
Barrier®)	does	lead	to	a	significant	reduction	in	the	amount	of	adhesions.	The	fact	
that	the	PTMC	results	are	comparable	to	HA‐CMC	(Seprafilm®),	which	is	also	a	solid	
film,	indicates	that	physical	barriers	are	an	effective	way	to	prevent	adhesions.	As	a	
more	slowly	degrading	material,	PTMC	provides	long‐term	and	effective	separation	
of	 tissues	 since	 degradation	 happens	 through	 surface	 erosion.	 This	 reduction	 is	
significant	compared	 to	 the	control	group,	 indicating	 the	application	of	a	physical	
barrier	 is	 beneficial	 in	 adhesion	 prevention.	 Surprisingly,	 the	 liquid	 adhesion	
barrier	 did	 not	 lead	 to	 a	 reduction	 in	 the	 amount	 of	 adhesions.	 Although	 human	
trials	 are	 inconclusive37,	 Icodextrin	 (Adept®)	does	 seem	 to	 be	 effective	 in	 several	
other	studies8,38.	
	
Furthermore,	 there	 are	 experimental	 studies	 indicating	 that	 Icodextrin	 is	 also	
effective	 in	 rat	 models,	 showing	 less	 adhesion	 formation	 compared	 to	 Ringers	
lactate13,39.	 However,	 in	 these	 studies	 Icodextrin	 solution	 was	 either	 provided	 in	
higher	volumes	or	in	higher	concentrations,	possibly	allowing	the	liquid	to	remain	
effective	 for	 longer	 periods	 of	 time.	 It	 is	 assumed	 that	 the	 reason	 for	 a	 reduced	
effectiveness	 in	 rats	 is	 the	 presence	 of	 α‐amylase	 in	 the	 peritoneal	 fluid	 of	 rats,	
leading	to	a	faster	resorption	of	the	Icodextrin	fluid,	reducing	the	duration	the	fluid	
remains	 present	 in	 the	 abdominal	 cavity13,40.	 This	 could	 have	 resulted	 in	 the	
ineffectiveness	of	the	fluid	in	our	study.	
	
Another	strong	aspect	of	 the	new	PTMC	 film	 is	 its	handling.	 In	contrast	 to	 the	
HA‐CMC	 film,	PTMC	 is	highly	 flexible	with	 sufficient	 tensile	 strength,	 allowing	 for	
easy	 positioning	 and	 repositioning	 within	 the	 first	 few	 minutes	 after	
implantation18,34.	 Whereas	 the	 HA‐CMC	 film	 is	 reported	 to	 be	 brittle,	 sticky,	 and	
difficult	to	apply,	limiting	its	use	in	surgical	practice15,41.		
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Furthermore,	the	HA‐CMC	barrier	was	completely	resorbed	in	all	animals	after	
the	14	days	follow‐up,	whereas	the	PTMC	film	kept	its	structural	integrity	at	 least	
until	 the	 14th	 day.	 Although	 peritoneal	 wound	 healing	 is	 completed	 after	 7	 to	
10	days,	the	HA‐CMC	material	loses	its	structural	integrity	within	the	first	24	hours	
by	 turning	 into	 a	 hydrophilic	 gel14,42,43.	 Because	 the	 PTMC	 material	 degrades	
through	 surface	 erosion	 it	might	 provide	 adequate	 tissue	 separation	 for	 a	 longer	
period	of	time16,34.		
	
Since	 damage	 to	 mesothelial	 lining	 and	 the	 subsequent	 fibrotic	 response	 are	
considered	 to	 be	 key	 components	 in	 adhesion	 formation,	 the	 main	 focus	 of	
adhesion	prevention	should	lie	within	the	first	7	to	10	days14,42.	For	this	reason,	we	
think	a	follow‐up	of	14	days	provides	adequate	information	on	the	effect	of	PTMC	
barrier	 on	 adhesion	 prevention.	 Besides,	 after	 14	 days,	 the	 presence	 of	 an	 intact	
barrier	 shows	 PTMC	 exceeds	 the	 duration	 of	 protection	 of	 both	 HA‐CMC	 and	
Icodextrin.	 Even	 though	 adhesion	 formation	 can	 cause	 long	 term	 detrimental	
effects	 on	 the	 quality	 of	 life	 of	 patients,	 in	 some	 cases	 adhesion	 formation	 is	
necessary,	for	example	in	anastomotic	healing.	It	has	been	shown	that	certain	anti‐
adhesive	products	may	predispose	to	peritonitis	and	anastomotic	dehiscence11,44.	In	
order	to	address	this	issue,	we	placed	PTMC	film	in	both	the	presence	of	a	colonic	
anastomosis	 as	 well	 as	 in	 a	 model	 for	 controlled	 infection.	 In	 both	 models,	 the	
presence	of	the	PTMC	film	was	safe	and	did	not	cause	any	increase	in	anastomotic	
leakage	rate,	nor	did	it	aggravate	the	induced	infection.		
	
Unfortunately,	at	this	moment	PTMC	film	needs	suture	fixation	to	keep	adequate	
positioning	 throughout	 the	 follow‐up.	Although	 the	PTMC	 reduced	 the	 amount	of	
adhesions	to	the	ischemic	buttons	significantly,	unprotected	sutures	fixing	the	film	
seemed	 to	 induce	 adhesion	 formation	 at	 this	 site.	 The	 need	 for	 sutured	 fixations	
was	one	of	the	limitations	for	practical	PTMC	film	application.	Before	the	film	can	
be	tested	in	a	clinical	setting,	the	fixation	strength	of	an	attached	tacky	copolymer	
layer	should	be	sufficient	to	provide	sutureless	fixation.		
	
Another	 limitation	 in	 this	 study	 is	 the	 possible	 lack	 of	 power	 to	 detect	 any	
significant	differences	 in	amount	of	adhesions	 to	 the	cecal	abrasion.	Although	 the	
results	of	PTMC	 films	are	excellent	 for	 the	adhesions	 to	 the	 ischemic	buttons,	 the	
effectiveness	in	preventing	adhesions	in	other	locations	in	the	abdomen	could	not	
be	shown	in	this	model.	However,	there	still	seems	to	be	a	small,	but	not	significant,	
reduction	in	the	cecal	adhesion	formation,	which	could	have	clinical	implications	in	
larger	groups.	
	 PTMC	as	a	safe	and	effective	adhesion	barrier		
175	
Conclusion	
A	 new	 PTMC	 film	 with	 a	 tacky	 PTMC‐PEG	 layer	 is	 effective	 in	 reducing	
postoperative	 adhesions	 to	 the	 abdominal	 wall	 in	 a	 rat	 ischemic	 button	 model.	
Furthermore,	 the	 use	 of	 this	 film	 does	 not	 compromise	 anastomotic	 healing	 nor	
peritonitis.	The	proven	efficacy,	safety	and	easy	handling	of	the	PTMC	film	make	it	a	
promising	 new	 prevention	 tool	 in	 postoperative	 adhesions.	 Further	 research	 is	
necessary	to	elucidate	whether	these	results	are	also	valid	in	humans.	
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General	discussion	
Over	15,500	patients	are	diagnosed	with	colorectal	cancer	(CRC)	in	the	Netherlands	
every	 year,	 making	 it	 the	 most	 common	 oncological	 disease	 in	 20151.	 Due	 to	
national	 screening	 programs	 and	 a	 growing	 elderly	 patient	 population	 the	
incidence	of	CRC	is	expected	to	rise	in	the	coming	years,	increasing	the	frequency	of	
colorectal	 cancer	 treatable	 by	 surgery2.	 Two	 thirds	 of	 patients	 with	 CRC	 will	
undergo	 surgical	 treatment	 involving	 resection	 of	 the	 tumour,	 since	 surgery	
remains	 the	 cornerstone	 of	 treatment.	 Therefore,	 the	 perioperative	 course	 of	
colorectal	surgery	is	of	great	importance	and	relates	strongly	with	clinical	outcome	
in	terms	of	mortality	and	functional	recovery.	In	recent	decades,	perioperative	care	
has	 significantly	 improved	 due	 to	 advances	 in	 anaesthesia,	 minimally	 invasive	
surgical	 techniques	 and	 the	 introduction	 of	 'fast	 track'	 protocols3.	 However,	
complications	 after	 colorectal	 surgery	 still	 occur	 regularly,	 of	 which	 anastomotic	
leakage	 (AL)	 is	 the	 most	 feared.	 AL	 develops	 when	 the	 construction	 of	 two	
intestinal	ends	–	the	anastomosis	‐	does	not	heal	properly;	subsequently,	intestinal	
content	leaks	into	the	abdominal	cavity	causing	abscess	formation	and	peritonitis.	
In	2014,	712	of	 the	10.426	 (6.8%)	nationwide	 registered	 cancer	patients	who	
underwent	colorectal	resection	developed	severe	AL	(447/7580	[5.9%]	colon	and	
265/2846	[9.3%]	rectum)	that	required	re‐intervention	(Dutch	Surgical	Colorectal	
Audit,	 2014).	 These	 patients	 suffered	 from	 high	 morbidity,	 prolonged	
hospitalization	and	even	mortality.	Moreover,	some	studies	even	suggested	that	AL	
is	associated	with	reduced	disease‐specific	survival	and	increased	recurrence	rates	
of	CRC	after	colorectal	surgery4‐6.		
	
Despite	 extensive	 observational	 and	 experimental	 research	 in	 both	 animal	
models	and	in	humans,	the	incidence	of	AL	has	remained	unchanged	over	the	past	
decades.	There	 is	 still	no	 solution	 for	 this	 important	 clinical	problem,	despite	 the	
increasing	 amount	 of	 studies	 that	 have	 investigated	 numerous	 interventions	 to	
promote	anastomotic	healing.	We	suggest	that	this	is	largely	because	causal	factors	
leading	to	colorectal	AL	are	still	not	recognized.	And	although	some	patient	factors	
and	 specific	 drug	 treatments	 have	 been	 associated	with	 an	 increased	 risk	 of	 AL,	
there	is	still	a	large	knowledge	gap	in	normal	anastomotic	healing	(Chapter	1).		
The	process	of	wound	healing	in	the	intestinal	tract,	upon	the	construction	of	an	
anastomosis,	is	often	compared	with	the	process	of	wound	healing	observed	in	the	
skin	(i.e.	cutaneous	healing).	Intestinal	healing	indeed	takes	place	in	the	three	well‐
known	phases	of	inflammation,	proliferation	and	remodelling7.	However,	there	are	
substantial	differences,	as	 intestinal	healing	 is	1)	 faster	than	cutaneous	healing	2)	
other	 types	 of	 cells	 and	 substances	 are	 involved,	 and	 3)	 both	 the	 skin	 and	 the	
intestines	 house	 unique	 microbiota	 that	 cannot	 be	 compared	 directly8.	 It	 is	
essential	to	distinguish	between	cell	types	and	functions/reactions	of	different	cells	
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to	 come	 to	understanding	of	AL,	not	 to	mention	 to	 find	a	 solution	 for	 the	 clinical	
burden	of	AL.	Interaction	between	intraluminal	content	and	the	layers	of	the	bowel	
wall,	 with	 their	 separate	 cell	 types	 and	 function,	 may	 be	 key	 in	 unravelling	 the	
healing	process.	Thus	far,	certain	cell	types	are	known	to	play	a	role	in	anastomotic	
healing	 such	 as	 matrix	 metalloproteinases	 (MMPs)9,10,	 inflammatory	 cells	 as	
macrophages11	 and	 intestinal	 microbiota12,13	 but	 the	 interaction	 between	 these	
different	 types	 and	 their	 exact	 role	 in	 time	 during	 the	 healing	 process	 is	 not	 yet	
clarified.	 Therefore,	 research	 should	 refocus	 on	 the	 healing	 process	 of	 colorectal	
anastomoses	and	the	pathophysiology	that	results	in	AL.		
Animal	models	for	research	on	intestinal	anastomotic	healing	
Laboratory	animals	are	often	used	to	study	intestinal	healing	and	ways	to	prevent	
anastomotic	 leakage;	 several	 models	 exist	 in	 which	 an	 anastomosis	 is	 being	
constructed.	 However,	 none	 of	 these	 models	 are	 completely	 translatable	 to	 the	
human	 setting	 and	 it	 is	 difficult	 to	 compare	 models	 between	 different	 species.	
There	 is	 still	 debate	 on	 which	 models	 are	 suitable	 for	 research	 on	 anastomotic	
healing	and	leakage	in	the	lower	gastrointestinal	tract.	
To	generate	more	clarity	on	animal	models	for	AL	and	to	obtain	comparability	
between	 different	 studies,	 it	 is	 crucial	 that	 researchers	 agree	 on	 what	 outcome	
parameters	 and	experimental	 setup	 is	 important	 in	 the	 investigation	of	 intestinal	
anastomoses.	For	this	reason,	we	conducted	a	Delphi	analysis	(Chapter	2).	This	is	a	
research	method	that	relies	on	a	panel	of	experts.	These	experts	are	requested	to	
answer	a	single	questionnaire	in	multiple	rounds.	After	each	round,	they	receive	an	
anonymous	summary	of	the	experts’	forecasts	from	the	previous	round	as	well	as	
the	reasons	they	provided	for	their	judgments.	In	this	way,	experts	are	encouraged	
to	 revise	 their	 earlier	 answers	 in	 light	 of	 the	 replies	 of	 other	 members	 of	 their	
panel.	It	is	believed	that	during	this	process	the	range	of	the	answers	will	decrease	
and	the	group	will	converge	towards	the	"correct"	answer14.	We	reasoned	that	such	
an	 approach	 could	 lead	 to	 consensus	 among	 experts	 investigating	 AL	 in	 animal	
models	 regarding	 anastomoses	 in	 the	 lower	 gastrointestinal	 tract,	 specifically	 on	
which	 animal,	 location,	 and	 type	 of	 surgery;	 macroscopic	 outcome;	 histological	
assessment;	 mechanical	 and	 biochemical	 outcome	 measures;	 and	 animal	 testing	
and	welfare.	
	
One	of	 the	main	outcomes	of	 the	Delphi	analysis	 is	 that	dog	and	rabbit	animal	
models	 should	 no	 longer	 be	 considered,	 and	 thus	 used,	 as	 validated	 models	 for	
research	 into	 anastomotic	 healing	 of	 the	 lower	 gastrointestinal	 tract.	 The	mouse,	
rat	 and	 pig	 models	 are	 considered	 appropriate,	 but	 experiments	 ought	 to	 be	
executed	 according	 to	 current	 legislation	 and	 reported	 more	 into	 detail.	 The	
macroscopic	 result	 of	 anastomotic	 leakage	 should	 always	 be	 one	 of	 the	 main	
outcome	 parameters,	 together	 with	 the	 different	 grades	 of	 leakage	 (small/large	
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abscesses,	 faecal	 peritonitis,	 complete	 dehiscence).	 None	 of	 the	 available	 scoring	
systems	 in	 literature	 regarding	AL	were	considered	 to	be	appropriate,	however	a	
new	‘anastomotic	complication	score’	was	proposed	by	one	of	the	panel	members	
and	was	directly	considered	as	an	appropriate	and	useful	tool	by	the	other	experts,	
although	 the	 usability	 has	 yet	 to	 be	 proven	 in	 practice	 (i.e.	 external	 validation	 is	
required).	This	score	also	 implicates	adhesions	 to	the	anastomotic	site,	which	are	
considered	 relevant	 to	mention	as	 they	might	 cover	 signs	of	 leakage.	Histological	
assessment	of	the	anastomotic	site	such	as	amount	of	inflammation,	vascularisation	
and	collagen	deposition	is	very	valuable	and	considered	as	an	appropriate	outcome	
measure,	 especially	 in	 studies	 that	 focus	 on	 anastomotic	 healing.	 Both	 bursting	
pressure	 and	 tensile	 strength	 are	 considered	 appropriate	 measurements	 for	
anastomotic	 strength,	 where	 it	 should	 be	 mentioned	 that	 these	 measurements	
could	be	 compared	within	one	experiment	but	due	 to	heterogeneity	not	between	
different	experiments.	There	were	no	additional	outcome	measures	(e.g.	amount	of	
collagen,	 specific	 immunohistochemical	 stainings,	 ELISA	 measurements	 or	 qPCR	
regarding	 specific	 genes)	 considered	 appropriate	 as	 a	 surrogate	 marker	 for	
anastomotic	 healing,	 but	 they	 can	 provide	 information	 on	 a	 specific	 research	
question.		
All	 animal	 studies	 should	 be	 reported	 according	 to	 the	 Animal	 Research:	
Reporting	 of	 In	 Vivo	 Experiments	 (ARRIVE)	 guidelines15.	 This	 improves	
transparency	and	increases	the	quality	of	animal	studies.	In	addition,	blinding	and	
randomization	 procedures	 should	 be	 reported	 in	 animal	 studies	 as	 in	 human	
studies.	 A	 publicly	 available	 online	 registry	 (comparable	 to	 clinicaltrials.gov	 for	
human	studies)	together	with	standardized	protocols	per	animal	model	can	aid	in	
advancing	 the	 field	 of	 animal	 research	 on	 bowel	 anastomoses.	 Also,	 innovative	
methods	such	as	 intestinal	organoids	or	 the	use	of	human	tissue	 that	 can	replace	
animal	 models	 should	 be	 further	 investigated	 to	 reduce	 the	 use	 of	 animals,	
according	to	the	3R	(Replacement,	Reduction	and	Refinement)	principle.	This	was	
incorporated	in	the	recently	published	report	by	the	National	Advisory	Committee	
on	Animal	Experiments	 (NCad),	which	 aims	 that	 in	 2025	 the	Netherlands	will	 be	
the	world	leader	in	animal‐free	innovative	research.		
	
Based	on	previous	(animal)	experiments,	we	hypothesize	that	AL	has	a	complex	
multifactorial	pathophysiology,	where	at	least	ischemia,	bacteria	and	inflammation	
are	 involved12.	To	study	anastomotic	healing	and	 leakage	 in	depth,	a	 technique	or	
approach	 is	 required	 that	 can	 1)	 provide	 an	 overview	 of	 the	 healing	 process	 at	
different	 time	points,	2)	differentiate	between	 inflammatory	markers	and	various	
cell	 types	 and	 3)	 visualize	 the	 site	 of	 the	 leakage	 in	 the	 anastomotic	 line.	 Such	 a	
technique	could	help	unravel	the	biological	process	of	anastomotic	healing.	In	this	
thesis,	a	start	with	such	a	relatively	new	technique	has	been	made.	We	are	currently	
studying	the	anastomotic	healing	process	by	means	of	mass	spectrometry	imaging	
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(Chapter	 3).	 This	 technique	 will	 enable	 us	 to	 identify	 specific	 substances	 in	 the	
various	 layers	 of	 the	 intestinal	 wall	 as	 potential	 leverage	 to	 further	 unravel	 the	
anastomotic	 healing	 process.	 Identifying	 how	 the	 intestinal	 healing	 works	 and	
where	exactly	the	different	phases	of	healing	take	place	may	lead	to	possible	new	
interventions	that	can	improve	healing	and	eventually	cause	a	lower	percentage	of	
AL	in	the	future.	Obviously,	more	research	needs	to	be	performed	and	as	any	other	
relatively	new	technique,	it	has	to	be	compared	to	conservative,	validated	methods	
to	prove	its	reliability,	but	it	seems	to	have	a	high	potential	and	may	be	the	answer	
to	the	call	for	a	different	approach	in	the	research	field	of	colorectal	AL.	
The	use	of	knockout	mice	to	identify	risk	factors	for	colonic	anastomotic	
leakage	
In	 the	 past	 decades,	 important	 risk	 factors	 for	 AL	 such	 as	 male	 gender16,	
neoadjuvant	 chemotherapy17,	 tumor	 size18,	 malnutrition19,	 smoking20,	 steroid	
treatment21	and	the	use	of	non‐steroidal	anti‐inflammatory	drugs	(NSAIDs)22	have	
been	identified.	
In	 this	 thesis,	 the	 association	 between	 NSAIDs	 and	 a	 higher	 AL	 rate	 is	 partly	
elucidated.	 In	 chapter	 4	 it	 has	 been	 demonstrated	 that	 depletion	 or	 inhibition	 of	
Cyclo‐oxygenase	2	 (COX‐2)	 leads	 to	 an	 increase	 in	 the	percentage	of	AL	 rate	 in	 a	
mouse	model,	 possibly	 by	 affecting	 the	 blood	 flow	 of	 the	 intestinal	 anastomosis,	
since	 neoangiogenesis	 was	 diminished	 in	 these	 animals,	 as	 investigated	 through	
CD31	 immunohistochemistry.	 Additionally,	 COX‐2	 plays	 a	 major	 role	 in	 the	
inflammatory	 phase	 of	 the	 healing	 process	 and	 is	 therefore	 considered	 to	 be	
essential	 in	the	healing	process	after	anastomotic	surgery.	Moreover,	 in	this	same	
study,	we	 translated	our	 findings	 from	 the	 animal	 study	 to	 the	 clinical	 setting	by	
identifying	 that	patients	with	a	 specific	COX2	polymorphism	were	more	prone	 to	
develop	colorectal	anastomotic	leakage.		
	
Among	 the	 numerous	 factors	 contributing	 to	 healing	 of	 surgical	 anastomoses,	
the	 intestinal	mucus	 system	has	 been	 largely	 overlooked.	 This	 is	 despite	 the	 fact	
that	 various	 studies	 have	 shown	 that	 mucus	 is	 essential	 for	 protection	 of	 the	
epithelium	from	luminal	challenge23,24.	Since	mucus	is	a	first	line	of	defence	against	
external	luminal	factors	in	the	gastrointestinal	tract,	we	investigated	if	depletion	of	
the	structural	mucus	protein	Muc2,	which	is	the	most	abundant	mucin	in	the	colon,	
is	associated	with	impaired	colon	anastomotic	healing	(Chapter	5).		
	
We	 noticed	 that	 in	 Muc2	 knockout	 mice,	 which	 lack	 the	 main	 component	 of	
mucus	 in	 the	 colon,	 the	 rate	 of	 AL	 was	 significantly	 higher	 than	 that	 of	 control	
animals.	 Also,	 when	 a	 clear	 relation	 between	 mucus	 and	 AL	 rate	 in	 humans	 is	
established,	one	could	reason	that	patients	who	have	an	impaired	mucous	lining	in	
the	gut	may	become	eligible	to	undergo	interventions	that	thicken	the	mucus.	We	
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have	 tried	 to	 enhance	 the	mucus	 layer	with	 prostaglandine	 E2	 (PGE2),	 since	 it	 is	
known	that	this	can	stimulate	mucus	secretion	in	both	small	intestine	and	proximal	
colon	 ex	 vivo.	 Furthermore,	 Non‐steroidal	 anti‐inflammatory	 drugs	 (NSAIDS)	
inhibit	 COX	 enzymes,	which	 leads	 to	 a	decrease	 in	 prostaglandin	 synthesis.	 Since	
there	 is	 an	 association	 between	 the	 use	 of	 NSAIDs	 and	 AL	 there	 must	 be	 an	
interaction	between	prostaglandins	and	anastomotic	healing.	Unfortunately,	we	did	
not	find	a	positive	influence	of	PGE2	on	anastomotic	healing.	However,	other	factors	
might	 influence	 the	 mucus	 layer	 stronger	 than	 prostaglandins.	 For	 example,	
experimental	 studies	 suggest	 a	 positive	 effect	 of	 antibiotics	 on	 the	 strength	 of	
colonic	anastomosis25,26.	 It	 is	widely	accepted	that	the	mucus	 layer	 in	 the	colon	 is	
the	natural	habitat	for	a	variety	of	bacteria	and	that	these	bacteria	are	essential	in	
order	 to	 maintain	 the	 natural	 balance	 in	 the	 intestine.	 One	 of	 the	 tasks	 of	 the	
bacteria	in	the	gut	is	to	break	down	dietary	fibers	into	smaller	particles	that	we	can	
extract	 energy	 from.	 As	 a	 consequence	 short‐chain	 fatty	 acids	 (SCFAs)	 are	 being	
released.	 These	 are	 elements	 that	 can	 be	 used	 again	 by	 the	 intestinal	 cells	 as	 a	
nutrient.	 If	 these	 SCFA‐producing	 bacteria	 are	 inhibited,	 this	 may	 lead	 to	 a	
diminished	function	of	enterocytes	due	to	a	lack	of	energy27.	The	balance	between	
pathogenic	 and	 commensal	 bacteria	 has	 been	 described	 in	 the	 frame	 of	 different	
pathologies28‐30.	Recently,	the	group	of	professor	Alverdy	postulated	the	hypothesis	
that	 bacteria	play	 a	 significant	 role	 in	 the	pathophysiology	 of	AL31.	Over	 the	past	
years,	 they	 have	 shown	 that	 virulent	 bacteria	with	 high	 collagenase	 activity	may	
contribute	 to	 developing	 AL12.	 These	 results	 strengthen	 the	 statement	 of	 the	
previous	chapter	that	in	depth	research	into	the	pathophysiology	of	AL	may	lead	to	
new	 insights	 and	 potential	 targets	 that	 can	 improve	 anastomotic	 healing	 after	
colorectal	surgery.		
Reducing	colorectal	anastomotic	leakage	rate:	glues	and	enema	interventions	
Many	 attempts	 have	 been	made	 to	 prevent	AL	 after	 colorectal	 surgery,	 either	 by	
enhancing	 the	 healing	 process	 through	 different	 pharmaceutical	 approaches,	
mechanically	strengthen	the	anastomosis	or	by	preventing	the	sequelae	of	leakage	
with	 specific	 intraluminal	 devices.	 All	 these	 interventions	 were	 tested	 in	 animal	
studies	or	in	the	experimental	trial	setting	in	humans32‐34.	None	of	these	measures	
have	been	incorporated	in	standard	medical	care,	some	because	they	had	negative	
side	effects,	others	were	never	tested	in	humans,	but	 in	the	most	cases	it	remains	
unclear	 why	 successful	 attempts	 have	 not	 been	 investigated	 further.	 Recent	
advances	that	seem	to	be	promising	are	to	strengthen	the	anastomotic	line,	either	
directly	 by	 the	 applications	 of	 sealants	 or	 glues	 around	 the	 anastomosis	 or	 by	
influencing	 the	 healing	 process	 through	 an	 increased	 interaction	 of	 colonocytes	
with	their	surroundings,	such	as	intraluminal	content.		
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One	 of	 the	most	 abundant	 short	 chain	 fatty	 acids	 in	 the	 intestine	 is	 butyrate,	
which	is	also	produced	by	bacteria	in	the	process	of	digestion35.	This	SCFA	has	often	
been	 investigated	 in	 the	 intestine	 and	 it	 has	 been	 shown	 that	 it	 enhances	
anastomotic	 strength	when	 it	 is	 given	as	 an	 enema	 in	 rats36.	During	 the	 research	
performed	 for	 this	 thesis,	 an	 attempt	 has	 been	 made	 to	 come	 up	 with	 a	 better	
method	 than	 enemas	 (Chapter	 6).	 This	 is	 of	 interest,	 since	 surgeons	 are	 often	
reluctant	to	give	enemas	when	an	intestinal	anastomosis	is	constructed.	Clinicians	
are	 concerned	 that	 the	 enema	 by	 direct	 mechanical	 forces	 or	 through	 increased	
tension	 on	 the	 seam	 just	 causes	 a	 dehiscence	 of	 the	 anastomosis,	 in	 fact	 causing	
mechanical	 AL.	 The	 possibility	 to	 strengthen	 proximal	 anastomosis	 with	 topical	
application	 prior	 to	 construction	 of	 the	 anastomosis	was	 investigated,	 as	well	 as	
enrichment	of	the	butyrate	enemas	with	other	substances	such	as	hyaluronan	since	
it	 is	 known	 that	 hyaluronan	 contributes	 significantly	 to	 cell	 proliferation	 and	
migration37.	 Unfortunately,	 these	 experiments	 yielded	 few	 new	 insights	 and	 it	
seems	that	butyrate	supplementation	via	an	enema	remains	the	best	option.		
Numerous	 attempts	 have	 been	 made	 to	 reinforce	 the	 colonic	 anastomosis	
during	 surgery	 in	 order	 to	 prevent	 AL.	 Commonly	 used	 materials	 are	 tissue	
adhesives	(TAs),	adhesive	strips	or	patches	consisting	of	biological	materials33,38,39.	
It	 is	 known	 that	 certain	 adhesives	 such	 as	 fibrin	 glue	 do	 not	 lead	 to	 a	 lower	
anastomotic	 leakage	 rate40	 and	 that	 the	 application	 of	 cyanoacrylate	 in	
gastrointestinal	anastomoses	seems	promising41.	This	is	why	our	colleagues	at	the	
Erasmus	Medical	Centre	started	a	stepwise	approach	to	detect	which	TA	is	the	most	
promising	 to	 translate	 from	 the	 experimental	 setting	 into	 the	 clinical	 situation.	
First,	 they	 investigated	ex	vivo	 that	 cyanoacrylate	 is	 indeed	capable	of	 increasing	
the	 mechanical	 strength	 of	 anastomoses,	 both	 in	 a	 normal	 and	 a	 technical	
insufficient	situation42	and	compared	several	 types	of	TAs	 in	a	rat	study43.	 In	 this	
latter	study	it	was	shown	that	cyanoacrylates	are	indeed	the	most	promising	group	
of	 TAs	 for	 colonic	 sealing,	 however	 certain	 types	 of	 cyanoacrylate	 may	 have	 a	
negative	 influence	on	anastomotic	healing44,45.	 In	Chapter	7,	we	examined	several	
cyanoacrylate	 based	 commercially	 available	 glues	 and	 their	 effect	 on	 the	
occurrence	 of	 AL,	 stenosis	 and	 general	well	 being	 of	 the	 animals	 in	 a	model	 of	 a	
mechanically	 insufficient	 colonic	 anastomosis.	 Of	 the	 three	 TAs	 Histoacryl	 Flex,	
Glubran	 2	 and	Omnex,	 the	 first	 showed	 the	 lowest	 leakage	 rate	 compared	 to	 the	
other	TAs	whereas	Glubran	2	showed	the	highest	AL	rate	and	caused	an	increased	
inflammatory	 response.	 Despite	 positive	 findings	 in	 literature,	 it	 has	 also	 been	
reported	 that	 Glubran	 2	 causes	 severe	 inflammation,	 with	 multiple	 micro‐
abscedation	 in	 a	 model	 for	 experimental	 hernia	 repair46.	 Thus	 far,	 it	 remains	
unclear	why	Glubran	2	has	a	pro‐inflammatory	effect,	especially	since	there	are	also	
reports	 on	 the	 beneficial	 effects	 of	 this	 adhesive	 for	 intestinal	 healing43,47.	
Histoacryl	 Flex	 was	 associated	 with	 the	 presence	 of	 more	 mature	 collagen,	
suggesting	 to	 promote	 anastomotic	 healing	 without	 any	 harmful	 reaction.	
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Additional	 in	vivo	 testing	has	 to	be	performed,	especially	 in	a	 large	animal	model	
before	 this	 tissue	 adhesive	 can	 be	 implemented	 in	 clinical	 practice,	 which	 is	
something	that	is	currently	being	investigated	in	Rotterdam.	The	big	advantage	of	
Histoacryl	Flex	 seems	 to	be	 that	 it	has	an	enhanced	 flexibility	 compared	 to	other	
adhesives	and	that	they	appear	to	adapt	easier	three‐dimensionally.	This	is	of	great	
importance	 in	 the	 mobile	 intestine	 where	 it	 is	 known	 that	 TAs	 can	 cause	
inflammation	and	mechanical	ileus,	which	was	also	the	case	in	our	study	(5/11	rats	
in	Glubran	2	group).		
Potential	disruption	of	the	balance	between	intestinal	anastomotic	healing	
and	adhesion	formation	
Tissue	 adhesives	 are	 studied	 as	 preventive	 measures	 for	 AL,	 since	 their	 main	
functions	 are	 to	 repair	 injured	 tissues,	 reinforce	 surgical	 wound	 or	 even	 replace	
common	 suturing	 techniques.	 Biopolymers	 can	 also	 reach	 these	 aims48.	 These	
polymeric	materials	can	be	constructed	 into	 three‐dimensional	networks	 that	can	
physically	of	chemically	bind	to	the	target	tissue	and	act	as	hemostats,	adhesives	or	
sealants.	In	this	perspective,	we	also	examined	the	option	of	a	sealing	patch	able	to	
reduce	 AL,	 which	 was	 developed	 in	 the	 framework	 of	 the	 European	 project	
'AnastomoSEAL'	where	we,	 as	 a	 research	 group,	were	 responsible	 for	 the	 animal	
experiments.	In	this	project,	different	consortium	members	developed	a	patch	with	
bioactive	 components	 from	 scratch.	 A	 patch	 is	 a	 three‐dimensional	 network	
consisting	of	several	(bio)polymers	and	the	combination	of	these	polymeric	agents	
has	 a	 big	 influence	 on	 adhesion	 mechanisms,	 mechanical	 performance	 and	
resistance	 to	 body	 fluid.	 Therefore,	 these	 various	 aspects	 should	 be	 taken	 into	
account	 to	 choose	 the	 most	 suitable	 formulation	 for	 the	 target	 application.	 The	
most	difficult	 aspect	 in	 the	specific	development	of	materials	 for	 intra‐abdominal	
use	 is	 the	 degree	 of	 adhesion.	 The	 aimed	material	 needs	 to	 be	 sticky	 enough	 to	
adhere	in	a	moist	environment,	but	should	not	be	too	adhesive	since	that	may	cause	
stenosis	or	adhesions	between	the	intestines	and	the	abdominal	wall.	In	addition,	it	
is	 a	 risk	 to	 insert	 a	 foreign	 body	material	 in	 the	 vicinity	 of	 a	 complex	 biological	
process	such	as	anastomotic	healing	of	which	 it	 is	 impossible	 to	predict	what	 the	
reaction	to	the	material	will	be.	Substances	that	may	appear	promising	in	vitro	may	
react	differently	in	vivo.	Therefore,	during	the	development	process	of	biomaterials	
not	only	the	main	components	of	the	end	product	should	be	individually	tested,	but	
also	the	auxiliary	substances,	since	they	may	lead	to	unwanted	side	effects.	During	
the	 ‘AnastomoSEAL’	 project,	 we	 noticed	 severe	 adverse	 events	 in	 the	 animal	
experiments	 when	 patches	 were	 tested	 that	 contained	 glycerol	 as	 a	 plasticizer	
(Chapter	 8).	 The	 addition	 of	 a	 plasticizer	 agent	 to	 biodegradable	 blend	 films	
represents	 a	 feasible	 approach	 to	 enhance	 the	 pliability	 of	 biopolymer‐based	
membranes49.	 After	 the	 observed	 effects	 of	 the	 patches,	 additional	 analyses	
identified	glycerol	as	the	cause	of	adverse	patch‐host	reactions.	In	our	cell	culture	
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experiment,	high	percentages	of	glycerol	had	an	obvious	harmful	effect	on	adipose‐
derived	stem	cells.	In	addition,	a	chorioallantoic	membrane	assay	showed	that	the	
materials	 evoked	 a	 negative	 biological	 response	 leading	 to	 tissue	 injury,	
characterized	by	vessel	damage	and	bleeding.	Therefore,	we	advocate	that	caution	
should	be	taken	when	selecting	glycerol	as	plasticizer	in	biomaterials	designed	for	
intra‐abdominal	use.	Safety	should	always	be	the	main	priority	when	new	materials	
are	 being	 developed,	 but	 is	 of	 particular	 importance	 when	 these	 materials	
intervene	with	 complex	biological	processes.	As	 stated	 in	 the	 introduction	of	 this	
thesis,	 the	 so‐called	 collagenous	 equilibrium	 (the	 balance	 between	 collagen	
synthesis	and	lysis)	is	critical	to	anastomotic	healing.	It	has	been	shown	that	certain	
anti‐adhesive	 products	 may	 predispose	 to	 peritonitis	 and	 anastomotic	
dehiscence50,51.	In	this	thesis,	a	newly	developed	anti‐adhesive	material	was	placed	
in	both	the	presence	of	a	colonic	anastomosis	as	well	as	 in	a	model	for	controlled	
infection	 to	 evaluate	 both	 efficacy	 and	 safety	 of	 this	 potential	 adhesion	 barrier	
(Chapter	 9).	 Poly(trimethylene	 carbonate)	 (PTMC),	 an	 inert,	 slow	 degrading	
polymer	was	shown	to	have	excellent	biocompatibility	and	 to	be	phagocytised	by	
macrophages,	enabling	it	to	be	completely	degraded	at	12	weeks	with	only	a	small	
area	of	inflammatory	cells	that	was	observed	at	the	site	of	implantation52,53.	Unlike	
other	membranous	materials,	such	as	collagen	membranes,	this	polymer	degrades	
through	 surface	 degradation,	 allowing	 it	 to	 retain	 its	 mechanical	 characteristics	
throughout	the	degradation	process54.	
	
In	both	animal	models	to	evaluate	the	safety	of	PTMC,	presence	of	the	film	did	
not	 cause	 any	 increase	 in	 AL	 rate,	 nor	 did	 it	 aggravate	 the	 induced	 infection.	
Prevention	of	 intraperitoneal	 adhesions	 remains	 an	 integral	part	 of	 daily	 surgery	
and	new	materials	are	being	developed	that	may	reduce	the	devastating	impact	of	
adhesions	 on	 quality	 of	 life	 and	 diminish	 the	 risk	 for	 reoperations.	 However,	 it	
should	 always	 be	 taken	 into	 account	 that	 it	 is	 all	 a	 matter	 of	 balance	 between	
anastomotic	 healing	 and	 adhesion	 formation,	 which	 remains	 a	 complicated,	
mysterious	process	where	interventions	can	have	detrimental	effects.	
Future	perspectives	and	recommendations	
Despite	important	improvements	in	perioperative	care	and	increased	awareness	of	
AL,	incidence	rates	of	this	dreaded	complication	have	remained	stable	over	the	past	
decades.	Most	strikingly,	 leakage	continues	 to	occur	 in	patients	 treated	under	 the	
most	 expert	 care,	 without	 the	 presence	 of	 any	 known	 risk	 factors55.	 The	 lack	 of	
knowledge	 regarding	 the	 pathophysiological	 process	 of	 AL	 and	 the	 process	 of	
normal	 intestinal	 healing	 hampers	 the	 development	 of	 novel	 predictive	 and	
preventive	methods.	AL	has	significant	impact	on	morbidity	and	mortality,	quality	
of	 life,	 health	 care	 costs	 and	 is	 suggested	 to	negatively	 interfere	with	 oncological	
prognosis5,6,56.	 Even	 though	 large	 numbers	 of	 clinical	 trials	 have	 identified	
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important	patient‐related	and	technical	factors	that	aid	in	the	prediction	of	AL57,58,	
the	search	for	a	predictive	biomarker	for	AL	has	hitherto	remained	unsuccessful.		
Therefore,	 we	 have	 designed	 a	 study	 that	 focuses	 on	 predictive	 factors	 for	
anastomotic	 leakage	 (REVEAL‐study)	 after	 colorectal	 surgery.	 This	 prospective,	
observational	 study	 is	 based	 on	 the	 hypothesis	 that	 AL	 is	 partly	 due	 to	 patient‐
derived	factors	such	as	a	derailed	immune	response,	genetical	predisposition	and	a	
deficient	 microbiota	 composition,	 and	 that	 the	 clinical	 course	 can	 be	 further	
influenced	by	surgical	stress,	ischemia	and	a	compromised	systemic	response.	This	
study	aims	at	1)	broadening	our	understanding	of	the	pathophysiological	process	of	
AL	 by	 introducing	 novel	 biomarkers	 of	 intestinal	 damage	 and	 2)	 decreasing	 the	
clinical	burden	of	AL	by	individual	risk	assessment	in	the	future.	Study	enrolment	
of	588	patients	undergoing	colorectal	surgery	with	the	creation	of	an	anastomosis	
has	 started	 in	 the	 fall	 of	 2015	 and	 is	 currently	 on‐going	 (Clinicaltrials.gov	
NCT02347735).	
In	order	to	minimize	the	potentially	 life	 threatening	clinical	consequences	of	a	
leak,	some	surgeons	opt	to	perform	a	deviating	stoma	directly	following	the	initial	
operation31.	Although	 it	 is	generally	accepted	that	 the	presence	of	a	colostomy	or	
ileostomy	reduces	the	sequelae	of	AL	and	the	need	for	re‐intervention	(surgery)	in	
case	 of	 a	 leak59,60	 a	 decrease	 in	 incidence	 of	 postoperative	mortality	 has	 not	 yet	
been	proven61,62.	The	presence	of	selection	bias,	where	an	ostomy	is	performed	in	
high‐risk	patients,	should	be	considered	when	interpreting	these	results.	Surgeons	
perform	elective	deviating	ostomy	in	about	70%	of	cases	of	low	rectal	carcinoma,	of	
which	a	 significant	percentage	 (19‐40%)	will	never	have	 their	 temporary	ostomy	
reversed63,64.	 Possible	 benefits	 of	 a	 deviating	 stoma	 should	 be	 weighed	 against	
stoma‐related	morbidity,	the	impact	on	quality	of	life	and	the	mortality	rates	after	
stoma	closure65,66.	An	adequate	preoperative	risk	analysis	could	aid	surgeons	and	
their	 patients	 in	 the	 decision	 making	 process	 regarding	 the	 construction	 of	
temporary	ostomies.		
There	 are	 already	 some	 prediction	 measures	 available	 for	 clinical	 practice,	
however	these	are	designed	to	detect	anastomotic	leakage	in	an	early	stage,	such	as	
the	 DULK	 score	 or	 the	 PREDICS	 study67,68.	 Both	 scores	 are	 based	 on	 clinical	
markers,	indicating	a	‘sick’	patient	at	risk	of	having	AL.	Moreover,	these	studies	also	
suggest	 using	 their	 scores	 as	 a	 tool	 for	 safe	 and	 early	 discharge	 after	 elective	
colorectal	 surgery,	 just	as	 the	 IMACORS	study69.	 In	 this	 study	procalcitonin	 (PCT)	
and	C‐reactive	protein	 (CRP)	was	 studied	 and	 showed	 that	CRP	 is	more	 accurate	
than	PCT	for	the	detection	of	infectious	complications.	However,	their	conclusion	is	
not	 only	 based	 on	 the	 AL	 rate,	 but	 on	 all	 postoperative	 infectious	 complications.	
The	authors	from	the	PREDICS	study	demonstrated	that	both	PCT	and	CRP	have	a	
good	negative	predictive	value	for	AL	both	in	3rd	and	5th	postoperative	day68,	which	
was	also	shown	by	Reisinger	et	al.70.	CRP	is	already	a	commonly	used	marker	in	the	
clinical	 setting,	but	 the	use	of	aforementioned	scores	 is	not	standard	practice	yet.	
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Currently,	there	are	still	studies	enrolling	patients	to	develop	an	optimal	diagnostic	
algorithm	for	early	detection	of	AL,	indicating	that	the	optimal	scoring	method	still	
has	 not	 been	 found71.	 Perhaps	 the	 Dutch	 Taskforce	 on	 Anastomotic	 Leakage	 can	
play	a	 role	 in	 analysing	which	 score	 is	most	 accurate	 for	 the	detection	of	AL	 and	
implement	 one	 of	 these	 scores	 into	 the	 Dutch	 guidelines	 for	 postoperative	 care	
after	colorectal	surgery.	
Recently,	a	new	prognostic	 index	called	PROCOLE	was	designed	 to	predict	 the	
risk	 of	 a	 certain	 individual	 developing	 AL	 after	 colorectal	 surgery72.	 The	 big	
difference	with	our	REVEAL	study	is	that	the	PROCOLE	is	solely	based	on	potential	
risk	 factors	 already	 described	 in	 literature	 and	 is	 therefore	 –	 until	 now	 –	 only	 a	
theoretical	index,	not	taken	individual	measurements	into	account.		
The	 successful	 implementation	of	 risk	 assessment	 tools	 that	 can	be	 the	 result	
from	the	REVEAL‐study	would	have	a	positive	influence	on	morbidity	and	mortality	
rates,	 duration	 of	 hospital	 stay,	 number	 of	 readmissions,	 re‐interventions	 and	
admissions	 to	 the	 ICU,	 leading	 to	 a	 significant	 increase	 in	 quality	 of	 life	 for	 the	
general	patient	population57.	
In	addition	to	the	clinical	focus	on	risk	factors	and	individual	risk	profiling,	the	
main	goal	for	researchers	in	the	experimental	field	of	colorectal	anastomosis	should	
be	 to	 completely	 elucidate	 the	 healing	 process	 and	 the	 multifactorial	
pathophysiology	that	leads	to	anastomotic	leakage.	In	the	future	there	should	be	an	
interplay	between	clinical	findings	and	experimental	results	that	will	continuously	
influence	 one	 another;	 observed	 risk	 factors	 in	 the	 clinic	 should	 be	 further	
investigated	 with	 new	 techniques	 in	 the	 lab	 and	 potential	 key	 factors	 in	
anastomotic	healing	should	be	identified	in	the	patient	population.	Only	when	these	
two	approaches	are	combined,	without	aiming	directly	at	reducing	AL	rates,	it	will	
lead	to	a	substantial	contribution	to	the	field	of	gastrointestinal	research.		
Main	conclusion	
Numerous	 studies	 have	 focused	 on	 the	 effect	 of	 a	 certain	 intervention	 on	 the	AL	
rate,	 without	 studying	 the	 biochemical	 process	 of	 anastomotic	 healing	 first.	 An	
international	 summit	 on	 intestinal	 AL	 concluded	 that	 research	 into	 the	
pathogenesis	of	AL	could	be	advanced	markedly	by	performing	additional	analyses	
in	human	anastomotic	tissues	during	and	after	surgery73.	The	use	of	human	tissue	
will	 lead	 to	 a	 reduced	 demand	 of	 experimental	 research,	 thereby	 reducing	 the	
numbers	 of	 animals	 that	 are	 being	 used	 nowadays.	 Furthermore,	 with	 current	
technologies,	we	are	capable	of	 replacing	animals	with,	 for	example,	organoids	 to	
investigate	 the	molecular	 process	 of	 intestinal	 healing	 in	more	 detail	 or	 to	 use	 a	
reduced	 amount	 of	 animals	 since	 high	 resolution	 mass‐spectrometry	 imaging	
techniques	or	digital	holographic	microscopy	can	provide	more	information	for	the	
assessment	of	gastrointestinal	wound	healing74‐76.	
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We	have	argued	that	the	ill‐defined	pathogenesis	of	AL	is	a	direct	consequence	
from	 the	 largely	 unexplained,	 complicated	 biological	 process	 of	 anastomotic	
healing.	Anastomotic	healing	should	be	completely	elucidated	 in	order	 to	develop	
interventions	that	may	stimulate	anastomotic	healing	and	subsequently	prevent	AL.	
New	 studies	 should	 focus	 on	 identifying	 risk	 factors	 for	 AL	 before	 starting	 large	
randomized	controlled	trials	for	specific	interventions.	This	can	positively	influence	
the	quality	and	decrease	 the	quantity	of	animal	 research	on	AL	 in	 the	short	 term	
and	hopefully	reduce	the	clinical	burden	of	AL	in	the	long	term. 
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In	Nederland	worden	per	 jaar	meer	dan	15.500	nieuwe	patiënten	met	colorectaal	
carcinoom	 (CRC)	 gediagnostiseerd.	 Het	 was	 daarmee	 de	 meest	 voorkomende	
oncologische	 aandoening	 in	 2015,	 bij	 zowel	 mannen	 als	 vrouwen.	 Het	 aantal	
patiënten	 met	 CRC	 zal	 toenemen	 door	 een	 stijgende	 incidentie,	 door	 de	
bevolkingsgroei,	 door	 de	 vergrijzing	 en	 door	 het	 recent	 gestarte	 bevolkings‐
onderzoek.	Jaarlijks	overlijden	4.000	mensen	aan	de	gevolgen	van	CRC.	Twee	derde	
van	 de	 patiënten	 met	 CRC	 ondergaat	 een	 operatieve	 behandeling	 waarbij	 de	
darmtumor	verwijderd	wordt.	Dit	blijft	ondanks	allerlei	nieuwe	(radio)therapieën	
de	hoeksteen	van	de	behandeling	voor	colorectaal	carcinoom.	Het	beloop	rondom	
de	 operatie	 bij	 colorectale	 chirurgie	 is	 cruciaal	 voor	 de	 klinische	 uitkomst	 met	
betrekking	 tot	 overlijden	 en	 functioneel	 herstel.	 Daarnaast	 heeft	 deze	 operatieve	
behandeling	een	grote	impact	op	de	zorgkosten.		
In	 de	 afgelopen	 decennia	 is	 de	 perioperatieve	 zorg	 verbeterd	 dankzij	
ontwikkelingen	 in	de	anesthesie,	minimaal	 invasieve	operatieve	 technieken	en	de	
introductie	van	‘fast‐track’	protocollen	welke	gericht	zijn	op	een	snel	postoperatief	
herstel	 van	 de	 patiënt.	 Er	 ontstaan	 echter	 nog	 steeds	 complicaties	 na	 colorectale	
chirurgie,	waarvan	naadlekkage	de	meest	gevreesde	is.	Naadlekkage	ontstaat	als	de	
twee	aan	elkaar	gemaakte	darmuiteinden	‐	de	darmnaad	oftewel	anastomose	‐	niet	
goed	 geneest;	 de	 darminhoud	 lekt	 dan	 in	 de	 buikholte	wat	 kan	 leiden	 tot	 onder	
andere	buikvliesontsteking	en	abcesvorming.		
Bij	 712	 van	 de	 10.426	 (6,8%)	 geregistreerde	 patiënten	 met	 een	 colorectale	
resectie	 ontstond	 in	Nederland	 in	2014	een	naadlekkage	met	 een	heroperatie	 tot	
gevolg	 (Dutch	 Surgical	 Colorectal	 Audit	 (DSCA)	 2014).	 Dit	 ging	 gepaard	met	 een	
hoge	 morbiditeit,	 verlengd	 ziekenhuisverblijf	 en	 zelfs	 mortaliteit.	 Naadlekkage	
wordt	 bovendien	 geassocieerd	 met	 verminderde	 ziekte‐specifieke	 overleving	 en	
toegenomen	kans	op	het	 terugkeren	van	colorectaal	carcinoom.	De	 incidentie	van	
naadlekkage	is	helaas	gelijk	gebleven	in	de	afgelopen	decennia,	dit	komt	met	name	
door	 het	 gebrek	 aan	 kennis	 van	 een	 normale	 naadgenezing	 (Hoofdstuk	 1).	 Het	
proces	van	wondgenezing	in	de	darm,	bijvoorbeeld	bij	het	aanleggen	van	een	naad,	
wordt	 vaak	 vergeleken	 met	 wondgenezing	 van	 de	 huid.	 De	 darmgenezing	 vindt	
inderdaad	 plaats	 in	 de	 drie	 bekende	 fasen	 van	 ontsteking,	 proliferatie	 en	
remodelling.	Er	zijn	echter	ook	substantiële	verschillen;	 zo	gaat	de	darmgenezing	
veel	 sneller	 dan	 de	 genezing	 van	 de	 huid,	 zijn	 er	 verschillende	 cellen	 en	 stoffen	
(bijvoorbeeld	 ander	 type	 collageen)	 bij	 betrokken	 en	 heeft	 zowel	 de	 huid	 als	 de	
darm	een	unieke,	microbiota.		
Diermodellen	voor	onderzoek	naar	naadlekkage	na	darmchirurgie	
Aangezien	het	probleem	van	naadlekkage	helemaal	niet	minder	is	geworden	in	de	
afgelopen	jaren,	zijn	veel	mensen	geïnteresseerd	in	dit	mysterie.	Daarom	er	wordt	
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er	wereldwijd	dan	ook	uitgebreid	onderzoek	naar	gedaan	naar	dit	fenomeen.	Vaak	
worden	 hiervoor	 proefdieren	 gebruikt,	 waarin	 een	 darmnaad	 gemaakt	 wordt.	
Omdat	het	nog	onmogelijk	is	de	darmgenezing	op	moleculair	niveau	bij	de	mens	in	
kaart	 te	 brengen	 wordt	 ook	 in	 de	 experimenten	 beschreven	 in	 dit	 proefschrift	
gebruikt	gemaakt	van	diermodellen.		
Niet	alle	modellen	worden	even	vaak	 in	de	 literatuur	gebruikt.	Teneinde	meer	
duidelijkheid	 over	 deze	 modellen	 en	 vergelijkbaarheid	 tussen	 de	 verschillende	
studies	 te	verkrijgen,	 is	het	cruciaal	dat	onderzoekers	overeenstemming	bereiken	
over	wat	belangrijk	is	bij	het	onderzoek	naar	darmnaden.	Om	die	reden	hebben	we	
een	 Delphi‐analyse	 uitgevoerd.	 Dat	 is	 een	 onderzoeksmethode	 waarbij	 de	
meningen	van	een	groot	aantal	experts	wordt	gevraagd	en	door	de	antwoorden	van	
de	 experts	 anoniem	 terug	 te	 koppelen	 aan	 eenieder	 wordt	 in	 een	 aantal	 rondes	
geprobeerd	 tot	 consensus	 te	 komen.	Een	van	de	uitkomsten	van	deze	 studie	was	
dat	de	hond	en	het	konijn	geen	gevalideerde	modellen	zijn	voor	dit	soort	onderzoek	
(Hoofdstuk	2).	De	muis,	 rat	 en	het	varken	zijn	wel	 geschikt	 geacht	als	diermodel,	
mits	er	gewerkt	wordt	volgens	de	huidige	wet‐	en	regelgeving	en	de	experimenten	
gerapporteerd	worden	volgens	de	ARRIVE‐guidelines.	Uit	deze	studie	is	een	nieuwe	
score	gekomen	om	experimentele	anastomoses	 te	kunnen	beoordelen.	Deze	werd	
door	 de	 respondenten	 als	 zeer	 geschikt	 bevonden,	 hoewel	 de	 bruikbaarheid	 nog	
bewezen	dient	te	worden	in	de	praktijk.		
	
Ondanks	 de	 hoeveelheid	 studies	 die	 worden	 uitgevoerd	 naar	 het	 onderwerp	
naadlekkage,	is	het	nog	steeds	onduidelijk	hoe	zo’n	naadlekkage	eigenlijk	ontstaat.	
We	weten	niet	goed	wat	er	mis	gaat	bij	normale	naadgenezing	wat	leidt	tot	lekkage	
van	darminhoud.	Om	het	naadgenezingsproces	meer	 in	detail	 in	kaart	 te	brengen	
hebben	 we	 gebruik	 gemaakt	 van	 de	 relatieve	 nieuwe	 techniek	 ‘massa‐
spectrometrie	 imaging’	 (Hoofdstuk	 3).	 Deze	 techniek	 stelt	 ons	 in	 staat	 om	
onderscheid	 te	 maken	 tussen	 de	 verschillende	 lagen	 van	 de	 darmwand	 en	
specifieke	 stoffen	 te	 identificeren	 als	 potentiele	 aangrijpingspunten	 om	 het	
naadgenezingproces	 verder	 te	 ontrafelen.	 Dit	 kan	 weer	 tot	 mogelijke	 nieuwe	
interventies,	die	tot	een	betere	heling	en	dus	een	lager	percentage	naadlekkage	in	
de	toekomst	leiden.	
Risico‐factoren	opsporen	middels	specifieke	‘knock‐out’	proefdieren	
Het	is	bekend	dat	bepaalde	patiëntfactoren	het	risico	op	naadlekkage	vergroten:	zo	
heeft	bijvoorbeeld	een	oudere	man	met	overgewicht	die	rookt	een	groter	risico	op	
naadlekkage	dan	een	slanke,	niet‐rokende	dame.	Ook	is	gebleken	uit	observationeel	
en	 experimenteel	 onderzoek	 dat	 patiënten	 die	 bepaalde	 pijnstillers	 met	
ontstekingsremmende	werking,	 zogenaamde	NSAIDs,	 kregen	 rondom	de	 operatie	
vaker	 een	 naadlekkage	 ontwikkelden.	 In	 dit	 proefschrift	 is	 een	 deel	 van	 het	
mechanisme	opgehelderd	waarom	deze	medicijnen	bijdragen	aan	een	hoger	risico	
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op	 naadlekkage;	 zo	 is	 aangetoond	dat	 remming	of	 depletie	 van	 het	 enzym	Cyclo‐
oxygenase	 2	 (COX‐2)	 leidt	 tot	 een	 toename	 van	 het	 aantal	 naadlekkages	 in	 een	
muismodel,	mogelijk	door	de	doorbloeding	van	de	darmnaad	te	beïnvloeden.	COX‐2	
speelt	een	grote	rol	bij	de	ontstekingsfase	van	het	genezingsproces	en	is	essentieel	
voor	een	normale	naadgenezing	(Hoofdstuk	4).		
	
Verder	 zijn	 er	 aanwijzingen	 dat	 een	 normale	 samenstelling	 van	 de	 slijmlaag	
(mucus)	in	de	darm	belangrijk	is	bij	de	normale	naadgenezing.	Zo	zagen	we	dat	het	
naadlekkage	 percentage	 significant	 hoger	 was	 in	 muizen	 die	 de	 belangrijkste	
component	van	mucus	in	het	colon	missen,	de	zogenoemde	Muc2	knockout	muizen,	
dan	dat	van	controle	dieren	(Hoofdstuk	5).	Er	zijn	verschillende	verklaringen	voor	
dit	resultaat	mogelijk.	Een	van	die	verklaringen	kan	zijn	dat	door	het	gebrek	aan	de	
mucuslaag	 in	de	darmen	geen	natuurlijke	habitat	 is	 voor	 verschillende	bacteriën.	
Bacteriën	 zijn	 essentieel	 om	het	 natuurlijk	 evenwicht	 in	 de	darmen	 te	 behouden.	
Een	van	de	taken	van	de	bacteriën	in	de	darm	is	vezels	uit	de	voeding	af	te	breken	
naar	kleinere	deeltjes	waar	wij	energie	uit	kunnen	halen.	Bij	deze	omzetting	komen	
korte‐keten	 vetzuren	 vrij,	 stofjes	 die	 weer	 door	 de	 darmcellen	 als	 voedingsstof	
gebruikt	kunnen	worden.	Een	van	die	korte‐keten	vetzuren	is	butyraat.	Dit	stofje	is	
al	 vaker	 onderzocht	 in	 de	 darm	 en	 er	 is	 aangetoond	 dat	 dit	 de	 naad	 versterkt	
wanneer	dit	als	klysma	wordt	gegeven	in	ratten.	In	dit	proefschrift	is	getracht	een	
betere	 methode	 dan	 klysma’s	 uit	 te	 testen	 om	 zo	 ook	 darmnaden	 in	 het	 colon	
hogerop	 (proximaal)	 te	 kunnen	 versterken,	 alsmede	 het	 butyraatklysma	 te	
verrijken	 met	 andere	 stoffen	 (Hoofdstuk	 6).	 Helaas	 leverden	 deze	 experimenten	
weinig	nieuwe	inzichten	op	en	lijkt	butyraat	suppletie	middels	klysma	toch	de	beste	
optie.	 In	 de	 kliniek	 is	 men	 echter	 terughoudend	 met	 het	 geven	 van	 klysma’s	
wanneer	 een	 darmnaad	 is	 aangelegd.	 Artsen	 zijn	 bezorgd	 dat	 het	 klysma	 door	
directe	 mechanische	 krachten	 of	 via	 verhoogde	 spanning	 op	 de	 naad	 juist	 kan	
leiden	tot	het	‘scheuren	of	knappen’	van	de	naad.		
Het	verminderen	van	naadlekkage	door	innovatieve	technieken	
Er	zijn	veel	pogingen	gedaan	om	de	naad	gedurende	de	operatie	te	versterken	om	
naadlekkage	te	voorkomen.	Veel	gebruikte	middelen	hierbij	zijn:	lijmen,	plakstrips	
of	patches	bestaande	uit	biologische	materialen.	Ook	in	dit	proefschrift	 is	getracht	
om	 preventie	 van	 naadlekkage	 middels	 een	 lijm	 of	 een	 patch	 te	 bereiken.	 In	
hoofdstuk	7	onderzochten	we	verschillende	commercieel	verkrijgbare	lijmen	en	het	
effect	daarvan	op	het	ontstaan	van	naadlekkage,	stenose	en	algeheel	welzijn	van	de	
dieren.	Het	bleek	dat	sommige	 lijmen	wel	degelijk	 tot	een	reductie	kunnen	 leiden	
van	het	aantal	naadlekkages,	maar	dat	veel	lijmen	ook	een	negatief	effect	hebben	op	
de	darmmotiliteit	en	ongerief	veroorzaakten	bij	de	ratten.	De	optimale	lijm	die	de	
naad	kan	verstevigen	zonder	verder	enige	reactie	te	geven	is	nog	niet	gevonden.		
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Daarom	hebben	we	tevens	de	optie	van	een	patch	onderzocht,	dit	 in	het	kader	
van	 het	 Europese	 project	 ‘AnastomoSEAL’	 waarbij	 wij,	 als	 onderzoeksgroep,	
verantwoordelijk	waren	voor	de	dierexperimenten.	Een	lastig	aspect	van	dit	soort	
materialen	voor	intra‐abdominaal	gebruik	is	de	mate	van	adhesie:	dus	hoe	goed	iets	
plakt	daar	de	buikholte	een	redelijk	vochtige	omgeving	is.	Daarnaast	wordt	er	toch	
een	 materiaal	 ingebracht	 in	 de	 nabijheid	 van	 een	 complex	 biologisch	 proces,	
waarbij	het	lastig	is	te	voorspellen	wat	de	reactie	zal	zijn.		
Mogelijke	verstoring	tussen	het	evenwicht	van	adhesievorming	en	
naadgenezing	
Stoffen	die	veelbelovend	lijken	in	het	lab	kunnen	in	een	levend	wezen	heel	anders	
reageren.	Hier	dient	bij	het	ontwikkelen	van	biomedische	producten	rekening	mee	
te	 worden	 gehouden	 Niet	 alleen	moeten	 de	 hoofdbestanddelen	 goed	 onderzocht	
zijn,	ook	de	hulpstoffen,	want	ook	deze	kunnen	tot	ongewenste	effecten	leiden.	Zo	
kan	de	stof	glycerol	in	bepaalde	doseringen	toxisch	zijn	voor	cellen	van	omentum,	
wat	normaal	gesproken	om	de	darmnaad	heen	zit	en	bijdraagt	aan	de	naadgenezing	
(Hoofdstuk	 8).	 Voorzichtigheid	 is	 dus	 geboden	wanneer	 het	 gaat	 om	 het	 gebruik	
van	 nieuw	 ontwikkelde	 materialen.	 Naast	 effectiviteit	 is	 veiligheid	 ook	 een	
belangrijk	 punt	 voor	 het	 testen	 in	 een	 diermodel.	 Zo	 zijn	 adhesies	 veel	
voorkomende	 complicaties	 na	 grote	 buikchirurgie.	 Er	 worden	 veel	 preventieve	
middelen	ontwikkeld	die	het	ontstaan	van	adhesies	kunnen	verminderen.	Dit	soort	
stoffen	kunnen	echter	een	nadelig	effect	hebben	op	de	natuurlijke	naadgenezing	en	
dus	een	groter	risico	op	naadlekkage	geven.	 In	dit	proefschrift	 is	zo’n	nieuw	anti‐
adhesief	 materiaal,	 zowel	 effectief	 tegen	 adhesies	 als	 veilig	 voor	 de	 darmnaad	
bevonden	(Hoofdstuk	9).		
	
Helaas	is	er	nog	geen	acceptabel	alternatief	gevonden	om	het	effect	van	dit	soort	
materialen	 te	 testen.	 Er	 wordt	 er	 dus	 nog	 steeds	 gebruik	 gemaakt	 van	 dier‐
modellen.	 Dit	 is	 zeer	 belangrijk	 en	 resultaten	 hiervan	moeten	 altijd	 openbaar	 en	
beschikbaar	zijn	voor	de	wetenschappelijke	wereld.	Niets	is	zo	verderfelijk	als	het	
herhalen	van	experimenten	die	al	eerder	hebben	geleid	tot	het	 lijden	van	mens	of	
dier.	
Conclusie	
Het	 proces	 van	 naadlekkage	 na	 dikke‐darm	 chirurgie	 blijft	 tot	 op	 heden	nog	 niet	
opgehelderd.	 Hierdoor	 blijken	 veelbelovende	 technieken	 ter	 preventie	 van	
naadlekkage	 in	 de	 klinische	 praktijk	 helaas	 niet	 succesvol.	 Wanneer	 de	
pathofysiologie	van	naadlekkage	beter	in	beeld	kan	worden	gebracht	kan	dit	leiden	
tot	nieuwe	aangrijpingspunten	waarmee	 in	de	 toekomst	het	 genezingsproces	 van	
de	 darmnaad	 kan	 worden	 verbeterd	 en	 daarmee	 naadlekkage	 kan	 worden	
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voorkomen.	 Dit	 zal	 op	 de	 langere	 termijn	 leiden	 tot	 minder	 morbiditeit	 en	
mortaliteit	na	colorectale	chirurgie.	
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Valorisation	addendum	
Valorisation	 is	often	defined	as	 the	process	of	 value	 creation	 from	knowledge,	by	
making	 it	 applicable	 and	 available	 for	 economic	 or	 societal	 utilisation,	 and	 by	
translating	it	in	the	form	of	new	business,	products,	services	or	processes1.		
	
The	 aim	 of	 this	 chapter	 is	 to	 take	 a	 brief	 look	 upon	 the	 return	 of	 investment	
society	 has	 received	 from	 the	 knowledge	 gathered	during	 this	 PhD	 trajectory.	As	
the	work	in	this	thesis	largely	focuses	on	experimental	animal	studies,	it	is	evident	
that	 not	 all	 results	 can	 directly	 be	 translated	 to	 the	 clinical	 setting.	 Here	 the	
translation	 of	 our	 academic	 findings	 regarding	 possibilities	 for	 future	
implementation	and	economic/societal	value	will	be	discussed.		
Economical	relevance		
This	 thesis	 focused	on	the	problem	of	anastomotic	 leakage,	a	severe	complication	
after	 colorectal	 surgery.	 The	 burden	 to	 society	 of	 colorectal	 cancer	 surgery	 can	
significantly	 be	 reduced	 by	 implementation	 of	 the	 knowledge	 obtained	 from	 this	
project	 for	 several	 reasons.	 In	 the	Netherlands	 approximately	 10.000	 oncological	
colorectal	operations	are	performed	each	year2.	With	an	 incidence	 in	anastomotic	
leakage	of	about	15%,	this	implies	1500	cases.	Notably,	the	incidence	of	colorectal	
carcinoma	 is	 expected	 to	 rise	 in	 the	 coming	 years	 due	 to	 national	 screening	
programs,	 increasing	 the	 frequency	 of	 colorectal	 cancer	 treatable	 by	 surgery	 and	
people	becoming	older.		
	
We	estimate	that	a	reduction	of	30‐40%	in	anastomotic	leakage	incidence	can	be	
achieved	by	combining	perioperative	innovations	–	some	of	which	have	their	basis	
in	 this	 thesis	 ‐,	 preventing	 complications	 in	 approximately	 500	patients	 yearly	 in	
the	Netherlands.	With	a	mortality	of	15%,	roughly	75	deaths	can	be	prevented	each	
year.	Moreover,	 a	 decrease	 in	 intensive	 care	unit	 admissions	 can	 reduce	national	
healthcare	costs	dramatically.	Additional	significant	contributions	to	the	cost	build‐
up	that	can	be	decreased	are	prolonged	hospitalization,	extra	radiographic	studies	
during	and	after	admission,	more	consultation	services,	more	extended	use	of	 the	
operating	 room,	 stoma‐related	 complications,	 re‐intervention	 for	 ostomy	 closure,	
longer	nursing	care,	materials	(e.g.	antibiotics,	ostomy	bags)3.	It	has	been	estimated	
that	 the	 actual	 cost	 per	 patient	 increased	 fivefold	 in	 case	 of	 serious	 anastomotic	
leakage	(in	patients	who	did	not	receive	a	diverting	stoma)4‐5.	
	
No	attempt	has	been	made	in	the	Netherlands	to	assess	the	total	cost	involved	
for	a	single	case	of	colorectal	leak.	This	largely	due	to	the	fact	that	hospitals	do	not	
have	 a	 scale	 of	 charges	 for	 individual	 consultations	 and	 services	 involved.	
Moreover,	the	costs	of	rehabilitation,	physiotherapy,	prolonged	absence	from	work	
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of	 patients	 and	 family	 members	 (i.e.	 caregivers),	 and	 nursing	 homes	 must	 be	
considered.		
Societal	relevance	
Not	only	would	a	solution	to	anastomotic	leakage	be	beneficial	for	the	economy,	it	
also	 has	 significant	 advantages	 for	 patients	 who	 undergo	 colorectal	 surgery;	 as	
anastomotic	leakage	is	associated	with	high	disability,	diminished	quality	of	life	and	
a	 potential	 worse	 oncological	 outcome6,7.	 In	 2008	 a	 study	 was	 published	 that	
describes	 how	 patients	 receiving	 a	 stoma	 after	 colorectal	 surgery	 had	 poorer	
quality	 of	 life,	 lower	 body	 image,	 poor	 social	 activity	 and	 also	 had	 significantly	
higher	depression	and	anxiety8.	All	 these	morbidities	can	be	explained	by	the	fact	
that	these	patients	face	problems	including	adapting	to	the	new	anatomy,	managing	
the	 stoma	 and	 continuing	 normal	 activities	 in	 their	 socio‐cultural	 environment.	
Also,	work	productivity	of	these	patients	decreases	significantly	due	to	the	level	of	
disability	related	to	multiple	abdominal	operations	or	presence	of	a	stoma.	Finally,	
anastomotic	 leakage	 itself	 has	 an	 adverse	 effect	 on	 postoperative	 health‐related	
quality	of	 life	when	 compared	 to	patients	 that	 also	 received	a	 stoma,	but	did	not	
develop	anastomotic	leakage	postoperatively9.		
Scientific	relevance	
As	stated	in	the	introduction	of	this	thesis,	unraveling	the	healing	process	of	bowel	
anastomosis	 and	 identifying	 local	 molecular	 and	 biochemical	 responses	 that	
disturb	healing	is	scientifically	relevant	in	itself.	In	depth	studies	into	this	topic	are	
essential	 in	 order	 to	 develop	 effective	 strategies	 and	 agents	 to	 combat	 healing	
disturbance	 and	 to	 prevent	 leakage.	 Knowledge	 gained	 on	 disturbed	 bowel	
anastomotic	 healing	 can	 be	 tested	 on	 other	 intestinal	 anastomoses,	 such	 as	
pancreatic	and	esophageal	anastomoses,	that	are	known	to	frequently	leak.	In	this	
thesis	 relative	 new	 techniques	 such	 as	 mass	 spectrometry	 were	 used	 in	 a	 pilot	
study	 and	 this	 study	 will	 be	 able	 to	 define	 the	 value	 of	 mass	 spectrometry	 in	
identifying	biochemical	processes	in	the	gut	wall.	This	may	reveal	data	relevant	for	
other	pathophysiological	processes,	such	as	cancer	development	and	inflammatory	
bowel	 disease	 and	 diverticulitis.	 In	 addition	 to	 new	 techniques,	 relatively	 new	
animal	models	were	used	to	investigate	leakage	prevention.		
Use	of	animal	models	
The	 studies	 performed	 during	 this	 PhD	 thesis	 focused	 on	 risk	 factors	 of	
anastomotic	leakage	on	the	one	hand	and	on	potential	preventive	interventions	on	
the	other	hand.	The	latter	was	extensively	studied	in	the	European	AnastomoSEAL	
project10.	 The	 AnastomoSEAL	 Consortium	 worked	 on	 the	 development	 of	 a	 new	
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product	 to	 prevent	 anastomotic	 leakage.	 AnastomoSEAL	 was	 produced	 as	 a	
biocompatible,	 resorbable	 sealant	 patch	 that	 was	 applied	 around	 the	 site	 of	
anastomosis;	 unfortunately	 this	 project	 did	 not	 reach	 its	 final	 goal,	 since	
experimental	studies	showed	unexpected	adverse	events.	The	use	of	animal	models	
during	 the	 development	 of	 new	 biomaterials	 for	 human	 use	 is	 irreplaceable	 and	
crucial	since	the	effect	of	biomaterials	in	vivo	are	a	complex,	dynamic	process	that	
sadly	cannot	be	investigated	in	vitro	yet.		
	
In	this	thesis	we	have	reached	consensus	on	animal	models	specifically	designed	
for	research	into	bowel	anastomoses	of	the	lower	gastrointestinal	tract	(Chapter	2).	
One	of	the	main	conclusions	was	that	rabbit	and	dog	models	should	be	abandoned	
in	 this	 type	 of	 research.	 Furthermore,	 more	 standardization	 can	 be	 reached	 by	
following	 the	 ARRIVE	 guidelines11.	 Experienced	 researchers	 in	 the	 field	 are	
convinced	that	this	provides	more	transparency	and	more	comparability	between	
studies.	 In	 addition,	 experts	 on	 intestinal	 anastomotic	 leak	 have	 held	 an	
International	 Summit	 (first	 in	 2012,	 recently	 in	 2016)	where	 the	majority	 of	 the	
respondents	 consider	 that	 current	 experimental	 animal	 models	 of	 anastomotic	
leakage	are	useful	 and	 should	 continue12.	However,	 they	also	advocate	 the	use	of	
human	 anastomotic	 tissues	 for	 more	 analytical	 research	 and	 promote	 clinical	
studies	to	define	and	characterize	the	biological	variables	that	are	associated	with	
anastomotic	healing	versus	 leakage.	The	REVEAL	study	 (started	Summer	2015	 in	
Maastricht)	 aims	 to	 establish	 and	 validate	 a	 diagnostic	 algorithm	 for	 the	 pre‐
operative	 prediction	 of	 AL	using	 a	 combination	of	 inflammatory,	 immune‐related	
and	genetic	parameters13.	With	the	results	from	the	REVEAL	study,	the	recognition	
of	 patients	 who	 are	 at	 risk	 for	 AL	 is	 expected	 to	 increase;	 subsequently	
recommendations	for	patients	at	risk	can	be	made	regarding	deviating	stomas	and	
possible	 preventive	 strategies.	 Lastly,	 the	 REVEAL	 study	 aims	 to	 develop	 an	
algorithm	 for	 post‐operative	 diagnosis	 of	 AL	 at	 an	 earlier	 stage,	 which	 will	
positively	reflect	on	short‐term	survival	rates.	
Perspective	on	knowledge	utilisation	
During	 the	 work	 for	 this	 thesis,	 collaboration	 with	 several	 national	 and	
international	 scientists	 has	 been	 established.	 These	 partnerships	 are	 crucial	 to	
accelerate	research,	improve	transparency	between	research	centres	(Rotterdam	&	
Nijmegen)	and	to	direct	cross‐fertilize,	which	 leads	 to	 innovation.	Furthermore,	 it	
can	 be	 considered	 irrational	 that	 in	 a	 relative	 small	 country	 as	 the	 Netherlands	
researchers	are	investigating	the	same	topics,	unintentionally	delaying	work	–	not	
to	 mention	 wasting	 time	 and	 money	 –	 that	 may	 lead	 to	 the	 solution	 of	 AL;	 an	
important	health	problem	that	is	too	extensive	to	be	studied	by	a	single	researcher.	
Therefore,	 the	 taskforce	 anastomotic	 leakage	 was	 re‐established	 (as	 part	 of	 the	
work	 group	 Coloproctology),	 with	 the	 purpose	 to	 provide	 more	 transparency	 in	
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current	 experimental	 research,	 national	 registration	 of	 patients	 with	 AL	 and	
increase	collaboration	regarding	the	conduction	of	clinical	studies14.	This	is	in	line	
with	one	of	the	aims	of	the	Dutch	Organization	for	Scientific	Research	(NWO):	that	
researchers	 should	 no	 longer	work	 against	 each	 other,	 back	 to	 back,	 but	 instead	
work	together,	side‐by‐side15.		
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Dankwoord	
Hoewel	ik	in	het	echte	leven	vol	enthousiasme	eindeloze	woorden	kan	spuien,	vind	
ik	 het	 op	 papier	 toch	 wat	 lastiger.	 Dit	 wil	 niet	 zeggen	 dat	 ik	 niet	 ontzettend	
dankbaar	ben	voor	alle	hulp,	steun	en	gezelligheid	die	ik	tijdens	mijn	promotie‐tijd	
heb	mogen	ontvangen.	Hopelijk	komt	het	met	weinig	woorden	toch	goed	over	en	zo	
niet,	dan	weet	je	het	wel	als	ik	je	persoonlijk	met	een	echte	knuffel	bedank!	
	
Allereerst	 natuurlijk	 mijn	 promotor	 en	 co‐promotor,	 ik	 had	 met	 geen	 ander	
team	dit	willen	meemaken….	
Prof.	 Bouvy,	 beste	Nicole,	 als	 jij	 niet	 m’n	 promotor	 was	 geweest	 had	 ik	
nooit	zo’n	leuke	tijd	gehad!	Altijd	welkom	om	even	binnen	te	lopen,	even	te	bellen,	
een	 smsje	 als	 het	 dringend	 is	 en	 een	what’s	 appje	 voor	 de	 leuke	 foto’s.	 Zelfs	 bij	
serieuze	onderzoeksbesprekingen	is	er	altijd	tijd	voor	een	grapje	en	ik	ken	niemand	
die	meer	geïnteresseerd	 is	 in	het	privéleven	van	alle	onderzoekers	en	assistenten	
dan	jij.	En	dan	te	bedenken	dat	het	waardevolste	wat	ik	heb	geleerd	van	jou	is	om	te	
weten	wanneer	je	je	mond	moet	houden	;)		
Ik	 hoop	 dat	 we	 in	 de	 toekomst	 nog	 veel	 zullen	 samenwerken	 en	 ben	 je	 erg	
dankbaar	voor	alle	mogelijkheden	die	je	me	hebt	gegeven	de	afgelopen	jaren!	
Dr.	 Derikx	 ofwel	 Professor	 Joep,	 ook	 al	 ben	 je	 dan	 officieel	 nog	 geen	
professor,	 aan	 je	 kennis,	 kunde	 en	 inzet	 zal	 het	 niet	 liggen.	 Jij	 bent	 de	 meest	
enthousiaste	dokter	die	ik	ken,	zowel	over	klinische	zaken	als	over	het	onderzoek.	
Het	 is	 inspirerend	 om	 te	 zien	 wat	 voor	 pretoogjes	 je	 krijgt	 als	 je	 me	 weer	 eens	
inlicht	over	je	meest	recente	plannen.	Het	is	een	eer	dat	je	een	rol	voor	mij	daarin	
ziet.	Ik	weet	zeker	dat	door	jouw	onderzoek	patiënten	betere	zorg	krijgen	en	dat	je	
nog	vele	jaren	succesvol	zult	zijn	in	alles	wat	je	doet!	Goed	dat	je	als	echte	Limbo	nu	
geniet	van	het	Amsterdamse		
	
De	 leden	 van	 mijn	 promotiecommissie,	 allereerst	 natuurlijk	 Prof.	 Stassen,	
bedankt	voor	het	vertrouwen	 in	zowel	mijn	wetenschappelijke	werk	als	klinische	
potentie.	Prof.	van	Goor,	dank	u	wel	voor	de	samenwerking,	aan	de	ideeën	zal	het	
niet	 liggen,	 jammer	 dat	 de	 tijd	 en	 moeite	 (nog)	 niet	 heeft	 geresulteerd	 in	 de	
financiële	boost	waar	we	op	gehoopt	hadden.	Dr.	Roumen	en	Dr.	Jonkers,	helaas	
nog	 niet	 veel	 intensief	 samengewerkt,	 maar	 daardoor	 kon	 u	 wel	 in	 de	
beoordelingscommissie	 plaatsnemen:	 heel	 veel	 dank	 voor	 het	 lezen	 en	 kritisch	
beoordelen	 van	 dit	 manuscript.	 Daarnaast	 in	 het	 bijzonder	 Steven,	 we	 hebben	
flinke	 discussies	 gehad,	 maar	 je	 regelt	 het	 allemaal	 toch	 maar!	 Dat	 het	 lab	 mag	
groeien	en	bloeien	tot	in	de	lengte	der	dagen…		
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Alle	 co‐auteurs	 die	 hun	 bijdrage	 hebben	 gelegen	 aan	 de	 artikelen	 in	 dit	
proefschrift	en	daarbuiten,	 jullie	 inbreng	heeft	zeker	bijgedragen	aan	de	kwaliteit	
ervan!	
	
Lieve	David,	Frans,	Irene‐Fleur,	Martine,	Kim,	Kiran	&	Junfang,	zonder	jullie	
als	 harde	 kern	 was	mijn	 promotietijd	 nooit	 zo	 gezellig	 geweest;	 van	 Thembi	 tot	
samen	wielrennen,	van	pubquizzen	tot	postprandiale	puzzelpauzes,	van	de	Efteling	
tot	eindeloze	etentjes.		Woorden	zijn	niet	genoeg	om	te	zeggen	hoeveel	ik	aan	jullie	
gehad	heb,	individueel,	met	aanhang	(Sophie	)	of	met	z’n	allen,	ik	ga	jullie	missen!	
	
0ddrie	 oftewel	Audrey,	we	 leerden	 elkaar	 snel	 kennen	 toen	 jij	mijn	 semi‐arts	
was	(en	we	 in	1	bed	sliepen;	dat	helpt	ook)	maar	had	geen	 fijnere	directe	collega	
kunnen	wensen!	Toch	duidelijk	te	zien	he,	als	je	in	de	horeca	gewerkt	hebt	;)	Weet	
zeker	dat	we	nog	veel	contact	gaan	houden	al	 is	het	maar	om	de	REVEAL	tot	een	
groot	succes	 te	maken!	Ga	zo	door,	dan	komt	het	vast	helemaal	goed	en	switchen	
mag	altijd	hoor,	oftalmologie	is	niet	eens	uit	te	spreken!		
	
Leo‐leooooooo	(iedereen	komt	als	je	Leo	roept),	Luukster,	medebrabo	van	me	
(alleen	de	rood‐witte	kleurencombi	is	mooi	aan	PSV)	en	Claire‐what’s‐up‐with‐the‐
hair:	 volgens	mij	 heb	 ik	 inmiddels	met	bijna	 iedereen	van	het	 lab	wel	 een	kamer	
gedeeld,	 maar	 gezien	 de	 jaloezie‐app	 –	 laten	 we	 in	 het	 midden	 houden	 wie	 nou	
wel/niet	jaloers	was	op	wie	–	en	het	feit	dat	jullie	bij	mijn	laatste	meest	stressvolle	
periode	waren	 (thanx	 voor	 alle	 printjes!)	 +	mijn	 chocolade/limo/	 koffievoorraad	
zonder	gene	leegroofden	‐	 	zie	ik	jullie	als	mn	ware	roomies:	weet	zeker	dat	jullie	
mij	gaan	missen!	Ik	jullie	natuurlijk	ook	en	we	gaan	elkaar	zeker	weer	in	de	kliniek	
tegenkomen,	hėnnige	spoesjkoppen!	
	
Selwynovitch,	van	Rijn,	ga	je	lekkah?	Even	bakkie	doen	binnenkort	als	je	niet	te	
drukdrukdruk	bent?	Weet	zeker	dat	 je	harde	werken	je	gaat	brengen	waar	 je	wilt	
zijn!	
	
Kostanjos,	gekke	irritante	vent	die	je	bent,	wie	houdt	er	niet	van	jou?	Bedankt	
voor	 de	 supervisie	 tijdens	 m’n	 semistage,	 het	 zwart‐op‐wit	 zetten	 van	 mijn	
bekendste	uitspraak	en	de	serieuze	en	vooral	ook	niet‐serieuze	dingen	die	ik	van	je	
geleerd	heb	en	nog	steeds	leer,	tot	snel	he!	
	
Dirkster,	 ben	 jou	 en	 Kostan	 nog	 steeds	 dankbaar	 dat	 jullie	 me	 in	 de	 kelder	
hebben	achtergelaten	hoewel	ik	destijds	alleen	maar	kon	huilen	dat	ik	in	mn	uppie	
met	die	knaagdieren	zat.	De	enige	manier	om	 iets	 te	 leren	 is	om	het	zelf	 te	doen,	
daar	heb	je	helemaal	gelijk	 in,	maar	een	experiment	door	 jou	te	 laten	voordoen	is	
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een	 goede	 2e!	 Hoop	 dat	 jouw	 nauwkeurigheid	 je	 binnen	 de	 chirurgie	 tot	 grote	
hoogtes	brengt.		
	
Dennis	met	je	vieze	praatjes,	Inca	met	je	vieze	praatjes	–	stoer	van	buiten,	lief	
van	 binnen	 ;)	 Later	 tijdens	 ons	 gezamenlijk	 ANIOSsen	 werd	 dat	 meer	 dan	 eens	
duidelijk!	 Ben	 trots	 op	 je	 dat	 je	 je	 hart	 gevolgd	 hebt	 en	 als	 ik	 niet	 uit	 iets	
microscopisch	kom	ben	 jij	de	1e	die	 ik	bel!	Mo	met	de	bulderlach	–	altijd	 leuk	om	
die	 te	 horen,	Bas	 –	 “het	 ligt	 echt	 niet	 aan	mij!”	 Goeie	 gesprekken	waren	 dat	 ;)	 –	
Annemarie	ELISA‐queen,	jullie	als	‘oude	poep’	met	de	vroege	lunch	hebben	mij	als	
guppie	op	het	 lab	geadopteerd	en	waren	nooit	de	moeilijkste	als	 ik	weer	eens	om	
hulp	kwam	vragen.	Bedankt	daarvoor..	hoewel	ik	bepaalde	‘woorden	van	de	week’	
liever	niet	had	leren	kennen!	
	
Sander,	 verenigd	 door	 onze	 voorliefde	 voor	 mucus	 en	 lekker	 weer,	 bedankt	
voor	alle	tips	en	tricks	zowel	qua	onderzoek	als	bij	de	gezelschapsspellen.		
	
Kaatje,	 ik	waardeer	 al	 je	hulp	 en	 adviezen	die	 je	 lang	niet	had	hoeven	geven,	
bedankt	dat	je	zo	behulpzaam	bent	geweest,	volgende	x	als	we	samen	fietsen	zal	ik	
je	niet	meer	zo	laten	schrikken,	beloofd!		
	 	
Ruben,	Kevin	&	Marc:	jullie	hebben	mij	geïnspireerd	als	voorgangers,	bedankt	
voor	de	samenwerking,	sorry	voor	al	het	gespam	per	mail	en	whatsapp!		
	
Marion,	bedankt	dat	 je	me	wegwijs	hebt	gemaakt	 in	het	microscopisch	scoren	
van	darmnaden,	altijd	fijn	om	samen	een	beetje	te	kletsen	met	drop	en/of	taart.	
	
Het	 leuke	 aan	 een	 groot	 lab	 is	 dat	 je	 met	 heel	 veel	 verschillende	 mensen	
samenwerkt	 en	 dus	 ook	 veel	 verschillende	 dingen	 kan	 delen..	 in	 willekeurige	
volgorde:	Lieve	Lori	 fijn	dat	als	we	samen	eten	er	ook	echt	gekletst	en	geluisterd	
wordt,	let’s	keep	it	up,	maar	dat	gaat	helemaal	goedkomen	nu	we	herenigd	zijn	en	
de	 aankomende	 6	 jaar	 alle	 cursussen	 samen	 gaan	 volgen,	 ons	 vol	 storten	 in	 de	
opleiding	en	nog	veel	WBS’sen	onveilig	gaan	maken	met	onze	dansmoves!		
Lieve	 Briete	 &	 Yvonne,	 mn	 favo	 Uns40	 ladies,	 altijd	 fijn	 om	 even	 langs	 te	
huppelen	 bij	 jullie,	 even	 goed	 te	 kletsen	 over	 het	 leven	 en	 te	 dromen	 over	 de	
toekomst.	 Jasper	&	Tim,	 jammer	maar	misschien	 ook	 wel	 beter	 dat	 jullie	 apart	
zaten	al	die	 tijd	 ;)	Vic	 ik	ga	 je	nooit	Billy	noemen,	hoop	dat	het	goed	met	 je	blijft	
gaan	op	alle	vlakken!	Charlotte	–	altijd	het	goede	voorbeeld,	ook	nu	 in	de	kliniek	
als	mijn	mentor	;)	Altijd	mijn	go‐to‐girl	als	ik	vragen	heb	over	wat	dan	ook	en	dan	
ook	 nog	 gezellige	 eetsessies	 erbij!	 	 Givan,	 zullen	 we	 samen	 prijzen	 winnen	
voortzetten	en	vertalen	naar	goede	CASH	en	ABSITE‐scores?	 JM	 (bootypopping!),	
Liliane	 (mooi	 he,	 Afrikaanse	 billen),	Toine,	Rutger	&	RJ	 (in	 1	 adem),	Thiemo,	
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Britt,	Kirsten,	 Evelien,	Milou	 (nu	 weer	 collega’s!	),	Rianne	B,	Timme,	 Paul,	
Niek,	 Robert,	 Martijn,	 en	 de	 nieuwe	 garde:	 Jacqueline,	 Marissa,	 Rianne	 V,	
Mirjam	en	Liyanne:	succes	en	geniet	ervan!	
	
Dear	Nina,	Tiff,	Jo,	Berta	&	Shane,	together	with	Ron	you	came	with	the	entire	
lab	 from	Amsterdam	to	work	at	M4I,	what	a	move!	 I’m	sure	 there’s	so	much	cool	
stuff	resulting	from	your	experiments	and	I’m	happy	we	could	put	some	early	data	
in	this	thesis!	
	
Alle	mensen	van	het	CPV:	 bedankt	 voor	 de	 hulp	 beneden	 tijdens	 de	 studies!	
Sorry	voor	al	die	keren	dat	ik	weer	eens	last‐minute	een	ruimte	wilde	reserveren	
	
Dear	Sweden‐people	(that’s	how	I	call	you),	especially	Gunnar,	Karin,	George	
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